ã€ãã³ã
ã€ãã³ããæ¢ã
æ¬æ¥éå¬ã®ã€ãã³ã
ææ¥éå¬ã®ã€ãã³ã
ã©ã³ãã³ã°
ã«ã¬ã³ããŒ
ãã¬ãžã³
ãã¬ãžã³ãèªã
ãã¬ãžã³
æè¡ããã°
æžç±
åç»
åç»ãèŠã
ã°ã«ãŒã
ã°ã«ãŒããæ¢ã
ã°ã«ãŒããäœã
ã€ãã³ããäœæã»ç®¡ç
åŠçã®æ¹ã¯ãã¡ã
ãã°ã€ã³
|
æ°èŠäŒå¡ç»é²
TOP
ã°ã«ãŒã
æ ªåŒäŒç€Ÿã¡ãã¬ãŒ
ããã°
ããã
ã€ãã³ã
ããã°
æ ªåŒäŒç€Ÿã¡ãã¬ãŒ ã®æè¡ããã°
å š1406ä»¶
2024/04/05
<![CDATA[ FY22 æ°åå ¥ç€Ÿãšã³ãžãã¢ã¯ãã® 1 幎ã§ã©ã®ãããªæé·ãããŠããã®ãã€ã³ã¿ãã¥ãŒããŸãã ]]>
ã¯ããã« ã¿ãªãããããã«ã¡ã¯ããšã³ãžãã¢ã®æ°å± ã§ããä»å㯠2022 幎æ°åå ¥ç€Ÿãããšã³ãžãã¢éã«ã€ã³ã¿ãã¥ãŒããèšäºããéãããŸãã ãã® 1 幎ã§åœŒããã©ã®ãããªæ¥åãçµéšããŠããã®ããããªã¢ã«ãªçŸåšã®ç«ã¡äœçœ®ãªã©ããäŒãããããšèããŠããŸãã ããã§ã¯ãã芧ãã ãã! èªå·±çŽ¹ä» é£¯ç°ãã ç ä¿®åŸã¯ ãžã§ãã¡ãã¬ãŒ ã§é¡§å®¢åãã®æ©èœéçºãæ åœããã®åŸ ã·ãŽããŒã¯ ã§ã€ã³ãã©é åãäžå¿ã«ãªãã¥ãŒã¢ã«ã«åŸäºãããçŸåšã¯ Jobley ã§æœçã®éçºãã€ã³ãã©åšããŸã§å¹ åºãæ¥åãæ åœã 飯ç°ãã 岡ç°ãã ç ä¿®åŸã¯ãžã§ãã¡ãã¬ãŒã§ã®éçºæ¥åãæ åœåŸãã·ãŽããŒã¯ãžããžã§ãã¡ãã¬ãŒãšã®é£æºåŒ·åã®ãããžã§ã¯ããªã©çµéšããçŸåšã¯ã·ãŽããŒã¯ã®éçºå šè¬ãæ åœã 岡ç°ãã 埳氞ãã ç ä¿®åŸã¯ ãžã§ãã¡ãã¬ãŒã¢ã«ãã㌠ã«é å±ããããã¯ãæ¹åãªã©ãæ åœãã€ã€ãçŽè¿ã§ã¯çæ AI ã䜿ã£ãæ©èœã®éçºãããã¯ãšã³ãããã¢ãã€ã«ãŸã§å¹ åºãéçºã«åŸäºã 埳氞ãã å€å·ãã ç ä¿®åŸã¯ Pharms ã«é å±ãããã³ããšã³ãããã€ã³ãã©ãŸã§å¹ åºãæ åœãå°èŠæš¡æœçã®éçºã«å§ãŸãçŸåšã¯äžèŠæš¡æœçã®ãããžã§ã¯ããªãŒããããªããéçºãè¡ãªãã å€å·ãã æäžãã ç ä¿®åŸã¯ CLINICS ã«é å±ãé»åã«ã«ãé¢é£ã®éçºãçµãŠãçŸåšã¯äžèŠæš¡æœçã®ãããžã§ã¯ããªãŒããããªããéçºãè¡ãªãã æäžãã å岡ãã ç ä¿®åŸã¯ æ£è ã¢ã㪠CLINICS ã«é å±ãWeb ã¢ããªãšãã€ãã£ãã¢ããªã®æ©èœéçºãæ åœããåŸãCLINICS ã«é å±ãçŸåšã¯å®åžžæ¹åããããã³ããšã³ãã®å€§èŠæš¡æ¹ä¿®ãªã©ã«åŸäºã å岡ãã ãã¡ãŒã¹ããã£ãªã¢ãšããŠã¡ãã¬ãŒãéžãã çç±ã«ã€ã㊠ââ ãŸãã¯ãã¡ãŒã¹ããã£ãªã¢ã«ã¡ãã¬ãŒãžå ¥ç€Ÿã決ããçç±ãã䌺ãããŠãããããšæããŸãã é£¯ç° : å ã ãã³ãã£ãŒæ°è³ªãé«ãããšã軞ã«äŒç€Ÿéžã³ãããŠããŸãããæ°åå ¥ç€Ÿã®ç€Ÿå¡ã倿°ãããããªèŠæš¡ã倧ããäŒç€Ÿã ãšãèªåããã®äžã«åãããŠããŸããèªç±åºŠãé«ãåããã§ããªãããã ãšèããŠããããã§ããã¡ãã¬ãŒã¯æ°åãå°ãªãã®ã§ãã®èŸºãã¯ãããããŠããŸãããå»çãšããé åã«é¢ããŠãã æ¥åžžç掻ã«é¢ãããšããã§ç€ŸäŒã«è²¢ç®ã§ãããããªé åãè¯ããªãšèããŠããããšããå®¶æãçè·åž«ããã£ãŠããããšãããå»çæ¥çã®èª²é¡ã身è¿ã«æããããå»çã«å¯ŸããŠèå³ããã£ã ããšãçç±ã«ãªã£ãŠããŸãã å²¡ç° : èªåã®äœèª¿ãæªããªãããšãæããå€ãã£ããããã«ã¹ã±ã¢æ¥çã«èå³ããã£ãã®ã§ãããããã«è¿ãæ¥çã ã£ãã®ãã²ãšã€ã®çç±ã§ãããŸãäŒç€Ÿã®ããã·ã§ã³ããšãŠãåãããããã£ããšããã®ããããŸããä»ç€Ÿã«æ¯ã¹ãŠãã¡ãã¬ãŒã¯ äžã®äžãè¯ãããŠããšããäŒç€Ÿã®ããžã§ã³ã«ãã¡ãããšåºã¥ããŠãããã¯ããéçºããŠãã ãã ãªãšããã®ãå ·äœçã«åãã£ãŠäžè²«æ§ãæããããã®ã倧ããã§ãã ä»ã«ã¯ãããšã³ãžãã¢ããšããè·çš®ã ãšãã¡ããæè¡åéãå°éé åã«ãªã£ãŠããããã§ããããã®é åã«éããããããã¯ããäžå¿ã«èª²é¡è§£æ±ºããäžã§ãšã³ãžãã¢ãªã³ã°ä»¥å€ã®ããšãèããªããéçºãããŠãããããã¯ããã¡ãŒã¹ããªèããé åçã§ããã 埳氞 : èªåã¯å²¡ç°ããã®ããã«ç¹ã«ãã«ã¹ã±ã¢é åã«èå³ããã£ããšããããšã¯ãªãã£ããã§ããã©ã¡ãããšãããšã ãšã³ãžãã¢ãšããŠããããåããŠããäžã§èªåã倧åã«ãããå¿åã䟡å€èгãšããã®ããã¡ãã¬ãŒã®ãšã³ãžãã¢ã®æ¹éãšè©±ãããŠããäžã§ããããã ãªãšæããã®ã倧ããã§ãã ãããŸã§ãè²ã ãªäŒç€Ÿãããšã®éžèãããŠãããã§ãããã¡ãã¬ãŒã®ãšã³ãžãã¢ã¯ãæ¬è³ªãè¿œãæ±ããããšããå§¿å¢ã®å ããšã³ãžãã¢ãªã³ã°ã奜ãã§ãããããããã¯ããžéå ããŠãããšããéšåãèªåã®ãã£ãŒãªã³ã°ã«ãã£ããšããæãã§ããã ââ ãã£ãŒãªã³ã°ã«åã£ããšããããšã§ãããä»ã«ãããããããšæã£ãéšåã¯ãããŸããã? 埳氞 : ãšã³ãžãã¢ã®é°å²æ°ãå€§äººãªæãã®æ¹ãå€ããäœè²äŒç³»ã®ãæ°åãšæ ¹æ§ã§é 匵ãããšããé²ãæ¹ã§ã¯ãªããåççã«ç©äºãé²ããããã«å¿ èŠãªã³ãã¥ãã±ãŒã·ã§ã³ããã¡ããšåã£ãŠãããšãããªã©ãé åã§ãããããããéšåãå«ããŠèªåãåããŠããå°æ¥ãšããã®ãæ³åã§ããŸããã å€å· : èªåã¯èŠªãè¬å€åž«ã§å»çåéã«å ã èå³ããããå»ç x IT ãšãã軞ã§å°±æŽ»ãããŠããéçšã§ã¡ãã¬ãŒãç¥ã£ãã®ãæåã®åºäŒãã§ãããã話ãèããŠãããã¡ã«ã課é¡è§£æ±ºã®ããã®ãããã¯ãäœãããšããç¹ãéåžžã«é åã«æããŸããã瀟äŒãè¯ãããããã«ãããã¯ããè¯ãããŠããããšããå§¿å¢ã§äŒç€Ÿã«äžäœæãçãŸããŠããã®ãããããè¯ããªãšã äŒç€Ÿã«éããªããããããªãã§ãããçµç¹ã人ãå€ããªã£ãŠãããšãã£ã±ãæ¹åæ§ãå°ããã€ãºã¬ãŠãããšããæãã«ãªããã¡ã ãšæããã§ãããã¡ãã¬ãŒã®å Žå㯠äŒç€ŸãšããŠãå»çæ¥çããã£ãšè¯ãããŠããããã®äºæ¥ãããŠããããšãã軞ãéã£ãŠãã ã®ãæããŠãæçµçã«ã¯ãã®éšåã«æ¹ãããŠå ¥ç€Ÿã決ããŸããã ããšã¯ãäžå ŽäŒæ¥ãšãããå®å¿æãããã¡ãŒã¹ããã£ãªã¢ã®éžæã«åœ±é¿ããŸããã å²¡ç° : èªåãæ°åå ¥ç€Ÿã®ç€Ÿå¡ç®ç·ã ãšãå ¥ç€ŸããäŒç€Ÿã®å®å®æãšããã®ã¯éèŠã ãšæã£ãŠããŸããã æäž : 就掻ããåã¯ç¹å®ã®æ¥çã«éããè²ã ãªäŒç€ŸãèŠãŠããŸãããåŠçæä»£ã«æ§ã ãªæ¥çã®ãšã³ãžãã¢ã€ã³ã¿ãŒã³ãã¢ã«ãã€ããªã©ããŠããã®ã§ããããã®éçšã§ããã£ããæ£ç€Ÿå¡ã§åããªãããã瀟äŒçæçŸ©ãããäºæ¥ãããã¹ãã ãªããšæããŸãããããããæèã§å°±æŽ»ã«èšãã§ èªåãèå³ãæã£ãŠåãçµããããªã®ã¯å»çæ¥çã ãªãšæã£ã ã®ãæåã®ãã£ããã§ããã ã¡ãã¬ãŒã¯éžèã®äžã§ãæè¡é åãåããã«éçºã§ããããšãªã©ãããããããšæããã®ãšããµãŒãã¹ãå»çæ©é¢ã ãã§ãªãæ£è åŽãå å®ããŠãããšããããšãå ¥ç€Ÿã®æ±ºãæã«ãªããŸãããèªåãæ£è ã«ãªãããšãå€ãã®ã§ããšãŠã課é¡ãåãããããã£ããã§ãã å岡 : èªåãå ã ãšã³ã¿ã¡ãªã©ã®é åãããå»çãæè²ãéèé åãäžå¿ã«å°±æŽ»ãããŠããŸãããäžã§ãã¡ãã¬ãŒã®ãå»çãã«ã¹ã±ã¢ã®æªæ¥ãã€ããããšããããã·ã§ã³ãžã®èªåã®å ±æåºŠãéåžžã«é«ãã£ãã®ããå ¥ç€Ÿã®çç±ã§ãããæ¥æ¬ã®å»çå¶åºŠããã¡ããšç¶æããããã®ãããã¯ããäœã£ãŠãããã ãšããå§¿å¢ãéåžžã«è¯ãã£ãã§ãã ãŸãããã»ã©ã®è©±ã«ãåºãŠããŸãããã å»çæ©é¢ã®ããã®ãããã¯ããšæ£è ã®ããã®ãããã¯ããšããäž¡é¢ãžã®ã¢ãããŒããããŠãã ã®ã決ãæã§ããããã¯ãå»çè²»ã®åé¡ãªã©ã¯å»çæ©é¢ã ããžã®ã¢ãããŒãã§ã¯è§£æ±ºã§ããªããšæãã®ã§ãããããæå³ã§ãäžè²«æ§ãæããããŠè¯ãã£ãã§ãã çŸåšã®ããŒã å ã§ã®åœ¹å²ã«ã€ã㊠ââ ã§ã¯æ¬¡ã«çŸåšã®ããŒã ã§ã®çããã®åœ¹å²ãåãæ¹ãããŒã ã¡ã³ããŒãšã®é¢ããæ¹ã«ã€ããŠèããŠãããããšæããŸãã é£¯ç° : çŸåš Jobley ã®éçºããŒã ã§ã¯ãšã³ãžãã¢ã 4 人ããã®ã§ããããã®å 2 人ããããã¯ãæœçã®ç«æ¡ãè¡ãªãã€ã€ãèªåãå«ãæ®ãã® 2 人ãå®è£ ãã¡ã€ã³ã«ããŠéçºãè¡ãªã£ãŠããŸããç¶æ³ã«åãã PM å Œä»»ã®ãšã³ãžãã¢ãšå®è£ æ åœã®ãšã³ãžãã¢ãšã§äºäººäžèã§éçºãããããåç¬ã§ã®éçºãè¡ãªã£ãããšæè»ã«å¯Ÿå¿ããŠãã£ãŠãŸãã ããŒã ã¡ã³ããŒãšã®é¢ãããšããç¹ã§ã¯ã ãšã³ãžãã¢ããŒã ã ãã§éçºãããšããããšã¯ãªããã»ãŒã«ã¹ãã«ã¹ã¿ããŒãµã¯ã»ã¹ã®æ¹ãã¡ãšäžç·ã«èŠä»¶ãè©°ããŠãã ããšãæè¿ã¯å€ãã§ãããã®ããã»ãŒã«ã¹ã®æ¥åãããŒãªã©ããã£ããã¢ããããå¿ èŠãããã®ã§å€§å€ã§ãããé¢çœããããããæãããšããã§ããããŸããã å²¡ç° : ã·ãŽããŒã¯ã§ã¯ãPM ãšãšã³ãžãã¢ã®äºäººäžèãšããäœå¶ã§éçºãããŠããŸããPM ãšæ¥ã èŠä»¶ãå·ãåãããªãããå®è£ ã¯èªåãè¡ãªã£ãŠããŠãããšããã¹ã¿ã€ã«ã§ããPull Request ã®ã¬ãã¥ãŒã ãã¯å ã ã·ãŽããŒã¯ãéçºãããŠãããšã³ãžãã¢ã®æ¹ã ã«ãé¡ãããŠããŸãã ãŸããäŸãã°ãããã¯ãã®ã»ãã¥ãªãã£åŒ·åã®åãçµã¿ãã¢ããªã®èªèšŒæ©èœã®äžæ°ãQA ç°å¢ã®æŽåãªã©ãèªåãæ®æ®µè§Šããªãé åã®æœçãè¡ã£ãéã¯ã¹ãã«ã¢ããã宿ã§ããŸãããã©ã€ãã©ãªã®ã¢ããããŒããããªãã¡ã¯ã¿ãªã³ã°ãªã©ã è£éãæã£ãŠããããŠããã£ãŠããŸã ã 埳氞 : ãžã§ãã¡ãã¬ãŒã¢ã«ãããŒã¯ãžã§ãã¡ãã¬ãŒã CLINICS ã«æ¯ã¹ããšå°èŠæš¡ãªããŒã æ§æãšãªã£ãŠããŸãããšã³ãžãã¢ã 7 人ãPM ã 3 人ããããã¯ããªãŒããŒã 1 人ãšããäœå¶ã§éçºãããŠãã®ã§ããã è¯ãæå³ã§æ°åå ¥ç€Ÿãšã³ãžãã¢ãšããŠè£éãæã£ãŠéçºããããŠããã£ãŠããŸã ã éçºããŒã ãåŸã ã«å€§ãããªã£ãŠããã®ã§ãã¿ã¹ã¯ãäžæãåãããã®ä»çµã¿ãèããããããŒã ãäžæãæ©èœãããããã«æäŒã®æ§æã倿ŽããŠã¿ãããæè¡çãªéšåã§ã¯ CI/CD ãªã©éçºå šäœã«é¢ããåéã«ã€ããŠããä»»ããŠããã£ãŠããŸãã ãŸã ãã¥ãŒã¹ãªãªãŒã¹ ã«ããªããŸãããã瀟å ã§åããŠã® çæ AI ã䜿ã£ãæ©èœã®éçº ã¯ããããã¯ããªãŒããŒãšèªåã® 2 人ãäžå¿ã«ãªã£ãŠé²ããŠãããŸããã éçºã«å ¥ãåæ®µéã§ããžã«ã«ã«ããããã£ã課é¡ããã®æ©èœã§è§£æ±ºããŠããããšããããšãäŒããããã°ãããçšåºŠæè¡çã«å®éšçãªãã®ãå°å ¥ããããšãã§ããç°å¢ã§ã ã å€å· : Pharms ã§ã¯çŸåšãšã³ãžãã¢ã 4 人ãPM 1 人ããã¶ã€ããŒã 1 人ãšããã®ãäžå¿ã¡ã³ããŒãšãªã£ãŠããŸããPharms ã¯çŸåšè²ã ãšæ©èœæ¡å€§ãããŠãã£ãŠããã®ã§ããããšã³ãžãã¢ã 4 人ãªã®ã§æ¬åœã«å šå¡ã§äœã§ããã£ãŠãããšããæãã§éçºããŠããŸãããšã¯ãããã¡ã³ããŒåã ã§åŸæåéã¯éãã®ã§ãåŸæãªãšããã¯ç©æ¥µçã«æŸãã«è¡ãæãã§ãã èªåã¯ãšèšããšãåŸæåéã®ã€ã³ãã©éšåã«é¢ããŠã¯ã»ãšãã©ä»»ããŠããã£ãŠãããèªåããã®çºä¿¡ã§å 茩ã®ããã¯ãªãŒããšã³ãžãã¢ã®æ¹ãšããåããããªããè²ã ãªæœçãè¡ãªã£ãŠããŸãããã®ä»ã«ãã¯ã©ãŒã¿ãŒæ¯ã«æ°åã¯äžã»å€§èŠæš¡ãªæœçãèšç»ãããã®ã§ããããããã®ã®ããã€ãã®ãªãŒãããããŠããã£ããããŠããŸããã§ãã®ã§ã ã¢ããªã±ãŒã·ã§ã³ã®éçºãšããé¢ã§ããããžã§ã¯ããäžæãé²è¡ããããšããé¢ã§ãããšãŠã楜ããæ¥åãããŠããŸã ã æäž : CLINICS ã§ã¯ãŸããåºå¹¹ããšãåšèŸºããšãã£ãã 2 ã€ã®ããŒã ã«åãããŠããããåºå¹¹ããäž»ã«ã¬ã»ã³ã³(ã¬ã»ããã³ã³ãã¥ãŒã¿ã®ç¥ãå»çæœèšããå¥åº·ä¿éºçµåãªã©ã®æ¯æãæ©é¢ã«å¯Ÿãã蚺çå ±é ¬ãè«æ±ããããã«ãé»åã«ã«ããšé£åããŠã¬ã»ãããšåŒã°ãã蚺çå ±é ¬æçްæžãäœæããã·ã¹ãã )ãšã®ãããšããããåšèŸºãã§ã¯äºçŽãå蚺ãè³æ Œç¢ºèªãªã© CLINICS ãšæ£è ãšã®æ¥ç¹ãšãªãã·ã¹ãã ããšããåœ¢ã§æ åœæ¥åãåãããŠããŸããèªåã¯ãã£ãšåºå¹¹ããŒã ã«ã¢ãµã€ã³ãããŠããŸããããŒã å šå¯Ÿå¿ã®ãšã³ãžãã¢ã®å èš³ã¯ã¢ããªã±ãŒã·ã§ã³æ åœã 6~7 人ãã€ã³ãã©æ åœã 3 人ã»ã©ã«ãªã£ãŠããŸãã çŸåšã¯å€§ããªãããžã§ã¯ãã 1 ã€é²è¡ããŠããŠãæ¢åã®ã¬ã»ã³ã³ãã¡ãã¬ãŒã§æ°èŠéçºããŠããã¬ã»ã³ã³ã«ç§»è¡ãããšãããã®ã§ããããã®äžã« äžèŠæš¡ãªãããžã§ã¯ããè€æ°å¹³è¡ããŠé²ãã§ããŠããã®å ã®ããã€ããèªåããªãŒã ãããŠããã£ãŠããŸãã ãªãŒãããŠãããããžã§ã¯ãã®é²è¡ç®¡çãããŒã ã¡ã³ããŒéã§ã®åé¡å ±ææ¹æ³ãªã©ãèããŠããã®ã§ããããã®èŸºãã¯ææŠã§ããå¹ ãåºããé£ããã§ããé¢çœããšæããŠããŸãã課é¡ã«ã€ããŠãããžã§ã¯ãã«éå®ãããä»ã®ã·ã¹ãã ãé²æç¶æ³ã«åœ±é¿ããªãããé æ ®ããå¿ èŠããããããããèŠç¹ã§é©åã«ç°ãªãç«å Žã®é¢ä¿è ãå·»ã蟌ãããšã§ãããå æ¬çãªè§£æ±ºçãå°ãåºãããšæèãããŠããŸãã å岡 : èªåã¯ä»ã¯æäžãšäžç·ã®ããŒã ã§æ¥åãããŠãããã§ãããã¬ã»ã³ã³ãªã©ã®éšåãšããããã¯ãå çšã®è©±ã®ãåšèŸºãã®éçºãããããšãå€ãã§ããåºæ¬çã«å¹³è¡ããŠè€æ°ã®ãããžã§ã¯ããèµ°ã£ãŠãããããããã®ãããžã§ã¯ãã§ãã£ã¬ã¯ã¿ãŒ 1 人ããšã³ãžãã¢æ°äººãä»ã«ãã¶ã€ããŒãšãã圢ã§é²ããŠããããšãå€ãã§ãã 倧ãŸãã«ãã£ã¬ã¯ã¿ãŒãèŠä»¶ãªã©ããŸãšãããã®ãããŒã¹ãšããŠããã®åŸã«ãã¶ã€ããŒããšã³ãžãã¢ãå ¥ã£ãŠèŠä»¶å®çŸ©ãªã©ãããŠãããåŸã ã«åœ¢ã«ããŠãããšããäºãå€ãã§ããã ââ ãäºäººã§çµãã§ä»äºãããããšããããã§ãã? æäž : ã¯ãããšãŠãå€ãã§ãã é²è¡ããŠãããããžã§ã¯ãã®ä»ã«ããå®åžžæ¹åããã°æ¹ä¿®ãªã©ã®ã¿ã¹ã¯ããããŸãããããããã¿ã¹ã¯ããã©ã®ã¿ã€ãã³ã°ã§ããã©ã®åªå 床ã§ã察å¿ããŠããããªã©ãããŒã å ã§è°è«ããŠãã宿œããã®ã§ã å岡 : ãããžã§ã¯ããããããã¿ã¹ã¯ãšã¯å¥ã«ããšã³ãžãã¢äž»å°ã§å€§èŠæš¡ãªãªãã¡ã¯ã¿ãªã³ã°ãªã©ãè¡ãªã£ãŠããŸããæ åœããŠãããããžã§ã¯ãã®ä»ã«ãããããã®ãæãããŠããŠãäžç·ã«ãªãããšãå€ãã§ãã å ¥ç€ŸããŠã¡ãã¬ãŒã®æåã匷ãæèããåºæ¥äº ââ ã¡ãã¬ãŒã§åããŠããäžã§ãç¹ã«æåã匷ãæãããšããœãŒããªã©èããŠã¿ããã§ãã é£¯ç° : éçºã«é¢ä¿ããäººå šå¡ãããããã¯ãå¿åã匷ãããšããããšã§ãããããå ·äœçã«ã¯ãéçºã®èŠä»¶å®çŸ©æ®µéããå šå¡é¢ããã®ã§ããã¡ããããžãã¹ãµã€ãã®æ¹ããããããããæ¹ãè¯ãã®ã§ã¯ãªããããšããã¢ã€ãã¢ã¯åºãŠããŸãããéçºãµã€ãããããã©ãããæ©èœãäžçªãŠãŒã¶ã«äŸ¡å€ãå±ãããããããšããèŠç¹ã§äžç·ã«ãªã£ãŠèãããã§ããããããã©ããã£ã課é¡ã解決ãããã®ãªã®ããšããåºç€ã®éšåããäžç·ã«èããŠããã®ãã¡ãã¬ãŒã§ã¯åœããåã«ãªã£ãŠãããšããæããããŸãã éçºãµã€ããããžãã¹ãµã€ããåãæ¹åãåããŠããã®ã§ãææ¡ãªã©ãã¡ãããšããžã«ã«ã§çãéã£ãŠãããã®ã§ããã°éããšããã®ã¯ããããæèŠãããããã ãšæããŸãããã®ããã®çžè«ãªãããããã¡ããããããã§ããããšãŠãè¯ãæåã ãªãšæããŠããŸãã å²¡ç° : éçºã«ããã£ãŠ PM ã æœçãªã©ã Issue ãšããŠç«ãŠãŠãããã®ã§ãããèšèªåãè¡ãå±ããŠããŠäœãåé¡ã§ãã©ãããŠå®æœããã®ãããã®åœ±é¿ãªããããããåããããããšããç¹ã¯ã¡ãã¬ãŒã倧äºã«ããŠãããããã¥ã¡ã³ãããªãã³ããšããæåãæããŸãã ãã®ãããªç°å¢ãªã®ã§ã倧æµã®ããšã¯æäœéã®æç« ã®ããåãã ãã§ã¹ã ãŒãºã«é²ã¿ãŸãããäžæããããªãç¶æ³ã«ãªã£ãŠãååŸçãªã©ãç«ãŠããããªã£ãŠãããšæããŸãã 埳氞 : ã¡ãã¬ãŒã¯æ°åå ¥ç€Ÿã®ç€Ÿå¡æ°ã¯å°ãªãã®ã§ãäžéå ¥ç€Ÿã®æ¹ãã»ãšãã©ãšããç°å¢ã§ããå ¥ç€ŸããŠããã¯ãèªåã®æèŠã¯éãã®ããªããšããèªåããåŸã«å ¥ç€Ÿããçµéšå¹Žæ°ãé·ãäžéå ¥ç€Ÿã®æ¹ãšã©ãä»ãåããããªã©ãå¿é ã§ãããã§ã ã¡ãã¬ãŒã§ã¯ã建èšçã«é²ããããšããæåãããã®ã§ãç«å Žã«é¢ä¿ãªãè°è«ã§ããç°å¢ãããã®ã§ããšãŠãä»äºããããã ã§ããèªåã®æèŠãäŸãééã£ãŠãããšããŠãè°è«ãèµ·ãããšããããšã¯ãèªèããºã¬ãŠãããšããããšã ãããšè»éä¿®æ£ãã§ããã®ã§æ¬åœã«åããããã§ãã ãŸãããšãŠãè¯ããªãšæã£ãã®ããéšçœ²ãè·çš®ã«é¢ããã Confluence ã®æ å ±ã«èª°ã§ãã¢ã¯ã»ã¹ã§ãããšããæåã§ãããç§å¿æ å ±ä»¥å€ã¯åºæ¬çã«å šãŠ Confluence ã§ãªãŒãã³ã«ãªã£ãŠãããããã§ãèªåãšã¯çŽæ¥é¢ä¿ãªãéšçœ²ã®çŸåšã®åããªã©ããã£ããã¢ããã§ããã®ã§ããããã£ã人ãã¡ãšã³ãã¥ãã±ãŒã·ã§ã³ãåããšãã«ããããå©ãããŸãã å€å· : 埳氞ãšãã¶ããšããããããã§ãããã建èšçã«é²ããããšããéšåã¯éåžžã«ã¡ãã¬ãŒããããæããæåã§ããäŸãã° PM ããæœçãããããŸãããããšãªã£ãŠããèªåãããã®ãããŒã£ãŠãããªã£ãæ¹ãè¯ãã§ãããããšããæèŠãèšãããããããèµ·ç¹ã« è°è«ã«çºå±ããŠããè¯ããã®ãäœã£ãŠããããšããã®ã¯æ¬åœã«çŽ æŽããã ãšæããŠããŸãã å®éã«èªåããªãŒãããŠããæœçã®äžã§ããšã³ãžãã¢ã» ãã¶ã€ããŒã» PM ã»ã«ã¹ã¿ããŒãµã¯ã»ã¹ãšããç«å Žãéãã¡ã³ããŒåå£«ã§æ¹ããŠè¬å±ã®æ¥åãããŒãæŽçããªãããŠãããè¯ã仿§ã«ã§ããããšããããšããããŸããã æ©èœãªãªãŒã¹åŸãã¡ãããšãããã¹ãå§¿ããç®æããŠæ¹åãã§ãããããã®ã§ãããããèãæ¹ã¯ãšãŠãä»äºãããããã§ãã æäž : èªåããã¯ãçµç¹æ°Žæºãé«ããããšããæåã«ã€ããŠèšåãããŠãã ãããèªåãé¢ãã£ãŠããé»åã«ã«ããã¬ã»ã³ã³ãšããé åã¯æ·±ãæ¥åç¥èãå¿ èŠã§ãåããŠé¢ãã£ã人ãããããšãããããã©ããããããŒã§æ©èœã䜿ãããŠããããšããç¹å®ã®å Žåã«äœã§ãããªããã ãããšãããšããããçè§£ãã¥ãããã§ããã§ããèªåã®ããŒã ã¯æ°åã»äžéåããããŸã æ·±ããã¡ã€ã³ç¥èããªãããšãã£ãç¶æ ããã§ãå ¥ã£ãп޻èºããããç°å¢ã ãšããã®ãæããŠããŸãã ãããªãå°éã®æ¥åç¥èãå¿ èŠãªéçºãšããã®ã¯ãã¯ãé£ããã®ã§ãããããéšåãšçŽæ¥ã¯é¢ä¿ããªãåšèŸºé åã®éçºããå§ããŠããã£ãŠãåŸã ã«é»åã«ã«ããã¬ã»ã³ã³ã«çŽæ¥é¢ä¿ããéçºã«å ¥ã£ãŠãããããããªãªã³ããŒãã£ã³ã°ãã§ããŠããŸããéçºã®äžã§ãããã¹ãå§¿ã«ã€ããŠè°è«ã«ãªã£ããã§è²ã ãªã¡ã³ããŒãšè©±ãããŠããã®ã§ã å»çæ¥åã®ãã£ããã¢ããã¯ããªãããããç°å¢ ã ãšæããŸãã ããã²ãšã€ãé·æã®ã«ã¹ã¿ããŒäŸ¡å€ã远æ±ããããšããéšåãæåãæããŠããŠãäž»ã«ãããŒãžã£ãŒãå«ããçæç㪠KPI ã«æ²¿ã£ãéçºããããé·æçã«é¡§å®¢ãžã®äŸ¡å€æäŸã«å¯äžã§ããéçºãåªå ããŠãããšããæèãéåžžã«åŒ·ãã®ãè¯ããšæããŸãã ç¹ã«ä»çŸåšã瀟å ã§éçºãé²ãã§ããæ°èŠã¬ã»ã³ã³ã®éçºã«ã€ããŠã¯åŒ·ãæããŸããã å岡 : èªåã匷ãæããŠããã¡ãã¬ãŒã®æåãšããŠã¯ãããã¥ã¡ã³ãããªãã³ãã§ããããŒãã£ã³ã°ãªã©ããããããããšã®çµè«ãåŸãããã«åè°ããããšããã®ãæç¢ºã«åããè³æãäºåã«çšæããŠè¡ããŸããã§ãã®ã§ããããäœã®æéã ã£ã?ãã¿ãããªç¶æ ã«ãªãã«ããã®ãè¯ãã§ãã ããšã¯ ããŒãã£ã³ã°ã«ããåæçãSlack ã Confluence ãªã©ã«ããéåæã®ã³ãã¥ãã±ãŒã·ã§ã³ã驿驿ã§å šå¡ã䜿ããããŠããã®ã§ãããããã³ãã¥ãã±ãŒã·ã§ã³ã§ç¡é§ãªè¡ãéãã®ãããªãã®ããã»ãšãã©ç¡ã ã®ããä»äºããããããšæã£ãŠããŸãã ããã²ãšã€ã¯ãèªåããã¯ããããã¯ãå¿åã®åŒ·ããšãããšãããæããŠããŸããçŸåšã¯ãã£ã¬ã¯ã¿ãŒãªã©ãšäžç·ã«éçºãããŠããäœå¶ã«ãªã£ãŠãããã§ãããUI ã顧客äœéšãªã©ãå«ããŠãšã³ãžãã¢ã§ããã¡ãããšãããã¯ããšããŠã®çæ³ã®å§¿ãèããŠéçºãããšããå§¿å¢ããšãŠã匷ãã§ããèªåã®å°éã§ã¯ãªãé åã§ããã¡ããšèããªããéçºãããŠããã®ã§ãããããããããŸãã ããããã¡ãã¬ãŒã«å ¥ç€Ÿããæ¹ãžã®ã¡ãã»ãŒãž ââ ã§ã¯æåŸã«ãªããŸãããç¹ã«æ°åã§ã¡ãã¬ãŒã®å ¥ç€ŸãèããŠããæ¹ãžã®ã¡ãã»ãŒãžãªã©ããã°ãã䌺ããããã§ãã é£¯ç° : ããã§ããããå èŒ©ãæ°åã«å¯ŸããŠãšãŠãæåŸ ããŠãããŠããããšããã®ã¯äŒããããšæããŸããèªåã®å Žåãç ä¿®ãçµãã£ãŠ 3 ã¶æçµã£ããããã§ãã·ãŽããŒã¯ã®ã€ã³ãã©ç°å¢ãå šéšå·æ°ãããšãã倧ããªãããžã§ã¯ãã®ãªãŒããä»»ããŠãããããã§ãããã¡ãã SRE ã®å 茩ãªã©ãšååãã€ã€é²ãããã®ã ã£ããã§ããã ç ä¿®çµãã£ãŠããã«ãããªå€§ããªãããžã§ã¯ããè£éæã£ãŠé²ãããããããªç°å¢ãªã®ã§ããããããããããããŸã ã å²¡ç° : çš²æ¬(人æãã©ãããã©ãŒã CTO)ããæ°åã ãããã¿ãããªæ¥ãæ¹ãããã«ããã¡ãšã³ãžãã¢ãšããŠæ¥ããŠãããŠããã®ã¯å人çã«å¬ãããã€ã³ãã§ãããŸã 責任ãæã£ãäžã§è£éæã£ãŠèªç±ã«åããŠãããæ¥åç°å¢ãããã®ãããããè¯ã ã§ããã¡ãããšãããã¯ãã®äºãèããŠéçºãããã人ã«ã¯ããããã§ããç°å¢ã ãšæããŸãã 埳氞 : æ°åã®è¯ããšããã¯ãåæãæãæãŠããšããããªãšæããŸããä»ãã©ã³ãçã§ãã®ã¡ã³ããŒãšæè¡çãªãšãããªã©ãæ°è»œã«çžè«ã§ããã®ã¯ãšãŠãè¯ãã§ãã åç£ç¢ç£šããŠããç°å¢ãããªãããªãšæã£ãŠããã®ã§ãããããç°å¢ãæ±ãããªããããè¯ã ãšæããŸãã å€å· : åã身ã§ä»äºãè¡ãã®ã§ã¯ãªããã¬ãã¬ããšèªåã®æ¹ããæ±ãã«ããå§¿å¢ã®äººã«ã¯ãããããããããäŒç€Ÿã ãšæããŸãããã£ããè£éæã£ãŠæ¥åãé²ããããšãã§ããç°å¢ãªã®ã§ã é æ ®ããã«ãããããšç©äºé²ããããšãã§ãã人ã«ã¯æé« ãªããããªãããšèããŠããŸãã èªåã¯ã€ã³ãã©ã ãã§ã¯ãªããŠããµãŒããããã³ããšã³ããéçºããŠãããããšèããŠãããã§ãããå°èŠæš¡ãªãããžã§ã¯ãã§ããã°å šãŠè¡ããç°å¢ãªãããèªåäžäººã§ãããžã§ã¯ããå®çµããããšãã§ããã®ã¯ãæ§ã«åã£ãŠãããªãšæã£ãŠãŸããåšãã®ãµããŒããå 茩ãšã®å£æã¡ãªã©ã¯ã¡ãããšãã£ãŠããããã®ã§ããšãŠãå匷ã«ãªãæé·ã§ãããšæããŸãã æäž : ã¡ãã¬ãŒã§éçºãããŠããã«ã€ãããŠãå»çãã¡ã€ã³ãšããé åã§èªåãé¢ãã£ãŠããããšã人ã®åœ¹ã«ç«ã£ãŠãããã ãªãšããã®ãæ¥ã 宿ã§ãããšããã¯è¯ãã§ããç¹ã«è²ã ãªå»çæ©é¢ã®ãµããŒããã§ãããšãããããã¯ãã«é¢ãã£ãŠããã®ã§ãçŽæ¥å»çæ©é¢ããã®å ã«ããæ£è ãã㮠圹ã«ç«ã£ãŠãããšãã宿ã¯ãæ£çŽ 1 幎ç®ã§æãããããã®ã§ã¯ãªããšæã£ãŠããã®ã§ãè¯ãé©ã ã§ãã ãŸã倧ããããŒã¿ãåãæ±ããšããçµéšãã§ããŠããã®ã貎éã ãªãšæããŠããŸããçŸåšã®ãããã¯ãã§ã¯å¥çŽå»çæ©é¢ãéåžžã«å€ãã§ããããã®å€§éã®ããŒã¿ã®èšèšã倿Žããããšãããšããããè£éæã£ãŠå®æœã§ããã®ã¯è¯ãçµéšã«ãªã£ãŠããŸãã å岡 : ã¡ãã¬ãŒã®ããããã¯ãå¿åããæã£ãŠããå 茩ãšã³ãžãã¢ãšåãããšããã®ã¯ãšãŠãè¯ãçµéšã ãšæã£ãŠããŸããäžè¬çã«ã¯ãšã³ãžãã¢ã¯æè¡ããããã°ãšããæãã«ãªããããã£ãããããšæãã®ã§ãããã¡ãã¬ãŒã§ã¯ãã¡ããæ°ããæè¡ãªã©ã䜿ããªãããããã ããã«ãããã¯ãããã®å ã®ãŠãŒã¶ãžã®äŸ¡å€æäŸã«ç¹ããããèããŠããæ¹ãéã£ãŠãã ã®ã§ãããããæèã§ãããã¯ãéçºãã§ããŠããã®ã¯ãããå匷ã«ãªããŸãã ââ ããããšãããããŸãã! æ¬åœã« 1 幎ã§çãããæ¿ãæ¥åçµéšãç©ãã§ããã®ãåããã€ã³ã¿ãã¥ãŒã«ãªããŸããã ãããã« ããããç°ãªãããŒã ãæ¥åå 容ã§ãããæ°åãšã³ãžãã¢ã§ãè£éãæã£ãŠæ¥åã«èšããããšãããããã¯ãã®éèŠãªéšåã®éçºã«ã©ãã©ãé¢ãã£ãŠãããããšãäŒããã€ã³ã¿ãã¥ãŒãšãªããŸããã ã¡ãã¬ãŒã¯æ°åå ¥ç€Ÿã®ãšã³ãžãã¢ãç©æ¥µçã«åéããŠããŸãã®ã§ãä»åæ°ã«ãªã£ããšããæ¹ã¯ãæ°è»œã«ã«ãžã¥ã¢ã«é¢è«ãããŸããã! https://open.talentio.com/r/1/c/medley/pages/54863
æ ªåŒäŒç€Ÿã¡ãã¬ãŒ
2024/04/05
<![CDATA[ FY22 æ°åå ¥ç€Ÿãšã³ãžãã¢ã¯ãã® 1 幎ã§ã©ã®ãããªæé·ãããŠããã®ãã€ã³ã¿ãã¥ãŒããŸãã ]]>
ã¯ããã« ã¿ãªãããããã«ã¡ã¯ããšã³ãžãã¢ã®æ°å± ã§ããä»å㯠2022 幎æ°åå ¥ç€Ÿãããšã³ãžãã¢éã«ã€ã³ã¿ãã¥ãŒããèšäºããéãããŸãã ãã® 1 幎ã§åœŒããã©ã®ãããªæ¥åãçµéšããŠããã®ããããªã¢ã«ãªçŸåšã®ç«ã¡äœçœ®ãªã©ããäŒãããããšèããŠããŸãã ããã§ã¯ãã芧ãã ãã! èªå·±çŽ¹ä» é£¯ç°ãã ç ä¿®åŸã¯ ãžã§ãã¡ãã¬ãŒ ã§é¡§å®¢åãã®æ©èœéçºãæ åœããã®åŸ ã·ãŽããŒã¯ ã§ã€ã³ãã©é åãäžå¿ã«ãªãã¥ãŒã¢ã«ã«åŸäºãããçŸåšã¯ Jobley ã§æœçã®éçºãã€ã³ãã©åšããŸã§å¹ åºãæ¥åãæ åœã 飯ç°ãã 岡ç°ãã ç ä¿®åŸã¯ãžã§ãã¡ãã¬ãŒã§ã®éçºæ¥åãæ åœåŸãã·ãŽããŒã¯ãžããžã§ãã¡ãã¬ãŒãšã®é£æºåŒ·åã®ãããžã§ã¯ããªã©çµéšããçŸåšã¯ã·ãŽããŒã¯ã®éçºå šè¬ãæ åœã 岡ç°ãã 埳氞ãã ç ä¿®åŸã¯ ãžã§ãã¡ãã¬ãŒã¢ã«ãã㌠ã«é å±ããããã¯ãæ¹åãªã©ãæ åœãã€ã€ãçŽè¿ã§ã¯çæ AI ã䜿ã£ãæ©èœã®éçºãããã¯ãšã³ãããã¢ãã€ã«ãŸã§å¹ åºãéçºã«åŸäºã 埳氞ãã å€å·ãã ç ä¿®åŸã¯ Pharms ã«é å±ãããã³ããšã³ãããã€ã³ãã©ãŸã§å¹ åºãæ åœãå°èŠæš¡æœçã®éçºã«å§ãŸãçŸåšã¯äžèŠæš¡æœçã®ãããžã§ã¯ããªãŒããããªããéçºãè¡ãªãã å€å·ãã æäžãã ç ä¿®åŸã¯ CLINICS ã«é å±ãé»åã«ã«ãé¢é£ã®éçºãçµãŠãçŸåšã¯äžèŠæš¡æœçã®ãããžã§ã¯ããªãŒããããªããéçºãè¡ãªãã æäžãã å岡ãã ç ä¿®åŸã¯ æ£è ã¢ã㪠CLINICS ã«é å±ãWeb ã¢ããªãšãã€ãã£ãã¢ããªã®æ©èœéçºãæ åœããåŸãCLINICS ã«é å±ãçŸåšã¯å®åžžæ¹åããããã³ããšã³ãã®å€§èŠæš¡æ¹ä¿®ãªã©ã«åŸäºã å岡ãã ãã¡ãŒã¹ããã£ãªã¢ãšããŠã¡ãã¬ãŒãéžãã çç±ã«ã€ã㊠ââ ãŸãã¯ãã¡ãŒã¹ããã£ãªã¢ã«ã¡ãã¬ãŒãžå ¥ç€Ÿã決ããçç±ãã䌺ãããŠãããããšæããŸãã é£¯ç° : å ã ãã³ãã£ãŒæ°è³ªãé«ãããšã軞ã«äŒç€Ÿéžã³ãããŠããŸãããæ°åå ¥ç€Ÿã®ç€Ÿå¡ã倿°ãããããªèŠæš¡ã倧ããäŒç€Ÿã ãšãèªåããã®äžã«åãããŠããŸããèªç±åºŠãé«ãåããã§ããªãããã ãšèããŠããããã§ããã¡ãã¬ãŒã¯æ°åãå°ãªãã®ã§ãã®èŸºãã¯ãããããŠããŸãããå»çãšããé åã«é¢ããŠãã æ¥åžžç掻ã«é¢ãããšããã§ç€ŸäŒã«è²¢ç®ã§ãããããªé åãè¯ããªãšèããŠããããšããå®¶æãçè·åž«ããã£ãŠããããšãããå»çæ¥çã®èª²é¡ã身è¿ã«æããããå»çã«å¯ŸããŠèå³ããã£ã ããšãçç±ã«ãªã£ãŠããŸãã å²¡ç° : èªåã®äœèª¿ãæªããªãããšãæããå€ãã£ããããã«ã¹ã±ã¢æ¥çã«èå³ããã£ãã®ã§ãããããã«è¿ãæ¥çã ã£ãã®ãã²ãšã€ã®çç±ã§ãããŸãäŒç€Ÿã®ããã·ã§ã³ããšãŠãåãããããã£ããšããã®ããããŸããä»ç€Ÿã«æ¯ã¹ãŠãã¡ãã¬ãŒã¯ äžã®äžãè¯ãããŠããšããäŒç€Ÿã®ããžã§ã³ã«ãã¡ãããšåºã¥ããŠãããã¯ããéçºããŠãã ãã ãªãšããã®ãå ·äœçã«åãã£ãŠäžè²«æ§ãæããããã®ã倧ããã§ãã ä»ã«ã¯ãããšã³ãžãã¢ããšããè·çš®ã ãšãã¡ããæè¡åéãå°éé åã«ãªã£ãŠããããã§ããããã®é åã«éããããããã¯ããäžå¿ã«èª²é¡è§£æ±ºããäžã§ãšã³ãžãã¢ãªã³ã°ä»¥å€ã®ããšãèããªããéçºãããŠãããããã¯ããã¡ãŒã¹ããªèããé åçã§ããã 埳氞 : èªåã¯å²¡ç°ããã®ããã«ç¹ã«ãã«ã¹ã±ã¢é åã«èå³ããã£ããšããããšã¯ãªãã£ããã§ããã©ã¡ãããšãããšã ãšã³ãžãã¢ãšããŠããããåããŠããäžã§èªåã倧åã«ãããå¿åã䟡å€èгãšããã®ããã¡ãã¬ãŒã®ãšã³ãžãã¢ã®æ¹éãšè©±ãããŠããäžã§ããããã ãªãšæããã®ã倧ããã§ãã ãããŸã§ãè²ã ãªäŒç€Ÿãããšã®éžèãããŠãããã§ãããã¡ãã¬ãŒã®ãšã³ãžãã¢ã¯ãæ¬è³ªãè¿œãæ±ããããšããå§¿å¢ã®å ããšã³ãžãã¢ãªã³ã°ã奜ãã§ãããããããã¯ããžéå ããŠãããšããéšåãèªåã®ãã£ãŒãªã³ã°ã«ãã£ããšããæãã§ããã ââ ãã£ãŒãªã³ã°ã«åã£ããšããããšã§ãããä»ã«ãããããããšæã£ãéšåã¯ãããŸããã? 埳氞 : ãšã³ãžãã¢ã®é°å²æ°ãå€§äººãªæãã®æ¹ãå€ããäœè²äŒç³»ã®ãæ°åãšæ ¹æ§ã§é 匵ãããšããé²ãæ¹ã§ã¯ãªããåççã«ç©äºãé²ããããã«å¿ èŠãªã³ãã¥ãã±ãŒã·ã§ã³ããã¡ããšåã£ãŠãããšãããªã©ãé åã§ãããããããéšåãå«ããŠèªåãåããŠããå°æ¥ãšããã®ãæ³åã§ããŸããã å€å· : èªåã¯èŠªãè¬å€åž«ã§å»çåéã«å ã èå³ããããå»ç x IT ãšãã軞ã§å°±æŽ»ãããŠããéçšã§ã¡ãã¬ãŒãç¥ã£ãã®ãæåã®åºäŒãã§ãããã話ãèããŠãããã¡ã«ã課é¡è§£æ±ºã®ããã®ãããã¯ãäœãããšããç¹ãéåžžã«é åã«æããŸããã瀟äŒãè¯ãããããã«ãããã¯ããè¯ãããŠããããšããå§¿å¢ã§äŒç€Ÿã«äžäœæãçãŸããŠããã®ãããããè¯ããªãšã äŒç€Ÿã«éããªããããããªãã§ãããçµç¹ã人ãå€ããªã£ãŠãããšãã£ã±ãæ¹åæ§ãå°ããã€ãºã¬ãŠãããšããæãã«ãªããã¡ã ãšæããã§ãããã¡ãã¬ãŒã®å Žå㯠äŒç€ŸãšããŠãå»çæ¥çããã£ãšè¯ãããŠããããã®äºæ¥ãããŠããããšãã軞ãéã£ãŠãã ã®ãæããŠãæçµçã«ã¯ãã®éšåã«æ¹ãããŠå ¥ç€Ÿã決ããŸããã ããšã¯ãäžå ŽäŒæ¥ãšãããå®å¿æãããã¡ãŒã¹ããã£ãªã¢ã®éžæã«åœ±é¿ããŸããã å²¡ç° : èªåãæ°åå ¥ç€Ÿã®ç€Ÿå¡ç®ç·ã ãšãå ¥ç€ŸããäŒç€Ÿã®å®å®æãšããã®ã¯éèŠã ãšæã£ãŠããŸããã æäž : 就掻ããåã¯ç¹å®ã®æ¥çã«éããè²ã ãªäŒç€ŸãèŠãŠããŸãããåŠçæä»£ã«æ§ã ãªæ¥çã®ãšã³ãžãã¢ã€ã³ã¿ãŒã³ãã¢ã«ãã€ããªã©ããŠããã®ã§ããããã®éçšã§ããã£ããæ£ç€Ÿå¡ã§åããªãããã瀟äŒçæçŸ©ãããäºæ¥ãããã¹ãã ãªããšæããŸãããããããæèã§å°±æŽ»ã«èšãã§ èªåãèå³ãæã£ãŠåãçµããããªã®ã¯å»çæ¥çã ãªãšæã£ã ã®ãæåã®ãã£ããã§ããã ã¡ãã¬ãŒã¯éžèã®äžã§ãæè¡é åãåããã«éçºã§ããããšãªã©ãããããããšæããã®ãšããµãŒãã¹ãå»çæ©é¢ã ãã§ãªãæ£è åŽãå å®ããŠãããšããããšãå ¥ç€Ÿã®æ±ºãæã«ãªããŸãããèªåãæ£è ã«ãªãããšãå€ãã®ã§ããšãŠã課é¡ãåãããããã£ããã§ãã å岡 : èªåãå ã ãšã³ã¿ã¡ãªã©ã®é åãããå»çãæè²ãéèé åãäžå¿ã«å°±æŽ»ãããŠããŸãããäžã§ãã¡ãã¬ãŒã®ãå»çãã«ã¹ã±ã¢ã®æªæ¥ãã€ããããšããããã·ã§ã³ãžã®èªåã®å ±æåºŠãéåžžã«é«ãã£ãã®ããå ¥ç€Ÿã®çç±ã§ãããæ¥æ¬ã®å»çå¶åºŠããã¡ããšç¶æããããã®ãããã¯ããäœã£ãŠãããã ãšããå§¿å¢ãéåžžã«è¯ãã£ãã§ãã ãŸãããã»ã©ã®è©±ã«ãåºãŠããŸãããã å»çæ©é¢ã®ããã®ãããã¯ããšæ£è ã®ããã®ãããã¯ããšããäž¡é¢ãžã®ã¢ãããŒããããŠãã ã®ã決ãæã§ããããã¯ãå»çè²»ã®åé¡ãªã©ã¯å»çæ©é¢ã ããžã®ã¢ãããŒãã§ã¯è§£æ±ºã§ããªããšæãã®ã§ãããããæå³ã§ãäžè²«æ§ãæããããŠè¯ãã£ãã§ãã çŸåšã®ããŒã å ã§ã®åœ¹å²ã«ã€ã㊠ââ ã§ã¯æ¬¡ã«çŸåšã®ããŒã ã§ã®çããã®åœ¹å²ãåãæ¹ãããŒã ã¡ã³ããŒãšã®é¢ããæ¹ã«ã€ããŠèããŠãããããšæããŸãã é£¯ç° : çŸåš Jobley ã®éçºããŒã ã§ã¯ãšã³ãžãã¢ã 4 人ããã®ã§ããããã®å 2 人ããããã¯ãæœçã®ç«æ¡ãè¡ãªãã€ã€ãèªåãå«ãæ®ãã® 2 人ãå®è£ ãã¡ã€ã³ã«ããŠéçºãè¡ãªã£ãŠããŸããç¶æ³ã«åãã PM å Œä»»ã®ãšã³ãžãã¢ãšå®è£ æ åœã®ãšã³ãžãã¢ãšã§äºäººäžèã§éçºãããããåç¬ã§ã®éçºãè¡ãªã£ãããšæè»ã«å¯Ÿå¿ããŠãã£ãŠãŸãã ããŒã ã¡ã³ããŒãšã®é¢ãããšããç¹ã§ã¯ã ãšã³ãžãã¢ããŒã ã ãã§éçºãããšããããšã¯ãªããã»ãŒã«ã¹ãã«ã¹ã¿ããŒãµã¯ã»ã¹ã®æ¹ãã¡ãšäžç·ã«èŠä»¶ãè©°ããŠãã ããšãæè¿ã¯å€ãã§ãããã®ããã»ãŒã«ã¹ã®æ¥åãããŒãªã©ããã£ããã¢ããããå¿ èŠãããã®ã§å€§å€ã§ãããé¢çœããããããæãããšããã§ããããŸããã å²¡ç° : ã·ãŽããŒã¯ã§ã¯ãPM ãšãšã³ãžãã¢ã®äºäººäžèãšããäœå¶ã§éçºãããŠããŸããPM ãšæ¥ã èŠä»¶ãå·ãåãããªãããå®è£ ã¯èªåãè¡ãªã£ãŠããŠãããšããã¹ã¿ã€ã«ã§ããPull Request ã®ã¬ãã¥ãŒã ãã¯å ã ã·ãŽããŒã¯ãéçºãããŠãããšã³ãžãã¢ã®æ¹ã ã«ãé¡ãããŠããŸãã ãŸããäŸãã°ãããã¯ãã®ã»ãã¥ãªãã£åŒ·åã®åãçµã¿ãã¢ããªã®èªèšŒæ©èœã®äžæ°ãQA ç°å¢ã®æŽåãªã©ãèªåãæ®æ®µè§Šããªãé åã®æœçãè¡ã£ãéã¯ã¹ãã«ã¢ããã宿ã§ããŸãããã©ã€ãã©ãªã®ã¢ããããŒããããªãã¡ã¯ã¿ãªã³ã°ãªã©ã è£éãæã£ãŠããããŠããã£ãŠããŸã ã 埳氞 : ãžã§ãã¡ãã¬ãŒã¢ã«ãããŒã¯ãžã§ãã¡ãã¬ãŒã CLINICS ã«æ¯ã¹ããšå°èŠæš¡ãªããŒã æ§æãšãªã£ãŠããŸãããšã³ãžãã¢ã 7 人ãPM ã 3 人ããããã¯ããªãŒããŒã 1 人ãšããäœå¶ã§éçºãããŠãã®ã§ããã è¯ãæå³ã§æ°åå ¥ç€Ÿãšã³ãžãã¢ãšããŠè£éãæã£ãŠéçºããããŠããã£ãŠããŸã ã éçºããŒã ãåŸã ã«å€§ãããªã£ãŠããã®ã§ãã¿ã¹ã¯ãäžæãåãããã®ä»çµã¿ãèããããããŒã ãäžæãæ©èœãããããã«æäŒã®æ§æã倿ŽããŠã¿ãããæè¡çãªéšåã§ã¯ CI/CD ãªã©éçºå šäœã«é¢ããåéã«ã€ããŠããä»»ããŠããã£ãŠããŸãã ãŸã ãã¥ãŒã¹ãªãªãŒã¹ ã«ããªããŸãããã瀟å ã§åããŠã® çæ AI ã䜿ã£ãæ©èœã®éçº ã¯ããããã¯ããªãŒããŒãšèªåã® 2 人ãäžå¿ã«ãªã£ãŠé²ããŠãããŸããã éçºã«å ¥ãåæ®µéã§ããžã«ã«ã«ããããã£ã課é¡ããã®æ©èœã§è§£æ±ºããŠããããšããããšãäŒããããã°ãããçšåºŠæè¡çã«å®éšçãªãã®ãå°å ¥ããããšãã§ããç°å¢ã§ã ã å€å· : Pharms ã§ã¯çŸåšãšã³ãžãã¢ã 4 人ãPM 1 人ããã¶ã€ããŒã 1 人ãšããã®ãäžå¿ã¡ã³ããŒãšãªã£ãŠããŸããPharms ã¯çŸåšè²ã ãšæ©èœæ¡å€§ãããŠãã£ãŠããã®ã§ããããšã³ãžãã¢ã 4 人ãªã®ã§æ¬åœã«å šå¡ã§äœã§ããã£ãŠãããšããæãã§éçºããŠããŸãããšã¯ãããã¡ã³ããŒåã ã§åŸæåéã¯éãã®ã§ãåŸæãªãšããã¯ç©æ¥µçã«æŸãã«è¡ãæãã§ãã èªåã¯ãšèšããšãåŸæåéã®ã€ã³ãã©éšåã«é¢ããŠã¯ã»ãšãã©ä»»ããŠããã£ãŠãããèªåããã®çºä¿¡ã§å 茩ã®ããã¯ãªãŒããšã³ãžãã¢ã®æ¹ãšããåããããªããè²ã ãªæœçãè¡ãªã£ãŠããŸãããã®ä»ã«ãã¯ã©ãŒã¿ãŒæ¯ã«æ°åã¯äžã»å€§èŠæš¡ãªæœçãèšç»ãããã®ã§ããããããã®ã®ããã€ãã®ãªãŒãããããŠããã£ããããŠããŸããã§ãã®ã§ã ã¢ããªã±ãŒã·ã§ã³ã®éçºãšããé¢ã§ããããžã§ã¯ããäžæãé²è¡ããããšããé¢ã§ãããšãŠã楜ããæ¥åãããŠããŸã ã æäž : CLINICS ã§ã¯ãŸããåºå¹¹ããšãåšèŸºããšãã£ãã 2 ã€ã®ããŒã ã«åãããŠããããåºå¹¹ããäž»ã«ã¬ã»ã³ã³(ã¬ã»ããã³ã³ãã¥ãŒã¿ã®ç¥ãå»çæœèšããå¥åº·ä¿éºçµåãªã©ã®æ¯æãæ©é¢ã«å¯Ÿãã蚺çå ±é ¬ãè«æ±ããããã«ãé»åã«ã«ããšé£åããŠã¬ã»ãããšåŒã°ãã蚺çå ±é ¬æçްæžãäœæããã·ã¹ãã )ãšã®ãããšããããåšèŸºãã§ã¯äºçŽãå蚺ãè³æ Œç¢ºèªãªã© CLINICS ãšæ£è ãšã®æ¥ç¹ãšãªãã·ã¹ãã ããšããåœ¢ã§æ åœæ¥åãåãããŠããŸããèªåã¯ãã£ãšåºå¹¹ããŒã ã«ã¢ãµã€ã³ãããŠããŸããããŒã å šå¯Ÿå¿ã®ãšã³ãžãã¢ã®å èš³ã¯ã¢ããªã±ãŒã·ã§ã³æ åœã 6~7 人ãã€ã³ãã©æ åœã 3 人ã»ã©ã«ãªã£ãŠããŸãã çŸåšã¯å€§ããªãããžã§ã¯ãã 1 ã€é²è¡ããŠããŠãæ¢åã®ã¬ã»ã³ã³ãã¡ãã¬ãŒã§æ°èŠéçºããŠããã¬ã»ã³ã³ã«ç§»è¡ãããšãããã®ã§ããããã®äžã« äžèŠæš¡ãªãããžã§ã¯ããè€æ°å¹³è¡ããŠé²ãã§ããŠããã®å ã®ããã€ããèªåããªãŒã ãããŠããã£ãŠããŸãã ãªãŒãããŠãããããžã§ã¯ãã®é²è¡ç®¡çãããŒã ã¡ã³ããŒéã§ã®åé¡å ±ææ¹æ³ãªã©ãèããŠããã®ã§ããããã®èŸºãã¯ææŠã§ããå¹ ãåºããé£ããã§ããé¢çœããšæããŠããŸãã課é¡ã«ã€ããŠãããžã§ã¯ãã«éå®ãããä»ã®ã·ã¹ãã ãé²æç¶æ³ã«åœ±é¿ããªãããé æ ®ããå¿ èŠããããããããèŠç¹ã§é©åã«ç°ãªãç«å Žã®é¢ä¿è ãå·»ã蟌ãããšã§ãããå æ¬çãªè§£æ±ºçãå°ãåºãããšæèãããŠããŸãã å岡 : èªåã¯ä»ã¯æäžãšäžç·ã®ããŒã ã§æ¥åãããŠãããã§ãããã¬ã»ã³ã³ãªã©ã®éšåãšããããã¯ãå çšã®è©±ã®ãåšèŸºãã®éçºãããããšãå€ãã§ããåºæ¬çã«å¹³è¡ããŠè€æ°ã®ãããžã§ã¯ããèµ°ã£ãŠãããããããã®ãããžã§ã¯ãã§ãã£ã¬ã¯ã¿ãŒ 1 人ããšã³ãžãã¢æ°äººãä»ã«ãã¶ã€ããŒãšãã圢ã§é²ããŠããããšãå€ãã§ãã 倧ãŸãã«ãã£ã¬ã¯ã¿ãŒãèŠä»¶ãªã©ããŸãšãããã®ãããŒã¹ãšããŠããã®åŸã«ãã¶ã€ããŒããšã³ãžãã¢ãå ¥ã£ãŠèŠä»¶å®çŸ©ãªã©ãããŠãããåŸã ã«åœ¢ã«ããŠãããšããäºãå€ãã§ããã ââ ãäºäººã§çµãã§ä»äºãããããšããããã§ãã? æäž : ã¯ãããšãŠãå€ãã§ãã é²è¡ããŠãããããžã§ã¯ãã®ä»ã«ããå®åžžæ¹åããã°æ¹ä¿®ãªã©ã®ã¿ã¹ã¯ããããŸãããããããã¿ã¹ã¯ããã©ã®ã¿ã€ãã³ã°ã§ããã©ã®åªå 床ã§ã察å¿ããŠããããªã©ãããŒã å ã§è°è«ããŠãã宿œããã®ã§ã å岡 : ãããžã§ã¯ããããããã¿ã¹ã¯ãšã¯å¥ã«ããšã³ãžãã¢äž»å°ã§å€§èŠæš¡ãªãªãã¡ã¯ã¿ãªã³ã°ãªã©ãè¡ãªã£ãŠããŸããæ åœããŠãããããžã§ã¯ãã®ä»ã«ãããããã®ãæãããŠããŠãäžç·ã«ãªãããšãå€ãã§ãã å ¥ç€ŸããŠã¡ãã¬ãŒã®æåã匷ãæèããåºæ¥äº ââ ã¡ãã¬ãŒã§åããŠããäžã§ãç¹ã«æåã匷ãæãããšããœãŒããªã©èããŠã¿ããã§ãã é£¯ç° : éçºã«é¢ä¿ããäººå šå¡ãããããã¯ãå¿åã匷ãããšããããšã§ãããããå ·äœçã«ã¯ãéçºã®èŠä»¶å®çŸ©æ®µéããå šå¡é¢ããã®ã§ããã¡ããããžãã¹ãµã€ãã®æ¹ããããããããæ¹ãè¯ãã®ã§ã¯ãªããããšããã¢ã€ãã¢ã¯åºãŠããŸãããéçºãµã€ãããããã©ãããæ©èœãäžçªãŠãŒã¶ã«äŸ¡å€ãå±ãããããããšããèŠç¹ã§äžç·ã«ãªã£ãŠèãããã§ããããããã©ããã£ã課é¡ã解決ãããã®ãªã®ããšããåºç€ã®éšåããäžç·ã«èããŠããã®ãã¡ãã¬ãŒã§ã¯åœããåã«ãªã£ãŠãããšããæããããŸãã éçºãµã€ããããžãã¹ãµã€ããåãæ¹åãåããŠããã®ã§ãææ¡ãªã©ãã¡ãããšããžã«ã«ã§çãéã£ãŠãããã®ã§ããã°éããšããã®ã¯ããããæèŠãããããã ãšæããŸãããã®ããã®çžè«ãªãããããã¡ããããããã§ããããšãŠãè¯ãæåã ãªãšæããŠããŸãã å²¡ç° : éçºã«ããã£ãŠ PM ã æœçãªã©ã Issue ãšããŠç«ãŠãŠãããã®ã§ãããèšèªåãè¡ãå±ããŠããŠäœãåé¡ã§ãã©ãããŠå®æœããã®ãããã®åœ±é¿ãªããããããåããããããšããç¹ã¯ã¡ãã¬ãŒã倧äºã«ããŠãããããã¥ã¡ã³ãããªãã³ããšããæåãæããŸãã ãã®ãããªç°å¢ãªã®ã§ã倧æµã®ããšã¯æäœéã®æç« ã®ããåãã ãã§ã¹ã ãŒãºã«é²ã¿ãŸãããäžæããããªãç¶æ³ã«ãªã£ãŠãååŸçãªã©ãç«ãŠããããªã£ãŠãããšæããŸãã 埳氞 : ã¡ãã¬ãŒã¯æ°åå ¥ç€Ÿã®ç€Ÿå¡æ°ã¯å°ãªãã®ã§ãäžéå ¥ç€Ÿã®æ¹ãã»ãšãã©ãšããç°å¢ã§ããå ¥ç€ŸããŠããã¯ãèªåã®æèŠã¯éãã®ããªããšããèªåããåŸã«å ¥ç€Ÿããçµéšå¹Žæ°ãé·ãäžéå ¥ç€Ÿã®æ¹ãšã©ãä»ãåããããªã©ãå¿é ã§ãããã§ã ã¡ãã¬ãŒã§ã¯ã建èšçã«é²ããããšããæåãããã®ã§ãç«å Žã«é¢ä¿ãªãè°è«ã§ããç°å¢ãããã®ã§ããšãŠãä»äºããããã ã§ããèªåã®æèŠãäŸãééã£ãŠãããšããŠãè°è«ãèµ·ãããšããããšã¯ãèªèããºã¬ãŠãããšããããšã ãããšè»éä¿®æ£ãã§ããã®ã§æ¬åœã«åããããã§ãã ãŸãããšãŠãè¯ããªãšæã£ãã®ããéšçœ²ãè·çš®ã«é¢ããã Confluence ã®æ å ±ã«èª°ã§ãã¢ã¯ã»ã¹ã§ãããšããæåã§ãããç§å¿æ å ±ä»¥å€ã¯åºæ¬çã«å šãŠ Confluence ã§ãªãŒãã³ã«ãªã£ãŠãããããã§ãèªåãšã¯çŽæ¥é¢ä¿ãªãéšçœ²ã®çŸåšã®åããªã©ããã£ããã¢ããã§ããã®ã§ããããã£ã人ãã¡ãšã³ãã¥ãã±ãŒã·ã§ã³ãåããšãã«ããããå©ãããŸãã å€å· : 埳氞ãšãã¶ããšããããããã§ãããã建èšçã«é²ããããšããéšåã¯éåžžã«ã¡ãã¬ãŒããããæããæåã§ããäŸãã° PM ããæœçãããããŸãããããšãªã£ãŠããèªåãããã®ãããŒã£ãŠãããªã£ãæ¹ãè¯ãã§ãããããšããæèŠãèšãããããããèµ·ç¹ã« è°è«ã«çºå±ããŠããè¯ããã®ãäœã£ãŠããããšããã®ã¯æ¬åœã«çŽ æŽããã ãšæããŠããŸãã å®éã«èªåããªãŒãããŠããæœçã®äžã§ããšã³ãžãã¢ã» ãã¶ã€ããŒã» PM ã»ã«ã¹ã¿ããŒãµã¯ã»ã¹ãšããç«å Žãéãã¡ã³ããŒåå£«ã§æ¹ããŠè¬å±ã®æ¥åãããŒãæŽçããªãããŠãããè¯ã仿§ã«ã§ããããšããããšããããŸããã æ©èœãªãªãŒã¹åŸãã¡ãããšãããã¹ãå§¿ããç®æããŠæ¹åãã§ãããããã®ã§ãããããèãæ¹ã¯ãšãŠãä»äºãããããã§ãã æäž : èªåããã¯ãçµç¹æ°Žæºãé«ããããšããæåã«ã€ããŠèšåãããŠãã ãããèªåãé¢ãã£ãŠããé»åã«ã«ããã¬ã»ã³ã³ãšããé åã¯æ·±ãæ¥åç¥èãå¿ èŠã§ãåããŠé¢ãã£ã人ãããããšãããããã©ããããããŒã§æ©èœã䜿ãããŠããããšããç¹å®ã®å Žåã«äœã§ãããªããã ãããšãããšããããçè§£ãã¥ãããã§ããã§ããèªåã®ããŒã ã¯æ°åã»äžéåããããŸã æ·±ããã¡ã€ã³ç¥èããªãããšãã£ãç¶æ ããã§ãå ¥ã£ãп޻èºããããç°å¢ã ãšããã®ãæããŠããŸãã ãããªãå°éã®æ¥åç¥èãå¿ èŠãªéçºãšããã®ã¯ãã¯ãé£ããã®ã§ãããããéšåãšçŽæ¥ã¯é¢ä¿ããªãåšèŸºé åã®éçºããå§ããŠããã£ãŠãåŸã ã«é»åã«ã«ããã¬ã»ã³ã³ã«çŽæ¥é¢ä¿ããéçºã«å ¥ã£ãŠãããããããªãªã³ããŒãã£ã³ã°ãã§ããŠããŸããéçºã®äžã§ãããã¹ãå§¿ã«ã€ããŠè°è«ã«ãªã£ããã§è²ã ãªã¡ã³ããŒãšè©±ãããŠããã®ã§ã å»çæ¥åã®ãã£ããã¢ããã¯ããªãããããç°å¢ ã ãšæããŸãã ããã²ãšã€ãé·æã®ã«ã¹ã¿ããŒäŸ¡å€ã远æ±ããããšããéšåãæåãæããŠããŠãäž»ã«ãããŒãžã£ãŒãå«ããçæç㪠KPI ã«æ²¿ã£ãéçºããããé·æçã«é¡§å®¢ãžã®äŸ¡å€æäŸã«å¯äžã§ããéçºãåªå ããŠãããšããæèãéåžžã«åŒ·ãã®ãè¯ããšæããŸãã ç¹ã«ä»çŸåšã瀟å ã§éçºãé²ãã§ããæ°èŠã¬ã»ã³ã³ã®éçºã«ã€ããŠã¯åŒ·ãæããŸããã å岡 : èªåã匷ãæããŠããã¡ãã¬ãŒã®æåãšããŠã¯ãããã¥ã¡ã³ãããªãã³ãã§ããããŒãã£ã³ã°ãªã©ããããããããšã®çµè«ãåŸãããã«åè°ããããšããã®ãæç¢ºã«åããè³æãäºåã«çšæããŠè¡ããŸããã§ãã®ã§ããããäœã®æéã ã£ã?ãã¿ãããªç¶æ ã«ãªãã«ããã®ãè¯ãã§ãã ããšã¯ ããŒãã£ã³ã°ã«ããåæçãSlack ã Confluence ãªã©ã«ããéåæã®ã³ãã¥ãã±ãŒã·ã§ã³ã驿驿ã§å šå¡ã䜿ããããŠããã®ã§ãããããã³ãã¥ãã±ãŒã·ã§ã³ã§ç¡é§ãªè¡ãéãã®ãããªãã®ããã»ãšãã©ç¡ã ã®ããä»äºããããããšæã£ãŠããŸãã ããã²ãšã€ã¯ãèªåããã¯ããããã¯ãå¿åã®åŒ·ããšãããšãããæããŠããŸããçŸåšã¯ãã£ã¬ã¯ã¿ãŒãªã©ãšäžç·ã«éçºãããŠããäœå¶ã«ãªã£ãŠãããã§ãããUI ã顧客äœéšãªã©ãå«ããŠãšã³ãžãã¢ã§ããã¡ãããšãããã¯ããšããŠã®çæ³ã®å§¿ãèããŠéçºãããšããå§¿å¢ããšãŠã匷ãã§ããèªåã®å°éã§ã¯ãªãé åã§ããã¡ããšèããªããéçºãããŠããã®ã§ãããããããããŸãã ããããã¡ãã¬ãŒã«å ¥ç€Ÿããæ¹ãžã®ã¡ãã»ãŒãž ââ ã§ã¯æåŸã«ãªããŸãããç¹ã«æ°åã§ã¡ãã¬ãŒã®å ¥ç€ŸãèããŠããæ¹ãžã®ã¡ãã»ãŒãžãªã©ããã°ãã䌺ããããã§ãã é£¯ç° : ããã§ããããå èŒ©ãæ°åã«å¯ŸããŠãšãŠãæåŸ ããŠãããŠããããšããã®ã¯äŒããããšæããŸããèªåã®å Žåãç ä¿®ãçµãã£ãŠ 3 ã¶æçµã£ããããã§ãã·ãŽããŒã¯ã®ã€ã³ãã©ç°å¢ãå šéšå·æ°ãããšãã倧ããªãããžã§ã¯ãã®ãªãŒããä»»ããŠãããããã§ãããã¡ãã SRE ã®å 茩ãªã©ãšååãã€ã€é²ãããã®ã ã£ããã§ããã ç ä¿®çµãã£ãŠããã«ãããªå€§ããªãããžã§ã¯ããè£éæã£ãŠé²ãããããããªç°å¢ãªã®ã§ããããããããããããŸã ã å²¡ç° : çš²æ¬(人æãã©ãããã©ãŒã CTO)ããæ°åã ãããã¿ãããªæ¥ãæ¹ãããã«ããã¡ãšã³ãžãã¢ãšããŠæ¥ããŠãããŠããã®ã¯å人çã«å¬ãããã€ã³ãã§ãããŸã 責任ãæã£ãäžã§è£éæã£ãŠèªç±ã«åããŠãããæ¥åç°å¢ãããã®ãããããè¯ã ã§ããã¡ãããšãããã¯ãã®äºãèããŠéçºãããã人ã«ã¯ããããã§ããç°å¢ã ãšæããŸãã 埳氞 : æ°åã®è¯ããšããã¯ãåæãæãæãŠããšããããªãšæããŸããä»ãã©ã³ãçã§ãã®ã¡ã³ããŒãšæè¡çãªãšãããªã©ãæ°è»œã«çžè«ã§ããã®ã¯ãšãŠãè¯ãã§ãã åç£ç¢ç£šããŠããç°å¢ãããªãããªãšæã£ãŠããã®ã§ãããããç°å¢ãæ±ãããªããããè¯ã ãšæããŸãã å€å· : åã身ã§ä»äºãè¡ãã®ã§ã¯ãªããã¬ãã¬ããšèªåã®æ¹ããæ±ãã«ããå§¿å¢ã®äººã«ã¯ãããããããããäŒç€Ÿã ãšæããŸãããã£ããè£éæã£ãŠæ¥åãé²ããããšãã§ããç°å¢ãªã®ã§ã é æ ®ããã«ãããããšç©äºé²ããããšãã§ãã人ã«ã¯æé« ãªããããªãããšèããŠããŸãã èªåã¯ã€ã³ãã©ã ãã§ã¯ãªããŠããµãŒããããã³ããšã³ããéçºããŠãããããšèããŠãããã§ãããå°èŠæš¡ãªãããžã§ã¯ãã§ããã°å šãŠè¡ããç°å¢ãªãããèªåäžäººã§ãããžã§ã¯ããå®çµããããšãã§ããã®ã¯ãæ§ã«åã£ãŠãããªãšæã£ãŠãŸããåšãã®ãµããŒããå 茩ãšã®å£æã¡ãªã©ã¯ã¡ãããšãã£ãŠããããã®ã§ããšãŠãå匷ã«ãªãæé·ã§ãããšæããŸãã æäž : ã¡ãã¬ãŒã§éçºãããŠããã«ã€ãããŠãå»çãã¡ã€ã³ãšããé åã§èªåãé¢ãã£ãŠããããšã人ã®åœ¹ã«ç«ã£ãŠãããã ãªãšããã®ãæ¥ã 宿ã§ãããšããã¯è¯ãã§ããç¹ã«è²ã ãªå»çæ©é¢ã®ãµããŒããã§ãããšãããããã¯ãã«é¢ãã£ãŠããã®ã§ãçŽæ¥å»çæ©é¢ããã®å ã«ããæ£è ãã㮠圹ã«ç«ã£ãŠãããšãã宿ã¯ãæ£çŽ 1 幎ç®ã§æãããããã®ã§ã¯ãªããšæã£ãŠããã®ã§ãè¯ãé©ã ã§ãã ãŸã倧ããããŒã¿ãåãæ±ããšããçµéšãã§ããŠããã®ã貎éã ãªãšæããŠããŸããçŸåšã®ãããã¯ãã§ã¯å¥çŽå»çæ©é¢ãéåžžã«å€ãã§ããããã®å€§éã®ããŒã¿ã®èšèšã倿Žããããšãããšããããè£éæã£ãŠå®æœã§ããã®ã¯è¯ãçµéšã«ãªã£ãŠããŸãã å岡 : ã¡ãã¬ãŒã®ããããã¯ãå¿åããæã£ãŠããå 茩ãšã³ãžãã¢ãšåãããšããã®ã¯ãšãŠãè¯ãçµéšã ãšæã£ãŠããŸããäžè¬çã«ã¯ãšã³ãžãã¢ã¯æè¡ããããã°ãšããæãã«ãªããããã£ãããããšæãã®ã§ãããã¡ãã¬ãŒã§ã¯ãã¡ããæ°ããæè¡ãªã©ã䜿ããªãããããã ããã«ãããã¯ãããã®å ã®ãŠãŒã¶ãžã®äŸ¡å€æäŸã«ç¹ããããèããŠããæ¹ãéã£ãŠãã ã®ã§ãããããæèã§ãããã¯ãéçºãã§ããŠããã®ã¯ãããå匷ã«ãªããŸãã ââ ããããšãããããŸãã! æ¬åœã« 1 幎ã§çãããæ¿ãæ¥åçµéšãç©ãã§ããã®ãåããã€ã³ã¿ãã¥ãŒã«ãªããŸããã ãããã« ããããç°ãªãããŒã ãæ¥åå 容ã§ãããæ°åãšã³ãžãã¢ã§ãè£éãæã£ãŠæ¥åã«èšããããšãããããã¯ãã®éèŠãªéšåã®éçºã«ã©ãã©ãé¢ãã£ãŠãããããšãäŒããã€ã³ã¿ãã¥ãŒãšãªããŸããã ã¡ãã¬ãŒã¯æ°åå ¥ç€Ÿã®ãšã³ãžãã¢ãç©æ¥µçã«åéããŠããŸãã®ã§ãä»åæ°ã«ãªã£ããšããæ¹ã¯ãæ°è»œã«ã«ãžã¥ã¢ã«é¢è«ãããŸããã! open.talentio.com open.talentio.com
æ ªåŒäŒç€Ÿã¡ãã¬ãŒ
2024/04/05
<![CDATA[ FY22 æ°åå ¥ç€Ÿãšã³ãžãã¢ã¯ãã® 1 幎ã§ã©ã®ãããªæé·ãããŠããã®ãã€ã³ã¿ãã¥ãŒããŸãã ]]>
ã¯ããã« ã¿ãªãããããã«ã¡ã¯ããšã³ãžãã¢ã®æ°å± ã§ããä»å㯠2022 幎æ°åå ¥ç€Ÿãããšã³ãžãã¢éã«ã€ã³ã¿ãã¥ãŒããèšäºããéãããŸãã ãã® 1 幎ã§åœŒããã©ã®ãããªæ¥åãçµéšããŠããã®ããããªã¢ã«ãªçŸåšã®ç«ã¡äœçœ®ãªã©ããäŒãããããšèããŠããŸãã ããã§ã¯ãã芧ãã ãã! èªå·±çŽ¹ä» é£¯ç°ãã ç ä¿®åŸã¯ ãžã§ãã¡ãã¬ãŒ ã§é¡§å®¢åãã®æ©èœéçºãæ åœããã®åŸ ã·ãŽããŒã¯ ã§ã€ã³ãã©é åãäžå¿ã«ãªãã¥ãŒã¢ã«ã«åŸäºãããçŸåšã¯ Jobley ã§æœçã®éçºãã€ã³ãã©åšããŸã§å¹ åºãæ¥åãæ åœã 飯ç°ãã 岡ç°ãã ç ä¿®åŸã¯ãžã§ãã¡ãã¬ãŒã§ã®éçºæ¥åãæ åœåŸãã·ãŽããŒã¯ãžããžã§ãã¡ãã¬ãŒãšã®é£æºåŒ·åã®ãããžã§ã¯ããªã©çµéšããçŸåšã¯ã·ãŽããŒã¯ã®éçºå šè¬ãæ åœã 岡ç°ãã 埳氞ãã ç ä¿®åŸã¯ ãžã§ãã¡ãã¬ãŒã¢ã«ãã㌠ã«é å±ããããã¯ãæ¹åãªã©ãæ åœãã€ã€ãçŽè¿ã§ã¯çæ AI ã䜿ã£ãæ©èœã®éçºãããã¯ãšã³ãããã¢ãã€ã«ãŸã§å¹ åºãéçºã«åŸäºã 埳氞ãã å€å·ãã ç ä¿®åŸã¯ Pharms ã«é å±ãããã³ããšã³ãããã€ã³ãã©ãŸã§å¹ åºãæ åœãå°èŠæš¡æœçã®éçºã«å§ãŸãçŸåšã¯äžèŠæš¡æœçã®ãããžã§ã¯ããªãŒããããªããéçºãè¡ãªãã å€å·ãã æäžãã ç ä¿®åŸã¯ CLINICS ã«é å±ãé»åã«ã«ãé¢é£ã®éçºãçµãŠãçŸåšã¯äžèŠæš¡æœçã®ãããžã§ã¯ããªãŒããããªããéçºãè¡ãªãã æäžãã å岡ãã ç ä¿®åŸã¯ æ£è ã¢ã㪠CLINICS ã«é å±ãWeb ã¢ããªãšãã€ãã£ãã¢ããªã®æ©èœéçºãæ åœããåŸãCLINICS ã«é å±ãçŸåšã¯å®åžžæ¹åããããã³ããšã³ãã®å€§èŠæš¡æ¹ä¿®ãªã©ã«åŸäºã å岡ãã ãã¡ãŒã¹ããã£ãªã¢ãšããŠã¡ãã¬ãŒãéžãã çç±ã«ã€ã㊠ââ ãŸãã¯ãã¡ãŒã¹ããã£ãªã¢ã«ã¡ãã¬ãŒãžå ¥ç€Ÿã決ããçç±ãã䌺ãããŠãããããšæããŸãã é£¯ç° : å ã ãã³ãã£ãŒæ°è³ªãé«ãããšã軞ã«äŒç€Ÿéžã³ãããŠããŸãããæ°åå ¥ç€Ÿã®ç€Ÿå¡ã倿°ãããããªèŠæš¡ã倧ããäŒç€Ÿã ãšãèªåããã®äžã«åãããŠããŸããèªç±åºŠãé«ãåããã§ããªãããã ãšèããŠããããã§ããã¡ãã¬ãŒã¯æ°åãå°ãªãã®ã§ãã®èŸºãã¯ãããããŠããŸãããå»çãšããé åã«é¢ããŠãã æ¥åžžç掻ã«é¢ãããšããã§ç€ŸäŒã«è²¢ç®ã§ãããããªé åãè¯ããªãšèããŠããããšããå®¶æãçè·åž«ããã£ãŠããããšãããå»çæ¥çã®èª²é¡ã身è¿ã«æããããå»çã«å¯ŸããŠèå³ããã£ã ããšãçç±ã«ãªã£ãŠããŸãã å²¡ç° : èªåã®äœèª¿ãæªããªãããšãæããå€ãã£ããããã«ã¹ã±ã¢æ¥çã«èå³ããã£ãã®ã§ãããããã«è¿ãæ¥çã ã£ãã®ãã²ãšã€ã®çç±ã§ãããŸãäŒç€Ÿã®ããã·ã§ã³ããšãŠãåãããããã£ããšããã®ããããŸããä»ç€Ÿã«æ¯ã¹ãŠãã¡ãã¬ãŒã¯ äžã®äžãè¯ãããŠããšããäŒç€Ÿã®ããžã§ã³ã«ãã¡ãããšåºã¥ããŠãããã¯ããéçºããŠãã ãã ãªãšããã®ãå ·äœçã«åãã£ãŠäžè²«æ§ãæããããã®ã倧ããã§ãã ä»ã«ã¯ãããšã³ãžãã¢ããšããè·çš®ã ãšãã¡ããæè¡åéãå°éé åã«ãªã£ãŠããããã§ããããã®é åã«éããããããã¯ããäžå¿ã«èª²é¡è§£æ±ºããäžã§ãšã³ãžãã¢ãªã³ã°ä»¥å€ã®ããšãèããªããéçºãããŠãããããã¯ããã¡ãŒã¹ããªèããé åçã§ããã 埳氞 : èªåã¯å²¡ç°ããã®ããã«ç¹ã«ãã«ã¹ã±ã¢é åã«èå³ããã£ããšããããšã¯ãªãã£ããã§ããã©ã¡ãããšãããšã ãšã³ãžãã¢ãšããŠããããåããŠããäžã§èªåã倧åã«ãããå¿åã䟡å€èгãšããã®ããã¡ãã¬ãŒã®ãšã³ãžãã¢ã®æ¹éãšè©±ãããŠããäžã§ããããã ãªãšæããã®ã倧ããã§ãã ãããŸã§ãè²ã ãªäŒç€Ÿãããšã®éžèãããŠãããã§ãããã¡ãã¬ãŒã®ãšã³ãžãã¢ã¯ãæ¬è³ªãè¿œãæ±ããããšããå§¿å¢ã®å ããšã³ãžãã¢ãªã³ã°ã奜ãã§ãããããããã¯ããžéå ããŠãããšããéšåãèªåã®ãã£ãŒãªã³ã°ã«ãã£ããšããæãã§ããã ââ ãã£ãŒãªã³ã°ã«åã£ããšããããšã§ãããä»ã«ãããããããšæã£ãéšåã¯ãããŸããã? 埳氞 : ãšã³ãžãã¢ã®é°å²æ°ãå€§äººãªæãã®æ¹ãå€ããäœè²äŒç³»ã®ãæ°åãšæ ¹æ§ã§é 匵ãããšããé²ãæ¹ã§ã¯ãªããåççã«ç©äºãé²ããããã«å¿ èŠãªã³ãã¥ãã±ãŒã·ã§ã³ããã¡ããšåã£ãŠãããšãããªã©ãé åã§ãããããããéšåãå«ããŠèªåãåããŠããå°æ¥ãšããã®ãæ³åã§ããŸããã å€å· : èªåã¯èŠªãè¬å€åž«ã§å»çåéã«å ã èå³ããããå»ç x IT ãšãã軞ã§å°±æŽ»ãããŠããéçšã§ã¡ãã¬ãŒãç¥ã£ãã®ãæåã®åºäŒãã§ãããã話ãèããŠãããã¡ã«ã課é¡è§£æ±ºã®ããã®ãããã¯ãäœãããšããç¹ãéåžžã«é åã«æããŸããã瀟äŒãè¯ãããããã«ãããã¯ããè¯ãããŠããããšããå§¿å¢ã§äŒç€Ÿã«äžäœæãçãŸããŠããã®ãããããè¯ããªãšã äŒç€Ÿã«éããªããããããªãã§ãããçµç¹ã人ãå€ããªã£ãŠãããšãã£ã±ãæ¹åæ§ãå°ããã€ãºã¬ãŠãããšããæãã«ãªããã¡ã ãšæããã§ãããã¡ãã¬ãŒã®å Žå㯠äŒç€ŸãšããŠãå»çæ¥çããã£ãšè¯ãããŠããããã®äºæ¥ãããŠããããšãã軞ãéã£ãŠãã ã®ãæããŠãæçµçã«ã¯ãã®éšåã«æ¹ãããŠå ¥ç€Ÿã決ããŸããã ããšã¯ãäžå ŽäŒæ¥ãšãããå®å¿æãããã¡ãŒã¹ããã£ãªã¢ã®éžæã«åœ±é¿ããŸããã å²¡ç° : èªåãæ°åå ¥ç€Ÿã®ç€Ÿå¡ç®ç·ã ãšãå ¥ç€ŸããäŒç€Ÿã®å®å®æãšããã®ã¯éèŠã ãšæã£ãŠããŸããã æäž : 就掻ããåã¯ç¹å®ã®æ¥çã«éããè²ã ãªäŒç€ŸãèŠãŠããŸãããåŠçæä»£ã«æ§ã ãªæ¥çã®ãšã³ãžãã¢ã€ã³ã¿ãŒã³ãã¢ã«ãã€ããªã©ããŠããã®ã§ããããã®éçšã§ããã£ããæ£ç€Ÿå¡ã§åããªãããã瀟äŒçæçŸ©ãããäºæ¥ãããã¹ãã ãªããšæããŸãããããããæèã§å°±æŽ»ã«èšãã§ èªåãèå³ãæã£ãŠåãçµããããªã®ã¯å»çæ¥çã ãªãšæã£ã ã®ãæåã®ãã£ããã§ããã ã¡ãã¬ãŒã¯éžèã®äžã§ãæè¡é åãåããã«éçºã§ããããšãªã©ãããããããšæããã®ãšããµãŒãã¹ãå»çæ©é¢ã ãã§ãªãæ£è åŽãå å®ããŠãããšããããšãå ¥ç€Ÿã®æ±ºãæã«ãªããŸãããèªåãæ£è ã«ãªãããšãå€ãã®ã§ããšãŠã課é¡ãåãããããã£ããã§ãã å岡 : èªåãå ã ãšã³ã¿ã¡ãªã©ã®é åãããå»çãæè²ãéèé åãäžå¿ã«å°±æŽ»ãããŠããŸãããäžã§ãã¡ãã¬ãŒã®ãå»çãã«ã¹ã±ã¢ã®æªæ¥ãã€ããããšããããã·ã§ã³ãžã®èªåã®å ±æåºŠãéåžžã«é«ãã£ãã®ããå ¥ç€Ÿã®çç±ã§ãããæ¥æ¬ã®å»çå¶åºŠããã¡ããšç¶æããããã®ãããã¯ããäœã£ãŠãããã ãšããå§¿å¢ãéåžžã«è¯ãã£ãã§ãã ãŸãããã»ã©ã®è©±ã«ãåºãŠããŸãããã å»çæ©é¢ã®ããã®ãããã¯ããšæ£è ã®ããã®ãããã¯ããšããäž¡é¢ãžã®ã¢ãããŒããããŠãã ã®ã決ãæã§ããããã¯ãå»çè²»ã®åé¡ãªã©ã¯å»çæ©é¢ã ããžã®ã¢ãããŒãã§ã¯è§£æ±ºã§ããªããšæãã®ã§ãããããæå³ã§ãäžè²«æ§ãæããããŠè¯ãã£ãã§ãã çŸåšã®ããŒã å ã§ã®åœ¹å²ã«ã€ã㊠ââ ã§ã¯æ¬¡ã«çŸåšã®ããŒã ã§ã®çããã®åœ¹å²ãåãæ¹ãããŒã ã¡ã³ããŒãšã®é¢ããæ¹ã«ã€ããŠèããŠãããããšæããŸãã é£¯ç° : çŸåš Jobley ã®éçºããŒã ã§ã¯ãšã³ãžãã¢ã 4 人ããã®ã§ããããã®å 2 人ããããã¯ãæœçã®ç«æ¡ãè¡ãªãã€ã€ãèªåãå«ãæ®ãã® 2 人ãå®è£ ãã¡ã€ã³ã«ããŠéçºãè¡ãªã£ãŠããŸããç¶æ³ã«åãã PM å Œä»»ã®ãšã³ãžãã¢ãšå®è£ æ åœã®ãšã³ãžãã¢ãšã§äºäººäžèã§éçºãããããåç¬ã§ã®éçºãè¡ãªã£ãããšæè»ã«å¯Ÿå¿ããŠãã£ãŠãŸãã ããŒã ã¡ã³ããŒãšã®é¢ãããšããç¹ã§ã¯ã ãšã³ãžãã¢ããŒã ã ãã§éçºãããšããããšã¯ãªããã»ãŒã«ã¹ãã«ã¹ã¿ããŒãµã¯ã»ã¹ã®æ¹ãã¡ãšäžç·ã«èŠä»¶ãè©°ããŠãã ããšãæè¿ã¯å€ãã§ãããã®ããã»ãŒã«ã¹ã®æ¥åãããŒãªã©ããã£ããã¢ããããå¿ èŠãããã®ã§å€§å€ã§ãããé¢çœããããããæãããšããã§ããããŸããã å²¡ç° : ã·ãŽããŒã¯ã§ã¯ãPM ãšãšã³ãžãã¢ã®äºäººäžèãšããäœå¶ã§éçºãããŠããŸããPM ãšæ¥ã èŠä»¶ãå·ãåãããªãããå®è£ ã¯èªåãè¡ãªã£ãŠããŠãããšããã¹ã¿ã€ã«ã§ããPull Request ã®ã¬ãã¥ãŒã ãã¯å ã ã·ãŽããŒã¯ãéçºãããŠãããšã³ãžãã¢ã®æ¹ã ã«ãé¡ãããŠããŸãã ãŸããäŸãã°ãããã¯ãã®ã»ãã¥ãªãã£åŒ·åã®åãçµã¿ãã¢ããªã®èªèšŒæ©èœã®äžæ°ãQA ç°å¢ã®æŽåãªã©ãèªåãæ®æ®µè§Šããªãé åã®æœçãè¡ã£ãéã¯ã¹ãã«ã¢ããã宿ã§ããŸãããã©ã€ãã©ãªã®ã¢ããããŒããããªãã¡ã¯ã¿ãªã³ã°ãªã©ã è£éãæã£ãŠããããŠããã£ãŠããŸã ã 埳氞 : ãžã§ãã¡ãã¬ãŒã¢ã«ãããŒã¯ãžã§ãã¡ãã¬ãŒã CLINICS ã«æ¯ã¹ããšå°èŠæš¡ãªããŒã æ§æãšãªã£ãŠããŸãããšã³ãžãã¢ã 7 人ãPM ã 3 人ããããã¯ããªãŒããŒã 1 人ãšããäœå¶ã§éçºãããŠãã®ã§ããã è¯ãæå³ã§æ°åå ¥ç€Ÿãšã³ãžãã¢ãšããŠè£éãæã£ãŠéçºããããŠããã£ãŠããŸã ã éçºããŒã ãåŸã ã«å€§ãããªã£ãŠããã®ã§ãã¿ã¹ã¯ãäžæãåãããã®ä»çµã¿ãèããããããŒã ãäžæãæ©èœãããããã«æäŒã®æ§æã倿ŽããŠã¿ãããæè¡çãªéšåã§ã¯ CI/CD ãªã©éçºå šäœã«é¢ããåéã«ã€ããŠããä»»ããŠããã£ãŠããŸãã ãŸã ãã¥ãŒã¹ãªãªãŒã¹ ã«ããªããŸãããã瀟å ã§åããŠã® çæ AI ã䜿ã£ãæ©èœã®éçº ã¯ããããã¯ããªãŒããŒãšèªåã® 2 人ãäžå¿ã«ãªã£ãŠé²ããŠãããŸããã éçºã«å ¥ãåæ®µéã§ããžã«ã«ã«ããããã£ã課é¡ããã®æ©èœã§è§£æ±ºããŠããããšããããšãäŒããããã°ãããçšåºŠæè¡çã«å®éšçãªãã®ãå°å ¥ããããšãã§ããç°å¢ã§ã ã å€å· : Pharms ã§ã¯çŸåšãšã³ãžãã¢ã 4 人ãPM 1 人ããã¶ã€ããŒã 1 人ãšããã®ãäžå¿ã¡ã³ããŒãšãªã£ãŠããŸããPharms ã¯çŸåšè²ã ãšæ©èœæ¡å€§ãããŠãã£ãŠããã®ã§ããããšã³ãžãã¢ã 4 人ãªã®ã§æ¬åœã«å šå¡ã§äœã§ããã£ãŠãããšããæãã§éçºããŠããŸãããšã¯ãããã¡ã³ããŒåã ã§åŸæåéã¯éãã®ã§ãåŸæãªãšããã¯ç©æ¥µçã«æŸãã«è¡ãæãã§ãã èªåã¯ãšèšããšãåŸæåéã®ã€ã³ãã©éšåã«é¢ããŠã¯ã»ãšãã©ä»»ããŠããã£ãŠãããèªåããã®çºä¿¡ã§å 茩ã®ããã¯ãªãŒããšã³ãžãã¢ã®æ¹ãšããåããããªããè²ã ãªæœçãè¡ãªã£ãŠããŸãããã®ä»ã«ãã¯ã©ãŒã¿ãŒæ¯ã«æ°åã¯äžã»å€§èŠæš¡ãªæœçãèšç»ãããã®ã§ããããããã®ã®ããã€ãã®ãªãŒãããããŠããã£ããããŠããŸããã§ãã®ã§ã ã¢ããªã±ãŒã·ã§ã³ã®éçºãšããé¢ã§ããããžã§ã¯ããäžæãé²è¡ããããšããé¢ã§ãããšãŠã楜ããæ¥åãããŠããŸã ã æäž : CLINICS ã§ã¯ãŸããåºå¹¹ããšãåšèŸºããšãã£ãã 2 ã€ã®ããŒã ã«åãããŠããããåºå¹¹ããäž»ã«ã¬ã»ã³ã³(ã¬ã»ããã³ã³ãã¥ãŒã¿ã®ç¥ãå»çæœèšããå¥åº·ä¿éºçµåãªã©ã®æ¯æãæ©é¢ã«å¯Ÿãã蚺çå ±é ¬ãè«æ±ããããã«ãé»åã«ã«ããšé£åããŠã¬ã»ãããšåŒã°ãã蚺çå ±é ¬æçްæžãäœæããã·ã¹ãã )ãšã®ãããšããããåšèŸºãã§ã¯äºçŽãå蚺ãè³æ Œç¢ºèªãªã© CLINICS ãšæ£è ãšã®æ¥ç¹ãšãªãã·ã¹ãã ããšããåœ¢ã§æ åœæ¥åãåãããŠããŸããèªåã¯ãã£ãšåºå¹¹ããŒã ã«ã¢ãµã€ã³ãããŠããŸããããŒã å šå¯Ÿå¿ã®ãšã³ãžãã¢ã®å èš³ã¯ã¢ããªã±ãŒã·ã§ã³æ åœã 6~7 人ãã€ã³ãã©æ åœã 3 人ã»ã©ã«ãªã£ãŠããŸãã çŸåšã¯å€§ããªãããžã§ã¯ãã 1 ã€é²è¡ããŠããŠãæ¢åã®ã¬ã»ã³ã³ãã¡ãã¬ãŒã§æ°èŠéçºããŠããã¬ã»ã³ã³ã«ç§»è¡ãããšãããã®ã§ããããã®äžã« äžèŠæš¡ãªãããžã§ã¯ããè€æ°å¹³è¡ããŠé²ãã§ããŠããã®å ã®ããã€ããèªåããªãŒã ãããŠããã£ãŠããŸãã ãªãŒãããŠãããããžã§ã¯ãã®é²è¡ç®¡çãããŒã ã¡ã³ããŒéã§ã®åé¡å ±ææ¹æ³ãªã©ãèããŠããã®ã§ããããã®èŸºãã¯ææŠã§ããå¹ ãåºããé£ããã§ããé¢çœããšæããŠããŸãã課é¡ã«ã€ããŠãããžã§ã¯ãã«éå®ãããä»ã®ã·ã¹ãã ãé²æç¶æ³ã«åœ±é¿ããªãããé æ ®ããå¿ èŠããããããããèŠç¹ã§é©åã«ç°ãªãç«å Žã®é¢ä¿è ãå·»ã蟌ãããšã§ãããå æ¬çãªè§£æ±ºçãå°ãåºãããšæèãããŠããŸãã å岡 : èªåã¯ä»ã¯æäžãšäžç·ã®ããŒã ã§æ¥åãããŠãããã§ãããã¬ã»ã³ã³ãªã©ã®éšåãšããããã¯ãå çšã®è©±ã®ãåšèŸºãã®éçºãããããšãå€ãã§ããåºæ¬çã«å¹³è¡ããŠè€æ°ã®ãããžã§ã¯ããèµ°ã£ãŠãããããããã®ãããžã§ã¯ãã§ãã£ã¬ã¯ã¿ãŒ 1 人ããšã³ãžãã¢æ°äººãä»ã«ãã¶ã€ããŒãšãã圢ã§é²ããŠããããšãå€ãã§ãã 倧ãŸãã«ãã£ã¬ã¯ã¿ãŒãèŠä»¶ãªã©ããŸãšãããã®ãããŒã¹ãšããŠããã®åŸã«ãã¶ã€ããŒããšã³ãžãã¢ãå ¥ã£ãŠèŠä»¶å®çŸ©ãªã©ãããŠãããåŸã ã«åœ¢ã«ããŠãããšããäºãå€ãã§ããã ââ ãäºäººã§çµãã§ä»äºãããããšããããã§ãã? æäž : ã¯ãããšãŠãå€ãã§ãã é²è¡ããŠãããããžã§ã¯ãã®ä»ã«ããå®åžžæ¹åããã°æ¹ä¿®ãªã©ã®ã¿ã¹ã¯ããããŸãããããããã¿ã¹ã¯ããã©ã®ã¿ã€ãã³ã°ã§ããã©ã®åªå 床ã§ã察å¿ããŠããããªã©ãããŒã å ã§è°è«ããŠãã宿œããã®ã§ã å岡 : ãããžã§ã¯ããããããã¿ã¹ã¯ãšã¯å¥ã«ããšã³ãžãã¢äž»å°ã§å€§èŠæš¡ãªãªãã¡ã¯ã¿ãªã³ã°ãªã©ãè¡ãªã£ãŠããŸããæ åœããŠãããããžã§ã¯ãã®ä»ã«ãããããã®ãæãããŠããŠãäžç·ã«ãªãããšãå€ãã§ãã å ¥ç€ŸããŠã¡ãã¬ãŒã®æåã匷ãæèããåºæ¥äº ââ ã¡ãã¬ãŒã§åããŠããäžã§ãç¹ã«æåã匷ãæãããšããœãŒããªã©èããŠã¿ããã§ãã é£¯ç° : éçºã«é¢ä¿ããäººå šå¡ãããããã¯ãå¿åã匷ãããšããããšã§ãããããå ·äœçã«ã¯ãéçºã®èŠä»¶å®çŸ©æ®µéããå šå¡é¢ããã®ã§ããã¡ããããžãã¹ãµã€ãã®æ¹ããããããããæ¹ãè¯ãã®ã§ã¯ãªããããšããã¢ã€ãã¢ã¯åºãŠããŸãããéçºãµã€ãããããã©ãããæ©èœãäžçªãŠãŒã¶ã«äŸ¡å€ãå±ãããããããšããèŠç¹ã§äžç·ã«ãªã£ãŠèãããã§ããããããã©ããã£ã課é¡ã解決ãããã®ãªã®ããšããåºç€ã®éšåããäžç·ã«èããŠããã®ãã¡ãã¬ãŒã§ã¯åœããåã«ãªã£ãŠãããšããæããããŸãã éçºãµã€ããããžãã¹ãµã€ããåãæ¹åãåããŠããã®ã§ãææ¡ãªã©ãã¡ãããšããžã«ã«ã§çãéã£ãŠãããã®ã§ããã°éããšããã®ã¯ããããæèŠãããããã ãšæããŸãããã®ããã®çžè«ãªãããããã¡ããããããã§ããããšãŠãè¯ãæåã ãªãšæããŠããŸãã å²¡ç° : éçºã«ããã£ãŠ PM ã æœçãªã©ã Issue ãšããŠç«ãŠãŠãããã®ã§ãããèšèªåãè¡ãå±ããŠããŠäœãåé¡ã§ãã©ãããŠå®æœããã®ãããã®åœ±é¿ãªããããããåããããããšããç¹ã¯ã¡ãã¬ãŒã倧äºã«ããŠãããããã¥ã¡ã³ãããªãã³ããšããæåãæããŸãã ãã®ãããªç°å¢ãªã®ã§ã倧æµã®ããšã¯æäœéã®æç« ã®ããåãã ãã§ã¹ã ãŒãºã«é²ã¿ãŸãããäžæããããªãç¶æ³ã«ãªã£ãŠãååŸçãªã©ãç«ãŠããããªã£ãŠãããšæããŸãã 埳氞 : ã¡ãã¬ãŒã¯æ°åå ¥ç€Ÿã®ç€Ÿå¡æ°ã¯å°ãªãã®ã§ãäžéå ¥ç€Ÿã®æ¹ãã»ãšãã©ãšããç°å¢ã§ããå ¥ç€ŸããŠããã¯ãèªåã®æèŠã¯éãã®ããªããšããèªåããåŸã«å ¥ç€Ÿããçµéšå¹Žæ°ãé·ãäžéå ¥ç€Ÿã®æ¹ãšã©ãä»ãåããããªã©ãå¿é ã§ãããã§ã ã¡ãã¬ãŒã§ã¯ã建èšçã«é²ããããšããæåãããã®ã§ãç«å Žã«é¢ä¿ãªãè°è«ã§ããç°å¢ãããã®ã§ããšãŠãä»äºããããã ã§ããèªåã®æèŠãäŸãééã£ãŠãããšããŠãè°è«ãèµ·ãããšããããšã¯ãèªèããºã¬ãŠãããšããããšã ãããšè»éä¿®æ£ãã§ããã®ã§æ¬åœã«åããããã§ãã ãŸãããšãŠãè¯ããªãšæã£ãã®ããéšçœ²ãè·çš®ã«é¢ããã Confluence ã®æ å ±ã«èª°ã§ãã¢ã¯ã»ã¹ã§ãããšããæåã§ãããç§å¿æ å ±ä»¥å€ã¯åºæ¬çã«å šãŠ Confluence ã§ãªãŒãã³ã«ãªã£ãŠãããããã§ãèªåãšã¯çŽæ¥é¢ä¿ãªãéšçœ²ã®çŸåšã®åããªã©ããã£ããã¢ããã§ããã®ã§ããããã£ã人ãã¡ãšã³ãã¥ãã±ãŒã·ã§ã³ãåããšãã«ããããå©ãããŸãã å€å· : 埳氞ãšãã¶ããšããããããã§ãããã建èšçã«é²ããããšããéšåã¯éåžžã«ã¡ãã¬ãŒããããæããæåã§ããäŸãã° PM ããæœçãããããŸãããããšãªã£ãŠããèªåãããã®ãããŒã£ãŠãããªã£ãæ¹ãè¯ãã§ãããããšããæèŠãèšãããããããèµ·ç¹ã« è°è«ã«çºå±ããŠããè¯ããã®ãäœã£ãŠããããšããã®ã¯æ¬åœã«çŽ æŽããã ãšæããŠããŸãã å®éã«èªåããªãŒãããŠããæœçã®äžã§ããšã³ãžãã¢ã» ãã¶ã€ããŒã» PM ã»ã«ã¹ã¿ããŒãµã¯ã»ã¹ãšããç«å Žãéãã¡ã³ããŒåå£«ã§æ¹ããŠè¬å±ã®æ¥åãããŒãæŽçããªãããŠãããè¯ã仿§ã«ã§ããããšããããšããããŸããã æ©èœãªãªãŒã¹åŸãã¡ãããšãããã¹ãå§¿ããç®æããŠæ¹åãã§ãããããã®ã§ãããããèãæ¹ã¯ãšãŠãä»äºãããããã§ãã æäž : èªåããã¯ãçµç¹æ°Žæºãé«ããããšããæåã«ã€ããŠèšåãããŠãã ãããèªåãé¢ãã£ãŠããé»åã«ã«ããã¬ã»ã³ã³ãšããé åã¯æ·±ãæ¥åç¥èãå¿ èŠã§ãåããŠé¢ãã£ã人ãããããšãããããã©ããããããŒã§æ©èœã䜿ãããŠããããšããç¹å®ã®å Žåã«äœã§ãããªããã ãããšãããšããããçè§£ãã¥ãããã§ããã§ããèªåã®ããŒã ã¯æ°åã»äžéåããããŸã æ·±ããã¡ã€ã³ç¥èããªãããšãã£ãç¶æ ããã§ãå ¥ã£ãп޻èºããããç°å¢ã ãšããã®ãæããŠããŸãã ãããªãå°éã®æ¥åç¥èãå¿ èŠãªéçºãšããã®ã¯ãã¯ãé£ããã®ã§ãããããéšåãšçŽæ¥ã¯é¢ä¿ããªãåšèŸºé åã®éçºããå§ããŠããã£ãŠãåŸã ã«é»åã«ã«ããã¬ã»ã³ã³ã«çŽæ¥é¢ä¿ããéçºã«å ¥ã£ãŠãããããããªãªã³ããŒãã£ã³ã°ãã§ããŠããŸããéçºã®äžã§ãããã¹ãå§¿ã«ã€ããŠè°è«ã«ãªã£ããã§è²ã ãªã¡ã³ããŒãšè©±ãããŠããã®ã§ã å»çæ¥åã®ãã£ããã¢ããã¯ããªãããããç°å¢ ã ãšæããŸãã ããã²ãšã€ãé·æã®ã«ã¹ã¿ããŒäŸ¡å€ã远æ±ããããšããéšåãæåãæããŠããŠãäž»ã«ãããŒãžã£ãŒãå«ããçæç㪠KPI ã«æ²¿ã£ãéçºããããé·æçã«é¡§å®¢ãžã®äŸ¡å€æäŸã«å¯äžã§ããéçºãåªå ããŠãããšããæèãéåžžã«åŒ·ãã®ãè¯ããšæããŸãã ç¹ã«ä»çŸåšã瀟å ã§éçºãé²ãã§ããæ°èŠã¬ã»ã³ã³ã®éçºã«ã€ããŠã¯åŒ·ãæããŸããã å岡 : èªåã匷ãæããŠããã¡ãã¬ãŒã®æåãšããŠã¯ãããã¥ã¡ã³ãããªãã³ãã§ããããŒãã£ã³ã°ãªã©ããããããããšã®çµè«ãåŸãããã«åè°ããããšããã®ãæç¢ºã«åããè³æãäºåã«çšæããŠè¡ããŸããã§ãã®ã§ããããäœã®æéã ã£ã?ãã¿ãããªç¶æ ã«ãªãã«ããã®ãè¯ãã§ãã ããšã¯ ããŒãã£ã³ã°ã«ããåæçãSlack ã Confluence ãªã©ã«ããéåæã®ã³ãã¥ãã±ãŒã·ã§ã³ã驿驿ã§å šå¡ã䜿ããããŠããã®ã§ãããããã³ãã¥ãã±ãŒã·ã§ã³ã§ç¡é§ãªè¡ãéãã®ãããªãã®ããã»ãšãã©ç¡ã ã®ããä»äºããããããšæã£ãŠããŸãã ããã²ãšã€ã¯ãèªåããã¯ããããã¯ãå¿åã®åŒ·ããšãããšãããæããŠããŸããçŸåšã¯ãã£ã¬ã¯ã¿ãŒãªã©ãšäžç·ã«éçºãããŠããäœå¶ã«ãªã£ãŠãããã§ãããUI ã顧客äœéšãªã©ãå«ããŠãšã³ãžãã¢ã§ããã¡ãããšãããã¯ããšããŠã®çæ³ã®å§¿ãèããŠéçºãããšããå§¿å¢ããšãŠã匷ãã§ããèªåã®å°éã§ã¯ãªãé åã§ããã¡ããšèããªããéçºãããŠããã®ã§ãããããããããŸãã ããããã¡ãã¬ãŒã«å ¥ç€Ÿããæ¹ãžã®ã¡ãã»ãŒãž ââ ã§ã¯æåŸã«ãªããŸãããç¹ã«æ°åã§ã¡ãã¬ãŒã®å ¥ç€ŸãèããŠããæ¹ãžã®ã¡ãã»ãŒãžãªã©ããã°ãã䌺ããããã§ãã é£¯ç° : ããã§ããããå èŒ©ãæ°åã«å¯ŸããŠãšãŠãæåŸ ããŠãããŠããããšããã®ã¯äŒããããšæããŸããèªåã®å Žåãç ä¿®ãçµãã£ãŠ 3 ã¶æçµã£ããããã§ãã·ãŽããŒã¯ã®ã€ã³ãã©ç°å¢ãå šéšå·æ°ãããšãã倧ããªãããžã§ã¯ãã®ãªãŒããä»»ããŠãããããã§ãããã¡ãã SRE ã®å 茩ãªã©ãšååãã€ã€é²ãããã®ã ã£ããã§ããã ç ä¿®çµãã£ãŠããã«ãããªå€§ããªãããžã§ã¯ããè£éæã£ãŠé²ãããããããªç°å¢ãªã®ã§ããããããããããããŸã ã å²¡ç° : çš²æ¬(人æãã©ãããã©ãŒã CTO)ããæ°åã ãããã¿ãããªæ¥ãæ¹ãããã«ããã¡ãšã³ãžãã¢ãšããŠæ¥ããŠãããŠããã®ã¯å人çã«å¬ãããã€ã³ãã§ãããŸã 責任ãæã£ãäžã§è£éæã£ãŠèªç±ã«åããŠãããæ¥åç°å¢ãããã®ãããããè¯ã ã§ããã¡ãããšãããã¯ãã®äºãèããŠéçºãããã人ã«ã¯ããããã§ããç°å¢ã ãšæããŸãã 埳氞 : æ°åã®è¯ããšããã¯ãåæãæãæãŠããšããããªãšæããŸããä»ãã©ã³ãçã§ãã®ã¡ã³ããŒãšæè¡çãªãšãããªã©ãæ°è»œã«çžè«ã§ããã®ã¯ãšãŠãè¯ãã§ãã åç£ç¢ç£šããŠããç°å¢ãããªãããªãšæã£ãŠããã®ã§ãããããç°å¢ãæ±ãããªããããè¯ã ãšæããŸãã å€å· : åã身ã§ä»äºãè¡ãã®ã§ã¯ãªããã¬ãã¬ããšèªåã®æ¹ããæ±ãã«ããå§¿å¢ã®äººã«ã¯ãããããããããäŒç€Ÿã ãšæããŸãããã£ããè£éæã£ãŠæ¥åãé²ããããšãã§ããç°å¢ãªã®ã§ã é æ ®ããã«ãããããšç©äºé²ããããšãã§ãã人ã«ã¯æé« ãªããããªãããšèããŠããŸãã èªåã¯ã€ã³ãã©ã ãã§ã¯ãªããŠããµãŒããããã³ããšã³ããéçºããŠãããããšèããŠãããã§ãããå°èŠæš¡ãªãããžã§ã¯ãã§ããã°å šãŠè¡ããç°å¢ãªãããèªåäžäººã§ãããžã§ã¯ããå®çµããããšãã§ããã®ã¯ãæ§ã«åã£ãŠãããªãšæã£ãŠãŸããåšãã®ãµããŒããå 茩ãšã®å£æã¡ãªã©ã¯ã¡ãããšãã£ãŠããããã®ã§ããšãŠãå匷ã«ãªãæé·ã§ãããšæããŸãã æäž : ã¡ãã¬ãŒã§éçºãããŠããã«ã€ãããŠãå»çãã¡ã€ã³ãšããé åã§èªåãé¢ãã£ãŠããããšã人ã®åœ¹ã«ç«ã£ãŠãããã ãªãšããã®ãæ¥ã 宿ã§ãããšããã¯è¯ãã§ããç¹ã«è²ã ãªå»çæ©é¢ã®ãµããŒããã§ãããšãããããã¯ãã«é¢ãã£ãŠããã®ã§ãçŽæ¥å»çæ©é¢ããã®å ã«ããæ£è ãã㮠圹ã«ç«ã£ãŠãããšãã宿ã¯ãæ£çŽ 1 幎ç®ã§æãããããã®ã§ã¯ãªããšæã£ãŠããã®ã§ãè¯ãé©ã ã§ãã ãŸã倧ããããŒã¿ãåãæ±ããšããçµéšãã§ããŠããã®ã貎éã ãªãšæããŠããŸããçŸåšã®ãããã¯ãã§ã¯å¥çŽå»çæ©é¢ãéåžžã«å€ãã§ããããã®å€§éã®ããŒã¿ã®èšèšã倿Žããããšãããšããããè£éæã£ãŠå®æœã§ããã®ã¯è¯ãçµéšã«ãªã£ãŠããŸãã å岡 : ã¡ãã¬ãŒã®ããããã¯ãå¿åããæã£ãŠããå 茩ãšã³ãžãã¢ãšåãããšããã®ã¯ãšãŠãè¯ãçµéšã ãšæã£ãŠããŸããäžè¬çã«ã¯ãšã³ãžãã¢ã¯æè¡ããããã°ãšããæãã«ãªããããã£ãããããšæãã®ã§ãããã¡ãã¬ãŒã§ã¯ãã¡ããæ°ããæè¡ãªã©ã䜿ããªãããããã ããã«ãããã¯ãããã®å ã®ãŠãŒã¶ãžã®äŸ¡å€æäŸã«ç¹ããããèããŠããæ¹ãéã£ãŠãã ã®ã§ãããããæèã§ãããã¯ãéçºãã§ããŠããã®ã¯ãããå匷ã«ãªããŸãã ââ ããããšãããããŸãã! æ¬åœã« 1 幎ã§çãããæ¿ãæ¥åçµéšãç©ãã§ããã®ãåããã€ã³ã¿ãã¥ãŒã«ãªããŸããã ãããã« ããããç°ãªãããŒã ãæ¥åå 容ã§ãããæ°åãšã³ãžãã¢ã§ãè£éãæã£ãŠæ¥åã«èšããããšãããããã¯ãã®éèŠãªéšåã®éçºã«ã©ãã©ãé¢ãã£ãŠãããããšãäŒããã€ã³ã¿ãã¥ãŒãšãªããŸããã ã¡ãã¬ãŒã¯æ°åå ¥ç€Ÿã®ãšã³ãžãã¢ãç©æ¥µçã«åéããŠããŸãã®ã§ãä»åæ°ã«ãªã£ããšããæ¹ã¯ãæ°è»œã«ã«ãžã¥ã¢ã«é¢è«ãããŸããã! open.talentio.com open.talentio.com
æ ªåŒäŒç€Ÿã¡ãã¬ãŒ
2024/04/05
<![CDATA[ FY22 æ°åå ¥ç€Ÿãšã³ãžãã¢ã¯ãã® 1 幎ã§ã©ã®ãããªæé·ãããŠããã®ãã€ã³ã¿ãã¥ãŒããŸãã ]]>
ã¯ããã« ã¿ãªãããããã«ã¡ã¯ããšã³ãžãã¢ã®æ°å± ã§ããä»å㯠2022 幎æ°åå ¥ç€Ÿãããšã³ãžãã¢éã«ã€ã³ã¿ãã¥ãŒããèšäºããéãããŸãã ãã® 1 幎ã§åœŒããã©ã®ãããªæ¥åãçµéšããŠããã®ããããªã¢ã«ãªçŸåšã®ç«ã¡äœçœ®ãªã©ããäŒãããããšèããŠããŸãã ããã§ã¯ãã芧ãã ãã! èªå·±çŽ¹ä» é£¯ç°ãã ç ä¿®åŸã¯ ãžã§ãã¡ãã¬ãŒ ã§é¡§å®¢åãã®æ©èœéçºãæ åœããã®åŸ ã·ãŽããŒã¯ ã§ã€ã³ãã©é åãäžå¿ã«ãªãã¥ãŒã¢ã«ã«åŸäºãããçŸåšã¯ Jobley ã§æœçã®éçºãã€ã³ãã©åšããŸã§å¹ åºãæ¥åãæ åœã 飯ç°ãã 岡ç°ãã ç ä¿®åŸã¯ãžã§ãã¡ãã¬ãŒã§ã®éçºæ¥åãæ åœåŸãã·ãŽããŒã¯ãžããžã§ãã¡ãã¬ãŒãšã®é£æºåŒ·åã®ãããžã§ã¯ããªã©çµéšããçŸåšã¯ã·ãŽããŒã¯ã®éçºå šè¬ãæ åœã 岡ç°ãã 埳氞ãã ç ä¿®åŸã¯ ãžã§ãã¡ãã¬ãŒã¢ã«ãã㌠ã«é å±ããããã¯ãæ¹åãªã©ãæ åœãã€ã€ãçŽè¿ã§ã¯çæ AI ã䜿ã£ãæ©èœã®éçºãããã¯ãšã³ãããã¢ãã€ã«ãŸã§å¹ åºãéçºã«åŸäºã 埳氞ãã å€å·ãã ç ä¿®åŸã¯ Pharms ã«é å±ãããã³ããšã³ãããã€ã³ãã©ãŸã§å¹ åºãæ åœãå°èŠæš¡æœçã®éçºã«å§ãŸãçŸåšã¯äžèŠæš¡æœçã®ãããžã§ã¯ããªãŒããããªããéçºãè¡ãªãã å€å·ãã æäžãã ç ä¿®åŸã¯ CLINICS ã«é å±ãé»åã«ã«ãé¢é£ã®éçºãçµãŠãçŸåšã¯äžèŠæš¡æœçã®ãããžã§ã¯ããªãŒããããªããéçºãè¡ãªãã æäžãã å岡ãã ç ä¿®åŸã¯ æ£è ã¢ã㪠CLINICS ã«é å±ãWeb ã¢ããªãšãã€ãã£ãã¢ããªã®æ©èœéçºãæ åœããåŸãCLINICS ã«é å±ãçŸåšã¯å®åžžæ¹åããããã³ããšã³ãã®å€§èŠæš¡æ¹ä¿®ãªã©ã«åŸäºã å岡ãã ãã¡ãŒã¹ããã£ãªã¢ãšããŠã¡ãã¬ãŒãéžãã çç±ã«ã€ã㊠ââ ãŸãã¯ãã¡ãŒã¹ããã£ãªã¢ã«ã¡ãã¬ãŒãžå ¥ç€Ÿã決ããçç±ãã䌺ãããŠãããããšæããŸãã é£¯ç° : å ã ãã³ãã£ãŒæ°è³ªãé«ãããšã軞ã«äŒç€Ÿéžã³ãããŠããŸãããæ°åå ¥ç€Ÿã®ç€Ÿå¡ã倿°ãããããªèŠæš¡ã倧ããäŒç€Ÿã ãšãèªåããã®äžã«åãããŠããŸããèªç±åºŠãé«ãåããã§ããªãããã ãšèããŠããããã§ããã¡ãã¬ãŒã¯æ°åãå°ãªãã®ã§ãã®èŸºãã¯ãããããŠããŸãããå»çãšããé åã«é¢ããŠãã æ¥åžžç掻ã«é¢ãããšããã§ç€ŸäŒã«è²¢ç®ã§ãããããªé åãè¯ããªãšèããŠããããšããå®¶æãçè·åž«ããã£ãŠããããšãããå»çæ¥çã®èª²é¡ã身è¿ã«æããããå»çã«å¯ŸããŠèå³ããã£ã ããšãçç±ã«ãªã£ãŠããŸãã å²¡ç° : èªåã®äœèª¿ãæªããªãããšãæããå€ãã£ããããã«ã¹ã±ã¢æ¥çã«èå³ããã£ãã®ã§ãããããã«è¿ãæ¥çã ã£ãã®ãã²ãšã€ã®çç±ã§ãããŸãäŒç€Ÿã®ããã·ã§ã³ããšãŠãåãããããã£ããšããã®ããããŸããä»ç€Ÿã«æ¯ã¹ãŠãã¡ãã¬ãŒã¯ äžã®äžãè¯ãããŠããšããäŒç€Ÿã®ããžã§ã³ã«ãã¡ãããšåºã¥ããŠãããã¯ããéçºããŠãã ãã ãªãšããã®ãå ·äœçã«åãã£ãŠäžè²«æ§ãæããããã®ã倧ããã§ãã ä»ã«ã¯ãããšã³ãžãã¢ããšããè·çš®ã ãšãã¡ããæè¡åéãå°éé åã«ãªã£ãŠããããã§ããããã®é åã«éããããããã¯ããäžå¿ã«èª²é¡è§£æ±ºããäžã§ãšã³ãžãã¢ãªã³ã°ä»¥å€ã®ããšãèããªããéçºãããŠãããããã¯ããã¡ãŒã¹ããªèããé åçã§ããã 埳氞 : èªåã¯å²¡ç°ããã®ããã«ç¹ã«ãã«ã¹ã±ã¢é åã«èå³ããã£ããšããããšã¯ãªãã£ããã§ããã©ã¡ãããšãããšã ãšã³ãžãã¢ãšããŠããããåããŠããäžã§èªåã倧åã«ãããå¿åã䟡å€èгãšããã®ããã¡ãã¬ãŒã®ãšã³ãžãã¢ã®æ¹éãšè©±ãããŠããäžã§ããããã ãªãšæããã®ã倧ããã§ãã ãããŸã§ãè²ã ãªäŒç€Ÿãããšã®éžèãããŠãããã§ãããã¡ãã¬ãŒã®ãšã³ãžãã¢ã¯ãæ¬è³ªãè¿œãæ±ããããšããå§¿å¢ã®å ããšã³ãžãã¢ãªã³ã°ã奜ãã§ãããããããã¯ããžéå ããŠãããšããéšåãèªåã®ãã£ãŒãªã³ã°ã«ãã£ããšããæãã§ããã ââ ãã£ãŒãªã³ã°ã«åã£ããšããããšã§ãããä»ã«ãããããããšæã£ãéšåã¯ãããŸããã? 埳氞 : ãšã³ãžãã¢ã®é°å²æ°ãå€§äººãªæãã®æ¹ãå€ããäœè²äŒç³»ã®ãæ°åãšæ ¹æ§ã§é 匵ãããšããé²ãæ¹ã§ã¯ãªããåççã«ç©äºãé²ããããã«å¿ èŠãªã³ãã¥ãã±ãŒã·ã§ã³ããã¡ããšåã£ãŠãããšãããªã©ãé åã§ãããããããéšåãå«ããŠèªåãåããŠããå°æ¥ãšããã®ãæ³åã§ããŸããã å€å· : èªåã¯èŠªãè¬å€åž«ã§å»çåéã«å ã èå³ããããå»ç x IT ãšãã軞ã§å°±æŽ»ãããŠããéçšã§ã¡ãã¬ãŒãç¥ã£ãã®ãæåã®åºäŒãã§ãããã話ãèããŠãããã¡ã«ã課é¡è§£æ±ºã®ããã®ãããã¯ãäœãããšããç¹ãéåžžã«é åã«æããŸããã瀟äŒãè¯ãããããã«ãããã¯ããè¯ãããŠããããšããå§¿å¢ã§äŒç€Ÿã«äžäœæãçãŸããŠããã®ãããããè¯ããªãšã äŒç€Ÿã«éããªããããããªãã§ãããçµç¹ã人ãå€ããªã£ãŠãããšãã£ã±ãæ¹åæ§ãå°ããã€ãºã¬ãŠãããšããæãã«ãªããã¡ã ãšæããã§ãããã¡ãã¬ãŒã®å Žå㯠äŒç€ŸãšããŠãå»çæ¥çããã£ãšè¯ãããŠããããã®äºæ¥ãããŠããããšãã軞ãéã£ãŠãã ã®ãæããŠãæçµçã«ã¯ãã®éšåã«æ¹ãããŠå ¥ç€Ÿã決ããŸããã ããšã¯ãäžå ŽäŒæ¥ãšãããå®å¿æãããã¡ãŒã¹ããã£ãªã¢ã®éžæã«åœ±é¿ããŸããã å²¡ç° : èªåãæ°åå ¥ç€Ÿã®ç€Ÿå¡ç®ç·ã ãšãå ¥ç€ŸããäŒç€Ÿã®å®å®æãšããã®ã¯éèŠã ãšæã£ãŠããŸããã æäž : 就掻ããåã¯ç¹å®ã®æ¥çã«éããè²ã ãªäŒç€ŸãèŠãŠããŸãããåŠçæä»£ã«æ§ã ãªæ¥çã®ãšã³ãžãã¢ã€ã³ã¿ãŒã³ãã¢ã«ãã€ããªã©ããŠããã®ã§ããããã®éçšã§ããã£ããæ£ç€Ÿå¡ã§åããªãããã瀟äŒçæçŸ©ãããäºæ¥ãããã¹ãã ãªããšæããŸãããããããæèã§å°±æŽ»ã«èšãã§ èªåãèå³ãæã£ãŠåãçµããããªã®ã¯å»çæ¥çã ãªãšæã£ã ã®ãæåã®ãã£ããã§ããã ã¡ãã¬ãŒã¯éžèã®äžã§ãæè¡é åãåããã«éçºã§ããããšãªã©ãããããããšæããã®ãšããµãŒãã¹ãå»çæ©é¢ã ãã§ãªãæ£è åŽãå å®ããŠãããšããããšãå ¥ç€Ÿã®æ±ºãæã«ãªããŸãããèªåãæ£è ã«ãªãããšãå€ãã®ã§ããšãŠã課é¡ãåãããããã£ããã§ãã å岡 : èªåãå ã ãšã³ã¿ã¡ãªã©ã®é åãããå»çãæè²ãéèé åãäžå¿ã«å°±æŽ»ãããŠããŸãããäžã§ãã¡ãã¬ãŒã®ãå»çãã«ã¹ã±ã¢ã®æªæ¥ãã€ããããšããããã·ã§ã³ãžã®èªåã®å ±æåºŠãéåžžã«é«ãã£ãã®ããå ¥ç€Ÿã®çç±ã§ãããæ¥æ¬ã®å»çå¶åºŠããã¡ããšç¶æããããã®ãããã¯ããäœã£ãŠãããã ãšããå§¿å¢ãéåžžã«è¯ãã£ãã§ãã ãŸãããã»ã©ã®è©±ã«ãåºãŠããŸãããã å»çæ©é¢ã®ããã®ãããã¯ããšæ£è ã®ããã®ãããã¯ããšããäž¡é¢ãžã®ã¢ãããŒããããŠãã ã®ã決ãæã§ããããã¯ãå»çè²»ã®åé¡ãªã©ã¯å»çæ©é¢ã ããžã®ã¢ãããŒãã§ã¯è§£æ±ºã§ããªããšæãã®ã§ãããããæå³ã§ãäžè²«æ§ãæããããŠè¯ãã£ãã§ãã çŸåšã®ããŒã å ã§ã®åœ¹å²ã«ã€ã㊠ââ ã§ã¯æ¬¡ã«çŸåšã®ããŒã ã§ã®çããã®åœ¹å²ãåãæ¹ãããŒã ã¡ã³ããŒãšã®é¢ããæ¹ã«ã€ããŠèããŠãããããšæããŸãã é£¯ç° : çŸåš Jobley ã®éçºããŒã ã§ã¯ãšã³ãžãã¢ã 4 人ããã®ã§ããããã®å 2 人ããããã¯ãæœçã®ç«æ¡ãè¡ãªãã€ã€ãèªåãå«ãæ®ãã® 2 人ãå®è£ ãã¡ã€ã³ã«ããŠéçºãè¡ãªã£ãŠããŸããç¶æ³ã«åãã PM å Œä»»ã®ãšã³ãžãã¢ãšå®è£ æ åœã®ãšã³ãžãã¢ãšã§äºäººäžèã§éçºãããããåç¬ã§ã®éçºãè¡ãªã£ãããšæè»ã«å¯Ÿå¿ããŠãã£ãŠãŸãã ããŒã ã¡ã³ããŒãšã®é¢ãããšããç¹ã§ã¯ã ãšã³ãžãã¢ããŒã ã ãã§éçºãããšããããšã¯ãªããã»ãŒã«ã¹ãã«ã¹ã¿ããŒãµã¯ã»ã¹ã®æ¹ãã¡ãšäžç·ã«èŠä»¶ãè©°ããŠãã ããšãæè¿ã¯å€ãã§ãããã®ããã»ãŒã«ã¹ã®æ¥åãããŒãªã©ããã£ããã¢ããããå¿ èŠãããã®ã§å€§å€ã§ãããé¢çœããããããæãããšããã§ããããŸããã å²¡ç° : ã·ãŽããŒã¯ã§ã¯ãPM ãšãšã³ãžãã¢ã®äºäººäžèãšããäœå¶ã§éçºãããŠããŸããPM ãšæ¥ã èŠä»¶ãå·ãåãããªãããå®è£ ã¯èªåãè¡ãªã£ãŠããŠãããšããã¹ã¿ã€ã«ã§ããPull Request ã®ã¬ãã¥ãŒã ãã¯å ã ã·ãŽããŒã¯ãéçºãããŠãããšã³ãžãã¢ã®æ¹ã ã«ãé¡ãããŠããŸãã ãŸããäŸãã°ãããã¯ãã®ã»ãã¥ãªãã£åŒ·åã®åãçµã¿ãã¢ããªã®èªèšŒæ©èœã®äžæ°ãQA ç°å¢ã®æŽåãªã©ãèªåãæ®æ®µè§Šããªãé åã®æœçãè¡ã£ãéã¯ã¹ãã«ã¢ããã宿ã§ããŸãããã©ã€ãã©ãªã®ã¢ããããŒããããªãã¡ã¯ã¿ãªã³ã°ãªã©ã è£éãæã£ãŠããããŠããã£ãŠããŸã ã 埳氞 : ãžã§ãã¡ãã¬ãŒã¢ã«ãããŒã¯ãžã§ãã¡ãã¬ãŒã CLINICS ã«æ¯ã¹ããšå°èŠæš¡ãªããŒã æ§æãšãªã£ãŠããŸãããšã³ãžãã¢ã 7 人ãPM ã 3 人ããããã¯ããªãŒããŒã 1 人ãšããäœå¶ã§éçºãããŠãã®ã§ããã è¯ãæå³ã§æ°åå ¥ç€Ÿãšã³ãžãã¢ãšããŠè£éãæã£ãŠéçºããããŠããã£ãŠããŸã ã éçºããŒã ãåŸã ã«å€§ãããªã£ãŠããã®ã§ãã¿ã¹ã¯ãäžæãåãããã®ä»çµã¿ãèããããããŒã ãäžæãæ©èœãããããã«æäŒã®æ§æã倿ŽããŠã¿ãããæè¡çãªéšåã§ã¯ CI/CD ãªã©éçºå šäœã«é¢ããåéã«ã€ããŠããä»»ããŠããã£ãŠããŸãã ãŸã ãã¥ãŒã¹ãªãªãŒã¹ ã«ããªããŸãããã瀟å ã§åããŠã® çæ AI ã䜿ã£ãæ©èœã®éçº ã¯ããããã¯ããªãŒããŒãšèªåã® 2 人ãäžå¿ã«ãªã£ãŠé²ããŠãããŸããã éçºã«å ¥ãåæ®µéã§ããžã«ã«ã«ããããã£ã課é¡ããã®æ©èœã§è§£æ±ºããŠããããšããããšãäŒããããã°ãããçšåºŠæè¡çã«å®éšçãªãã®ãå°å ¥ããããšãã§ããç°å¢ã§ã ã å€å· : Pharms ã§ã¯çŸåšãšã³ãžãã¢ã 4 人ãPM 1 人ããã¶ã€ããŒã 1 人ãšããã®ãäžå¿ã¡ã³ããŒãšãªã£ãŠããŸããPharms ã¯çŸåšè²ã ãšæ©èœæ¡å€§ãããŠãã£ãŠããã®ã§ããããšã³ãžãã¢ã 4 人ãªã®ã§æ¬åœã«å šå¡ã§äœã§ããã£ãŠãããšããæãã§éçºããŠããŸãããšã¯ãããã¡ã³ããŒåã ã§åŸæåéã¯éãã®ã§ãåŸæãªãšããã¯ç©æ¥µçã«æŸãã«è¡ãæãã§ãã èªåã¯ãšèšããšãåŸæåéã®ã€ã³ãã©éšåã«é¢ããŠã¯ã»ãšãã©ä»»ããŠããã£ãŠãããèªåããã®çºä¿¡ã§å 茩ã®ããã¯ãªãŒããšã³ãžãã¢ã®æ¹ãšããåããããªããè²ã ãªæœçãè¡ãªã£ãŠããŸãããã®ä»ã«ãã¯ã©ãŒã¿ãŒæ¯ã«æ°åã¯äžã»å€§èŠæš¡ãªæœçãèšç»ãããã®ã§ããããããã®ã®ããã€ãã®ãªãŒãããããŠããã£ããããŠããŸããã§ãã®ã§ã ã¢ããªã±ãŒã·ã§ã³ã®éçºãšããé¢ã§ããããžã§ã¯ããäžæãé²è¡ããããšããé¢ã§ãããšãŠã楜ããæ¥åãããŠããŸã ã æäž : CLINICS ã§ã¯ãŸããåºå¹¹ããšãåšèŸºããšãã£ãã 2 ã€ã®ããŒã ã«åãããŠããããåºå¹¹ããäž»ã«ã¬ã»ã³ã³(ã¬ã»ããã³ã³ãã¥ãŒã¿ã®ç¥ãå»çæœèšããå¥åº·ä¿éºçµåãªã©ã®æ¯æãæ©é¢ã«å¯Ÿãã蚺çå ±é ¬ãè«æ±ããããã«ãé»åã«ã«ããšé£åããŠã¬ã»ãããšåŒã°ãã蚺çå ±é ¬æçްæžãäœæããã·ã¹ãã )ãšã®ãããšããããåšèŸºãã§ã¯äºçŽãå蚺ãè³æ Œç¢ºèªãªã© CLINICS ãšæ£è ãšã®æ¥ç¹ãšãªãã·ã¹ãã ããšããåœ¢ã§æ åœæ¥åãåãããŠããŸããèªåã¯ãã£ãšåºå¹¹ããŒã ã«ã¢ãµã€ã³ãããŠããŸããããŒã å šå¯Ÿå¿ã®ãšã³ãžãã¢ã®å èš³ã¯ã¢ããªã±ãŒã·ã§ã³æ åœã 6~7 人ãã€ã³ãã©æ åœã 3 人ã»ã©ã«ãªã£ãŠããŸãã çŸåšã¯å€§ããªãããžã§ã¯ãã 1 ã€é²è¡ããŠããŠãæ¢åã®ã¬ã»ã³ã³ãã¡ãã¬ãŒã§æ°èŠéçºããŠããã¬ã»ã³ã³ã«ç§»è¡ãããšãããã®ã§ããããã®äžã« äžèŠæš¡ãªãããžã§ã¯ããè€æ°å¹³è¡ããŠé²ãã§ããŠããã®å ã®ããã€ããèªåããªãŒã ãããŠããã£ãŠããŸãã ãªãŒãããŠãããããžã§ã¯ãã®é²è¡ç®¡çãããŒã ã¡ã³ããŒéã§ã®åé¡å ±ææ¹æ³ãªã©ãèããŠããã®ã§ããããã®èŸºãã¯ææŠã§ããå¹ ãåºããé£ããã§ããé¢çœããšæããŠããŸãã課é¡ã«ã€ããŠãããžã§ã¯ãã«éå®ãããä»ã®ã·ã¹ãã ãé²æç¶æ³ã«åœ±é¿ããªãããé æ ®ããå¿ èŠããããããããèŠç¹ã§é©åã«ç°ãªãç«å Žã®é¢ä¿è ãå·»ã蟌ãããšã§ãããå æ¬çãªè§£æ±ºçãå°ãåºãããšæèãããŠããŸãã å岡 : èªåã¯ä»ã¯æäžãšäžç·ã®ããŒã ã§æ¥åãããŠãããã§ãããã¬ã»ã³ã³ãªã©ã®éšåãšããããã¯ãå çšã®è©±ã®ãåšèŸºãã®éçºãããããšãå€ãã§ããåºæ¬çã«å¹³è¡ããŠè€æ°ã®ãããžã§ã¯ããèµ°ã£ãŠãããããããã®ãããžã§ã¯ãã§ãã£ã¬ã¯ã¿ãŒ 1 人ããšã³ãžãã¢æ°äººãä»ã«ãã¶ã€ããŒãšãã圢ã§é²ããŠããããšãå€ãã§ãã 倧ãŸãã«ãã£ã¬ã¯ã¿ãŒãèŠä»¶ãªã©ããŸãšãããã®ãããŒã¹ãšããŠããã®åŸã«ãã¶ã€ããŒããšã³ãžãã¢ãå ¥ã£ãŠèŠä»¶å®çŸ©ãªã©ãããŠãããåŸã ã«åœ¢ã«ããŠãããšããäºãå€ãã§ããã ââ ãäºäººã§çµãã§ä»äºãããããšããããã§ãã? æäž : ã¯ãããšãŠãå€ãã§ãã é²è¡ããŠãããããžã§ã¯ãã®ä»ã«ããå®åžžæ¹åããã°æ¹ä¿®ãªã©ã®ã¿ã¹ã¯ããããŸãããããããã¿ã¹ã¯ããã©ã®ã¿ã€ãã³ã°ã§ããã©ã®åªå 床ã§ã察å¿ããŠããããªã©ãããŒã å ã§è°è«ããŠãã宿œããã®ã§ã å岡 : ãããžã§ã¯ããããããã¿ã¹ã¯ãšã¯å¥ã«ããšã³ãžãã¢äž»å°ã§å€§èŠæš¡ãªãªãã¡ã¯ã¿ãªã³ã°ãªã©ãè¡ãªã£ãŠããŸããæ åœããŠãããããžã§ã¯ãã®ä»ã«ãããããã®ãæãããŠããŠãäžç·ã«ãªãããšãå€ãã§ãã å ¥ç€ŸããŠã¡ãã¬ãŒã®æåã匷ãæèããåºæ¥äº ââ ã¡ãã¬ãŒã§åããŠããäžã§ãç¹ã«æåã匷ãæãããšããœãŒããªã©èããŠã¿ããã§ãã é£¯ç° : éçºã«é¢ä¿ããäººå šå¡ãããããã¯ãå¿åã匷ãããšããããšã§ãããããå ·äœçã«ã¯ãéçºã®èŠä»¶å®çŸ©æ®µéããå šå¡é¢ããã®ã§ããã¡ããããžãã¹ãµã€ãã®æ¹ããããããããæ¹ãè¯ãã®ã§ã¯ãªããããšããã¢ã€ãã¢ã¯åºãŠããŸãããéçºãµã€ãããããã©ãããæ©èœãäžçªãŠãŒã¶ã«äŸ¡å€ãå±ãããããããšããèŠç¹ã§äžç·ã«ãªã£ãŠèãããã§ããããããã©ããã£ã課é¡ã解決ãããã®ãªã®ããšããåºç€ã®éšåããäžç·ã«èããŠããã®ãã¡ãã¬ãŒã§ã¯åœããåã«ãªã£ãŠãããšããæããããŸãã éçºãµã€ããããžãã¹ãµã€ããåãæ¹åãåããŠããã®ã§ãææ¡ãªã©ãã¡ãããšããžã«ã«ã§çãéã£ãŠãããã®ã§ããã°éããšããã®ã¯ããããæèŠãããããã ãšæããŸãããã®ããã®çžè«ãªãããããã¡ããããããã§ããããšãŠãè¯ãæåã ãªãšæããŠããŸãã å²¡ç° : éçºã«ããã£ãŠ PM ã æœçãªã©ã Issue ãšããŠç«ãŠãŠãããã®ã§ãããèšèªåãè¡ãå±ããŠããŠäœãåé¡ã§ãã©ãããŠå®æœããã®ãããã®åœ±é¿ãªããããããåããããããšããç¹ã¯ã¡ãã¬ãŒã倧äºã«ããŠãããããã¥ã¡ã³ãããªãã³ããšããæåãæããŸãã ãã®ãããªç°å¢ãªã®ã§ã倧æµã®ããšã¯æäœéã®æç« ã®ããåãã ãã§ã¹ã ãŒãºã«é²ã¿ãŸãããäžæããããªãç¶æ³ã«ãªã£ãŠãååŸçãªã©ãç«ãŠããããªã£ãŠãããšæããŸãã 埳氞 : ã¡ãã¬ãŒã¯æ°åå ¥ç€Ÿã®ç€Ÿå¡æ°ã¯å°ãªãã®ã§ãäžéå ¥ç€Ÿã®æ¹ãã»ãšãã©ãšããç°å¢ã§ããå ¥ç€ŸããŠããã¯ãèªåã®æèŠã¯éãã®ããªããšããèªåããåŸã«å ¥ç€Ÿããçµéšå¹Žæ°ãé·ãäžéå ¥ç€Ÿã®æ¹ãšã©ãä»ãåããããªã©ãå¿é ã§ãããã§ã ã¡ãã¬ãŒã§ã¯ã建èšçã«é²ããããšããæåãããã®ã§ãç«å Žã«é¢ä¿ãªãè°è«ã§ããç°å¢ãããã®ã§ããšãŠãä»äºããããã ã§ããèªåã®æèŠãäŸãééã£ãŠãããšããŠãè°è«ãèµ·ãããšããããšã¯ãèªèããºã¬ãŠãããšããããšã ãããšè»éä¿®æ£ãã§ããã®ã§æ¬åœã«åããããã§ãã ãŸãããšãŠãè¯ããªãšæã£ãã®ããéšçœ²ãè·çš®ã«é¢ããã Confluence ã®æ å ±ã«èª°ã§ãã¢ã¯ã»ã¹ã§ãããšããæåã§ãããç§å¿æ å ±ä»¥å€ã¯åºæ¬çã«å šãŠ Confluence ã§ãªãŒãã³ã«ãªã£ãŠãããããã§ãèªåãšã¯çŽæ¥é¢ä¿ãªãéšçœ²ã®çŸåšã®åããªã©ããã£ããã¢ããã§ããã®ã§ããããã£ã人ãã¡ãšã³ãã¥ãã±ãŒã·ã§ã³ãåããšãã«ããããå©ãããŸãã å€å· : 埳氞ãšãã¶ããšããããããã§ãããã建èšçã«é²ããããšããéšåã¯éåžžã«ã¡ãã¬ãŒããããæããæåã§ããäŸãã° PM ããæœçãããããŸãããããšãªã£ãŠããèªåãããã®ãããŒã£ãŠãããªã£ãæ¹ãè¯ãã§ãããããšããæèŠãèšãããããããèµ·ç¹ã« è°è«ã«çºå±ããŠããè¯ããã®ãäœã£ãŠããããšããã®ã¯æ¬åœã«çŽ æŽããã ãšæããŠããŸãã å®éã«èªåããªãŒãããŠããæœçã®äžã§ããšã³ãžãã¢ã» ãã¶ã€ããŒã» PM ã»ã«ã¹ã¿ããŒãµã¯ã»ã¹ãšããç«å Žãéãã¡ã³ããŒåå£«ã§æ¹ããŠè¬å±ã®æ¥åãããŒãæŽçããªãããŠãããè¯ã仿§ã«ã§ããããšããããšããããŸããã æ©èœãªãªãŒã¹åŸãã¡ãããšãããã¹ãå§¿ããç®æããŠæ¹åãã§ãããããã®ã§ãããããèãæ¹ã¯ãšãŠãä»äºãããããã§ãã æäž : èªåããã¯ãçµç¹æ°Žæºãé«ããããšããæåã«ã€ããŠèšåãããŠãã ãããèªåãé¢ãã£ãŠããé»åã«ã«ããã¬ã»ã³ã³ãšããé åã¯æ·±ãæ¥åç¥èãå¿ èŠã§ãåããŠé¢ãã£ã人ãããããšãããããã©ããããããŒã§æ©èœã䜿ãããŠããããšããç¹å®ã®å Žåã«äœã§ãããªããã ãããšãããšããããçè§£ãã¥ãããã§ããã§ããèªåã®ããŒã ã¯æ°åã»äžéåããããŸã æ·±ããã¡ã€ã³ç¥èããªãããšãã£ãç¶æ ããã§ãå ¥ã£ãп޻èºããããç°å¢ã ãšããã®ãæããŠããŸãã ãããªãå°éã®æ¥åç¥èãå¿ èŠãªéçºãšããã®ã¯ãã¯ãé£ããã®ã§ãããããéšåãšçŽæ¥ã¯é¢ä¿ããªãåšèŸºé åã®éçºããå§ããŠããã£ãŠãåŸã ã«é»åã«ã«ããã¬ã»ã³ã³ã«çŽæ¥é¢ä¿ããéçºã«å ¥ã£ãŠãããããããªãªã³ããŒãã£ã³ã°ãã§ããŠããŸããéçºã®äžã§ãããã¹ãå§¿ã«ã€ããŠè°è«ã«ãªã£ããã§è²ã ãªã¡ã³ããŒãšè©±ãããŠããã®ã§ã å»çæ¥åã®ãã£ããã¢ããã¯ããªãããããç°å¢ ã ãšæããŸãã ããã²ãšã€ãé·æã®ã«ã¹ã¿ããŒäŸ¡å€ã远æ±ããããšããéšåãæåãæããŠããŠãäž»ã«ãããŒãžã£ãŒãå«ããçæç㪠KPI ã«æ²¿ã£ãéçºããããé·æçã«é¡§å®¢ãžã®äŸ¡å€æäŸã«å¯äžã§ããéçºãåªå ããŠãããšããæèãéåžžã«åŒ·ãã®ãè¯ããšæããŸãã ç¹ã«ä»çŸåšã瀟å ã§éçºãé²ãã§ããæ°èŠã¬ã»ã³ã³ã®éçºã«ã€ããŠã¯åŒ·ãæããŸããã å岡 : èªåã匷ãæããŠããã¡ãã¬ãŒã®æåãšããŠã¯ãããã¥ã¡ã³ãããªãã³ãã§ããããŒãã£ã³ã°ãªã©ããããããããšã®çµè«ãåŸãããã«åè°ããããšããã®ãæç¢ºã«åããè³æãäºåã«çšæããŠè¡ããŸããã§ãã®ã§ããããäœã®æéã ã£ã?ãã¿ãããªç¶æ ã«ãªãã«ããã®ãè¯ãã§ãã ããšã¯ ããŒãã£ã³ã°ã«ããåæçãSlack ã Confluence ãªã©ã«ããéåæã®ã³ãã¥ãã±ãŒã·ã§ã³ã驿驿ã§å šå¡ã䜿ããããŠããã®ã§ãããããã³ãã¥ãã±ãŒã·ã§ã³ã§ç¡é§ãªè¡ãéãã®ãããªãã®ããã»ãšãã©ç¡ã ã®ããä»äºããããããšæã£ãŠããŸãã ããã²ãšã€ã¯ãèªåããã¯ããããã¯ãå¿åã®åŒ·ããšãããšãããæããŠããŸããçŸåšã¯ãã£ã¬ã¯ã¿ãŒãªã©ãšäžç·ã«éçºãããŠããäœå¶ã«ãªã£ãŠãããã§ãããUI ã顧客äœéšãªã©ãå«ããŠãšã³ãžãã¢ã§ããã¡ãããšãããã¯ããšããŠã®çæ³ã®å§¿ãèããŠéçºãããšããå§¿å¢ããšãŠã匷ãã§ããèªåã®å°éã§ã¯ãªãé åã§ããã¡ããšèããªããéçºãããŠããã®ã§ãããããããããŸãã ããããã¡ãã¬ãŒã«å ¥ç€Ÿããæ¹ãžã®ã¡ãã»ãŒãž ââ ã§ã¯æåŸã«ãªããŸãããç¹ã«æ°åã§ã¡ãã¬ãŒã®å ¥ç€ŸãèããŠããæ¹ãžã®ã¡ãã»ãŒãžãªã©ããã°ãã䌺ããããã§ãã é£¯ç° : ããã§ããããå èŒ©ãæ°åã«å¯ŸããŠãšãŠãæåŸ ããŠãããŠããããšããã®ã¯äŒããããšæããŸããèªåã®å Žåãç ä¿®ãçµãã£ãŠ 3 ã¶æçµã£ããããã§ãã·ãŽããŒã¯ã®ã€ã³ãã©ç°å¢ãå šéšå·æ°ãããšãã倧ããªãããžã§ã¯ãã®ãªãŒããä»»ããŠãããããã§ãããã¡ãã SRE ã®å 茩ãªã©ãšååãã€ã€é²ãããã®ã ã£ããã§ããã ç ä¿®çµãã£ãŠããã«ãããªå€§ããªãããžã§ã¯ããè£éæã£ãŠé²ãããããããªç°å¢ãªã®ã§ããããããããããããŸã ã å²¡ç° : çš²æ¬(人æãã©ãããã©ãŒã CTO)ããæ°åã ãããã¿ãããªæ¥ãæ¹ãããã«ããã¡ãšã³ãžãã¢ãšããŠæ¥ããŠãããŠããã®ã¯å人çã«å¬ãããã€ã³ãã§ãããŸã 責任ãæã£ãäžã§è£éæã£ãŠèªç±ã«åããŠãããæ¥åç°å¢ãããã®ãããããè¯ã ã§ããã¡ãããšãããã¯ãã®äºãèããŠéçºãããã人ã«ã¯ããããã§ããç°å¢ã ãšæããŸãã 埳氞 : æ°åã®è¯ããšããã¯ãåæãæãæãŠããšããããªãšæããŸããä»ãã©ã³ãçã§ãã®ã¡ã³ããŒãšæè¡çãªãšãããªã©ãæ°è»œã«çžè«ã§ããã®ã¯ãšãŠãè¯ãã§ãã åç£ç¢ç£šããŠããç°å¢ãããªãããªãšæã£ãŠããã®ã§ãããããç°å¢ãæ±ãããªããããè¯ã ãšæããŸãã å€å· : åã身ã§ä»äºãè¡ãã®ã§ã¯ãªããã¬ãã¬ããšèªåã®æ¹ããæ±ãã«ããå§¿å¢ã®äººã«ã¯ãããããããããäŒç€Ÿã ãšæããŸãããã£ããè£éæã£ãŠæ¥åãé²ããããšãã§ããç°å¢ãªã®ã§ã é æ ®ããã«ãããããšç©äºé²ããããšãã§ãã人ã«ã¯æé« ãªããããªãããšèããŠããŸãã èªåã¯ã€ã³ãã©ã ãã§ã¯ãªããŠããµãŒããããã³ããšã³ããéçºããŠãããããšèããŠãããã§ãããå°èŠæš¡ãªãããžã§ã¯ãã§ããã°å šãŠè¡ããç°å¢ãªãããèªåäžäººã§ãããžã§ã¯ããå®çµããããšãã§ããã®ã¯ãæ§ã«åã£ãŠãããªãšæã£ãŠãŸããåšãã®ãµããŒããå 茩ãšã®å£æã¡ãªã©ã¯ã¡ãããšãã£ãŠããããã®ã§ããšãŠãå匷ã«ãªãæé·ã§ãããšæããŸãã æäž : ã¡ãã¬ãŒã§éçºãããŠããã«ã€ãããŠãå»çãã¡ã€ã³ãšããé åã§èªåãé¢ãã£ãŠããããšã人ã®åœ¹ã«ç«ã£ãŠãããã ãªãšããã®ãæ¥ã 宿ã§ãããšããã¯è¯ãã§ããç¹ã«è²ã ãªå»çæ©é¢ã®ãµããŒããã§ãããšãããããã¯ãã«é¢ãã£ãŠããã®ã§ãçŽæ¥å»çæ©é¢ããã®å ã«ããæ£è ãã㮠圹ã«ç«ã£ãŠãããšãã宿ã¯ãæ£çŽ 1 幎ç®ã§æãããããã®ã§ã¯ãªããšæã£ãŠããã®ã§ãè¯ãé©ã ã§ãã ãŸã倧ããããŒã¿ãåãæ±ããšããçµéšãã§ããŠããã®ã貎éã ãªãšæããŠããŸããçŸåšã®ãããã¯ãã§ã¯å¥çŽå»çæ©é¢ãéåžžã«å€ãã§ããããã®å€§éã®ããŒã¿ã®èšèšã倿Žããããšãããšããããè£éæã£ãŠå®æœã§ããã®ã¯è¯ãçµéšã«ãªã£ãŠããŸãã å岡 : ã¡ãã¬ãŒã®ããããã¯ãå¿åããæã£ãŠããå 茩ãšã³ãžãã¢ãšåãããšããã®ã¯ãšãŠãè¯ãçµéšã ãšæã£ãŠããŸããäžè¬çã«ã¯ãšã³ãžãã¢ã¯æè¡ããããã°ãšããæãã«ãªããããã£ãããããšæãã®ã§ãããã¡ãã¬ãŒã§ã¯ãã¡ããæ°ããæè¡ãªã©ã䜿ããªãããããã ããã«ãããã¯ãããã®å ã®ãŠãŒã¶ãžã®äŸ¡å€æäŸã«ç¹ããããèããŠããæ¹ãéã£ãŠãã ã®ã§ãããããæèã§ãããã¯ãéçºãã§ããŠããã®ã¯ãããå匷ã«ãªããŸãã ââ ããããšãããããŸãã! æ¬åœã« 1 幎ã§çãããæ¿ãæ¥åçµéšãç©ãã§ããã®ãåããã€ã³ã¿ãã¥ãŒã«ãªããŸããã ãããã« ããããç°ãªãããŒã ãæ¥åå 容ã§ãããæ°åãšã³ãžãã¢ã§ãè£éãæã£ãŠæ¥åã«èšããããšãããããã¯ãã®éèŠãªéšåã®éçºã«ã©ãã©ãé¢ãã£ãŠãããããšãäŒããã€ã³ã¿ãã¥ãŒãšãªããŸããã ã¡ãã¬ãŒã¯æ°åå ¥ç€Ÿã®ãšã³ãžãã¢ãç©æ¥µçã«åéããŠããŸãã®ã§ãä»åæ°ã«ãªã£ããšããæ¹ã¯ãæ°è»œã«ã«ãžã¥ã¢ã«é¢è«ãããŸããã! open.talentio.com open.talentio.com
æ ªåŒäŒç€Ÿã¡ãã¬ãŒ
2024/03/29
<![CDATA[ æ°åé å±2ã¶æç®ã§ChatGPTãæŽ»çšããæ°èŠæ©èœéçºãããžã§ã¯ãã«ã¢ãµã€ã³ããã話 ]]>
ã¯ããã« èªå·±çŽ¹ä» ã¯ãããŸããŠã人æãã©ãããã©ãŒã æ¬éšãããã¯ãéçºå®€ç¬¬äžéçºã°ã«ãŒãã®ç°äžã§ãã ç§ã¯ã2023 幎㮠4 æã«æ°åãšã³ãžãã¢ãšããŠå ¥ç€Ÿããæ¥æ¬æå€§çŽã®å»çä»è·æ±äººãµã€ãã ãžã§ãã¡ãã¬ãŒ ãã®ããã³ããšã³ããšããã¯ãšã³ãã®éçºãæ åœããŠããŸãã åŠçæä»£ã¯æ å ±ç³»ã§ã¯ãªããçµæžåŠãå°æ»ããŠããŸãããããã°ã©ãã³ã°ã«ã¯å€§åŠã®ææ¥ã§åºäŒããäž»ã«ããŒã¿åæã«çšãã R ã Python ãè§Šã£ãŠããŸããããã®ãã Web ã¢ããªã±ãŒã·ã§ã³ã®éçºã¯è¡ã£ãŠããŸããã§ããã ãšã³ãžãã¢ãšããè·æ¥ã«èå³ãæã£ããã£ããã¯ã倧åŠé¢æä»£ã«åå ããã€ã³ã¿ãŒã³ã§ãããã€ã³ã¿ãŒã³å ã®äŒç€Ÿã§ã¯ãšã³ãžãã¢ã誰ãããªãã£ãã®ã§ãããéçºæªçµéšã®ç§ã«æ©æ¢°åŠç¿ã䜿ã£ãã¢ããªã® PoC ãäœããšãããããªãç Žå€©èãªçµéšãããããã§ããä»ã§ã¯ãšãŠãã¬ã¢ãªçµéšã ã£ããšæããŸããã詊è¡é¯èª€ããªããäœããäœãããšã«è奮ãèŠããã®ãä»ã§ãé®®æã«èŠããŠããŸãã ã¡ãã¬ãŒ ã«å ¥ç€Ÿããçç±ã¯ã倧ããªç€ŸäŒèª²é¡ã«åãçµãã§ãããè§Šããããæè¡ãããã³ããšã³ãã»ããã¯ãšã³ãã®ããã«é åã«éãããŠããªããªã©ãããŸããããäžçªå€§ããªçç±ã¯ã æè¡ã¯ãããŸã§ææ®µã§ããã顧客ãžã®äŸ¡å€æäŸãç®çã«ããŠãã ããšããèãã«å ±æããããšã§ããå ¥ç€ŸããŠãŸã æ¥ã¯æµ ãã§ããããã®èãã¯éæã§æããããŸãã 倧åŠè¿ãã®ããŒãã®å€çŒã å ¥ç€Ÿããåãããžã§ã¯ããŸã§ ããŠãä»åã®èšäºã§ã¯æ°åãšã³ãžãã¢ã®ç§ãåããŠæºãã£ããããžã§ã¯ãã®ç޹ä»ãéããŠãã¡ãã¬ãŒã§ã¯æ°åãšã³ãžãã¢ãå ¥ç€ŸåŸã«ã©ã®ãããªåãæ¹ãããŠããäŒããããšãã§ããã°ãšæããŸãã å ¥ç€ŸããŠããç ä¿®ãçµããŠãé å±åŸ 1 ã¶æåãããã¯äž»ã«ãããã¯ãã®å®åžžæ¹åç³»ã®ã¿ã¹ã¯ã«åãçµã¿ãªãããä»äºã®ãªãºã ãèŠããŠãããŸããã ãã®åŸãä»å玹ä»ãããããžã§ã¯ãã«åããŠã¢ãµã€ã³ãããŸããããã®æç¹ã§ãããžã§ã¯ãã§äž»ã«äœ¿çšããã¹ãã«ã»ããã®ããã³ããšã³ãã¯ãæ°åç ä¿®ã§åŠãã çšåºŠã§ããããã®ãããªç¶æ ã®æ°åã§ããçµéšãããããç©ãŸããŠããããè¯ãç°å¢ã ãšããããšããäŒãã§ããã°ãšæã£ãŠããŸãã ãããžã§ã¯ãã§è§£æ±ºãã課é¡ãšè§£æ±ºç ãŸããä»åæ åœãããããžã§ã¯ããçºè¶³ããèæ¯ãšãªã課é¡ãšããã®èª²é¡ã解決ããããã«æäŸããæ°æ©èœã«ã€ããŠç޹ä»ããŸãããã®ãããžã§ã¯ãã«ã€ããŠã¯ã ãã¥ãŒã¹ãªãªãŒã¹ ãå ¬éããŠããŸãã®ã§ãåãããŠã芧ãã ããã ãŠãŒã¶ãŒã®æ±ããèª²é¡ ãããŸã§ããžã§ãã¡ãã¬ãŒãã§ã¯é¡§å®¢ãæ±äººãäœæããéã«ããã©ãŒã 圢åŒã§åéèŠé ãèšå ¥ãã圢åŒãšãªã£ãŠããŸãããèšå ¥ã®èªç±åºŠãé«ãããšãããæ³ä»€ãã¬ã€ãã©ã€ã³çã§å®ããããé ç®ãæŒããªãèšèŒããããšããäºæ¥æã®é åã广çã«äŒãã工倫ãå¿ èŠã§ããã顧客ã«ãšã£ãŠã¯å€§ããªè² æ ã«ãªã£ãŠããŸããã ãã©ãŒã 圢åŒã®æ±äººäœææ©èœã®ã€ã¡ãŒãž 瀟å ãªãã¬ãŒã·ã§ã³ã®èгç¹ã§èŠããšãæ±äººãæ²èŒåºæºãæºãããŠããã®ããå ¥åãããæç« ããèªã¿åã確èªããæ¥åã«æéãããã£ãŠããŸããã ããã§ã顧客ãšç€Ÿå ãªãã¬ãŒã·ã§ã³ã®åæ¹ãæããŠãã課é¡ã解決ãããããžã§ã¯ããçºè¶³ããç§ãåç»ããŸããã ãŠãŒã¶ãŒç®ç·ã®è§£æ±ºç 顧客ãšç€Ÿå ãªãã¬ãŒã·ã§ã³ã®åæ¹ã®èª²é¡ã解決ãããããæ±äººäœæããã»ã¹ãããçŽæçãã€å¹ççã«æ¹åããŸãããå ·äœçã«ã¯ãåŸæ¥ã®ãã©ãŒã å ¥åæ¹åŒããã察話åŒã®è³ªåãšåçãéããŠæ±äººãäœæã§ããæ©èœãå°å ¥ããŸããããã®æ¹åã«ããã顧客ã¯ç°¡åã«ãè¿·ãããšãªãæ²èŒåºæºã«æ²¿ã£ãæ±äººãäœæãããããªããŸããã ããã«ãæç« äœæã®åŽåã軜æžããããã«ã ChatGPT ãæŽ»çšããææ¡æ©èœãå°å ¥ããŸããããã®æ©èœãéããŠã顧客ã¯å ¥åããå 容ã«åºã¥ããæ±è·è ã®ç®ã«æ¢ãŸããããæ±äººã¿ã€ãã«ãèšŽæ±æã ChatGPT ããææ¡ããŠããããŸããããã«ãããæ±äººåçš¿äœæã«ãããæéãç ©éãã軜æžãããå°ä»»ã®æ¡çšæ åœãããªãäºæ¥æã§ãæ¡çšæŽ»åãå¹ççã«é²ããããšãã§ããè¿ éãªäººæã®ç¢ºä¿ãžãšã€ãªãããŸãã瀟å ãªãã¬ãŒã·ã§ã³ã®èгç¹ã§ããæ²èŒåºæºãæºãããŠãããã確èªããæ¥åã®æéççž®ãæåŸ ã§ããŸãã 質å圢åŒã®æ±äººäœæè£å©æ©èœã®ã€ã¡ãŒãž ChatGPT ã®å°å ¥æç¡ã«é¢ããŠã¯ç€Ÿå ã§ãåè°ãããæç« çæã« ChatGPT ãçšããããšã§é¡§å®¢ã®äœæ¥ã³ã¹ããäžããããã®ã§ããã°å°å ¥ããããšããæææ±ºå®ããããŸãããæµè¡ã£ãŠããæè¡ã ããå°å ¥ããã®ã§ã¯ãªãã 顧客ãžã®äŸ¡å€æäŸã®ããã«æ°ããæè¡ãå°å ¥ãã èããçŸããæææ±ºå®ã ãšæããŸãã æè¡ã¹ã¿ã㯠ä»åã®ãããžã§ã¯ãã§ã¯æ¬¡ã®ãããªæè¡ã¹ã¿ãã¯ã§éçºãè¡ããŸãããããã³ããšã³ã㯠React ã䜿çšãç¶æ 管çã©ã€ãã©ãªãšã㊠React Hooks ãéžæããŸãããåŸæ¥ã®æ±äººäœææ©èœã§ã¯ Redux ã§ç¶æ 管çãè¡ã£ãŠããŸãããããããã¯ãå šäœã®æ¹éãšããŠä»åŸ React Hooks ã䜿çšããŠããæ¹éã§ãã£ãããšãšãå®è£ ã®ã¹ããŒããæ©ããããã« React Hooks ãæ¡çšããŸããã ChatGPT ãçšããéšåã«é¢ããŠã¯ã顧客ããã®ãªã¯ãšã¹ããåããŠçºè¡ããããŒã¯ã³ãä¿åããããã« Amazon DynamoDB ã䜿çšããŸãããDynamoDB ã«ä¿åããããŒã¯ã³ã®ããªããŒã·ã§ã³ãš GPT ãžããã³ãããæž¡ããææ¡ã®åãåãã»è¿åŽããéšå㯠AWS Lambda function ã«ä»»ããŠããŸãããGPT æ¬äœã¯ Azure OpenAI Service ãå©çšããæ§æã§ãããAzure OpenAI Service ãæ¡çšããçç±ã¯ã顧客æ å ±ãå ¥åå 容ãåŠç¿ã«äœ¿çšãããããšããªããã©ã€ãã·ãŒé¢ã§ã®ãªã¹ã¯ãåé¿ã§ããããã§ããã æç« çææ©èœã®æ§æã€ã¡ãŒãž ãããžã§ã¯ããžã®é¢ãã ä»åã®ãããžã§ã¯ãã®ã¡ã³ããŒæ§æã¯ãšã³ãžã㢠3 人ããã¶ã€ã㌠1 人ãPM 1 人ãšããæ§æã§ãããéçºã«ã¯çŽ 3 ã¶æã®æéãèŠããŸããã ãããžã§ã¯ãåæ ç§èªèº«ã®ãããžã§ã¯ããžã®é¢ããæ¹ãšããŠã¯ããããžã§ã¯ãåææ®µéããããã³ããšã³ãã®å®è£ ã¿ã¹ã¯ãäžå¿ã§ããããã®äžã§ã¹ã¿ã€ã«ã®å®è£ ã«é¢ããŠã¯ãªãŒããŒã·ãããæãããŠããã ããŸãããä»åã®ãããžã§ã¯ãã§äœæãã UI ã³ã³ããŒãã³ãã§ã¯ã䌌ããããªãã®ãè€æ°ãã£ããããã§ããã ãæ¡åŒµæ§ãæãã䜿ãåããããã«æèããŠèšèšããŠããŸãããä»äºã®ãµã€ã¯ã«ãšããŠã¯ããã¶ã€ããŒãäœã£ããã¶ã€ã³ãå ã«ã现ãã仿§ã調æŽããŠå®è£ ãããã¶ã€ã³ã¬ãã¥ãŒãããŠããããµã€ã¯ã«ãåããŠããŸããã ãã ãReact ãªã©ããã£ããã¢ããããªããã®å®è£ ã ã£ããããä»ã®ãšã³ãžãã¢ããå®è£ ã«æéãããã£ãŠããŸã£ãŠããŸãããé©å®å 茩ãšã³ãžãã¢ã«è³ªåããªããé²ããŠããŸããããããã€ãã®ã¿ã¹ã¯ã¯å·»ãåã£ãŠãããããšã«ãªããªã©ãæããæ°æã¡ãèŠãããããžã§ã¯ãåæã§ããã ãããžã§ã¯ãäžç€ä»¥é ãããžã§ã¯ãäžç€ãããã§äžã€ãšã³ãžãã¢ãšããŠã®ä»äºã®åãåãæ¹ã«å€åããããŸããããããžã§ã¯ãã®ã¹ã±ãžã¥ãŒã«ãã¿ã€ãã ã£ãã®ãçžãŸã£ãŠããããžã§ã¯ãåæã§ã¯ãšããããå®è£ ããŠæ©ãã¿ã¹ã¯ãçµããããããšã«æ³šåããŠããŸãããããããæéãããã£ãŠãè¯ãããäžã€äžã€äžå¯§ã«ã³ãŒãã远ã£ãŠçè§£ããããšã«åªããããšå 茩ãšã³ãžãã¢ã«ã¢ããã€ã¹ãããã ããŸããã ãããããçè§£ã«æ³šåããããšã§æèãã¯ãªã¢ã«ãªããçµæçã«å®è£ ã¹ããŒããäžãã£ãŠãããŸããããŸããå®è£ 以å€ã«ãç®ãåããäœè£ãçãŸãã仿§ã«ã€ã㊠PM ããã¶ã€ããŒã«ææ¡ããããšãã§ããŸããããããžã§ã¯ãäžç€ä»¥éã¯èªä¿¡ãæã£ãŠã¿ã¹ã¯ã«åãçµãããšãã§ããçµç€ã«ã¯ä»ã®ãšã³ãžãã¢ã®ã¿ã¹ã¯ãå·»ãåãããšãã§ãããŸã§ã«ãªããŸããã ãããžã§ã¯ãã®äžã§ã¯ãããã³ããã®æ¹åã¿ã¹ã¯ãä»»ããŠããããŸãããå 容ãšããŠã¯æå³ããªãåçãåŒŸãæ¹åã§ããããAWS Lambda ãè§Šããªã©ãå¿ èŠãããã°ã¯ã©ãŠããµãŒãã¹ãè§Šãæ©äŒããããšæããŸããã ChatGPT ã«ããææ¡æ©èœã®ã€ã¡ãŒãž ãããã« ãããžã§ã¯ããæ¯ãè¿ã£ãŠ æ°æ©èœããªãªãŒã¹ãããŠæ°ã¶æçµã¡ãŸããããå®ããŠãã KPI ãéæããçµæãçŸããŠããããšããšãŠãå¬ããã§ããäžäŸãšããŠãé¡§å®¢ãæ°æ©èœã§æ±äººãäœæããŠãã瀟å ã§ã®å¯©æ»ãçµãŠæ²èŒã«è³ããŸã§ã®æ¥æ°ããåŸæ¥ã®äœææ¹æ³ãšæ¯ã¹ãŠåå以äžãšå€§å¹ ã«åæžãããŠããŸãã ããŒã ãšããŠã¯ä»åã®ãããžã§ã¯ãã®é²ãæ¹ã«ã€ããŠæ¯ãè¿ããè¡ããŸãããPM ããã¶ã€ããŒããšã³ãžãã¢ãããããæ¬¡ã®ãããžã§ã¯ããããè¯ãéè¡ããææ¡ãåºãåããä»åã®ãããžã§ã¯ãã®çµéšãç¡é§ã«ãªããªãããã«ããŠããŸããçŸåšãç§èªèº«ã¯ãšã³ãžãã¢äžäººã®æ°ãããããžã§ã¯ããä»»ãããŠããŸããããã®æã®æ¯ãè¿ãã§ã®åçãã¿ã¹ã¯åè§£ãã¹ã±ãžã¥ãŒã«çå®ã«åœ¹ç«ãŠãããŠããŸãã å人çã«ã¯ä»åã®ãããžã§ã¯ããéããŠãããã³ããšã³ãã®æè¡ç¿åŸã¯ãã¡ããã®ããšããããžã§ã¯ãã¡ã³ããŒãšã®ã³ãã¥ãã±ãŒã·ã§ã³ã§æç« ã®æ§é åãç»åã«ç·šéãå ãããªã©ã®å·¥å€«ãå ããããšã§ã³ãã¥ãã±ãŒã·ã§ã³ã³ã¹ããäžããããšãã§ãããšãã£ãæè¡ä»¥å€ã®ããšãåŠã¶ããšãã§ããŸããã ãŸããããžã§ã¯ããéããŠãè¥æã®ãšã³ãžãã¢ãæé·ã§ããç°å¢ã ãšèã§æããŸãããé å±åŸãŸããªããããžã§ã¯ãã«åç»ãããŠããããããšãå¿ èŠã«å¿ããŠæ§ã ãªæè¡ãè§ŠãããŠããããããšã¯ãã¡ããã®ããšã§ãããåãããªãããšãèããããããŠãããé°å²æ°ãæãäžãããææŠãããŠããããç°å¢ã¯èŽ æ²¢ã«æããã»ã©ã§ãã ãã®ãããªæé·ã§ããç°å¢ã§è¥ææä»£ãéããããæ°åãšã³ãžãã¢ã®æ¹ããæè¡ã¯ãããŸã§ææ®µã§ããã顧客ãžã®äŸ¡å€æäŸãç®çã«ããŠããããŒã ã§åããããšã³ãžãã¢ã®æ¹ãçµ¶è³åéããŠããŸãã®ã§ããèå³ãããæ¹ã¯ãã²ã«ãžã¥ã¢ã«ã«ã話ããå§ããŠã¿ãŸãããã åéã®äžèЧ | æ ªåŒäŒç€Ÿã¡ãã¬ãŒ ã¡ãã¬ãŒã®æ¡çšæ å ±ã¯ãã¡ãããã確èªãã ããã www.medley.jp
æ ªåŒäŒç€Ÿã¡ãã¬ãŒ
2024/03/29
<![CDATA[ æ°åé å±2ã¶æç®ã§ChatGPTãæŽ»çšããæ°èŠæ©èœéçºãããžã§ã¯ãã«ã¢ãµã€ã³ããã話 ]]>
ã¯ããã« èªå·±çŽ¹ä» ã¯ãããŸããŠã人æãã©ãããã©ãŒã æ¬éšãããã¯ãéçºå®€ç¬¬äžéçºã°ã«ãŒãã®ç°äžã§ãã ç§ã¯ã2023 幎㮠4 æã«æ°åãšã³ãžãã¢ãšããŠå ¥ç€Ÿããæ¥æ¬æå€§çŽã®å»çä»è·æ±äººãµã€ãã ãžã§ãã¡ãã¬ãŒ ãã®ããã³ããšã³ããšããã¯ãšã³ãã®éçºãæ åœããŠããŸãã åŠçæä»£ã¯æ å ±ç³»ã§ã¯ãªããçµæžåŠãå°æ»ããŠããŸãããããã°ã©ãã³ã°ã«ã¯å€§åŠã®ææ¥ã§åºäŒããäž»ã«ããŒã¿åæã«çšãã R ã Python ãè§Šã£ãŠããŸããããã®ãã Web ã¢ããªã±ãŒã·ã§ã³ã®éçºã¯è¡ã£ãŠããŸããã§ããã ãšã³ãžãã¢ãšããè·æ¥ã«èå³ãæã£ããã£ããã¯ã倧åŠé¢æä»£ã«åå ããã€ã³ã¿ãŒã³ã§ãããã€ã³ã¿ãŒã³å ã®äŒç€Ÿã§ã¯ãšã³ãžãã¢ã誰ãããªãã£ãã®ã§ãããéçºæªçµéšã®ç§ã«æ©æ¢°åŠç¿ã䜿ã£ãã¢ããªã® PoC ãäœããšãããããªãç Žå€©èãªçµéšãããããã§ããä»ã§ã¯ãšãŠãã¬ã¢ãªçµéšã ã£ããšæããŸããã詊è¡é¯èª€ããªããäœããäœãããšã«è奮ãèŠããã®ãä»ã§ãé®®æã«èŠããŠããŸãã ã¡ãã¬ãŒ ã«å ¥ç€Ÿããçç±ã¯ã倧ããªç€ŸäŒèª²é¡ã«åãçµãã§ãããè§Šããããæè¡ãããã³ããšã³ãã»ããã¯ãšã³ãã®ããã«é åã«éãããŠããªããªã©ãããŸããããäžçªå€§ããªçç±ã¯ã æè¡ã¯ãããŸã§ææ®µã§ããã顧客ãžã®äŸ¡å€æäŸãç®çã«ããŠãã ããšããèãã«å ±æããããšã§ããå ¥ç€ŸããŠãŸã æ¥ã¯æµ ãã§ããããã®èãã¯éæã§æããããŸãã 倧åŠè¿ãã®ããŒãã®å€çŒã å ¥ç€Ÿããåãããžã§ã¯ããŸã§ ããŠãä»åã®èšäºã§ã¯æ°åãšã³ãžãã¢ã®ç§ãåããŠæºãã£ããããžã§ã¯ãã®ç޹ä»ãéããŠãã¡ãã¬ãŒã§ã¯æ°åãšã³ãžãã¢ãå ¥ç€ŸåŸã«ã©ã®ãããªåãæ¹ãããŠããäŒããããšãã§ããã°ãšæããŸãã å ¥ç€ŸããŠããç ä¿®ãçµããŠãé å±åŸ 1 ã¶æåãããã¯äž»ã«ãããã¯ãã®å®åžžæ¹åç³»ã®ã¿ã¹ã¯ã«åãçµã¿ãªãããä»äºã®ãªãºã ãèŠããŠãããŸããã ãã®åŸãä»å玹ä»ãããããžã§ã¯ãã«åããŠã¢ãµã€ã³ãããŸããããã®æç¹ã§ãããžã§ã¯ãã§äž»ã«äœ¿çšããã¹ãã«ã»ããã®ããã³ããšã³ãã¯ãæ°åç ä¿®ã§åŠãã çšåºŠã§ããããã®ãããªç¶æ ã®æ°åã§ããçµéšãããããç©ãŸããŠããããè¯ãç°å¢ã ãšããããšããäŒãã§ããã°ãšæã£ãŠããŸãã ãããžã§ã¯ãã§è§£æ±ºãã課é¡ãšè§£æ±ºç ãŸããä»åæ åœãããããžã§ã¯ããçºè¶³ããèæ¯ãšãªã課é¡ãšããã®èª²é¡ã解決ããããã«æäŸããæ°æ©èœã«ã€ããŠç޹ä»ããŸãããã®ãããžã§ã¯ãã«ã€ããŠã¯ã ãã¥ãŒã¹ãªãªãŒã¹ ãå ¬éããŠããŸãã®ã§ãåãããŠã芧ãã ããã ãŠãŒã¶ãŒã®æ±ããèª²é¡ ãããŸã§ããžã§ãã¡ãã¬ãŒãã§ã¯é¡§å®¢ãæ±äººãäœæããéã«ããã©ãŒã 圢åŒã§åéèŠé ãèšå ¥ãã圢åŒãšãªã£ãŠããŸãããèšå ¥ã®èªç±åºŠãé«ãããšãããæ³ä»€ãã¬ã€ãã©ã€ã³çã§å®ããããé ç®ãæŒããªãèšèŒããããšããäºæ¥æã®é åã广çã«äŒãã工倫ãå¿ èŠã§ããã顧客ã«ãšã£ãŠã¯å€§ããªè² æ ã«ãªã£ãŠããŸããã ãã©ãŒã 圢åŒã®æ±äººäœææ©èœã®ã€ã¡ãŒãž 瀟å ãªãã¬ãŒã·ã§ã³ã®èгç¹ã§èŠããšãæ±äººãæ²èŒåºæºãæºãããŠããã®ããå ¥åãããæç« ããèªã¿åã確èªããæ¥åã«æéãããã£ãŠããŸããã ããã§ã顧客ãšç€Ÿå ãªãã¬ãŒã·ã§ã³ã®åæ¹ãæããŠãã課é¡ã解決ãããããžã§ã¯ããçºè¶³ããç§ãåç»ããŸããã ãŠãŒã¶ãŒç®ç·ã®è§£æ±ºç 顧客ãšç€Ÿå ãªãã¬ãŒã·ã§ã³ã®åæ¹ã®èª²é¡ã解決ãããããæ±äººäœæããã»ã¹ãããçŽæçãã€å¹ççã«æ¹åããŸãããå ·äœçã«ã¯ãåŸæ¥ã®ãã©ãŒã å ¥åæ¹åŒããã察話åŒã®è³ªåãšåçãéããŠæ±äººãäœæã§ããæ©èœãå°å ¥ããŸããããã®æ¹åã«ããã顧客ã¯ç°¡åã«ãè¿·ãããšãªãæ²èŒåºæºã«æ²¿ã£ãæ±äººãäœæãããããªããŸããã ããã«ãæç« äœæã®åŽåã軜æžããããã«ã ChatGPT ãæŽ»çšããææ¡æ©èœãå°å ¥ããŸããããã®æ©èœãéããŠã顧客ã¯å ¥åããå 容ã«åºã¥ããæ±è·è ã®ç®ã«æ¢ãŸããããæ±äººã¿ã€ãã«ãèšŽæ±æã ChatGPT ããææ¡ããŠããããŸããããã«ãããæ±äººåçš¿äœæã«ãããæéãç ©éãã軜æžãããå°ä»»ã®æ¡çšæ åœãããªãäºæ¥æã§ãæ¡çšæŽ»åãå¹ççã«é²ããããšãã§ããè¿ éãªäººæã®ç¢ºä¿ãžãšã€ãªãããŸãã瀟å ãªãã¬ãŒã·ã§ã³ã®èгç¹ã§ããæ²èŒåºæºãæºãããŠãããã確èªããæ¥åã®æéççž®ãæåŸ ã§ããŸãã 質å圢åŒã®æ±äººäœæè£å©æ©èœã®ã€ã¡ãŒãž ChatGPT ã®å°å ¥æç¡ã«é¢ããŠã¯ç€Ÿå ã§ãåè°ãããæç« çæã« ChatGPT ãçšããããšã§é¡§å®¢ã®äœæ¥ã³ã¹ããäžããããã®ã§ããã°å°å ¥ããããšããæææ±ºå®ããããŸãããæµè¡ã£ãŠããæè¡ã ããå°å ¥ããã®ã§ã¯ãªãã 顧客ãžã®äŸ¡å€æäŸã®ããã«æ°ããæè¡ãå°å ¥ãã èããçŸããæææ±ºå®ã ãšæããŸãã æè¡ã¹ã¿ã㯠ä»åã®ãããžã§ã¯ãã§ã¯æ¬¡ã®ãããªæè¡ã¹ã¿ãã¯ã§éçºãè¡ããŸãããããã³ããšã³ã㯠React ã䜿çšãç¶æ 管çã©ã€ãã©ãªãšã㊠React Hooks ãéžæããŸãããåŸæ¥ã®æ±äººäœææ©èœã§ã¯ Redux ã§ç¶æ 管çãè¡ã£ãŠããŸãããããããã¯ãå šäœã®æ¹éãšããŠä»åŸ React Hooks ã䜿çšããŠããæ¹éã§ãã£ãããšãšãå®è£ ã®ã¹ããŒããæ©ããããã« React Hooks ãæ¡çšããŸããã ChatGPT ãçšããéšåã«é¢ããŠã¯ã顧客ããã®ãªã¯ãšã¹ããåããŠçºè¡ããããŒã¯ã³ãä¿åããããã« Amazon DynamoDB ã䜿çšããŸãããDynamoDB ã«ä¿åããããŒã¯ã³ã®ããªããŒã·ã§ã³ãš GPT ãžããã³ãããæž¡ããææ¡ã®åãåãã»è¿åŽããéšå㯠AWS Lambda function ã«ä»»ããŠããŸãããGPT æ¬äœã¯ Azure OpenAI Service ãå©çšããæ§æã§ãããAzure OpenAI Service ãæ¡çšããçç±ã¯ã顧客æ å ±ãå ¥åå 容ãåŠç¿ã«äœ¿çšãããããšããªããã©ã€ãã·ãŒé¢ã§ã®ãªã¹ã¯ãåé¿ã§ããããã§ããã æç« çææ©èœã®æ§æã€ã¡ãŒãž ãããžã§ã¯ããžã®é¢ãã ä»åã®ãããžã§ã¯ãã®ã¡ã³ããŒæ§æã¯ãšã³ãžã㢠3 人ããã¶ã€ã㌠1 人ãPM 1 人ãšããæ§æã§ãããéçºã«ã¯çŽ 3 ã¶æã®æéãèŠããŸããã ãããžã§ã¯ãåæ ç§èªèº«ã®ãããžã§ã¯ããžã®é¢ããæ¹ãšããŠã¯ããããžã§ã¯ãåææ®µéããããã³ããšã³ãã®å®è£ ã¿ã¹ã¯ãäžå¿ã§ããããã®äžã§ã¹ã¿ã€ã«ã®å®è£ ã«é¢ããŠã¯ãªãŒããŒã·ãããæãããŠããã ããŸãããä»åã®ãããžã§ã¯ãã§äœæãã UI ã³ã³ããŒãã³ãã§ã¯ã䌌ããããªãã®ãè€æ°ãã£ããããã§ããã ãæ¡åŒµæ§ãæãã䜿ãåããããã«æèããŠèšèšããŠããŸãããä»äºã®ãµã€ã¯ã«ãšããŠã¯ããã¶ã€ããŒãäœã£ããã¶ã€ã³ãå ã«ã现ãã仿§ã調æŽããŠå®è£ ãããã¶ã€ã³ã¬ãã¥ãŒãããŠããããµã€ã¯ã«ãåããŠããŸããã ãã ãReact ãªã©ããã£ããã¢ããããªããã®å®è£ ã ã£ããããä»ã®ãšã³ãžãã¢ããå®è£ ã«æéãããã£ãŠããŸã£ãŠããŸãããé©å®å 茩ãšã³ãžãã¢ã«è³ªåããªããé²ããŠããŸããããããã€ãã®ã¿ã¹ã¯ã¯å·»ãåã£ãŠãããããšã«ãªããªã©ãæããæ°æã¡ãèŠãããããžã§ã¯ãåæã§ããã ãããžã§ã¯ãäžç€ä»¥é ãããžã§ã¯ãäžç€ãããã§äžã€ãšã³ãžãã¢ãšããŠã®ä»äºã®åãåãæ¹ã«å€åããããŸããããããžã§ã¯ãã®ã¹ã±ãžã¥ãŒã«ãã¿ã€ãã ã£ãã®ãçžãŸã£ãŠããããžã§ã¯ãåæã§ã¯ãšããããå®è£ ããŠæ©ãã¿ã¹ã¯ãçµããããããšã«æ³šåããŠããŸãããããããæéãããã£ãŠãè¯ãããäžã€äžã€äžå¯§ã«ã³ãŒãã远ã£ãŠçè§£ããããšã«åªããããšå 茩ãšã³ãžãã¢ã«ã¢ããã€ã¹ãããã ããŸããã ãããããçè§£ã«æ³šåããããšã§æèãã¯ãªã¢ã«ãªããçµæçã«å®è£ ã¹ããŒããäžãã£ãŠãããŸããããŸããå®è£ 以å€ã«ãç®ãåããäœè£ãçãŸãã仿§ã«ã€ã㊠PM ããã¶ã€ããŒã«ææ¡ããããšãã§ããŸããããããžã§ã¯ãäžç€ä»¥éã¯èªä¿¡ãæã£ãŠã¿ã¹ã¯ã«åãçµãããšãã§ããçµç€ã«ã¯ä»ã®ãšã³ãžãã¢ã®ã¿ã¹ã¯ãå·»ãåãããšãã§ãããŸã§ã«ãªããŸããã ãããžã§ã¯ãã®äžã§ã¯ãããã³ããã®æ¹åã¿ã¹ã¯ãä»»ããŠããããŸãããå 容ãšããŠã¯æå³ããªãåçãåŒŸãæ¹åã§ããããAWS Lambda ãè§Šããªã©ãå¿ èŠãããã°ã¯ã©ãŠããµãŒãã¹ãè§Šãæ©äŒããããšæããŸããã ChatGPT ã«ããææ¡æ©èœã®ã€ã¡ãŒãž ãããã« ãããžã§ã¯ããæ¯ãè¿ã£ãŠ æ°æ©èœããªãªãŒã¹ãããŠæ°ã¶æçµã¡ãŸããããå®ããŠãã KPI ãéæããçµæãçŸããŠããããšããšãŠãå¬ããã§ããäžäŸãšããŠãé¡§å®¢ãæ°æ©èœã§æ±äººãäœæããŠãã瀟å ã§ã®å¯©æ»ãçµãŠæ²èŒã«è³ããŸã§ã®æ¥æ°ããåŸæ¥ã®äœææ¹æ³ãšæ¯ã¹ãŠåå以äžãšå€§å¹ ã«åæžãããŠããŸãã ããŒã ãšããŠã¯ä»åã®ãããžã§ã¯ãã®é²ãæ¹ã«ã€ããŠæ¯ãè¿ããè¡ããŸãããPM ããã¶ã€ããŒããšã³ãžãã¢ãããããæ¬¡ã®ãããžã§ã¯ããããè¯ãéè¡ããææ¡ãåºãåããä»åã®ãããžã§ã¯ãã®çµéšãç¡é§ã«ãªããªãããã«ããŠããŸããçŸåšãç§èªèº«ã¯ãšã³ãžãã¢äžäººã®æ°ãããããžã§ã¯ããä»»ãããŠããŸããããã®æã®æ¯ãè¿ãã§ã®åçãã¿ã¹ã¯åè§£ãã¹ã±ãžã¥ãŒã«çå®ã«åœ¹ç«ãŠãããŠããŸãã å人çã«ã¯ä»åã®ãããžã§ã¯ããéããŠãããã³ããšã³ãã®æè¡ç¿åŸã¯ãã¡ããã®ããšããããžã§ã¯ãã¡ã³ããŒãšã®ã³ãã¥ãã±ãŒã·ã§ã³ã§æç« ã®æ§é åãç»åã«ç·šéãå ãããªã©ã®å·¥å€«ãå ããããšã§ã³ãã¥ãã±ãŒã·ã§ã³ã³ã¹ããäžããããšãã§ãããšãã£ãæè¡ä»¥å€ã®ããšãåŠã¶ããšãã§ããŸããã ãŸããããžã§ã¯ããéããŠãè¥æã®ãšã³ãžãã¢ãæé·ã§ããç°å¢ã ãšèã§æããŸãããé å±åŸãŸããªããããžã§ã¯ãã«åç»ãããŠããããããšãå¿ èŠã«å¿ããŠæ§ã ãªæè¡ãè§ŠãããŠããããããšã¯ãã¡ããã®ããšã§ãããåãããªãããšãèããããããŠãããé°å²æ°ãæãäžãããææŠãããŠããããç°å¢ã¯èŽ æ²¢ã«æããã»ã©ã§ãã ãã®ãããªæé·ã§ããç°å¢ã§è¥ææä»£ãéããããæ°åãšã³ãžãã¢ã®æ¹ããæè¡ã¯ãããŸã§ææ®µã§ããã顧客ãžã®äŸ¡å€æäŸãç®çã«ããŠããããŒã ã§åããããšã³ãžãã¢ã®æ¹ãçµ¶è³åéããŠããŸãã®ã§ããèå³ãããæ¹ã¯ãã²ã«ãžã¥ã¢ã«ã«ã話ããå§ããŠã¿ãŸãããã åéã®äžèЧ | æ ªåŒäŒç€Ÿã¡ãã¬ãŒ ã¡ãã¬ãŒã®æ¡çšæ å ±ã¯ãã¡ãããã確èªãã ããã www.medley.jp
æ ªåŒäŒç€Ÿã¡ãã¬ãŒ
2024/03/29
<![CDATA[ æ°åé å±2ã¶æç®ã§ChatGPTãæŽ»çšããæ°èŠæ©èœéçºãããžã§ã¯ãã«ã¢ãµã€ã³ããã話 ]]>
ã¯ããã« èªå·±çŽ¹ä» ã¯ãããŸããŠã人æãã©ãããã©ãŒã æ¬éšãããã¯ãéçºå®€ç¬¬äžéçºã°ã«ãŒãã®ç°äžã§ãã ç§ã¯ã2023 幎㮠4 æã«æ°åãšã³ãžãã¢ãšããŠå ¥ç€Ÿããæ¥æ¬æå€§çŽã®å»çä»è·æ±äººãµã€ãã ãžã§ãã¡ãã¬ãŒ ãã®ããã³ããšã³ããšããã¯ãšã³ãã®éçºãæ åœããŠããŸãã åŠçæä»£ã¯æ å ±ç³»ã§ã¯ãªããçµæžåŠãå°æ»ããŠããŸãããããã°ã©ãã³ã°ã«ã¯å€§åŠã®ææ¥ã§åºäŒããäž»ã«ããŒã¿åæã«çšãã R ã Python ãè§Šã£ãŠããŸããããã®ãã Web ã¢ããªã±ãŒã·ã§ã³ã®éçºã¯è¡ã£ãŠããŸããã§ããã ãšã³ãžãã¢ãšããè·æ¥ã«èå³ãæã£ããã£ããã¯ã倧åŠé¢æä»£ã«åå ããã€ã³ã¿ãŒã³ã§ãããã€ã³ã¿ãŒã³å ã®äŒç€Ÿã§ã¯ãšã³ãžãã¢ã誰ãããªãã£ãã®ã§ãããéçºæªçµéšã®ç§ã«æ©æ¢°åŠç¿ã䜿ã£ãã¢ããªã® PoC ãäœããšãããããªãç Žå€©èãªçµéšãããããã§ããä»ã§ã¯ãšãŠãã¬ã¢ãªçµéšã ã£ããšæããŸããã詊è¡é¯èª€ããªããäœããäœãããšã«è奮ãèŠããã®ãä»ã§ãé®®æã«èŠããŠããŸãã ã¡ãã¬ãŒ ã«å ¥ç€Ÿããçç±ã¯ã倧ããªç€ŸäŒèª²é¡ã«åãçµãã§ãããè§Šããããæè¡ãããã³ããšã³ãã»ããã¯ãšã³ãã®ããã«é åã«éãããŠããªããªã©ãããŸããããäžçªå€§ããªçç±ã¯ã æè¡ã¯ãããŸã§ææ®µã§ããã顧客ãžã®äŸ¡å€æäŸãç®çã«ããŠãã ããšããèãã«å ±æããããšã§ããå ¥ç€ŸããŠãŸã æ¥ã¯æµ ãã§ããããã®èãã¯éæã§æããããŸãã 倧åŠè¿ãã®ããŒãã®å€çŒã å ¥ç€Ÿããåãããžã§ã¯ããŸã§ ããŠãä»åã®èšäºã§ã¯æ°åãšã³ãžãã¢ã®ç§ãåããŠæºãã£ããããžã§ã¯ãã®ç޹ä»ãéããŠãã¡ãã¬ãŒã§ã¯æ°åãšã³ãžãã¢ãå ¥ç€ŸåŸã«ã©ã®ãããªåãæ¹ãããŠããäŒããããšãã§ããã°ãšæããŸãã å ¥ç€ŸããŠããç ä¿®ãçµããŠãé å±åŸ 1 ã¶æåãããã¯äž»ã«ãããã¯ãã®å®åžžæ¹åç³»ã®ã¿ã¹ã¯ã«åãçµã¿ãªãããä»äºã®ãªãºã ãèŠããŠãããŸããã ãã®åŸãä»å玹ä»ãããããžã§ã¯ãã«åããŠã¢ãµã€ã³ãããŸããããã®æç¹ã§ãããžã§ã¯ãã§äž»ã«äœ¿çšããã¹ãã«ã»ããã®ããã³ããšã³ãã¯ãæ°åç ä¿®ã§åŠãã çšåºŠã§ããããã®ãããªç¶æ ã®æ°åã§ããçµéšãããããç©ãŸããŠããããè¯ãç°å¢ã ãšããããšããäŒãã§ããã°ãšæã£ãŠããŸãã ãããžã§ã¯ãã§è§£æ±ºãã課é¡ãšè§£æ±ºç ãŸããä»åæ åœãããããžã§ã¯ããçºè¶³ããèæ¯ãšãªã課é¡ãšããã®èª²é¡ã解決ããããã«æäŸããæ°æ©èœã«ã€ããŠç޹ä»ããŸãããã®ãããžã§ã¯ãã«ã€ããŠã¯ã ãã¥ãŒã¹ãªãªãŒã¹ ãå ¬éããŠããŸãã®ã§ãåãããŠã芧ãã ããã ãŠãŒã¶ãŒã®æ±ããèª²é¡ ãããŸã§ããžã§ãã¡ãã¬ãŒãã§ã¯é¡§å®¢ãæ±äººãäœæããéã«ããã©ãŒã 圢åŒã§åéèŠé ãèšå ¥ãã圢åŒãšãªã£ãŠããŸãããèšå ¥ã®èªç±åºŠãé«ãããšãããæ³ä»€ãã¬ã€ãã©ã€ã³çã§å®ããããé ç®ãæŒããªãèšèŒããããšããäºæ¥æã®é åã广çã«äŒãã工倫ãå¿ èŠã§ããã顧客ã«ãšã£ãŠã¯å€§ããªè² æ ã«ãªã£ãŠããŸããã ãã©ãŒã 圢åŒã®æ±äººäœææ©èœã®ã€ã¡ãŒãž 瀟å ãªãã¬ãŒã·ã§ã³ã®èгç¹ã§èŠããšãæ±äººãæ²èŒåºæºãæºãããŠããã®ããå ¥åãããæç« ããèªã¿åã確èªããæ¥åã«æéãããã£ãŠããŸããã ããã§ã顧客ãšç€Ÿå ãªãã¬ãŒã·ã§ã³ã®åæ¹ãæããŠãã課é¡ã解決ãããããžã§ã¯ããçºè¶³ããç§ãåç»ããŸããã ãŠãŒã¶ãŒç®ç·ã®è§£æ±ºç 顧客ãšç€Ÿå ãªãã¬ãŒã·ã§ã³ã®åæ¹ã®èª²é¡ã解決ãããããæ±äººäœæããã»ã¹ãããçŽæçãã€å¹ççã«æ¹åããŸãããå ·äœçã«ã¯ãåŸæ¥ã®ãã©ãŒã å ¥åæ¹åŒããã察話åŒã®è³ªåãšåçãéããŠæ±äººãäœæã§ããæ©èœãå°å ¥ããŸããããã®æ¹åã«ããã顧客ã¯ç°¡åã«ãè¿·ãããšãªãæ²èŒåºæºã«æ²¿ã£ãæ±äººãäœæãããããªããŸããã ããã«ãæç« äœæã®åŽåã軜æžããããã«ã ChatGPT ãæŽ»çšããææ¡æ©èœãå°å ¥ããŸããããã®æ©èœãéããŠã顧客ã¯å ¥åããå 容ã«åºã¥ããæ±è·è ã®ç®ã«æ¢ãŸããããæ±äººã¿ã€ãã«ãèšŽæ±æã ChatGPT ããææ¡ããŠããããŸããããã«ãããæ±äººåçš¿äœæã«ãããæéãç ©éãã軜æžãããå°ä»»ã®æ¡çšæ åœãããªãäºæ¥æã§ãæ¡çšæŽ»åãå¹ççã«é²ããããšãã§ããè¿ éãªäººæã®ç¢ºä¿ãžãšã€ãªãããŸãã瀟å ãªãã¬ãŒã·ã§ã³ã®èгç¹ã§ããæ²èŒåºæºãæºãããŠãããã確èªããæ¥åã®æéççž®ãæåŸ ã§ããŸãã 質å圢åŒã®æ±äººäœæè£å©æ©èœã®ã€ã¡ãŒãž ChatGPT ã®å°å ¥æç¡ã«é¢ããŠã¯ç€Ÿå ã§ãåè°ãããæç« çæã« ChatGPT ãçšããããšã§é¡§å®¢ã®äœæ¥ã³ã¹ããäžããããã®ã§ããã°å°å ¥ããããšããæææ±ºå®ããããŸãããæµè¡ã£ãŠããæè¡ã ããå°å ¥ããã®ã§ã¯ãªãã 顧客ãžã®äŸ¡å€æäŸã®ããã«æ°ããæè¡ãå°å ¥ãã èããçŸããæææ±ºå®ã ãšæããŸãã æè¡ã¹ã¿ã㯠ä»åã®ãããžã§ã¯ãã§ã¯æ¬¡ã®ãããªæè¡ã¹ã¿ãã¯ã§éçºãè¡ããŸãããããã³ããšã³ã㯠React ã䜿çšãç¶æ 管çã©ã€ãã©ãªãšã㊠React Hooks ãéžæããŸãããåŸæ¥ã®æ±äººäœææ©èœã§ã¯ Redux ã§ç¶æ 管çãè¡ã£ãŠããŸãããããããã¯ãå šäœã®æ¹éãšããŠä»åŸ React Hooks ã䜿çšããŠããæ¹éã§ãã£ãããšãšãå®è£ ã®ã¹ããŒããæ©ããããã« React Hooks ãæ¡çšããŸããã ChatGPT ãçšããéšåã«é¢ããŠã¯ã顧客ããã®ãªã¯ãšã¹ããåããŠçºè¡ããããŒã¯ã³ãä¿åããããã« Amazon DynamoDB ã䜿çšããŸãããDynamoDB ã«ä¿åããããŒã¯ã³ã®ããªããŒã·ã§ã³ãš GPT ãžããã³ãããæž¡ããææ¡ã®åãåãã»è¿åŽããéšå㯠AWS Lambda function ã«ä»»ããŠããŸãããGPT æ¬äœã¯ Azure OpenAI Service ãå©çšããæ§æã§ãããAzure OpenAI Service ãæ¡çšããçç±ã¯ã顧客æ å ±ãå ¥åå 容ãåŠç¿ã«äœ¿çšãããããšããªããã©ã€ãã·ãŒé¢ã§ã®ãªã¹ã¯ãåé¿ã§ããããã§ããã æç« çææ©èœã®æ§æã€ã¡ãŒãž ãããžã§ã¯ããžã®é¢ãã ä»åã®ãããžã§ã¯ãã®ã¡ã³ããŒæ§æã¯ãšã³ãžã㢠3 人ããã¶ã€ã㌠1 人ãPM 1 人ãšããæ§æã§ãããéçºã«ã¯çŽ 3 ã¶æã®æéãèŠããŸããã ãããžã§ã¯ãåæ ç§èªèº«ã®ãããžã§ã¯ããžã®é¢ããæ¹ãšããŠã¯ããããžã§ã¯ãåææ®µéããããã³ããšã³ãã®å®è£ ã¿ã¹ã¯ãäžå¿ã§ããããã®äžã§ã¹ã¿ã€ã«ã®å®è£ ã«é¢ããŠã¯ãªãŒããŒã·ãããæãããŠããã ããŸãããä»åã®ãããžã§ã¯ãã§äœæãã UI ã³ã³ããŒãã³ãã§ã¯ã䌌ããããªãã®ãè€æ°ãã£ããããã§ããã ãæ¡åŒµæ§ãæãã䜿ãåããããã«æèããŠèšèšããŠããŸãããä»äºã®ãµã€ã¯ã«ãšããŠã¯ããã¶ã€ããŒãäœã£ããã¶ã€ã³ãå ã«ã现ãã仿§ã調æŽããŠå®è£ ãããã¶ã€ã³ã¬ãã¥ãŒãããŠããããµã€ã¯ã«ãåããŠããŸããã ãã ãReact ãªã©ããã£ããã¢ããããªããã®å®è£ ã ã£ããããä»ã®ãšã³ãžãã¢ããå®è£ ã«æéãããã£ãŠããŸã£ãŠããŸãããé©å®å 茩ãšã³ãžãã¢ã«è³ªåããªããé²ããŠããŸããããããã€ãã®ã¿ã¹ã¯ã¯å·»ãåã£ãŠãããããšã«ãªããªã©ãæããæ°æã¡ãèŠãããããžã§ã¯ãåæã§ããã ãããžã§ã¯ãäžç€ä»¥é ãããžã§ã¯ãäžç€ãããã§äžã€ãšã³ãžãã¢ãšããŠã®ä»äºã®åãåãæ¹ã«å€åããããŸããããããžã§ã¯ãã®ã¹ã±ãžã¥ãŒã«ãã¿ã€ãã ã£ãã®ãçžãŸã£ãŠããããžã§ã¯ãåæã§ã¯ãšããããå®è£ ããŠæ©ãã¿ã¹ã¯ãçµããããããšã«æ³šåããŠããŸãããããããæéãããã£ãŠãè¯ãããäžã€äžã€äžå¯§ã«ã³ãŒãã远ã£ãŠçè§£ããããšã«åªããããšå 茩ãšã³ãžãã¢ã«ã¢ããã€ã¹ãããã ããŸããã ãããããçè§£ã«æ³šåããããšã§æèãã¯ãªã¢ã«ãªããçµæçã«å®è£ ã¹ããŒããäžãã£ãŠãããŸããããŸããå®è£ 以å€ã«ãç®ãåããäœè£ãçãŸãã仿§ã«ã€ã㊠PM ããã¶ã€ããŒã«ææ¡ããããšãã§ããŸããããããžã§ã¯ãäžç€ä»¥éã¯èªä¿¡ãæã£ãŠã¿ã¹ã¯ã«åãçµãããšãã§ããçµç€ã«ã¯ä»ã®ãšã³ãžãã¢ã®ã¿ã¹ã¯ãå·»ãåãããšãã§ãããŸã§ã«ãªããŸããã ãããžã§ã¯ãã®äžã§ã¯ãããã³ããã®æ¹åã¿ã¹ã¯ãä»»ããŠããããŸãããå 容ãšããŠã¯æå³ããªãåçãåŒŸãæ¹åã§ããããAWS Lambda ãè§Šããªã©ãå¿ èŠãããã°ã¯ã©ãŠããµãŒãã¹ãè§Šãæ©äŒããããšæããŸããã ChatGPT ã«ããææ¡æ©èœã®ã€ã¡ãŒãž ãããã« ãããžã§ã¯ããæ¯ãè¿ã£ãŠ æ°æ©èœããªãªãŒã¹ãããŠæ°ã¶æçµã¡ãŸããããå®ããŠãã KPI ãéæããçµæãçŸããŠããããšããšãŠãå¬ããã§ããäžäŸãšããŠãé¡§å®¢ãæ°æ©èœã§æ±äººãäœæããŠãã瀟å ã§ã®å¯©æ»ãçµãŠæ²èŒã«è³ããŸã§ã®æ¥æ°ããåŸæ¥ã®äœææ¹æ³ãšæ¯ã¹ãŠåå以äžãšå€§å¹ ã«åæžãããŠããŸãã ããŒã ãšããŠã¯ä»åã®ãããžã§ã¯ãã®é²ãæ¹ã«ã€ããŠæ¯ãè¿ããè¡ããŸãããPM ããã¶ã€ããŒããšã³ãžãã¢ãããããæ¬¡ã®ãããžã§ã¯ããããè¯ãéè¡ããææ¡ãåºãåããä»åã®ãããžã§ã¯ãã®çµéšãç¡é§ã«ãªããªãããã«ããŠããŸããçŸåšãç§èªèº«ã¯ãšã³ãžãã¢äžäººã®æ°ãããããžã§ã¯ããä»»ãããŠããŸããããã®æã®æ¯ãè¿ãã§ã®åçãã¿ã¹ã¯åè§£ãã¹ã±ãžã¥ãŒã«çå®ã«åœ¹ç«ãŠãããŠããŸãã å人çã«ã¯ä»åã®ãããžã§ã¯ããéããŠãããã³ããšã³ãã®æè¡ç¿åŸã¯ãã¡ããã®ããšããããžã§ã¯ãã¡ã³ããŒãšã®ã³ãã¥ãã±ãŒã·ã§ã³ã§æç« ã®æ§é åãç»åã«ç·šéãå ãããªã©ã®å·¥å€«ãå ããããšã§ã³ãã¥ãã±ãŒã·ã§ã³ã³ã¹ããäžããããšãã§ãããšãã£ãæè¡ä»¥å€ã®ããšãåŠã¶ããšãã§ããŸããã ãŸããããžã§ã¯ããéããŠãè¥æã®ãšã³ãžãã¢ãæé·ã§ããç°å¢ã ãšèã§æããŸãããé å±åŸãŸããªããããžã§ã¯ãã«åç»ãããŠããããããšãå¿ èŠã«å¿ããŠæ§ã ãªæè¡ãè§ŠãããŠããããããšã¯ãã¡ããã®ããšã§ãããåãããªãããšãèããããããŠãããé°å²æ°ãæãäžãããææŠãããŠããããç°å¢ã¯èŽ æ²¢ã«æããã»ã©ã§ãã ãã®ãããªæé·ã§ããç°å¢ã§è¥ææä»£ãéããããæ°åãšã³ãžãã¢ã®æ¹ããæè¡ã¯ãããŸã§ææ®µã§ããã顧客ãžã®äŸ¡å€æäŸãç®çã«ããŠããããŒã ã§åããããšã³ãžãã¢ã®æ¹ãçµ¶è³åéããŠããŸãã®ã§ããèå³ãããæ¹ã¯ãã²ã«ãžã¥ã¢ã«ã«ã話ããå§ããŠã¿ãŸãããã åéã®äžèЧ | æ ªåŒäŒç€Ÿã¡ãã¬ãŒ ã¡ãã¬ãŒã®æ¡çšæ å ±ã¯ãã¡ãããã確èªãã ããã www.medley.jp
æ ªåŒäŒç€Ÿã¡ãã¬ãŒ
2024/03/29
<![CDATA[ æ°åé å±2ã¶æç®ã§ChatGPTãæŽ»çšããæ°èŠæ©èœéçºãããžã§ã¯ãã«ã¢ãµã€ã³ããã話 ]]>
ã¯ããã« èªå·±çŽ¹ä» ã¯ãããŸããŠã人æãã©ãããã©ãŒã æ¬éšãããã¯ãéçºå®€ç¬¬äžéçºã°ã«ãŒãã®ç°äžã§ãã ç§ã¯ã2023 幎㮠4 æã«æ°åãšã³ãžãã¢ãšããŠå ¥ç€Ÿããæ¥æ¬æå€§çŽã®å»çä»è·æ±äººãµã€ãã ãžã§ãã¡ãã¬ãŒ ãã®ããã³ããšã³ããšããã¯ãšã³ãã®éçºãæ åœããŠããŸãã åŠçæä»£ã¯æ å ±ç³»ã§ã¯ãªããçµæžåŠãå°æ»ããŠããŸãããããã°ã©ãã³ã°ã«ã¯å€§åŠã®ææ¥ã§åºäŒããäž»ã«ããŒã¿åæã«çšãã R ã Python ãè§Šã£ãŠããŸããããã®ãã Web ã¢ããªã±ãŒã·ã§ã³ã®éçºã¯è¡ã£ãŠããŸããã§ããã ãšã³ãžãã¢ãšããè·æ¥ã«èå³ãæã£ããã£ããã¯ã倧åŠé¢æä»£ã«åå ããã€ã³ã¿ãŒã³ã§ãããã€ã³ã¿ãŒã³å ã®äŒç€Ÿã§ã¯ãšã³ãžãã¢ã誰ãããªãã£ãã®ã§ãããéçºæªçµéšã®ç§ã«æ©æ¢°åŠç¿ã䜿ã£ãã¢ããªã® PoC ãäœããšãããããªãç Žå€©èãªçµéšãããããã§ããä»ã§ã¯ãšãŠãã¬ã¢ãªçµéšã ã£ããšæããŸããã詊è¡é¯èª€ããªããäœããäœãããšã«è奮ãèŠããã®ãä»ã§ãé®®æã«èŠããŠããŸãã ã¡ãã¬ãŒ ã«å ¥ç€Ÿããçç±ã¯ã倧ããªç€ŸäŒèª²é¡ã«åãçµãã§ãããè§Šããããæè¡ãããã³ããšã³ãã»ããã¯ãšã³ãã®ããã«é åã«éãããŠããªããªã©ãããŸããããäžçªå€§ããªçç±ã¯ã æè¡ã¯ãããŸã§ææ®µã§ããã顧客ãžã®äŸ¡å€æäŸãç®çã«ããŠãã ããšããèãã«å ±æããããšã§ããå ¥ç€ŸããŠãŸã æ¥ã¯æµ ãã§ããããã®èãã¯éæã§æããããŸãã 倧åŠè¿ãã®ããŒãã®å€çŒã å ¥ç€Ÿããåãããžã§ã¯ããŸã§ ããŠãä»åã®èšäºã§ã¯æ°åãšã³ãžãã¢ã®ç§ãåããŠæºãã£ããããžã§ã¯ãã®ç޹ä»ãéããŠãã¡ãã¬ãŒã§ã¯æ°åãšã³ãžãã¢ãå ¥ç€ŸåŸã«ã©ã®ãããªåãæ¹ãããŠããäŒããããšãã§ããã°ãšæããŸãã å ¥ç€ŸããŠããç ä¿®ãçµããŠãé å±åŸ 1 ã¶æåãããã¯äž»ã«ãããã¯ãã®å®åžžæ¹åç³»ã®ã¿ã¹ã¯ã«åãçµã¿ãªãããä»äºã®ãªãºã ãèŠããŠãããŸããã ãã®åŸãä»å玹ä»ãããããžã§ã¯ãã«åããŠã¢ãµã€ã³ãããŸããããã®æç¹ã§ãããžã§ã¯ãã§äž»ã«äœ¿çšããã¹ãã«ã»ããã®ããã³ããšã³ãã¯ãæ°åç ä¿®ã§åŠãã çšåºŠã§ããããã®ãããªç¶æ ã®æ°åã§ããçµéšãããããç©ãŸããŠããããè¯ãç°å¢ã ãšããããšããäŒãã§ããã°ãšæã£ãŠããŸãã ãããžã§ã¯ãã§è§£æ±ºãã課é¡ãšè§£æ±ºç ãŸããä»åæ åœãããããžã§ã¯ããçºè¶³ããèæ¯ãšãªã課é¡ãšããã®èª²é¡ã解決ããããã«æäŸããæ°æ©èœã«ã€ããŠç޹ä»ããŸãããã®ãããžã§ã¯ãã«ã€ããŠã¯ã ãã¥ãŒã¹ãªãªãŒã¹ ãå ¬éããŠããŸãã®ã§ãåãããŠã芧ãã ããã ãŠãŒã¶ãŒã®æ±ããèª²é¡ ãããŸã§ããžã§ãã¡ãã¬ãŒãã§ã¯é¡§å®¢ãæ±äººãäœæããéã«ããã©ãŒã 圢åŒã§åéèŠé ãèšå ¥ãã圢åŒãšãªã£ãŠããŸãããèšå ¥ã®èªç±åºŠãé«ãããšãããæ³ä»€ãã¬ã€ãã©ã€ã³çã§å®ããããé ç®ãæŒããªãèšèŒããããšããäºæ¥æã®é åã广çã«äŒãã工倫ãå¿ èŠã§ããã顧客ã«ãšã£ãŠã¯å€§ããªè² æ ã«ãªã£ãŠããŸããã ãã©ãŒã 圢åŒã®æ±äººäœææ©èœã®ã€ã¡ãŒãž 瀟å ãªãã¬ãŒã·ã§ã³ã®èгç¹ã§èŠããšãæ±äººãæ²èŒåºæºãæºãããŠããã®ããå ¥åãããæç« ããèªã¿åã確èªããæ¥åã«æéãããã£ãŠããŸããã ããã§ã顧客ãšç€Ÿå ãªãã¬ãŒã·ã§ã³ã®åæ¹ãæããŠãã課é¡ã解決ãããããžã§ã¯ããçºè¶³ããç§ãåç»ããŸããã ãŠãŒã¶ãŒç®ç·ã®è§£æ±ºç 顧客ãšç€Ÿå ãªãã¬ãŒã·ã§ã³ã®åæ¹ã®èª²é¡ã解決ãããããæ±äººäœæããã»ã¹ãããçŽæçãã€å¹ççã«æ¹åããŸãããå ·äœçã«ã¯ãåŸæ¥ã®ãã©ãŒã å ¥åæ¹åŒããã察話åŒã®è³ªåãšåçãéããŠæ±äººãäœæã§ããæ©èœãå°å ¥ããŸããããã®æ¹åã«ããã顧客ã¯ç°¡åã«ãè¿·ãããšãªãæ²èŒåºæºã«æ²¿ã£ãæ±äººãäœæãããããªããŸããã ããã«ãæç« äœæã®åŽåã軜æžããããã«ã ChatGPT ãæŽ»çšããææ¡æ©èœãå°å ¥ããŸããããã®æ©èœãéããŠã顧客ã¯å ¥åããå 容ã«åºã¥ããæ±è·è ã®ç®ã«æ¢ãŸããããæ±äººã¿ã€ãã«ãèšŽæ±æã ChatGPT ããææ¡ããŠããããŸããããã«ãããæ±äººåçš¿äœæã«ãããæéãç ©éãã軜æžãããå°ä»»ã®æ¡çšæ åœãããªãäºæ¥æã§ãæ¡çšæŽ»åãå¹ççã«é²ããããšãã§ããè¿ éãªäººæã®ç¢ºä¿ãžãšã€ãªãããŸãã瀟å ãªãã¬ãŒã·ã§ã³ã®èгç¹ã§ããæ²èŒåºæºãæºãããŠãããã確èªããæ¥åã®æéççž®ãæåŸ ã§ããŸãã 質å圢åŒã®æ±äººäœæè£å©æ©èœã®ã€ã¡ãŒãž ChatGPT ã®å°å ¥æç¡ã«é¢ããŠã¯ç€Ÿå ã§ãåè°ãããæç« çæã« ChatGPT ãçšããããšã§é¡§å®¢ã®äœæ¥ã³ã¹ããäžããããã®ã§ããã°å°å ¥ããããšããæææ±ºå®ããããŸãããæµè¡ã£ãŠããæè¡ã ããå°å ¥ããã®ã§ã¯ãªãã 顧客ãžã®äŸ¡å€æäŸã®ããã«æ°ããæè¡ãå°å ¥ãã èããçŸããæææ±ºå®ã ãšæããŸãã æè¡ã¹ã¿ã㯠ä»åã®ãããžã§ã¯ãã§ã¯æ¬¡ã®ãããªæè¡ã¹ã¿ãã¯ã§éçºãè¡ããŸãããããã³ããšã³ã㯠React ã䜿çšãç¶æ 管çã©ã€ãã©ãªãšã㊠React Hooks ãéžæããŸãããåŸæ¥ã®æ±äººäœææ©èœã§ã¯ Redux ã§ç¶æ 管çãè¡ã£ãŠããŸãããããããã¯ãå šäœã®æ¹éãšããŠä»åŸ React Hooks ã䜿çšããŠããæ¹éã§ãã£ãããšãšãå®è£ ã®ã¹ããŒããæ©ããããã« React Hooks ãæ¡çšããŸããã ChatGPT ãçšããéšåã«é¢ããŠã¯ã顧客ããã®ãªã¯ãšã¹ããåããŠçºè¡ããããŒã¯ã³ãä¿åããããã« Amazon DynamoDB ã䜿çšããŸãããDynamoDB ã«ä¿åããããŒã¯ã³ã®ããªããŒã·ã§ã³ãš GPT ãžããã³ãããæž¡ããææ¡ã®åãåãã»è¿åŽããéšå㯠AWS Lambda function ã«ä»»ããŠããŸãããGPT æ¬äœã¯ Azure OpenAI Service ãå©çšããæ§æã§ãããAzure OpenAI Service ãæ¡çšããçç±ã¯ã顧客æ å ±ãå ¥åå 容ãåŠç¿ã«äœ¿çšãããããšããªããã©ã€ãã·ãŒé¢ã§ã®ãªã¹ã¯ãåé¿ã§ããããã§ããã æç« çææ©èœã®æ§æã€ã¡ãŒãž ãããžã§ã¯ããžã®é¢ãã ä»åã®ãããžã§ã¯ãã®ã¡ã³ããŒæ§æã¯ãšã³ãžã㢠3 人ããã¶ã€ã㌠1 人ãPM 1 人ãšããæ§æã§ãããéçºã«ã¯çŽ 3 ã¶æã®æéãèŠããŸããã ãããžã§ã¯ãåæ ç§èªèº«ã®ãããžã§ã¯ããžã®é¢ããæ¹ãšããŠã¯ããããžã§ã¯ãåææ®µéããããã³ããšã³ãã®å®è£ ã¿ã¹ã¯ãäžå¿ã§ããããã®äžã§ã¹ã¿ã€ã«ã®å®è£ ã«é¢ããŠã¯ãªãŒããŒã·ãããæãããŠããã ããŸãããä»åã®ãããžã§ã¯ãã§äœæãã UI ã³ã³ããŒãã³ãã§ã¯ã䌌ããããªãã®ãè€æ°ãã£ããããã§ããã ãæ¡åŒµæ§ãæãã䜿ãåããããã«æèããŠèšèšããŠããŸãããä»äºã®ãµã€ã¯ã«ãšããŠã¯ããã¶ã€ããŒãäœã£ããã¶ã€ã³ãå ã«ã现ãã仿§ã調æŽããŠå®è£ ãããã¶ã€ã³ã¬ãã¥ãŒãããŠããããµã€ã¯ã«ãåããŠããŸããã ãã ãReact ãªã©ããã£ããã¢ããããªããã®å®è£ ã ã£ããããä»ã®ãšã³ãžãã¢ããå®è£ ã«æéãããã£ãŠããŸã£ãŠããŸãããé©å®å 茩ãšã³ãžãã¢ã«è³ªåããªããé²ããŠããŸããããããã€ãã®ã¿ã¹ã¯ã¯å·»ãåã£ãŠãããããšã«ãªããªã©ãæããæ°æã¡ãèŠãããããžã§ã¯ãåæã§ããã ãããžã§ã¯ãäžç€ä»¥é ãããžã§ã¯ãäžç€ãããã§äžã€ãšã³ãžãã¢ãšããŠã®ä»äºã®åãåãæ¹ã«å€åããããŸããããããžã§ã¯ãã®ã¹ã±ãžã¥ãŒã«ãã¿ã€ãã ã£ãã®ãçžãŸã£ãŠããããžã§ã¯ãåæã§ã¯ãšããããå®è£ ããŠæ©ãã¿ã¹ã¯ãçµããããããšã«æ³šåããŠããŸãããããããæéãããã£ãŠãè¯ãããäžã€äžã€äžå¯§ã«ã³ãŒãã远ã£ãŠçè§£ããããšã«åªããããšå 茩ãšã³ãžãã¢ã«ã¢ããã€ã¹ãããã ããŸããã ãããããçè§£ã«æ³šåããããšã§æèãã¯ãªã¢ã«ãªããçµæçã«å®è£ ã¹ããŒããäžãã£ãŠãããŸããããŸããå®è£ 以å€ã«ãç®ãåããäœè£ãçãŸãã仿§ã«ã€ã㊠PM ããã¶ã€ããŒã«ææ¡ããããšãã§ããŸããããããžã§ã¯ãäžç€ä»¥éã¯èªä¿¡ãæã£ãŠã¿ã¹ã¯ã«åãçµãããšãã§ããçµç€ã«ã¯ä»ã®ãšã³ãžãã¢ã®ã¿ã¹ã¯ãå·»ãåãããšãã§ãããŸã§ã«ãªããŸããã ãããžã§ã¯ãã®äžã§ã¯ãããã³ããã®æ¹åã¿ã¹ã¯ãä»»ããŠããããŸãããå 容ãšããŠã¯æå³ããªãåçãåŒŸãæ¹åã§ããããAWS Lambda ãè§Šããªã©ãå¿ èŠãããã°ã¯ã©ãŠããµãŒãã¹ãè§Šãæ©äŒããããšæããŸããã ChatGPT ã«ããææ¡æ©èœã®ã€ã¡ãŒãž ãããã« ãããžã§ã¯ããæ¯ãè¿ã£ãŠ æ°æ©èœããªãªãŒã¹ãããŠæ°ã¶æçµã¡ãŸããããå®ããŠãã KPI ãéæããçµæãçŸããŠããããšããšãŠãå¬ããã§ããäžäŸãšããŠãé¡§å®¢ãæ°æ©èœã§æ±äººãäœæããŠãã瀟å ã§ã®å¯©æ»ãçµãŠæ²èŒã«è³ããŸã§ã®æ¥æ°ããåŸæ¥ã®äœææ¹æ³ãšæ¯ã¹ãŠåå以äžãšå€§å¹ ã«åæžãããŠããŸãã ããŒã ãšããŠã¯ä»åã®ãããžã§ã¯ãã®é²ãæ¹ã«ã€ããŠæ¯ãè¿ããè¡ããŸãããPM ããã¶ã€ããŒããšã³ãžãã¢ãããããæ¬¡ã®ãããžã§ã¯ããããè¯ãéè¡ããææ¡ãåºãåããä»åã®ãããžã§ã¯ãã®çµéšãç¡é§ã«ãªããªãããã«ããŠããŸããçŸåšãç§èªèº«ã¯ãšã³ãžãã¢äžäººã®æ°ãããããžã§ã¯ããä»»ãããŠããŸããããã®æã®æ¯ãè¿ãã§ã®åçãã¿ã¹ã¯åè§£ãã¹ã±ãžã¥ãŒã«çå®ã«åœ¹ç«ãŠãããŠããŸãã å人çã«ã¯ä»åã®ãããžã§ã¯ããéããŠãããã³ããšã³ãã®æè¡ç¿åŸã¯ãã¡ããã®ããšããããžã§ã¯ãã¡ã³ããŒãšã®ã³ãã¥ãã±ãŒã·ã§ã³ã§æç« ã®æ§é åãç»åã«ç·šéãå ãããªã©ã®å·¥å€«ãå ããããšã§ã³ãã¥ãã±ãŒã·ã§ã³ã³ã¹ããäžããããšãã§ãããšãã£ãæè¡ä»¥å€ã®ããšãåŠã¶ããšãã§ããŸããã ãŸããããžã§ã¯ããéããŠãè¥æã®ãšã³ãžãã¢ãæé·ã§ããç°å¢ã ãšèã§æããŸãããé å±åŸãŸããªããããžã§ã¯ãã«åç»ãããŠããããããšãå¿ èŠã«å¿ããŠæ§ã ãªæè¡ãè§ŠãããŠããããããšã¯ãã¡ããã®ããšã§ãããåãããªãããšãèããããããŠãããé°å²æ°ãæãäžãããææŠãããŠããããç°å¢ã¯èŽ æ²¢ã«æããã»ã©ã§ãã ãã®ãããªæé·ã§ããç°å¢ã§è¥ææä»£ãéããããæ°åãšã³ãžãã¢ã®æ¹ããæè¡ã¯ãããŸã§ææ®µã§ããã顧客ãžã®äŸ¡å€æäŸãç®çã«ããŠããããŒã ã§åããããšã³ãžãã¢ã®æ¹ãçµ¶è³åéããŠããŸãã®ã§ããèå³ãããæ¹ã¯ãã²ã«ãžã¥ã¢ã«ã«ã話ããå§ããŠã¿ãŸãããã åéã®äžèЧ | æ ªåŒäŒç€Ÿã¡ãã¬ãŒ ã¡ãã¬ãŒã®æ¡çšæ å ±ã¯ãã¡ãããã確èªãã ããã www.medley.jp
æ ªåŒäŒç€Ÿã¡ãã¬ãŒ
2024/03/29
<![CDATA[ æ°åé å±2ã¶æç®ã§ChatGPTãæŽ»çšããæ°èŠæ©èœéçºãããžã§ã¯ãã«ã¢ãµã€ã³ããã話 ]]>
ã¯ããã« èªå·±çŽ¹ä» ã¯ãããŸããŠã人æãã©ãããã©ãŒã æ¬éšãããã¯ãéçºå®€ç¬¬äžéçºã°ã«ãŒãã®ç°äžã§ãã ç§ã¯ã2023 幎㮠4 æã«æ°åãšã³ãžãã¢ãšããŠå ¥ç€Ÿããæ¥æ¬æå€§çŽã®å»çä»è·æ±äººãµã€ãã ãžã§ãã¡ãã¬ãŒ ãã®ããã³ããšã³ããšããã¯ãšã³ãã®éçºãæ åœããŠããŸãã åŠçæä»£ã¯æ å ±ç³»ã§ã¯ãªããçµæžåŠãå°æ»ããŠããŸãããããã°ã©ãã³ã°ã«ã¯å€§åŠã®ææ¥ã§åºäŒããäž»ã«ããŒã¿åæã«çšãã R ã Python ãè§Šã£ãŠããŸããããã®ãã Web ã¢ããªã±ãŒã·ã§ã³ã®éçºã¯è¡ã£ãŠããŸããã§ããã ãšã³ãžãã¢ãšããè·æ¥ã«èå³ãæã£ããã£ããã¯ã倧åŠé¢æä»£ã«åå ããã€ã³ã¿ãŒã³ã§ãããã€ã³ã¿ãŒã³å ã®äŒç€Ÿã§ã¯ãšã³ãžãã¢ã誰ãããªãã£ãã®ã§ãããéçºæªçµéšã®ç§ã«æ©æ¢°åŠç¿ã䜿ã£ãã¢ããªã® PoC ãäœããšãããããªãç Žå€©èãªçµéšãããããã§ããä»ã§ã¯ãšãŠãã¬ã¢ãªçµéšã ã£ããšæããŸããã詊è¡é¯èª€ããªããäœããäœãããšã«è奮ãèŠããã®ãä»ã§ãé®®æã«èŠããŠããŸãã ã¡ãã¬ãŒ ã«å ¥ç€Ÿããçç±ã¯ã倧ããªç€ŸäŒèª²é¡ã«åãçµãã§ãããè§Šããããæè¡ãããã³ããšã³ãã»ããã¯ãšã³ãã®ããã«é åã«éãããŠããªããªã©ãããŸããããäžçªå€§ããªçç±ã¯ã æè¡ã¯ãããŸã§ææ®µã§ããã顧客ãžã®äŸ¡å€æäŸãç®çã«ããŠãã ããšããèãã«å ±æããããšã§ããå ¥ç€ŸããŠãŸã æ¥ã¯æµ ãã§ããããã®èãã¯éæã§æããããŸãã 倧åŠè¿ãã®ããŒãã®å€çŒã å ¥ç€Ÿããåãããžã§ã¯ããŸã§ ããŠãä»åã®èšäºã§ã¯æ°åãšã³ãžãã¢ã®ç§ãåããŠæºãã£ããããžã§ã¯ãã®ç޹ä»ãéããŠãã¡ãã¬ãŒã§ã¯æ°åãšã³ãžãã¢ãå ¥ç€ŸåŸã«ã©ã®ãããªåãæ¹ãããŠããäŒããããšãã§ããã°ãšæããŸãã å ¥ç€ŸããŠããç ä¿®ãçµããŠãé å±åŸ 1 ã¶æåãããã¯äž»ã«ãããã¯ãã®å®åžžæ¹åç³»ã®ã¿ã¹ã¯ã«åãçµã¿ãªãããä»äºã®ãªãºã ãèŠããŠãããŸããã ãã®åŸãä»å玹ä»ãããããžã§ã¯ãã«åããŠã¢ãµã€ã³ãããŸããããã®æç¹ã§ãããžã§ã¯ãã§äž»ã«äœ¿çšããã¹ãã«ã»ããã®ããã³ããšã³ãã¯ãæ°åç ä¿®ã§åŠãã çšåºŠã§ããããã®ãããªç¶æ ã®æ°åã§ããçµéšãããããç©ãŸããŠããããè¯ãç°å¢ã ãšããããšããäŒãã§ããã°ãšæã£ãŠããŸãã ãããžã§ã¯ãã§è§£æ±ºãã課é¡ãšè§£æ±ºç ãŸããä»åæ åœãããããžã§ã¯ããçºè¶³ããèæ¯ãšãªã課é¡ãšããã®èª²é¡ã解決ããããã«æäŸããæ°æ©èœã«ã€ããŠç޹ä»ããŸãããã®ãããžã§ã¯ãã«ã€ããŠã¯ã ãã¥ãŒã¹ãªãªãŒã¹ ãå ¬éããŠããŸãã®ã§ãåãããŠã芧ãã ããã ãŠãŒã¶ãŒã®æ±ããèª²é¡ ãããŸã§ããžã§ãã¡ãã¬ãŒãã§ã¯é¡§å®¢ãæ±äººãäœæããéã«ããã©ãŒã 圢åŒã§åéèŠé ãèšå ¥ãã圢åŒãšãªã£ãŠããŸãããèšå ¥ã®èªç±åºŠãé«ãããšãããæ³ä»€ãã¬ã€ãã©ã€ã³çã§å®ããããé ç®ãæŒããªãèšèŒããããšããäºæ¥æã®é åã广çã«äŒãã工倫ãå¿ èŠã§ããã顧客ã«ãšã£ãŠã¯å€§ããªè² æ ã«ãªã£ãŠããŸããã ãã©ãŒã 圢åŒã®æ±äººäœææ©èœã®ã€ã¡ãŒãž 瀟å ãªãã¬ãŒã·ã§ã³ã®èгç¹ã§èŠããšãæ±äººãæ²èŒåºæºãæºãããŠããã®ããå ¥åãããæç« ããèªã¿åã確èªããæ¥åã«æéãããã£ãŠããŸããã ããã§ã顧客ãšç€Ÿå ãªãã¬ãŒã·ã§ã³ã®åæ¹ãæããŠãã課é¡ã解決ãããããžã§ã¯ããçºè¶³ããç§ãåç»ããŸããã ãŠãŒã¶ãŒç®ç·ã®è§£æ±ºç 顧客ãšç€Ÿå ãªãã¬ãŒã·ã§ã³ã®åæ¹ã®èª²é¡ã解決ãããããæ±äººäœæããã»ã¹ãããçŽæçãã€å¹ççã«æ¹åããŸãããå ·äœçã«ã¯ãåŸæ¥ã®ãã©ãŒã å ¥åæ¹åŒããã察話åŒã®è³ªåãšåçãéããŠæ±äººãäœæã§ããæ©èœãå°å ¥ããŸããããã®æ¹åã«ããã顧客ã¯ç°¡åã«ãè¿·ãããšãªãæ²èŒåºæºã«æ²¿ã£ãæ±äººãäœæãããããªããŸããã ããã«ãæç« äœæã®åŽåã軜æžããããã«ã ChatGPT ãæŽ»çšããææ¡æ©èœãå°å ¥ããŸããããã®æ©èœãéããŠã顧客ã¯å ¥åããå 容ã«åºã¥ããæ±è·è ã®ç®ã«æ¢ãŸããããæ±äººã¿ã€ãã«ãèšŽæ±æã ChatGPT ããææ¡ããŠããããŸããããã«ãããæ±äººåçš¿äœæã«ãããæéãç ©éãã軜æžãããå°ä»»ã®æ¡çšæ åœãããªãäºæ¥æã§ãæ¡çšæŽ»åãå¹ççã«é²ããããšãã§ããè¿ éãªäººæã®ç¢ºä¿ãžãšã€ãªãããŸãã瀟å ãªãã¬ãŒã·ã§ã³ã®èгç¹ã§ããæ²èŒåºæºãæºãããŠãããã確èªããæ¥åã®æéççž®ãæåŸ ã§ããŸãã 質å圢åŒã®æ±äººäœæè£å©æ©èœã®ã€ã¡ãŒãž ChatGPT ã®å°å ¥æç¡ã«é¢ããŠã¯ç€Ÿå ã§ãåè°ãããæç« çæã« ChatGPT ãçšããããšã§é¡§å®¢ã®äœæ¥ã³ã¹ããäžããããã®ã§ããã°å°å ¥ããããšããæææ±ºå®ããããŸãããæµè¡ã£ãŠããæè¡ã ããå°å ¥ããã®ã§ã¯ãªãã 顧客ãžã®äŸ¡å€æäŸã®ããã«æ°ããæè¡ãå°å ¥ãã èããçŸããæææ±ºå®ã ãšæããŸãã æè¡ã¹ã¿ã㯠ä»åã®ãããžã§ã¯ãã§ã¯æ¬¡ã®ãããªæè¡ã¹ã¿ãã¯ã§éçºãè¡ããŸãããããã³ããšã³ã㯠React ã䜿çšãç¶æ 管çã©ã€ãã©ãªãšã㊠React Hooks ãéžæããŸãããåŸæ¥ã®æ±äººäœææ©èœã§ã¯ Redux ã§ç¶æ 管çãè¡ã£ãŠããŸãããããããã¯ãå šäœã®æ¹éãšããŠä»åŸ React Hooks ã䜿çšããŠããæ¹éã§ãã£ãããšãšãå®è£ ã®ã¹ããŒããæ©ããããã« React Hooks ãæ¡çšããŸããã ChatGPT ãçšããéšåã«é¢ããŠã¯ã顧客ããã®ãªã¯ãšã¹ããåããŠçºè¡ããããŒã¯ã³ãä¿åããããã« Amazon DynamoDB ã䜿çšããŸãããDynamoDB ã«ä¿åããããŒã¯ã³ã®ããªããŒã·ã§ã³ãš GPT ãžããã³ãããæž¡ããææ¡ã®åãåãã»è¿åŽããéšå㯠AWS Lambda function ã«ä»»ããŠããŸãããGPT æ¬äœã¯ Azure OpenAI Service ãå©çšããæ§æã§ãããAzure OpenAI Service ãæ¡çšããçç±ã¯ã顧客æ å ±ãå ¥åå 容ãåŠç¿ã«äœ¿çšãããããšããªããã©ã€ãã·ãŒé¢ã§ã®ãªã¹ã¯ãåé¿ã§ããããã§ããã æç« çææ©èœã®æ§æã€ã¡ãŒãž ãããžã§ã¯ããžã®é¢ãã ä»åã®ãããžã§ã¯ãã®ã¡ã³ããŒæ§æã¯ãšã³ãžã㢠3 人ããã¶ã€ã㌠1 人ãPM 1 人ãšããæ§æã§ãããéçºã«ã¯çŽ 3 ã¶æã®æéãèŠããŸããã ãããžã§ã¯ãåæ ç§èªèº«ã®ãããžã§ã¯ããžã®é¢ããæ¹ãšããŠã¯ããããžã§ã¯ãåææ®µéããããã³ããšã³ãã®å®è£ ã¿ã¹ã¯ãäžå¿ã§ããããã®äžã§ã¹ã¿ã€ã«ã®å®è£ ã«é¢ããŠã¯ãªãŒããŒã·ãããæãããŠããã ããŸãããä»åã®ãããžã§ã¯ãã§äœæãã UI ã³ã³ããŒãã³ãã§ã¯ã䌌ããããªãã®ãè€æ°ãã£ããããã§ããã ãæ¡åŒµæ§ãæãã䜿ãåããããã«æèããŠèšèšããŠããŸãããä»äºã®ãµã€ã¯ã«ãšããŠã¯ããã¶ã€ããŒãäœã£ããã¶ã€ã³ãå ã«ã现ãã仿§ã調æŽããŠå®è£ ãããã¶ã€ã³ã¬ãã¥ãŒãããŠããããµã€ã¯ã«ãåããŠããŸããã ãã ãReact ãªã©ããã£ããã¢ããããªããã®å®è£ ã ã£ããããä»ã®ãšã³ãžãã¢ããå®è£ ã«æéãããã£ãŠããŸã£ãŠããŸãããé©å®å 茩ãšã³ãžãã¢ã«è³ªåããªããé²ããŠããŸããããããã€ãã®ã¿ã¹ã¯ã¯å·»ãåã£ãŠãããããšã«ãªããªã©ãæããæ°æã¡ãèŠãããããžã§ã¯ãåæã§ããã ãããžã§ã¯ãäžç€ä»¥é ãããžã§ã¯ãäžç€ãããã§äžã€ãšã³ãžãã¢ãšããŠã®ä»äºã®åãåãæ¹ã«å€åããããŸããããããžã§ã¯ãã®ã¹ã±ãžã¥ãŒã«ãã¿ã€ãã ã£ãã®ãçžãŸã£ãŠããããžã§ã¯ãåæã§ã¯ãšããããå®è£ ããŠæ©ãã¿ã¹ã¯ãçµããããããšã«æ³šåããŠããŸãããããããæéãããã£ãŠãè¯ãããäžã€äžã€äžå¯§ã«ã³ãŒãã远ã£ãŠçè§£ããããšã«åªããããšå 茩ãšã³ãžãã¢ã«ã¢ããã€ã¹ãããã ããŸããã ãããããçè§£ã«æ³šåããããšã§æèãã¯ãªã¢ã«ãªããçµæçã«å®è£ ã¹ããŒããäžãã£ãŠãããŸããããŸããå®è£ 以å€ã«ãç®ãåããäœè£ãçãŸãã仿§ã«ã€ã㊠PM ããã¶ã€ããŒã«ææ¡ããããšãã§ããŸããããããžã§ã¯ãäžç€ä»¥éã¯èªä¿¡ãæã£ãŠã¿ã¹ã¯ã«åãçµãããšãã§ããçµç€ã«ã¯ä»ã®ãšã³ãžãã¢ã®ã¿ã¹ã¯ãå·»ãåãããšãã§ãããŸã§ã«ãªããŸããã ãããžã§ã¯ãã®äžã§ã¯ãããã³ããã®æ¹åã¿ã¹ã¯ãä»»ããŠããããŸãããå 容ãšããŠã¯æå³ããªãåçãåŒŸãæ¹åã§ããããAWS Lambda ãè§Šããªã©ãå¿ èŠãããã°ã¯ã©ãŠããµãŒãã¹ãè§Šãæ©äŒããããšæããŸããã ChatGPT ã«ããææ¡æ©èœã®ã€ã¡ãŒãž ãããã« ãããžã§ã¯ããæ¯ãè¿ã£ãŠ æ°æ©èœããªãªãŒã¹ãããŠæ°ã¶æçµã¡ãŸããããå®ããŠãã KPI ãéæããçµæãçŸããŠããããšããšãŠãå¬ããã§ããäžäŸãšããŠãé¡§å®¢ãæ°æ©èœã§æ±äººãäœæããŠãã瀟å ã§ã®å¯©æ»ãçµãŠæ²èŒã«è³ããŸã§ã®æ¥æ°ããåŸæ¥ã®äœææ¹æ³ãšæ¯ã¹ãŠåå以äžãšå€§å¹ ã«åæžãããŠããŸãã ããŒã ãšããŠã¯ä»åã®ãããžã§ã¯ãã®é²ãæ¹ã«ã€ããŠæ¯ãè¿ããè¡ããŸãããPM ããã¶ã€ããŒããšã³ãžãã¢ãããããæ¬¡ã®ãããžã§ã¯ããããè¯ãéè¡ããææ¡ãåºãåããä»åã®ãããžã§ã¯ãã®çµéšãç¡é§ã«ãªããªãããã«ããŠããŸããçŸåšãç§èªèº«ã¯ãšã³ãžãã¢äžäººã®æ°ãããããžã§ã¯ããä»»ãããŠããŸããããã®æã®æ¯ãè¿ãã§ã®åçãã¿ã¹ã¯åè§£ãã¹ã±ãžã¥ãŒã«çå®ã«åœ¹ç«ãŠãããŠããŸãã å人çã«ã¯ä»åã®ãããžã§ã¯ããéããŠãããã³ããšã³ãã®æè¡ç¿åŸã¯ãã¡ããã®ããšããããžã§ã¯ãã¡ã³ããŒãšã®ã³ãã¥ãã±ãŒã·ã§ã³ã§æç« ã®æ§é åãç»åã«ç·šéãå ãããªã©ã®å·¥å€«ãå ããããšã§ã³ãã¥ãã±ãŒã·ã§ã³ã³ã¹ããäžããããšãã§ãããšãã£ãæè¡ä»¥å€ã®ããšãåŠã¶ããšãã§ããŸããã ãŸããããžã§ã¯ããéããŠãè¥æã®ãšã³ãžãã¢ãæé·ã§ããç°å¢ã ãšèã§æããŸãããé å±åŸãŸããªããããžã§ã¯ãã«åç»ãããŠããããããšãå¿ èŠã«å¿ããŠæ§ã ãªæè¡ãè§ŠãããŠããããããšã¯ãã¡ããã®ããšã§ãããåãããªãããšãèããããããŠãããé°å²æ°ãæãäžãããææŠãããŠããããç°å¢ã¯èŽ æ²¢ã«æããã»ã©ã§ãã ãã®ãããªæé·ã§ããç°å¢ã§è¥ææä»£ãéããããæ°åãšã³ãžãã¢ã®æ¹ããæè¡ã¯ãããŸã§ææ®µã§ããã顧客ãžã®äŸ¡å€æäŸãç®çã«ããŠããããŒã ã§åããããšã³ãžãã¢ã®æ¹ãçµ¶è³åéããŠããŸãã®ã§ããèå³ãããæ¹ã¯ãã²ã«ãžã¥ã¢ã«ã«ã話ããå§ããŠã¿ãŸãããã åéã®äžèЧ | æ ªåŒäŒç€Ÿã¡ãã¬ãŒ ã¡ãã¬ãŒã®æ¡çšæ å ±ã¯ãã¡ãããã確èªãã ããã www.medley.jp
æ ªåŒäŒç€Ÿã¡ãã¬ãŒ
2024/03/29
<![CDATA[ æ°åé å±2ã¶æç®ã§ChatGPTãæŽ»çšããæ°èŠæ©èœéçºãããžã§ã¯ãã«ã¢ãµã€ã³ããã話 ]]>
ã¯ããã« èªå·±çŽ¹ä» ã¯ãããŸããŠã人æãã©ãããã©ãŒã æ¬éšãããã¯ãéçºå®€ç¬¬äžéçºã°ã«ãŒãã®ç°äžã§ãã ç§ã¯ã2023 幎㮠4 æã«æ°åãšã³ãžãã¢ãšããŠå ¥ç€Ÿããæ¥æ¬æå€§çŽã®å»çä»è·æ±äººãµã€ãã ãžã§ãã¡ãã¬ãŒ ãã®ããã³ããšã³ããšããã¯ãšã³ãã®éçºãæ åœããŠããŸãã åŠçæä»£ã¯æ å ±ç³»ã§ã¯ãªããçµæžåŠãå°æ»ããŠããŸãããããã°ã©ãã³ã°ã«ã¯å€§åŠã®ææ¥ã§åºäŒããäž»ã«ããŒã¿åæã«çšãã R ã Python ãè§Šã£ãŠããŸããããã®ãã Web ã¢ããªã±ãŒã·ã§ã³ã®éçºã¯è¡ã£ãŠããŸããã§ããã ãšã³ãžãã¢ãšããè·æ¥ã«èå³ãæã£ããã£ããã¯ã倧åŠé¢æä»£ã«åå ããã€ã³ã¿ãŒã³ã§ãããã€ã³ã¿ãŒã³å ã®äŒç€Ÿã§ã¯ãšã³ãžãã¢ã誰ãããªãã£ãã®ã§ãããéçºæªçµéšã®ç§ã«æ©æ¢°åŠç¿ã䜿ã£ãã¢ããªã® PoC ãäœããšãããããªãç Žå€©èãªçµéšãããããã§ããä»ã§ã¯ãšãŠãã¬ã¢ãªçµéšã ã£ããšæããŸããã詊è¡é¯èª€ããªããäœããäœãããšã«è奮ãèŠããã®ãä»ã§ãé®®æã«èŠããŠããŸãã ã¡ãã¬ãŒ ã«å ¥ç€Ÿããçç±ã¯ã倧ããªç€ŸäŒèª²é¡ã«åãçµãã§ãããè§Šããããæè¡ãããã³ããšã³ãã»ããã¯ãšã³ãã®ããã«é åã«éãããŠããªããªã©ãããŸããããäžçªå€§ããªçç±ã¯ã æè¡ã¯ãããŸã§ææ®µã§ããã顧客ãžã®äŸ¡å€æäŸãç®çã«ããŠãã ããšããèãã«å ±æããããšã§ããå ¥ç€ŸããŠãŸã æ¥ã¯æµ ãã§ããããã®èãã¯éæã§æããããŸãã 倧åŠè¿ãã®ããŒãã®å€çŒã å ¥ç€Ÿããåãããžã§ã¯ããŸã§ ããŠãä»åã®èšäºã§ã¯æ°åãšã³ãžãã¢ã®ç§ãåããŠæºãã£ããããžã§ã¯ãã®ç޹ä»ãéããŠãã¡ãã¬ãŒã§ã¯æ°åãšã³ãžãã¢ãå ¥ç€ŸåŸã«ã©ã®ãããªåãæ¹ãããŠããäŒããããšãã§ããã°ãšæããŸãã å ¥ç€ŸããŠããç ä¿®ãçµããŠãé å±åŸ 1 ã¶æåãããã¯äž»ã«ãããã¯ãã®å®åžžæ¹åç³»ã®ã¿ã¹ã¯ã«åãçµã¿ãªãããä»äºã®ãªãºã ãèŠããŠãããŸããã ãã®åŸãä»å玹ä»ãããããžã§ã¯ãã«åããŠã¢ãµã€ã³ãããŸããããã®æç¹ã§ãããžã§ã¯ãã§äž»ã«äœ¿çšããã¹ãã«ã»ããã®ããã³ããšã³ãã¯ãæ°åç ä¿®ã§åŠãã çšåºŠã§ããããã®ãããªç¶æ ã®æ°åã§ããçµéšãããããç©ãŸããŠããããè¯ãç°å¢ã ãšããããšããäŒãã§ããã°ãšæã£ãŠããŸãã ãããžã§ã¯ãã§è§£æ±ºãã課é¡ãšè§£æ±ºç ãŸããä»åæ åœãããããžã§ã¯ããçºè¶³ããèæ¯ãšãªã課é¡ãšããã®èª²é¡ã解決ããããã«æäŸããæ°æ©èœã«ã€ããŠç޹ä»ããŸãããã®ãããžã§ã¯ãã«ã€ããŠã¯ã ãã¥ãŒã¹ãªãªãŒã¹ ãå ¬éããŠããŸãã®ã§ãåãããŠã芧ãã ããã ãŠãŒã¶ãŒã®æ±ããèª²é¡ ãããŸã§ããžã§ãã¡ãã¬ãŒãã§ã¯é¡§å®¢ãæ±äººãäœæããéã«ããã©ãŒã 圢åŒã§åéèŠé ãèšå ¥ãã圢åŒãšãªã£ãŠããŸãããèšå ¥ã®èªç±åºŠãé«ãããšãããæ³ä»€ãã¬ã€ãã©ã€ã³çã§å®ããããé ç®ãæŒããªãèšèŒããããšããäºæ¥æã®é åã广çã«äŒãã工倫ãå¿ èŠã§ããã顧客ã«ãšã£ãŠã¯å€§ããªè² æ ã«ãªã£ãŠããŸããã ãã©ãŒã 圢åŒã®æ±äººäœææ©èœã®ã€ã¡ãŒãž 瀟å ãªãã¬ãŒã·ã§ã³ã®èгç¹ã§èŠããšãæ±äººãæ²èŒåºæºãæºãããŠããã®ããå ¥åãããæç« ããèªã¿åã確èªããæ¥åã«æéãããã£ãŠããŸããã ããã§ã顧客ãšç€Ÿå ãªãã¬ãŒã·ã§ã³ã®åæ¹ãæããŠãã課é¡ã解決ãããããžã§ã¯ããçºè¶³ããç§ãåç»ããŸããã ãŠãŒã¶ãŒç®ç·ã®è§£æ±ºç 顧客ãšç€Ÿå ãªãã¬ãŒã·ã§ã³ã®åæ¹ã®èª²é¡ã解決ãããããæ±äººäœæããã»ã¹ãããçŽæçãã€å¹ççã«æ¹åããŸãããå ·äœçã«ã¯ãåŸæ¥ã®ãã©ãŒã å ¥åæ¹åŒããã察話åŒã®è³ªåãšåçãéããŠæ±äººãäœæã§ããæ©èœãå°å ¥ããŸããããã®æ¹åã«ããã顧客ã¯ç°¡åã«ãè¿·ãããšãªãæ²èŒåºæºã«æ²¿ã£ãæ±äººãäœæãããããªããŸããã ããã«ãæç« äœæã®åŽåã軜æžããããã«ã ChatGPT ãæŽ»çšããææ¡æ©èœãå°å ¥ããŸããããã®æ©èœãéããŠã顧客ã¯å ¥åããå 容ã«åºã¥ããæ±è·è ã®ç®ã«æ¢ãŸããããæ±äººã¿ã€ãã«ãèšŽæ±æã ChatGPT ããææ¡ããŠããããŸããããã«ãããæ±äººåçš¿äœæã«ãããæéãç ©éãã軜æžãããå°ä»»ã®æ¡çšæ åœãããªãäºæ¥æã§ãæ¡çšæŽ»åãå¹ççã«é²ããããšãã§ããè¿ éãªäººæã®ç¢ºä¿ãžãšã€ãªãããŸãã瀟å ãªãã¬ãŒã·ã§ã³ã®èгç¹ã§ããæ²èŒåºæºãæºãããŠãããã確èªããæ¥åã®æéççž®ãæåŸ ã§ããŸãã 質å圢åŒã®æ±äººäœæè£å©æ©èœã®ã€ã¡ãŒãž ChatGPT ã®å°å ¥æç¡ã«é¢ããŠã¯ç€Ÿå ã§ãåè°ãããæç« çæã« ChatGPT ãçšããããšã§é¡§å®¢ã®äœæ¥ã³ã¹ããäžããããã®ã§ããã°å°å ¥ããããšããæææ±ºå®ããããŸãããæµè¡ã£ãŠããæè¡ã ããå°å ¥ããã®ã§ã¯ãªãã 顧客ãžã®äŸ¡å€æäŸã®ããã«æ°ããæè¡ãå°å ¥ãã èããçŸããæææ±ºå®ã ãšæããŸãã æè¡ã¹ã¿ã㯠ä»åã®ãããžã§ã¯ãã§ã¯æ¬¡ã®ãããªæè¡ã¹ã¿ãã¯ã§éçºãè¡ããŸãããããã³ããšã³ã㯠React ã䜿çšãç¶æ 管çã©ã€ãã©ãªãšã㊠React Hooks ãéžæããŸãããåŸæ¥ã®æ±äººäœææ©èœã§ã¯ Redux ã§ç¶æ 管çãè¡ã£ãŠããŸãããããããã¯ãå šäœã®æ¹éãšããŠä»åŸ React Hooks ã䜿çšããŠããæ¹éã§ãã£ãããšãšãå®è£ ã®ã¹ããŒããæ©ããããã« React Hooks ãæ¡çšããŸããã ChatGPT ãçšããéšåã«é¢ããŠã¯ã顧客ããã®ãªã¯ãšã¹ããåããŠçºè¡ããããŒã¯ã³ãä¿åããããã« Amazon DynamoDB ã䜿çšããŸãããDynamoDB ã«ä¿åããããŒã¯ã³ã®ããªããŒã·ã§ã³ãš GPT ãžããã³ãããæž¡ããææ¡ã®åãåãã»è¿åŽããéšå㯠AWS Lambda function ã«ä»»ããŠããŸãããGPT æ¬äœã¯ Azure OpenAI Service ãå©çšããæ§æã§ãããAzure OpenAI Service ãæ¡çšããçç±ã¯ã顧客æ å ±ãå ¥åå 容ãåŠç¿ã«äœ¿çšãããããšããªããã©ã€ãã·ãŒé¢ã§ã®ãªã¹ã¯ãåé¿ã§ããããã§ããã æç« çææ©èœã®æ§æã€ã¡ãŒãž ãããžã§ã¯ããžã®é¢ãã ä»åã®ãããžã§ã¯ãã®ã¡ã³ããŒæ§æã¯ãšã³ãžã㢠3 人ããã¶ã€ã㌠1 人ãPM 1 人ãšããæ§æã§ãããéçºã«ã¯çŽ 3 ã¶æã®æéãèŠããŸããã ãããžã§ã¯ãåæ ç§èªèº«ã®ãããžã§ã¯ããžã®é¢ããæ¹ãšããŠã¯ããããžã§ã¯ãåææ®µéããããã³ããšã³ãã®å®è£ ã¿ã¹ã¯ãäžå¿ã§ããããã®äžã§ã¹ã¿ã€ã«ã®å®è£ ã«é¢ããŠã¯ãªãŒããŒã·ãããæãããŠããã ããŸãããä»åã®ãããžã§ã¯ãã§äœæãã UI ã³ã³ããŒãã³ãã§ã¯ã䌌ããããªãã®ãè€æ°ãã£ããããã§ããã ãæ¡åŒµæ§ãæãã䜿ãåããããã«æèããŠèšèšããŠããŸãããä»äºã®ãµã€ã¯ã«ãšããŠã¯ããã¶ã€ããŒãäœã£ããã¶ã€ã³ãå ã«ã现ãã仿§ã調æŽããŠå®è£ ãããã¶ã€ã³ã¬ãã¥ãŒãããŠããããµã€ã¯ã«ãåããŠããŸããã ãã ãReact ãªã©ããã£ããã¢ããããªããã®å®è£ ã ã£ããããä»ã®ãšã³ãžãã¢ããå®è£ ã«æéãããã£ãŠããŸã£ãŠããŸãããé©å®å 茩ãšã³ãžãã¢ã«è³ªåããªããé²ããŠããŸããããããã€ãã®ã¿ã¹ã¯ã¯å·»ãåã£ãŠãããããšã«ãªããªã©ãæããæ°æã¡ãèŠãããããžã§ã¯ãåæã§ããã ãããžã§ã¯ãäžç€ä»¥é ãããžã§ã¯ãäžç€ãããã§äžã€ãšã³ãžãã¢ãšããŠã®ä»äºã®åãåãæ¹ã«å€åããããŸããããããžã§ã¯ãã®ã¹ã±ãžã¥ãŒã«ãã¿ã€ãã ã£ãã®ãçžãŸã£ãŠããããžã§ã¯ãåæã§ã¯ãšããããå®è£ ããŠæ©ãã¿ã¹ã¯ãçµããããããšã«æ³šåããŠããŸãããããããæéãããã£ãŠãè¯ãããäžã€äžã€äžå¯§ã«ã³ãŒãã远ã£ãŠçè§£ããããšã«åªããããšå 茩ãšã³ãžãã¢ã«ã¢ããã€ã¹ãããã ããŸããã ãããããçè§£ã«æ³šåããããšã§æèãã¯ãªã¢ã«ãªããçµæçã«å®è£ ã¹ããŒããäžãã£ãŠãããŸããããŸããå®è£ 以å€ã«ãç®ãåããäœè£ãçãŸãã仿§ã«ã€ã㊠PM ããã¶ã€ããŒã«ææ¡ããããšãã§ããŸããããããžã§ã¯ãäžç€ä»¥éã¯èªä¿¡ãæã£ãŠã¿ã¹ã¯ã«åãçµãããšãã§ããçµç€ã«ã¯ä»ã®ãšã³ãžãã¢ã®ã¿ã¹ã¯ãå·»ãåãããšãã§ãããŸã§ã«ãªããŸããã ãããžã§ã¯ãã®äžã§ã¯ãããã³ããã®æ¹åã¿ã¹ã¯ãä»»ããŠããããŸãããå 容ãšããŠã¯æå³ããªãåçãåŒŸãæ¹åã§ããããAWS Lambda ãè§Šããªã©ãå¿ èŠãããã°ã¯ã©ãŠããµãŒãã¹ãè§Šãæ©äŒããããšæããŸããã ChatGPT ã«ããææ¡æ©èœã®ã€ã¡ãŒãž ãããã« ãããžã§ã¯ããæ¯ãè¿ã£ãŠ æ°æ©èœããªãªãŒã¹ãããŠæ°ã¶æçµã¡ãŸããããå®ããŠãã KPI ãéæããçµæãçŸããŠããããšããšãŠãå¬ããã§ããäžäŸãšããŠãé¡§å®¢ãæ°æ©èœã§æ±äººãäœæããŠãã瀟å ã§ã®å¯©æ»ãçµãŠæ²èŒã«è³ããŸã§ã®æ¥æ°ããåŸæ¥ã®äœææ¹æ³ãšæ¯ã¹ãŠåå以äžãšå€§å¹ ã«åæžãããŠããŸãã ããŒã ãšããŠã¯ä»åã®ãããžã§ã¯ãã®é²ãæ¹ã«ã€ããŠæ¯ãè¿ããè¡ããŸãããPM ããã¶ã€ããŒããšã³ãžãã¢ãããããæ¬¡ã®ãããžã§ã¯ããããè¯ãéè¡ããææ¡ãåºãåããä»åã®ãããžã§ã¯ãã®çµéšãç¡é§ã«ãªããªãããã«ããŠããŸããçŸåšãç§èªèº«ã¯ãšã³ãžãã¢äžäººã®æ°ãããããžã§ã¯ããä»»ãããŠããŸããããã®æã®æ¯ãè¿ãã§ã®åçãã¿ã¹ã¯åè§£ãã¹ã±ãžã¥ãŒã«çå®ã«åœ¹ç«ãŠãããŠããŸãã å人çã«ã¯ä»åã®ãããžã§ã¯ããéããŠãããã³ããšã³ãã®æè¡ç¿åŸã¯ãã¡ããã®ããšããããžã§ã¯ãã¡ã³ããŒãšã®ã³ãã¥ãã±ãŒã·ã§ã³ã§æç« ã®æ§é åãç»åã«ç·šéãå ãããªã©ã®å·¥å€«ãå ããããšã§ã³ãã¥ãã±ãŒã·ã§ã³ã³ã¹ããäžããããšãã§ãããšãã£ãæè¡ä»¥å€ã®ããšãåŠã¶ããšãã§ããŸããã ãŸããããžã§ã¯ããéããŠãè¥æã®ãšã³ãžãã¢ãæé·ã§ããç°å¢ã ãšèã§æããŸãããé å±åŸãŸããªããããžã§ã¯ãã«åç»ãããŠããããããšãå¿ èŠã«å¿ããŠæ§ã ãªæè¡ãè§ŠãããŠããããããšã¯ãã¡ããã®ããšã§ãããåãããªãããšãèããããããŠãããé°å²æ°ãæãäžãããææŠãããŠããããç°å¢ã¯èŽ æ²¢ã«æããã»ã©ã§ãã ãã®ãããªæé·ã§ããç°å¢ã§è¥ææä»£ãéããããæ°åãšã³ãžãã¢ã®æ¹ããæè¡ã¯ãããŸã§ææ®µã§ããã顧客ãžã®äŸ¡å€æäŸãç®çã«ããŠããããŒã ã§åããããšã³ãžãã¢ã®æ¹ãçµ¶è³åéããŠããŸãã®ã§ããèå³ãããæ¹ã¯ãã²ã«ãžã¥ã¢ã«ã«ã話ããå§ããŠã¿ãŸãããã åéã®äžèЧ | æ ªåŒäŒç€Ÿã¡ãã¬ãŒ ã¡ãã¬ãŒã®æ¡çšæ å ±ã¯ãã¡ãããã確èªãã ããã www.medley.jp
æ ªåŒäŒç€Ÿã¡ãã¬ãŒ
2024/03/29
<![CDATA[ æ°åé å±2ã¶æç®ã§ChatGPTãæŽ»çšããæ°èŠæ©èœéçºãããžã§ã¯ãã«ã¢ãµã€ã³ããã話 ]]>
ã¯ããã« èªå·±çŽ¹ä» ã¯ãããŸããŠã人æãã©ãããã©ãŒã æ¬éšãããã¯ãéçºå®€ç¬¬äžéçºã°ã«ãŒãã®ç°äžã§ãã ç§ã¯ã2023 幎㮠4 æã«æ°åãšã³ãžãã¢ãšããŠå ¥ç€Ÿããæ¥æ¬æå€§çŽã®å»çä»è·æ±äººãµã€ãã ãžã§ãã¡ãã¬ãŒ ãã®ããã³ããšã³ããšããã¯ãšã³ãã®éçºãæ åœããŠããŸãã åŠçæä»£ã¯æ å ±ç³»ã§ã¯ãªããçµæžåŠãå°æ»ããŠããŸãããããã°ã©ãã³ã°ã«ã¯å€§åŠã®ææ¥ã§åºäŒããäž»ã«ããŒã¿åæã«çšãã R ã Python ãè§Šã£ãŠããŸããããã®ãã Web ã¢ããªã±ãŒã·ã§ã³ã®éçºã¯è¡ã£ãŠããŸããã§ããã ãšã³ãžãã¢ãšããè·æ¥ã«èå³ãæã£ããã£ããã¯ã倧åŠé¢æä»£ã«åå ããã€ã³ã¿ãŒã³ã§ãããã€ã³ã¿ãŒã³å ã®äŒç€Ÿã§ã¯ãšã³ãžãã¢ã誰ãããªãã£ãã®ã§ãããéçºæªçµéšã®ç§ã«æ©æ¢°åŠç¿ã䜿ã£ãã¢ããªã® PoC ãäœããšãããããªãç Žå€©èãªçµéšãããããã§ããä»ã§ã¯ãšãŠãã¬ã¢ãªçµéšã ã£ããšæããŸããã詊è¡é¯èª€ããªããäœããäœãããšã«è奮ãèŠããã®ãä»ã§ãé®®æã«èŠããŠããŸãã ã¡ãã¬ãŒ ã«å ¥ç€Ÿããçç±ã¯ã倧ããªç€ŸäŒèª²é¡ã«åãçµãã§ãããè§Šããããæè¡ãããã³ããšã³ãã»ããã¯ãšã³ãã®ããã«é åã«éãããŠããªããªã©ãããŸããããäžçªå€§ããªçç±ã¯ã æè¡ã¯ãããŸã§ææ®µã§ããã顧客ãžã®äŸ¡å€æäŸãç®çã«ããŠãã ããšããèãã«å ±æããããšã§ããå ¥ç€ŸããŠãŸã æ¥ã¯æµ ãã§ããããã®èãã¯éæã§æããããŸãã 倧åŠè¿ãã®ããŒãã®å€çŒã å ¥ç€Ÿããåãããžã§ã¯ããŸã§ ããŠãä»åã®èšäºã§ã¯æ°åãšã³ãžãã¢ã®ç§ãåããŠæºãã£ããããžã§ã¯ãã®ç޹ä»ãéããŠãã¡ãã¬ãŒã§ã¯æ°åãšã³ãžãã¢ãå ¥ç€ŸåŸã«ã©ã®ãããªåãæ¹ãããŠããäŒããããšãã§ããã°ãšæããŸãã å ¥ç€ŸããŠããç ä¿®ãçµããŠãé å±åŸ 1 ã¶æåãããã¯äž»ã«ãããã¯ãã®å®åžžæ¹åç³»ã®ã¿ã¹ã¯ã«åãçµã¿ãªãããä»äºã®ãªãºã ãèŠããŠãããŸããã ãã®åŸãä»å玹ä»ãããããžã§ã¯ãã«åããŠã¢ãµã€ã³ãããŸããããã®æç¹ã§ãããžã§ã¯ãã§äž»ã«äœ¿çšããã¹ãã«ã»ããã®ããã³ããšã³ãã¯ãæ°åç ä¿®ã§åŠãã çšåºŠã§ããããã®ãããªç¶æ ã®æ°åã§ããçµéšãããããç©ãŸããŠããããè¯ãç°å¢ã ãšããããšããäŒãã§ããã°ãšæã£ãŠããŸãã ãããžã§ã¯ãã§è§£æ±ºãã課é¡ãšè§£æ±ºç ãŸããä»åæ åœãããããžã§ã¯ããçºè¶³ããèæ¯ãšãªã課é¡ãšããã®èª²é¡ã解決ããããã«æäŸããæ°æ©èœã«ã€ããŠç޹ä»ããŸãããã®ãããžã§ã¯ãã«ã€ããŠã¯ã ãã¥ãŒã¹ãªãªãŒã¹ ãå ¬éããŠããŸãã®ã§ãåãããŠã芧ãã ããã ãŠãŒã¶ãŒã®æ±ããèª²é¡ ãããŸã§ããžã§ãã¡ãã¬ãŒãã§ã¯é¡§å®¢ãæ±äººãäœæããéã«ããã©ãŒã 圢åŒã§åéèŠé ãèšå ¥ãã圢åŒãšãªã£ãŠããŸãããèšå ¥ã®èªç±åºŠãé«ãããšãããæ³ä»€ãã¬ã€ãã©ã€ã³çã§å®ããããé ç®ãæŒããªãèšèŒããããšããäºæ¥æã®é åã广çã«äŒãã工倫ãå¿ èŠã§ããã顧客ã«ãšã£ãŠã¯å€§ããªè² æ ã«ãªã£ãŠããŸããã ãã©ãŒã 圢åŒã®æ±äººäœææ©èœã®ã€ã¡ãŒãž 瀟å ãªãã¬ãŒã·ã§ã³ã®èгç¹ã§èŠããšãæ±äººãæ²èŒåºæºãæºãããŠããã®ããå ¥åãããæç« ããèªã¿åã確èªããæ¥åã«æéãããã£ãŠããŸããã ããã§ã顧客ãšç€Ÿå ãªãã¬ãŒã·ã§ã³ã®åæ¹ãæããŠãã課é¡ã解決ãããããžã§ã¯ããçºè¶³ããç§ãåç»ããŸããã ãŠãŒã¶ãŒç®ç·ã®è§£æ±ºç 顧客ãšç€Ÿå ãªãã¬ãŒã·ã§ã³ã®åæ¹ã®èª²é¡ã解決ãããããæ±äººäœæããã»ã¹ãããçŽæçãã€å¹ççã«æ¹åããŸãããå ·äœçã«ã¯ãåŸæ¥ã®ãã©ãŒã å ¥åæ¹åŒããã察話åŒã®è³ªåãšåçãéããŠæ±äººãäœæã§ããæ©èœãå°å ¥ããŸããããã®æ¹åã«ããã顧客ã¯ç°¡åã«ãè¿·ãããšãªãæ²èŒåºæºã«æ²¿ã£ãæ±äººãäœæãããããªããŸããã ããã«ãæç« äœæã®åŽåã軜æžããããã«ã ChatGPT ãæŽ»çšããææ¡æ©èœãå°å ¥ããŸããããã®æ©èœãéããŠã顧客ã¯å ¥åããå 容ã«åºã¥ããæ±è·è ã®ç®ã«æ¢ãŸããããæ±äººã¿ã€ãã«ãèšŽæ±æã ChatGPT ããææ¡ããŠããããŸããããã«ãããæ±äººåçš¿äœæã«ãããæéãç ©éãã軜æžãããå°ä»»ã®æ¡çšæ åœãããªãäºæ¥æã§ãæ¡çšæŽ»åãå¹ççã«é²ããããšãã§ããè¿ éãªäººæã®ç¢ºä¿ãžãšã€ãªãããŸãã瀟å ãªãã¬ãŒã·ã§ã³ã®èгç¹ã§ããæ²èŒåºæºãæºãããŠãããã確èªããæ¥åã®æéççž®ãæåŸ ã§ããŸãã 質å圢åŒã®æ±äººäœæè£å©æ©èœã®ã€ã¡ãŒãž ChatGPT ã®å°å ¥æç¡ã«é¢ããŠã¯ç€Ÿå ã§ãåè°ãããæç« çæã« ChatGPT ãçšããããšã§é¡§å®¢ã®äœæ¥ã³ã¹ããäžããããã®ã§ããã°å°å ¥ããããšããæææ±ºå®ããããŸãããæµè¡ã£ãŠããæè¡ã ããå°å ¥ããã®ã§ã¯ãªãã 顧客ãžã®äŸ¡å€æäŸã®ããã«æ°ããæè¡ãå°å ¥ãã èããçŸããæææ±ºå®ã ãšæããŸãã æè¡ã¹ã¿ã㯠ä»åã®ãããžã§ã¯ãã§ã¯æ¬¡ã®ãããªæè¡ã¹ã¿ãã¯ã§éçºãè¡ããŸãããããã³ããšã³ã㯠React ã䜿çšãç¶æ 管çã©ã€ãã©ãªãšã㊠React Hooks ãéžæããŸãããåŸæ¥ã®æ±äººäœææ©èœã§ã¯ Redux ã§ç¶æ 管çãè¡ã£ãŠããŸãããããããã¯ãå šäœã®æ¹éãšããŠä»åŸ React Hooks ã䜿çšããŠããæ¹éã§ãã£ãããšãšãå®è£ ã®ã¹ããŒããæ©ããããã« React Hooks ãæ¡çšããŸããã ChatGPT ãçšããéšåã«é¢ããŠã¯ã顧客ããã®ãªã¯ãšã¹ããåããŠçºè¡ããããŒã¯ã³ãä¿åããããã« Amazon DynamoDB ã䜿çšããŸãããDynamoDB ã«ä¿åããããŒã¯ã³ã®ããªããŒã·ã§ã³ãš GPT ãžããã³ãããæž¡ããææ¡ã®åãåãã»è¿åŽããéšå㯠AWS Lambda function ã«ä»»ããŠããŸãããGPT æ¬äœã¯ Azure OpenAI Service ãå©çšããæ§æã§ãããAzure OpenAI Service ãæ¡çšããçç±ã¯ã顧客æ å ±ãå ¥åå 容ãåŠç¿ã«äœ¿çšãããããšããªããã©ã€ãã·ãŒé¢ã§ã®ãªã¹ã¯ãåé¿ã§ããããã§ããã æç« çææ©èœã®æ§æã€ã¡ãŒãž ãããžã§ã¯ããžã®é¢ãã ä»åã®ãããžã§ã¯ãã®ã¡ã³ããŒæ§æã¯ãšã³ãžã㢠3 人ããã¶ã€ã㌠1 人ãPM 1 人ãšããæ§æã§ãããéçºã«ã¯çŽ 3 ã¶æã®æéãèŠããŸããã ãããžã§ã¯ãåæ ç§èªèº«ã®ãããžã§ã¯ããžã®é¢ããæ¹ãšããŠã¯ããããžã§ã¯ãåææ®µéããããã³ããšã³ãã®å®è£ ã¿ã¹ã¯ãäžå¿ã§ããããã®äžã§ã¹ã¿ã€ã«ã®å®è£ ã«é¢ããŠã¯ãªãŒããŒã·ãããæãããŠããã ããŸãããä»åã®ãããžã§ã¯ãã§äœæãã UI ã³ã³ããŒãã³ãã§ã¯ã䌌ããããªãã®ãè€æ°ãã£ããããã§ããã ãæ¡åŒµæ§ãæãã䜿ãåããããã«æèããŠèšèšããŠããŸãããä»äºã®ãµã€ã¯ã«ãšããŠã¯ããã¶ã€ããŒãäœã£ããã¶ã€ã³ãå ã«ã现ãã仿§ã調æŽããŠå®è£ ãããã¶ã€ã³ã¬ãã¥ãŒãããŠããããµã€ã¯ã«ãåããŠããŸããã ãã ãReact ãªã©ããã£ããã¢ããããªããã®å®è£ ã ã£ããããä»ã®ãšã³ãžãã¢ããå®è£ ã«æéãããã£ãŠããŸã£ãŠããŸãããé©å®å 茩ãšã³ãžãã¢ã«è³ªåããªããé²ããŠããŸããããããã€ãã®ã¿ã¹ã¯ã¯å·»ãåã£ãŠãããããšã«ãªããªã©ãæããæ°æã¡ãèŠãããããžã§ã¯ãåæã§ããã ãããžã§ã¯ãäžç€ä»¥é ãããžã§ã¯ãäžç€ãããã§äžã€ãšã³ãžãã¢ãšããŠã®ä»äºã®åãåãæ¹ã«å€åããããŸããããããžã§ã¯ãã®ã¹ã±ãžã¥ãŒã«ãã¿ã€ãã ã£ãã®ãçžãŸã£ãŠããããžã§ã¯ãåæã§ã¯ãšããããå®è£ ããŠæ©ãã¿ã¹ã¯ãçµããããããšã«æ³šåããŠããŸãããããããæéãããã£ãŠãè¯ãããäžã€äžã€äžå¯§ã«ã³ãŒãã远ã£ãŠçè§£ããããšã«åªããããšå 茩ãšã³ãžãã¢ã«ã¢ããã€ã¹ãããã ããŸããã ãããããçè§£ã«æ³šåããããšã§æèãã¯ãªã¢ã«ãªããçµæçã«å®è£ ã¹ããŒããäžãã£ãŠãããŸããããŸããå®è£ 以å€ã«ãç®ãåããäœè£ãçãŸãã仿§ã«ã€ã㊠PM ããã¶ã€ããŒã«ææ¡ããããšãã§ããŸããããããžã§ã¯ãäžç€ä»¥éã¯èªä¿¡ãæã£ãŠã¿ã¹ã¯ã«åãçµãããšãã§ããçµç€ã«ã¯ä»ã®ãšã³ãžãã¢ã®ã¿ã¹ã¯ãå·»ãåãããšãã§ãããŸã§ã«ãªããŸããã ãããžã§ã¯ãã®äžã§ã¯ãããã³ããã®æ¹åã¿ã¹ã¯ãä»»ããŠããããŸãããå 容ãšããŠã¯æå³ããªãåçãåŒŸãæ¹åã§ããããAWS Lambda ãè§Šããªã©ãå¿ èŠãããã°ã¯ã©ãŠããµãŒãã¹ãè§Šãæ©äŒããããšæããŸããã ChatGPT ã«ããææ¡æ©èœã®ã€ã¡ãŒãž ãããã« ãããžã§ã¯ããæ¯ãè¿ã£ãŠ æ°æ©èœããªãªãŒã¹ãããŠæ°ã¶æçµã¡ãŸããããå®ããŠãã KPI ãéæããçµæãçŸããŠããããšããšãŠãå¬ããã§ããäžäŸãšããŠãé¡§å®¢ãæ°æ©èœã§æ±äººãäœæããŠãã瀟å ã§ã®å¯©æ»ãçµãŠæ²èŒã«è³ããŸã§ã®æ¥æ°ããåŸæ¥ã®äœææ¹æ³ãšæ¯ã¹ãŠåå以äžãšå€§å¹ ã«åæžãããŠããŸãã ããŒã ãšããŠã¯ä»åã®ãããžã§ã¯ãã®é²ãæ¹ã«ã€ããŠæ¯ãè¿ããè¡ããŸãããPM ããã¶ã€ããŒããšã³ãžãã¢ãããããæ¬¡ã®ãããžã§ã¯ããããè¯ãéè¡ããææ¡ãåºãåããä»åã®ãããžã§ã¯ãã®çµéšãç¡é§ã«ãªããªãããã«ããŠããŸããçŸåšãç§èªèº«ã¯ãšã³ãžãã¢äžäººã®æ°ãããããžã§ã¯ããä»»ãããŠããŸããããã®æã®æ¯ãè¿ãã§ã®åçãã¿ã¹ã¯åè§£ãã¹ã±ãžã¥ãŒã«çå®ã«åœ¹ç«ãŠãããŠããŸãã å人çã«ã¯ä»åã®ãããžã§ã¯ããéããŠãããã³ããšã³ãã®æè¡ç¿åŸã¯ãã¡ããã®ããšããããžã§ã¯ãã¡ã³ããŒãšã®ã³ãã¥ãã±ãŒã·ã§ã³ã§æç« ã®æ§é åãç»åã«ç·šéãå ãããªã©ã®å·¥å€«ãå ããããšã§ã³ãã¥ãã±ãŒã·ã§ã³ã³ã¹ããäžããããšãã§ãããšãã£ãæè¡ä»¥å€ã®ããšãåŠã¶ããšãã§ããŸããã ãŸããããžã§ã¯ããéããŠãè¥æã®ãšã³ãžãã¢ãæé·ã§ããç°å¢ã ãšèã§æããŸãããé å±åŸãŸããªããããžã§ã¯ãã«åç»ãããŠããããããšãå¿ èŠã«å¿ããŠæ§ã ãªæè¡ãè§ŠãããŠããããããšã¯ãã¡ããã®ããšã§ãããåãããªãããšãèããããããŠãããé°å²æ°ãæãäžãããææŠãããŠããããç°å¢ã¯èŽ æ²¢ã«æããã»ã©ã§ãã ãã®ãããªæé·ã§ããç°å¢ã§è¥ææä»£ãéããããæ°åãšã³ãžãã¢ã®æ¹ããæè¡ã¯ãããŸã§ææ®µã§ããã顧客ãžã®äŸ¡å€æäŸãç®çã«ããŠããããŒã ã§åããããšã³ãžãã¢ã®æ¹ãçµ¶è³åéããŠããŸãã®ã§ããèå³ãããæ¹ã¯ãã²ã«ãžã¥ã¢ã«ã«ã話ããå§ããŠã¿ãŸãããã åéã®äžèЧ | æ ªåŒäŒç€Ÿã¡ãã¬ãŒ ã¡ãã¬ãŒã®æ¡çšæ å ±ã¯ãã¡ãããã確èªãã ããã www.medley.jp
æ ªåŒäŒç€Ÿã¡ãã¬ãŒ
2024/03/29
<![CDATA[ æ°åé å±2ã¶æç®ã§ChatGPTãæŽ»çšããæ°èŠæ©èœéçºãããžã§ã¯ãã«ã¢ãµã€ã³ããã話 ]]>
ã¯ããã« èªå·±çŽ¹ä» ã¯ãããŸããŠã人æãã©ãããã©ãŒã æ¬éšãããã¯ãéçºå®€ç¬¬äžéçºã°ã«ãŒãã®ç°äžã§ãã ç§ã¯ã2023 幎㮠4 æã«æ°åãšã³ãžãã¢ãšããŠå ¥ç€Ÿããæ¥æ¬æå€§çŽã®å»çä»è·æ±äººãµã€ãã ãžã§ãã¡ãã¬ãŒ ãã®ããã³ããšã³ããšããã¯ãšã³ãã®éçºãæ åœããŠããŸãã åŠçæä»£ã¯æ å ±ç³»ã§ã¯ãªããçµæžåŠãå°æ»ããŠããŸãããããã°ã©ãã³ã°ã«ã¯å€§åŠã®ææ¥ã§åºäŒããäž»ã«ããŒã¿åæã«çšãã R ã Python ãè§Šã£ãŠããŸããããã®ãã Web ã¢ããªã±ãŒã·ã§ã³ã®éçºã¯è¡ã£ãŠããŸããã§ããã ãšã³ãžãã¢ãšããè·æ¥ã«èå³ãæã£ããã£ããã¯ã倧åŠé¢æä»£ã«åå ããã€ã³ã¿ãŒã³ã§ãããã€ã³ã¿ãŒã³å ã®äŒç€Ÿã§ã¯ãšã³ãžãã¢ã誰ãããªãã£ãã®ã§ãããéçºæªçµéšã®ç§ã«æ©æ¢°åŠç¿ã䜿ã£ãã¢ããªã® PoC ãäœããšãããããªãç Žå€©èãªçµéšãããããã§ããä»ã§ã¯ãšãŠãã¬ã¢ãªçµéšã ã£ããšæããŸããã詊è¡é¯èª€ããªããäœããäœãããšã«è奮ãèŠããã®ãä»ã§ãé®®æã«èŠããŠããŸãã ã¡ãã¬ãŒ ã«å ¥ç€Ÿããçç±ã¯ã倧ããªç€ŸäŒèª²é¡ã«åãçµãã§ãããè§Šããããæè¡ãããã³ããšã³ãã»ããã¯ãšã³ãã®ããã«é åã«éãããŠããªããªã©ãããŸããããäžçªå€§ããªçç±ã¯ã æè¡ã¯ãããŸã§ææ®µã§ããã顧客ãžã®äŸ¡å€æäŸãç®çã«ããŠãã ããšããèãã«å ±æããããšã§ããå ¥ç€ŸããŠãŸã æ¥ã¯æµ ãã§ããããã®èãã¯éæã§æããããŸãã 倧åŠè¿ãã®ããŒãã®å€çŒã å ¥ç€Ÿããåãããžã§ã¯ããŸã§ ããŠãä»åã®èšäºã§ã¯æ°åãšã³ãžãã¢ã®ç§ãåããŠæºãã£ããããžã§ã¯ãã®ç޹ä»ãéããŠãã¡ãã¬ãŒã§ã¯æ°åãšã³ãžãã¢ãå ¥ç€ŸåŸã«ã©ã®ãããªåãæ¹ãããŠããäŒããããšãã§ããã°ãšæããŸãã å ¥ç€ŸããŠããç ä¿®ãçµããŠãé å±åŸ 1 ã¶æåãããã¯äž»ã«ãããã¯ãã®å®åžžæ¹åç³»ã®ã¿ã¹ã¯ã«åãçµã¿ãªãããä»äºã®ãªãºã ãèŠããŠãããŸããã ãã®åŸãä»å玹ä»ãããããžã§ã¯ãã«åããŠã¢ãµã€ã³ãããŸããããã®æç¹ã§ãããžã§ã¯ãã§äž»ã«äœ¿çšããã¹ãã«ã»ããã®ããã³ããšã³ãã¯ãæ°åç ä¿®ã§åŠãã çšåºŠã§ããããã®ãããªç¶æ ã®æ°åã§ããçµéšãããããç©ãŸããŠããããè¯ãç°å¢ã ãšããããšããäŒãã§ããã°ãšæã£ãŠããŸãã ãããžã§ã¯ãã§è§£æ±ºãã課é¡ãšè§£æ±ºç ãŸããä»åæ åœãããããžã§ã¯ããçºè¶³ããèæ¯ãšãªã課é¡ãšããã®èª²é¡ã解決ããããã«æäŸããæ°æ©èœã«ã€ããŠç޹ä»ããŸãããã®ãããžã§ã¯ãã«ã€ããŠã¯ã ãã¥ãŒã¹ãªãªãŒã¹ ãå ¬éããŠããŸãã®ã§ãåãããŠã芧ãã ããã ãŠãŒã¶ãŒã®æ±ããèª²é¡ ãããŸã§ããžã§ãã¡ãã¬ãŒãã§ã¯é¡§å®¢ãæ±äººãäœæããéã«ããã©ãŒã 圢åŒã§åéèŠé ãèšå ¥ãã圢åŒãšãªã£ãŠããŸãããèšå ¥ã®èªç±åºŠãé«ãããšãããæ³ä»€ãã¬ã€ãã©ã€ã³çã§å®ããããé ç®ãæŒããªãèšèŒããããšããäºæ¥æã®é åã广çã«äŒãã工倫ãå¿ èŠã§ããã顧客ã«ãšã£ãŠã¯å€§ããªè² æ ã«ãªã£ãŠããŸããã ãã©ãŒã 圢åŒã®æ±äººäœææ©èœã®ã€ã¡ãŒãž 瀟å ãªãã¬ãŒã·ã§ã³ã®èгç¹ã§èŠããšãæ±äººãæ²èŒåºæºãæºãããŠããã®ããå ¥åãããæç« ããèªã¿åã確èªããæ¥åã«æéãããã£ãŠããŸããã ããã§ã顧客ãšç€Ÿå ãªãã¬ãŒã·ã§ã³ã®åæ¹ãæããŠãã課é¡ã解決ãããããžã§ã¯ããçºè¶³ããç§ãåç»ããŸããã ãŠãŒã¶ãŒç®ç·ã®è§£æ±ºç 顧客ãšç€Ÿå ãªãã¬ãŒã·ã§ã³ã®åæ¹ã®èª²é¡ã解決ãããããæ±äººäœæããã»ã¹ãããçŽæçãã€å¹ççã«æ¹åããŸãããå ·äœçã«ã¯ãåŸæ¥ã®ãã©ãŒã å ¥åæ¹åŒããã察話åŒã®è³ªåãšåçãéããŠæ±äººãäœæã§ããæ©èœãå°å ¥ããŸããããã®æ¹åã«ããã顧客ã¯ç°¡åã«ãè¿·ãããšãªãæ²èŒåºæºã«æ²¿ã£ãæ±äººãäœæãããããªããŸããã ããã«ãæç« äœæã®åŽåã軜æžããããã«ã ChatGPT ãæŽ»çšããææ¡æ©èœãå°å ¥ããŸããããã®æ©èœãéããŠã顧客ã¯å ¥åããå 容ã«åºã¥ããæ±è·è ã®ç®ã«æ¢ãŸããããæ±äººã¿ã€ãã«ãèšŽæ±æã ChatGPT ããææ¡ããŠããããŸããããã«ãããæ±äººåçš¿äœæã«ãããæéãç ©éãã軜æžãããå°ä»»ã®æ¡çšæ åœãããªãäºæ¥æã§ãæ¡çšæŽ»åãå¹ççã«é²ããããšãã§ããè¿ éãªäººæã®ç¢ºä¿ãžãšã€ãªãããŸãã瀟å ãªãã¬ãŒã·ã§ã³ã®èгç¹ã§ããæ²èŒåºæºãæºãããŠãããã確èªããæ¥åã®æéççž®ãæåŸ ã§ããŸãã 質å圢åŒã®æ±äººäœæè£å©æ©èœã®ã€ã¡ãŒãž ChatGPT ã®å°å ¥æç¡ã«é¢ããŠã¯ç€Ÿå ã§ãåè°ãããæç« çæã« ChatGPT ãçšããããšã§é¡§å®¢ã®äœæ¥ã³ã¹ããäžããããã®ã§ããã°å°å ¥ããããšããæææ±ºå®ããããŸãããæµè¡ã£ãŠããæè¡ã ããå°å ¥ããã®ã§ã¯ãªãã 顧客ãžã®äŸ¡å€æäŸã®ããã«æ°ããæè¡ãå°å ¥ãã èããçŸããæææ±ºå®ã ãšæããŸãã æè¡ã¹ã¿ã㯠ä»åã®ãããžã§ã¯ãã§ã¯æ¬¡ã®ãããªæè¡ã¹ã¿ãã¯ã§éçºãè¡ããŸãããããã³ããšã³ã㯠React ã䜿çšãç¶æ 管çã©ã€ãã©ãªãšã㊠React Hooks ãéžæããŸãããåŸæ¥ã®æ±äººäœææ©èœã§ã¯ Redux ã§ç¶æ 管çãè¡ã£ãŠããŸãããããããã¯ãå šäœã®æ¹éãšããŠä»åŸ React Hooks ã䜿çšããŠããæ¹éã§ãã£ãããšãšãå®è£ ã®ã¹ããŒããæ©ããããã« React Hooks ãæ¡çšããŸããã ChatGPT ãçšããéšåã«é¢ããŠã¯ã顧客ããã®ãªã¯ãšã¹ããåããŠçºè¡ããããŒã¯ã³ãä¿åããããã« Amazon DynamoDB ã䜿çšããŸãããDynamoDB ã«ä¿åããããŒã¯ã³ã®ããªããŒã·ã§ã³ãš GPT ãžããã³ãããæž¡ããææ¡ã®åãåãã»è¿åŽããéšå㯠AWS Lambda function ã«ä»»ããŠããŸãããGPT æ¬äœã¯ Azure OpenAI Service ãå©çšããæ§æã§ãããAzure OpenAI Service ãæ¡çšããçç±ã¯ã顧客æ å ±ãå ¥åå 容ãåŠç¿ã«äœ¿çšãããããšããªããã©ã€ãã·ãŒé¢ã§ã®ãªã¹ã¯ãåé¿ã§ããããã§ããã æç« çææ©èœã®æ§æã€ã¡ãŒãž ãããžã§ã¯ããžã®é¢ãã ä»åã®ãããžã§ã¯ãã®ã¡ã³ããŒæ§æã¯ãšã³ãžã㢠3 人ããã¶ã€ã㌠1 人ãPM 1 人ãšããæ§æã§ãããéçºã«ã¯çŽ 3 ã¶æã®æéãèŠããŸããã ãããžã§ã¯ãåæ ç§èªèº«ã®ãããžã§ã¯ããžã®é¢ããæ¹ãšããŠã¯ããããžã§ã¯ãåææ®µéããããã³ããšã³ãã®å®è£ ã¿ã¹ã¯ãäžå¿ã§ããããã®äžã§ã¹ã¿ã€ã«ã®å®è£ ã«é¢ããŠã¯ãªãŒããŒã·ãããæãããŠããã ããŸãããä»åã®ãããžã§ã¯ãã§äœæãã UI ã³ã³ããŒãã³ãã§ã¯ã䌌ããããªãã®ãè€æ°ãã£ããããã§ããã ãæ¡åŒµæ§ãæãã䜿ãåããããã«æèããŠèšèšããŠããŸãããä»äºã®ãµã€ã¯ã«ãšããŠã¯ããã¶ã€ããŒãäœã£ããã¶ã€ã³ãå ã«ã现ãã仿§ã調æŽããŠå®è£ ãããã¶ã€ã³ã¬ãã¥ãŒãããŠããããµã€ã¯ã«ãåããŠããŸããã ãã ãReact ãªã©ããã£ããã¢ããããªããã®å®è£ ã ã£ããããä»ã®ãšã³ãžãã¢ããå®è£ ã«æéãããã£ãŠããŸã£ãŠããŸãããé©å®å 茩ãšã³ãžãã¢ã«è³ªåããªããé²ããŠããŸããããããã€ãã®ã¿ã¹ã¯ã¯å·»ãåã£ãŠãããããšã«ãªããªã©ãæããæ°æã¡ãèŠãããããžã§ã¯ãåæã§ããã ãããžã§ã¯ãäžç€ä»¥é ãããžã§ã¯ãäžç€ãããã§äžã€ãšã³ãžãã¢ãšããŠã®ä»äºã®åãåãæ¹ã«å€åããããŸããããããžã§ã¯ãã®ã¹ã±ãžã¥ãŒã«ãã¿ã€ãã ã£ãã®ãçžãŸã£ãŠããããžã§ã¯ãåæã§ã¯ãšããããå®è£ ããŠæ©ãã¿ã¹ã¯ãçµããããããšã«æ³šåããŠããŸãããããããæéãããã£ãŠãè¯ãããäžã€äžã€äžå¯§ã«ã³ãŒãã远ã£ãŠçè§£ããããšã«åªããããšå 茩ãšã³ãžãã¢ã«ã¢ããã€ã¹ãããã ããŸããã ãããããçè§£ã«æ³šåããããšã§æèãã¯ãªã¢ã«ãªããçµæçã«å®è£ ã¹ããŒããäžãã£ãŠãããŸããããŸããå®è£ 以å€ã«ãç®ãåããäœè£ãçãŸãã仿§ã«ã€ã㊠PM ããã¶ã€ããŒã«ææ¡ããããšãã§ããŸããããããžã§ã¯ãäžç€ä»¥éã¯èªä¿¡ãæã£ãŠã¿ã¹ã¯ã«åãçµãããšãã§ããçµç€ã«ã¯ä»ã®ãšã³ãžãã¢ã®ã¿ã¹ã¯ãå·»ãåãããšãã§ãããŸã§ã«ãªããŸããã ãããžã§ã¯ãã®äžã§ã¯ãããã³ããã®æ¹åã¿ã¹ã¯ãä»»ããŠããããŸãããå 容ãšããŠã¯æå³ããªãåçãåŒŸãæ¹åã§ããããAWS Lambda ãè§Šããªã©ãå¿ èŠãããã°ã¯ã©ãŠããµãŒãã¹ãè§Šãæ©äŒããããšæããŸããã ChatGPT ã«ããææ¡æ©èœã®ã€ã¡ãŒãž ãããã« ãããžã§ã¯ããæ¯ãè¿ã£ãŠ æ°æ©èœããªãªãŒã¹ãããŠæ°ã¶æçµã¡ãŸããããå®ããŠãã KPI ãéæããçµæãçŸããŠããããšããšãŠãå¬ããã§ããäžäŸãšããŠãé¡§å®¢ãæ°æ©èœã§æ±äººãäœæããŠãã瀟å ã§ã®å¯©æ»ãçµãŠæ²èŒã«è³ããŸã§ã®æ¥æ°ããåŸæ¥ã®äœææ¹æ³ãšæ¯ã¹ãŠåå以äžãšå€§å¹ ã«åæžãããŠããŸãã ããŒã ãšããŠã¯ä»åã®ãããžã§ã¯ãã®é²ãæ¹ã«ã€ããŠæ¯ãè¿ããè¡ããŸãããPM ããã¶ã€ããŒããšã³ãžãã¢ãããããæ¬¡ã®ãããžã§ã¯ããããè¯ãéè¡ããææ¡ãåºãåããä»åã®ãããžã§ã¯ãã®çµéšãç¡é§ã«ãªããªãããã«ããŠããŸããçŸåšãç§èªèº«ã¯ãšã³ãžãã¢äžäººã®æ°ãããããžã§ã¯ããä»»ãããŠããŸããããã®æã®æ¯ãè¿ãã§ã®åçãã¿ã¹ã¯åè§£ãã¹ã±ãžã¥ãŒã«çå®ã«åœ¹ç«ãŠãããŠããŸãã å人çã«ã¯ä»åã®ãããžã§ã¯ããéããŠãããã³ããšã³ãã®æè¡ç¿åŸã¯ãã¡ããã®ããšããããžã§ã¯ãã¡ã³ããŒãšã®ã³ãã¥ãã±ãŒã·ã§ã³ã§æç« ã®æ§é åãç»åã«ç·šéãå ãããªã©ã®å·¥å€«ãå ããããšã§ã³ãã¥ãã±ãŒã·ã§ã³ã³ã¹ããäžããããšãã§ãããšãã£ãæè¡ä»¥å€ã®ããšãåŠã¶ããšãã§ããŸããã ãŸããããžã§ã¯ããéããŠãè¥æã®ãšã³ãžãã¢ãæé·ã§ããç°å¢ã ãšèã§æããŸãããé å±åŸãŸããªããããžã§ã¯ãã«åç»ãããŠããããããšãå¿ èŠã«å¿ããŠæ§ã ãªæè¡ãè§ŠãããŠããããããšã¯ãã¡ããã®ããšã§ãããåãããªãããšãèããããããŠãããé°å²æ°ãæãäžãããææŠãããŠããããç°å¢ã¯èŽ æ²¢ã«æããã»ã©ã§ãã ãã®ãããªæé·ã§ããç°å¢ã§è¥ææä»£ãéããããæ°åãšã³ãžãã¢ã®æ¹ããæè¡ã¯ãããŸã§ææ®µã§ããã顧客ãžã®äŸ¡å€æäŸãç®çã«ããŠããããŒã ã§åããããšã³ãžãã¢ã®æ¹ãçµ¶è³åéããŠããŸãã®ã§ããèå³ãããæ¹ã¯ãã²ã«ãžã¥ã¢ã«ã«ã話ããå§ããŠã¿ãŸãããã https://www.medley.jp/jobs/
æ ªåŒäŒç€Ÿã¡ãã¬ãŒ
2024/02/29
<![CDATA[ è€æ°ãããã¯ã暪æãããããžã§ã¯ããã©ããã£ãŠæåãããã®ãã¡ã³ããŒã«èããŠã¿ãŸãã ]]>
ã¯ããã« ã¿ãªãããããã«ã¡ã¯ããšã³ãžãã¢ã®å€å·ã§ãã ä»å㯠CLINICS / Pharms åæäºçŽãããžã§ã¯ã(以äžãåæäºçŽ Pj)ãšãããããã¯ã暪æã§æ§ã ãªéšçœ²ãé¢ãã£ãéçºãããžã§ã¯ãã«ã€ããŠãå°œåãããçããã«åº§è«äŒåœ¢åŒã§ã話ã䌺ããŸããã ã¡ãã¬ãŒã®å»çãã©ãããã©ãŒã (以äžãå»ç PF)ã§ã©ã®ããã«ããããæšªæãããžã§ã¯ããå®éããã®ãã®æ§åãçããã«ç¥ã£ãŠããããã°ãšæããŸãã 察è«ã¡ã³ããŒçŽ¹ä» ââ ã¯ããã«ãçããã®èªå·±ç޹ä»ããé¡ãããŸãã æ±è€ : æå±ã¯å»ç PF ã®ãããã¯ãéçºå®€ã® Pharms éçºããŒã ã§ãã 圹å²ãšããŠã¯èª¿å€è¬å±åãã®ã·ã¹ãã ã® Pharms ã®ãããã¯ããªãŒããŒãæ ã£ãŠããŸãã çµæŽãšããŠã¯ã2021 幎㮠1 æãã Pharms ã®ã«ã¹ã¿ããŒãµã¯ã»ã¹ãšããŠã¡ãã¬ãŒã«ãžã§ã€ã³ããŸããŠã2023 幎 1 æããéçºããŒã ã«æ¥ãŸããã ãããŸã§ã¯äºæ¥åŽã®çµéšãé·ããå¶æ¥å šè¬ãäºæ¥éçºãã¡ã€ã³ã§ãã£ãŠãããã£ãªã¢ã§ãã ãã®ãããžã§ã¯ãã® PO ãšããŠãªãŒãããåããããŠãããPharms ãæ ã調å€åŽã®ãªãŒãã«å ããŠãå šäœã®ææ¯ãã調æŽçã䞻軞ã«ãã£ãŠããŸããã æ±è€ãã ââ æ±è€ããããããžã§ã¯ãã®äžå¿ãšãªã£ãŠæšé²ãããã§ããã æ±è€ : 調å€ãã¡ã€ã³ã® Pharms ã«ãšã£ãŠäºæ¥ã€ã³ãã¯ããããã倧ããéçºã ã£ãã®ã§ã調å€ãã¡ã€ã³ã責任æã£ãŠãããŸãããããšããæŽçã§ãã å°ç° : èªåã®æå±ãæ±è€ãããšåãã«ãªããŸãã çµæŽã¯ã2021 幎 7 æã«ãšã³ãžãã¢ãšããŠå ¥ç€ŸãããããŸã§ãã£ãš Pharms ã®éçºããã£ãŠãŸãã å ¥ç€ŸåŸã¯ã¯ã©ã€ã¢ã³ãèªèšŒæ©èœãæ³äººæ åœè åãã®æ¬éšæ©èœãªã©ã®æ©èœéçºãè¡ã£ãŠããŸããã æšå¹Žãã Pharms ã®ãªãŒããšã³ãžãã¢ãšããŠããŒã å šäœãèŠã€ã€ãPharms ã®æè¡è²¬ä»»è ãšããŠæ±è€ãããšäž¡èŒªã§åããããªåœ¢ã§ãããžã§ã¯ãã®æšé²ã«é¢ãã£ãŠããŸãã å°ç°ãã æéŠ¬ : å»ç PF ãããã¯ãéçºå®€ãæ£è çµ±ååºç€ããŒã ã«æå±ããŠããŸããæ£è çµ±ååºç€ãšã¯ãCLINICSïŒæ£è ã¢ããªïŒãšããã¢ããªã®ããã¯ãšã³ãã·ã¹ãã ã§ããã蚺çæãæ¯ç§å»é¢ãè¬å±åãã®ã·ã¹ãã ãšã®é£æºåºç€ãšããŠãæ©èœããŠãããããã¯ãã«ãªããŸãã çµæŽã¯ããã®ã¡ã³ããŒã®äžã§ã¯äžçªå€ã 2018 幎 3 æã«å ¥ç€ŸããŠãåœå㯠CLINICS ã«ã«ãã®æ©èœæ¡åŒµã®éçºã«åå ããPKI åºç€ã CLINICS ãšãŒãžã§ã³ããå§ããšããä»ç€Ÿã·ã¹ãã ãšã®é£æºåºç€ã®éçºãè¡ã£ãŠããŸããã2020 幎ãããããæ£è çµ±ååºç€ã®ç«ã¡äžãã«åå ããŠãçŸåšã«è³ããŸãã æéŠ¬ãã é äº : å ¥ç€Ÿã¯ 2019 幎 8 æãªã®ã§ã 5 幎ç®ãšãªããŸãã ãã¶ã€ããŒãšããŠå ¥ç€ŸåŸ 1 幎éã¯ãžã§ãã¡ãã¬ãŒã«åšç±ããŠããŸããããã®åŸãªã³ã©ã€ã³èšºçã䌞ã³ãŠããææã«ãªããCLINICS åŽã®ãã¶ã€ããŒã®äººæ°ãè¶³ããªããªã£ãããšããããŸããŠãããããã¯é»åã«ã«ããå«ãã CLINICS ã®ãã¶ã€ã³å šè¬ãæ åœããŠããŸãããå»å¹Žããé»åã«ã«ã以å€ã®æ¥åé åã® PdM ãšããŠæŽ»åããŠããŸãã軞足ã¯ãã¶ã€ããŒãªã®ã§ãããããã¯ãã®ãããžã¡ã³ãã¿ãããªããšããå§ããŠãŸãã ãã®ãããžã§ã¯ãã«ãããŠã¯ããã£ãæ±è€ããããã£ããã£ãéããPharms ã®äŸ¡å€åäžãäžå¿ã®ãããžã§ã¯ããªã®ã§ãããžã§ã¯ãã®äžçªå€§ãããªãŒãã¯æ±è€ããã«ãªãããšæããã§ããã©ãCLINICS ãªã©ã®å»ç§åŽã®ãããžã§ã¯ããªãŒããšèšãç«ã¡äœçœ®ãåã«ãªãããªãšæããŸãã é äºãã å°å³¶ : å»ç PF ãããã¯ãéçºå®€ã® QA ã°ã«ãŒãã«æå±ããŠããŸããQA ã°ã«ãŒãã®ãããŒãžã£ã§ãã 米山 ããã®ã玹ä»ã§ 2022 幎 4 æã«ã¡ãã¬ãŒïŒäººç®ã® QA ãšã³ãžãã¢ãšããŠå ¥ç€ŸããŸãããäž»æ åœã¯ CLINICS ã®äºçŽæ©èœãäžå¿ãšããåšèŸºé åã§ãããããŸã§é äºãããšäžç·ã«åãããŠé ãæ©äŒãå€ããçŽè¿ã§ã¯äºçŽæ¹æ³ãæ¡åŒµããããªã¯ãšã¹ãäºçŽãæ©èœã® QA ãæ åœããŸããã åæäºçŽã«é¢ããŠã¯ãäž»ã«å»ç§åŽã®éšåã® QA ããå§ãŸãã調å€åŽã® QA ãå¿ èŠãšããããšã«ãªããæçµçã«ã¯å šäœã® QA ãæ åœããŸããã å°å³¶ãã åæäºçŽã®æ©èœã解決ããèª²é¡ ââ ããããšãããããŸããæ¬¡ã«ãä»åã®åæäºçŽã«ã€ããŠã©ããã£ãæ©èœã§ãã©ããã£ã課é¡ã解決ããã¹ãããã話ãããã ãããã§ãã æ±è€ : æ©èœãšããŠã¯ã CLINICSïŒæ£è ã¢ããªïŒãããªã³ã©ã€ã³èšºçãäºçŽããéã«ãè¬ã®åãåãå ãšããŠè¬å±ãäºåæå®ã§ããæ©èœ ã«ãªã£ãŠããŸãã ãã®æ©èœã«é¢ä¿ãããã¡ã€ã³ã¯æ£è ã»å»çæ©é¢ã»èª¿å€è¬å±ã®ïŒã€ã§ãã æ£è ãšå»çæ©é¢ã®ã¡ãªãããšããŠã¯ãè¬ã®åŠæ¹ãŸã§ã®æéãæžãããšã§ãã ãªã³ã©ã€ã³èšºçã§ã¯ãæ£è ãå»çæ©é¢ã«çŽæ¥èšªåããããã§ã¯ãªãã®ã§ãè¬ãçŽæ¥è¬å±ã«è¡ã£ãŠåãåãã®ããè¬å±ããé éãåžæããã®ããšãã£ãè¬ã®åãåãæ¹ããå»çæ©é¢ãšæ£è ããã§å£é ã§è©±ããŠæ±ºããŠããã£ãŠããã確èªã«æéãçºçããŠããŸãããæ£è ããã¯å£é ã§è©±ããå å®¹ã«æ²¿ã£ãŠããªã³ã©ã€ã³èšºççµäºåŸã«ãè¬å±ãžã®äºçŽãåã£ãŠããŸããã åæäºçŽæ©èœãå®è£ ãããããšã«ããã蚺å¯ã®äºçŽæã«ã©ã®è¬å±ã§ã©ãããåãåãæ¹ãããŸããšããéšåãæ£è ãããäºåæå®ã§ããããã«ãªã£ãã®ã§ã å»çæ©é¢ã¯äºåçãªè©±ã«æéããããã«èšºå¯ã«éäžã§ãããŸãæ£è ããããå»åž«ã«å£é ã§è¿œå 説æããªããŠãåžæéãã«è¬ãããããããšãããããŒã«å€æŽãããããšãå»çæ©é¢ãšæ£è ã®ã¡ãªãã ã ãšæã£ãŠãŸãã åæäºçŽæ©èœã®ãªãªãŒã¹ååŸã§ã®ãããŒã®éã ããäžã€ã®ãã¡ã€ã³ã§ãã調å€è¬å±ã«ã€ããŠã¯ãåè¿°ã®ããã«èšºå¯ã®äºçŽãããæã«æ£è ãããã¡ãã¬ãŒã®ãµãŒãã¹ã§ãã Pharms ã䜿ã£ãŠããè¬å±ããäºåæå®ãã§ããŸãã®ã§ã ãªã³ã©ã€ã³èšºçåŸã«çºè¡ãããåŠæ¹ç®ã®æµå ¥ãå¢å ããŸã ã 調å€è¬å±ã®å£²ãäžãã¯åŠæ¹ç®ã®ææ° à å䟡ã§å€§éšåãæ±ºãŸããŸãã®ã§ããã®ææ°ãå¢ããããšãã芳ç¹ã§ã¯è¬å±ã«ãšã£ãŠã€ã³ãã¯ãã®ããæ©èœã ãšæã£ãŠããŸãã ââ æ£è ã®äœéšãæ¬åœã«è¯ããªãããæ£è ãšå»çæ©é¢ã®ç¡é§ãªã³ãã¥ãã±ãŒã·ã§ã³ãæžãããã€è¬å±ã«å¯ŸããŠãåŠæ¹ç®ææ°ãå¢ããŠãå°ç·ã楜ã«äœ¿ããããã«ãªã£ãŠãããšããã®ããä»åã®ãããžã§ã¯ãã®èã«ãªã£ãŠããæãã§ãããããããèžãŸãããããã¯ãéãæšªæããŠéçºããªããšãããªããšããã®ã倧å€ããã§ãã éçºãããžã§ã¯ãã«ã€ã㊠ââ ã©ã®ãããªããŒã ããã®æšªæãããžã§ã¯ãã«é¢ãã£ãŠããããæããŠãã ããã æ±è€ : éçºåŽã§èšããšïŒã€ã®ãã¡ã€ã³ã«ãªã£ãŠãŸãã 調å€ãæ£è ãå»ç§ããã㊠æ£è çµ±ååºç€ ã§ããæ£è çµ±ååºç€ãšã¯å»ç PF ã®åãã¡ã€ã³ã«ååšããæ¥åã·ã¹ãã ãšæ£è ã¢ããªãç¹ãæ ¹å¹¹ãšãªããããã¯ãã§ãã ãã ä»åã®æ©èœã¯å»çæ©é¢ã®ãªãã¬ãŒã·ã§ã³ãå€ãããããéçºåŽã§ã®ã¿å®çµãããããžã§ã¯ãã§ã¯ãªããã§ããã ããã«çŸå Žã®éçšã«åããã€ã€ãäœéšãæ¹åã§ãããïŒãšããèŠç¹ã§èãããšãåäºæ¥åŽã®ã«ã¹ã¿ããŒãµã¯ã»ã¹ããŒã ãéèŠã«ãªããŸã ãç¹ã«å»ç§ãšèª¿å€ã®ã«ã¹ã¿ããŒãµã¯ã»ã¹ããŒã ãšã¯ãå¯ã«å£æã¡ãããªããéçºãé²ããŠããŸããã ââ ä»åã®ãããžã§ã¯ãã¯ç¹ã«äºæ¥éšãšã®é¢ä¿æ§ãéèŠãªéµã ã£ããã§ããã æ±è€ : ããã§ãããç¹ã«å»ççŸå Žã¯æ¥åãéŒè¿«ããŠããå Žé¢ãå€ãã§ãã®ã§ãäŸãã°ãã¯ã³ã¯ãªãã¯å¢ããŸãããããã§ããŒãžé·ç§»ãå¢ããŸãããšãã£ãããšã§ãæ¥åãžã®åœ±é¿ãéåžžã«å€§ãããªããŸãã ãŸããªãã¬ãŒã·ã§ãã«ã«çŸå ŽãåããŠããç®æãå€ãããããã¯ãéœåã§åæã«ãã®æ¹ãè¯ããããåççã ããããšæ±ºããŠãããã¯ããäœã£ãŠããŸããšä»ãŸã§ã®çŸå Žãªãã¬ãŒã·ã§ã³ã厩ããŠããŸãæ··ä¹±ãæãããšããããŸãã çŸå Žã®ç¿æ £ãçè§£ããæã ãç®æãå§¿ãšèª¿æŽããªããæé©è§£ãåºã ã®ããå¿ é ã«ãªã£ãŠããæ¥çã»æ¥æ ã ãšæãã®ã§ããã®èª¿æŽã¯äºæ¥éšãšãããªãæ°ãé£ã£ãŠãã£ãŠããŸããã ââ åæäºçŽ Pj ã¯ãéçºåŽãããããšããããšã§å§ãŸã£ããããžã§ã¯ããªãã§ãããã? æ±è€ : ã¯ããããã¯ã¡ãã¬ãŒã®ã©ã®ãããã¯ãããããªã®ã§ãããäºæ¥è²¬ä»»è ãšãããã¯ã責任è ããããããããäºæ¥ãšéçºã®äž¡èгç¹ããè°è«ããäºæ¥æ¹éãæ±ºããŠããããšããäœå¶ããšã£ãŠããŸãã Pharms ãæ£ããæé·ãããŠãããšãã芳ç¹ã§èŠããšãçŸãã§ãŒãºã§ã¯åŠæ¹ç®ããã£ãããšèª¿å€è¬å±ã«å±ããããšãè³äžåœé¡ã§ããããµãŒãã¹ã®ããã¹ãå§¿ãšã¯ïŒãšãã芳ç¹ã§äºæ¥ãšéçºäž¡èŒªã§ãããŸããããšããåœ¢ã§æ±ºãŸã£ããã®ã«ãªããŸãã æšªæãããžã§ã¯ãã§å·¥å€«ããããã€ã³ã ââ ä»åãæšªæã§è²ã ãªéçºãããã¯ããé¢ä¿ããŠããŸããã工倫ããç¹ãšãæ°ãã€ããç¹ãªã©ãã©ããªãã®ããããŸãããã æ±è€ : äžçªã¯åãã¡ã€ã³ã§è¿œã£ãŠããäºæ¥ææãããªãéã£ãŠããŸããã®ã§ããã®èª¿æŽãæéããããŠæŠãåããããç¹ã§ãã äŸãã°ã調å€ã®èгç¹ã§ã¯åŠæ¹ç®ãã¡ãããšè¬å±ã«å±ãããšããã®ãããããéèŠãªäºæ¥ã€ã³ãã¯ãã®å€§ããé ç®ã§ããäžæ¹ã§ãå»çã®èгç¹ã§èŠãæã«ããã¡ããæéãæžããã®ã¯ãããéèŠã§ã¯ãããã§ãããå»çãã¡ã€ã³ãšããŠãã®æ¹åã«èª¿å€ãšåèŠæš¡ã®ã¡ãªãããèŠåºããŠããããããšèšããšåœç¶ããã§ã¯ãªãã£ããããŸãã ããããéšåã§ããã¡ã€ã³éã§ãã®ãããžã§ã¯ããéæããåŸã«åŸãããã¡ãªããã«å·®åãåºãŠããŸããã¡ãªããã倧ããäºæ¥ãããããå·¥æ°ã倧ããå²ããã®ã§ãããã¡ãªããã匱ãäºæ¥ã§ã¯åãã ãå·¥æ°ãããŠãããŸãããããšããæææ±ºå®ã¯é£ãããšæããŸãã ããã§ æ¬ Pj ãéããŠåãã¡ã€ã³ã§ã¯ã©ãããäºæ¥ææãçãã®ãããã®ããã«äœã® KPI ã远ãã®ãããæç¢ºã«ããŸãã ãäºæ¥çãªã¡ãªãããå€ã調å€ã®ããã«æäŒã£ãŠãã ãããšãã圢ã§ã¯ãªããåãã¡ã€ã³ã§ã©ãããã¡ãªãããçãã§ãããŸããïŒãšãããšãããæãããã®ãããããéèŠã ã£ããšæã£ãŠããŸãã ãããæ ããšãã¡ãªããã®åŒ±ãäºæ¥ã«ãšã£ãŠã¯ãæäŒãã¿ãããªãããžã§ã¯ãã«ãªããŸããåçŽã«ãšã³ãžãã¢ãªã³ã°ãšããéšåã§ãé¢çœããã®ã«ãªããªãã§ããããã§ãã®ã§ãé¢ä¿ããå šå¡ã§ãããžã§ã¯ãã宿œããããšã§ã©ãããçµæãåŸãã®ã?ãã¡ãããšåãã¡ã€ã³éã§æããŸããã ââ ãªãã»ã©ããããããšããããæŠãåããã¯æ±è€ãããšé äºããããã£ãŠãããã§ããããã é äº : ã¯ããåã®ã»ãã§è¡ã£ãŠããŸãããåãåæã®ããåããæã«éèŠããŠããã®ã¯ãã¹ã³ãŒããé©åã«åºåããšããéšåã§ããã調å€åŽã®æäŸäŸ¡å€ã®æå€§åã ãã远ã£ãŠåæãã倧ããªæ©èœè¿œå ãè¡ãã®ã§ã¯ãªãã倿Žã«ããå»ç§ã»æ£è ã»èª¿å€ãžäžãããªã¹ã¯ãéçºã³ã¹ããæãã€ã€ã䟡å€ãæå€§åã§ããèœãšãæã¯ã©ããããšããéšåããå·ãåããããŠãããŸããã ã¡ãã¬ãŒãé¢çœããªã£ãŠæãã®ãããããã¯ãåç¬ã§åããŠããããã§ã¯ãªããŠã ãã€ã·ã§ã³ããžã£ãŒããŒ(æ£è äœéš)ãäžå¿ãšããŠããã¿ã¯ã矀ãååšããŠãããšãã ã§ãã æ£è äœéšãããè¯ãæ§ç¯ããããã«ããããã®ãããã¯ããåããŠãããã®ã§ããæäŒããšãããã¥ã¢ã³ã¹ãããªãããããã¯ããè¶ ããŠããã¯ããããŠãããŸããããšèšããæåããããšãããããéšåããªãšæããŸããããããããããéšåããªãšæããŸãã æ±è€ : ç¹ã«æšªæã®ãããžã§ã¯ãã ãšããããç®çæèã®çµ±äžã«äžçªæéã䜿ã£ãŠãè¯ãããããªãããšèããŠããŸãããããæ±ºãŸãããããã°ãåŸã è¿·ã£ãå Žåãç®çã«å³ããæææ±ºå®ãã§ããŸããããããåºããåŸã«åãã¡ã€ã³ã§ã®èª¿æŽãããšããé çªã倧äºã ãšæããŸãã ââ æè¡é¢ã§æ°ãã€ãããã€ã³ãã¯ã©ããªãã®ããã£ããã§ããããã æéŠ¬ : åæäºçŽæ©èœãšããŠããããããšã¯ããã€ã€ã蚺çæåŽã®æ¥åãããŒãæ£è ã®å°ç·ãä»ããã·ã¹ãã ã®å¶çŽãªã©ãèžãŸããã©ã®ãããªåœ¢ã«èœãšã蟌ã㰠蚺çæãè¬å±ãæ£è ã«ãšã£ãŠã䟡å€ã®ããæ©èœãšãªãã ããã€ã³ãã§ãã ã§ãã®ã§ãæè¡çãªé¢ãšäºæ¥çãªé¢ã䜵ããŠèããªãããã·ã¹ãã å šäœã®èŠä»¶ã決ããŠãããšããã®ãæåã«æãããéšåã§ããã ââ æ©èœãèããäžã§ãå šäœãèŠæ®ããèšèšãªã©ããã£ãŠãããšæããã§ãããä»åã¯ã©ãããçæããããã§ãããã?æ£è ã®å°ç·ã ã£ããå»çæ©é¢ã®æ¥åãããŒãªã©ææ¡ããåŸã«ãåãããã£ãéšåãèãããã®ã§ããã æéŠ¬ : åæäºçŽã«ãããã·ã¹ãã å šäœã®èŠä»¶ãåºããŠãããšåæã«ãå šäœã®ã·ãŒã±ã³ã¹ãšã¹ããŒããã·ã³ãäœã£ãŠãããŸãããåã·ã¹ãã éã®é£æºãããŒãšãããã«ããçã¿åºãããäºçŽãåŠæ¹ç®ãšãã£ããšã³ãã£ãã£ã®ç¶æ é·ç§»ã決ããŠããããã®ç¶æ ã®æã¯ãããã£ãããšã¯ã§ããªããšãããããã£ã蟻è€ãåããããšããããã£ãããã£ãŠãã£ããšããæãã§ãããã é äº : ä»åã¯ãç¹ã« ãããã¯ã暪æã®å ±éåºç€ãšããŠãåãããã¯ãã§ããããå šãå¥ç©ã®ä»çµã¿ãã¹ããŒã¿ã¹ãä¿æããŠããã®ããå ±éåã»æœè±¡åãããšããæ¥åãå¿ èŠã«ãªã ã®ã§ããããé£ããããé£æåºŠãé«ãéšåã ãªãšæã£ãŠãããã§ããã©ãããã綺éºã«ã·ãŒã±ã³ã¹å³ã«èœãšã蟌ãã æéŠ¬ãããåããªãšæããŸããã æ±è€ : åºç€åŽã§äœã£ãŠããã ããã·ãŒã±ã³ã¹å³ã¯ UX ã®éªšçµã¿ãªãã§ããããããããããã UX ãã¶ã€ããŒãå¥éãããšãã£ã现ååããããå®è£ ã®å¶éãå å³ãã€ã€ãæ£ããéçšãåãããã«ããã®äœéšãäœãããã«ãã®ã¹ããŒã¿ã¹é·ç§»ã§ããã¹ãã ããããšããéšåãæéЬããããšã³ãžãã¢èгç¹ã§æåã«äœã£ãŠãããŠããšããã®ãã ã¡ãã¬ãŒã®ãšã³ãžãã¢ã®ãšãŠãè¯ãéšå ã ãšæã£ãŠããŸããæè¡ã ãã§ãªã UX ãªã©ã«ãå¿ èŠã§ããã°è¶å¢ããŠãããæåã§ããã åæäºçŽ Pj éçºã®å®é ââ ããããåæãã§ãŒãºãçµãŠ Pharms ãš CLINICS ã©ã¡ãã®éçºã«ãé¢ãã£ãå°ç°ããã«èãããã®ããéçºã®æµãã®äžã§ãããããªãœãŒã¹çãªåé¡ã£ãŠå€§å€ã ã£ããšæãã®ã§ãããããã¯ã©ã解決ãããã§ããããã å°ç° : å ã« Pharms åŽã®æ©èœ ãäœã£ãŠãã®åŸã« CLINICS ã®ä»æ§ã決ããŠããã£ãŠãã CLINICS ã®éçºã«å ¥ãæµãã ã£ãã®ã§éçºã䞊è¡ããããšã¯ãªãã£ãã§ãããã Pharms ã§ã¯ãªãŒããšã³ãžãã¢ãšããç«å Žãªã®ã§ ãCLINICS ã®éçºã«å ¥ãããã®æºåãšãPharms åŽã®ã¬ãã¥ãŒããã©ããŒã®ãªãœãŒã¹é åã¯èªåã§èããŠãåã¿ã¹ã¯ã宿œããæéãšã¿ã€ãã³ã°ã調æŽããªãããã£ãŠããŸããã äžæ¹ã§ããã®äœå¶ã§ãé²ããããšãã§ããã®ã¯ Pharms ããŒã ã®åã¡ã³ããŒãæ¢ã«èªèµ°ã§ããç¶æ ã«ãã£ãã®ã§ãããã«æ¯ããããããããã§ãã ããªãšæã£ãŠãŸãã ââ ãããã¯ããè¶å¢ããªããéçºãããšããæåã¯ãããè¯ããšæã£ãã®ã§ãããããã¯ãããŒãªã©ãã£ãããããã§ãã? æ±è€ : å çšã話ããéã Pharms ãšããŠæ¬ãããžã§ã¯ãã®åªå 床ã¯é«ãã£ãã®ã§ãããCLINICS ã®äºæ¥èšç»ããªãœãŒã¹ãèžãŸãããšå»ç§åŽã®å®è£ çæã倧ããé ããããªèŠç«ãŠã§ãããããã§ãå°ç°ããã å»ç§åŽã®éçºã«ãã¢ãµã€ã³ã§ããããªãœãŒã¹åé¡ã解決ã§ããã®ã§ã¯ãšèª¿æŽããŸãããå»ç§åŽã®ãšã³ãžãã¢ããã®ãã©ããŒã¢ããã¯å¿ èŠãªã®ã§ããã®èª¿æŽããã€ã€ã§ãããéçºãæ©ãããããªãè¯ãããšéçºããŒã éã§æçµçã«å€æããŸããã é äº : ä»ãŸã§è§Šã£ãŠãªãã£ã CLINICS ã®ã·ã¹ãã ã«ãå°ç°ããã¯ã¬ã³ã¬ã³åã蟌ãã§ãã ãã£ãã®ã§ãå ã CLINICS ã®éçºããã£ãŠãã®ã§ã¯ãšæãããããã£ããã¢ãããæ©ãã£ãã§ãã ââ ãããã¯ãã®ã°ããŒã¹ã®ããã«ãªãœãŒã¹èª¿æŽãæåããããšãã圢ã ã£ããã§ããããããã¯ãéã®è¶å¢ããããããããªæåã ã£ããããããžã§ã¯ããæåãããããšããç®ç·åãããèªç¶ã«ã§ããã®ã¯è¯ãã§ããã ããŒã éãšãã話ã§ããã° QA ã¯åããŒã ã«è·šã£ãŠã®æŽ»åã ãšæããŸããããã®èгç¹ã§ã¯ãããã§ãã? å°å³¶ : èªåã¯éçºãçµç€ã«å ¥ã£ãã¿ã€ãã³ã°ã§ãããžã§ã¯ãã«åæµããŸããããããŸã§ã¯ç±³å±±ããã QA ãšããŠå ¥ã£ãŠããã®ã§ãããå»ç§åŽã§ãæ€èšŒãã¹ããã¹ã芳ç¹ã倿°ãã£ãèæ¯ããããå»ç§åŽã® QA ãã¡ã€ã³ã§èŠãæ åœãšããŠåç»ããŸããã åŸåã«åç»ããèæ¯ããããããããåŠæ¹ç®éä»ãšããæ¥åã Pharms ãããã¯ãã®ä»æ§çè§£ãæµ ãâŠãšããç¶æ ã§ãããã éçºç®çã»èŠä»¶å®çŸ©ã»èšèšã詳现ã«ããã¥ã¡ã³ãåãããŠããã®ã§ãã¹ã ãŒãºã«æ€èšŒã«å ¥ãããšãã§ããŸãã ãæ€èšŒã®äžã§ QA ãšã³ãžãã¢ãšããŠãããã®éšåã®ä»æ§ã¯èŠçŽããæ¹ãè¯ããªãããšãããã€ã³ããããã€ãåºãŠããã®ã§ã仿§ã®æ¹åææ¡ãè¡ããŸãããåŸçºåå ã§ããããå®éã«åãå ¥ããŠããã£ãæ¹åãå€ãã§ãã ã¡ãã¬ãŒã®ãããã¯ãéçºã®æåãšã㊠QA ãšã³ãžãã¢ã èŠä»¶å®çŸ©ããã¬ãã¥ãŒã«åå ããããæèŠãèšãã€ã€ãããã¯ããããè¯ãããããã®æ¹åãè¡ãã ã®ã§ããšãŠãåããããã§ããã ââ åŸããå ¥ã£ãŠãåãããããšããã®ã¯ãããã¥ã¡ã³ããªã©ãæŽåãããŠããããã§ããããšã ãšããã®ãåãããŸãããæšªæãããžã§ã¯ãã ããããæ°ãã€ããä»ã®ããŒã ã®è¯ãç¹ãªã©ãã£ããããŸãã? é äº : Pharms ã®ãããžã§ã¯ãã£ãŠããããããªããšæã£ãã®ã KPI èšèšããããæç¢ºãªãšããã ã£ããšããç¹ã§ããã è²ã çŽäœæ²æãã£ãçµæããã«èŸ¿ãçããŠããšããèŠåŽãç¥ã£ãŠã¯ãããã§ããã©ãä»ã® KPI èšèšã£ãŠãã£ã±ããããã·ã³ãã« ã§åŠæ¹ç®éä¿¡æ°ã§ããšãªããšãããããéç®ãã KPI ãå PF ã«æ¯ãã°ãããšèšãäœå¶ã ã£ãã®ã§ããããããã¯ãããããã£ããã€ã³ãã®äžã€ããªãšæããŸãã 話ãè«ç¹ãçµå±ããã£ãŠããéšåããããã³ãã¥ãã±ãŒã·ã§ã³ã³ã¹ããå®ãããã éšåã§ã¯ããããªãšæããŸããã æšªæãããžã§ã¯ããªãã§ã¯ã®ãšã³ãžãã¢ãªã³ã° ââ å šäœã®è©±ããåå¥ã®ãã¡ã€ã³ããšã®ãšã³ãžãã¢ãªã³ã°ãšããç¹ã§ã¯ã©ã®ãããªããšããããŠããŸããã? å°ç° : åºæ¬çã«ã¯æéЬããã®ã·ãŒã±ã³ã¹å³ãå ã«éçºãé²ããŠããŸãããCLINICS ã§ã¯ A ãšããç¶æ ã«ãªãããã®æã« B ãšããã¢ã¯ã·ã§ã³ããããš Pharms ã§ã¯ C ãšããç¶æ ã«ãªããšããããã«ç¶æ é·ç§»ãè€éã ã£ããããèšèšæã«ããã¹ãå§¿ã«è¿·ãããšãå€ãã£ãã®ã§ãããã·ãŒã±ã³ã¹ã«ç«ã¡è¿ããšããã«ãã®çåã解決ãããšãã£ãå ·åã§ãã æéŠ¬ : ã·ãŒã±ã³ã¹ã®æŽåæ§ãé£ãããªããããªãããã«èšèšãã ããšã«ã¯æ°ãã€ããŸããããåæäºçŽããšããèšèãå è¡ãããšã€ãã€ãè€éãªæ°æ©èœã®ãããªãã®ãäœããã¡ã§ããã蚺çæãè¬å±ã®äºçŽæ©èœãåŠæ¹ç®éä¿¡æ©èœãšãã£ãåã ã®ããŒãã¯ããšããšããããã§ããªãã¹ãã·ã³ãã«ã«ããããã€ãªãåãããããããã«å¿ãããŸããã æ±è€ : 现ãããããã¯ãéã®èª¿æŽãå¿ èŠã«ãªãã®ã§ ã¡ãããšèª¿å€ã®æ¬²ãã KPI ãæ±ãã€ã€ããã€çŸå Žã®ãªãã¬ãŒã·ã§ã³å質ãèœãšããªãã£ãŠãã芳ç¹ã§èª¿æŽãåãã¡ã€ã³ã§ãããŸããã 工倫ããããšã§ãããšãUX 調æ»ã培åºãããšããã§ããããã ä»åã®ãµãŒãã¹ã£ãŠæ¥ççã«ã¿ãæã«æ°ããããšãããšããã§ã¯ãªããã§ããããã§ãã®ã§ã忥çã®äŒæ¥ããã®åã¢ããªã®äœéšãšããèªåã§ãçµæ§è²ã 䜿ããªããäœéšããŠã¿ãŸããããããããããŒã¹ã«éã«çŸç¶ã®ãã¡ã®ä»æ§ãèžãŸãããšããããã颚ã«ãã¡ã§ã¯å®è£ ããŸãããã¿ãããªãšãããè²ã ãã£ãŠããŸããã å°ç° : ãšã³ãžãã¢ãªã³ã°ã®èгç¹ã§ãããšãç¹ã«æ£è ã¢ããªããŒã ãšã® API 飿ºã®ä»æ§èª¿æŽãšãéçºã®é²ãæ¹ã¯å¯ã«é£æºããªããé²ããŸãããå ã«ãã£ã¡ãã§ããŠãªããšåãããéçºã§ããªãç¶æ ã«ãªãã®ã§ãæ åœè å士ã§ã³ãã¥ãã±ãŒã·ã§ã³ãšãã€ã€ã工倫ããªããé²ããŠããŸããã é äº : CLINICS ã§æ°ã«ããŠãéšåã¯ã©ã¡ãããšãããš ãªã¹ã¯ãšã³ã¹ãã®éšåãããã«æå°åããŠäŸ¡å€ãæå€§åããããäžçªéèŠ ããªãšæã£ãŠããã®ã§ãäžçªå€§äºãªã®ã¯ãã£ã±ãå»ç§ã«ãšã£ãŠã©ããã䟡å€ãåºãŠãå»ç§ã«ãšã£ãŠã©ããããªã¹ã¯ãçºçããããèããŠãŸããã äŸãã°äžçªæåã®ããåããã§è¬å±äºçŽããæã«æ¥æãŸã§ç¢ºå®ãããŸããããšãã話ããã£ããã§ããã©ããããŸã§ã¹ã³ãŒããåºããªããŠãã¡ãªãããåºãã®ã§ããã°ãåºããããªãã§ããšãã話ãããŠããŸããã ããšã¯ãªãªãŒã¹ãã©ã³ã®çå®ãšãããªïŒå šå»çæ©é¢ã«äžæã«åºãã®ã§ã¯ãªãããŸãã¯äžéšå»çæ©é¢æ§ã ãã«å ¬éãããªãªãŒã¹æ¹åŒã«ããŸãããã¿ãããªãšãããå«ããŠã§ããããå»ç§åŽã§äžæŠãã¹ãããã£ãŠæ€èšŒããŠãã¹ã ãŒãºã«æ©èœã䜿ãããšããã確èªãããããã¹ããããèšããŸããããšå®å šçãåããªããé²ããŸããã ããã¯ãã®ãããžã§ã¯ãã«é¢ããããã©ããªãããžã§ã¯ãã§ãäžçªéèŠã§ãããåŸããã²ã£ããè¿ãã®ãäžçªææ»ãã«ãªã£ãŠããã®ã§ãããã¯éèŠããªãšæããªããé²ããŠãŸãããã å°å³¶ : QA èŠç¹ã ãšæšªæãããžã§ã¯ãããã«ã¹ããŒããæ¬åœã«è€éã§ãã¡ãã¬ãŒå ¥ç€ŸåŸã«çµéšãããããžã§ã¯ãã®äžã§æ€èšŒã®é£æåºŠãæãé«ãã£ãã§ããã ã§ãããçããä»°ãããŠããããã«åãŠãŒã¹ã±ãŒã¹ã«å¯Ÿããèšèšãå³ã§ããã¥ã¡ã³ãåãããŠããã®ã§ããã¹ãã±ãŒã¹ãšããŠè»¢çšã§ããéšåãå€ããããŸãããæéЬãããäœæããèšèšå³ããã£ãããããæŒããªããã¹ãã§ããéšåã¯å€§ããã§ãã倧å¢ãåå ãããããžã§ã¯ãã«ãããŠãå šå¡ãèªèåãããäžã§ãèšèšå³ã¯æ¬åœã«å€§äºã ãªãšçæããŸããã 工倫ããç¹ãšããŠã¯ãå°ç°ãã㯠Pharms éçºã®ãã¡ã€ã³ç¥èãè±å¯ã ã£ãã®ã§ãQA æã¯ Pharms åŽãã¡ã€ã³ã«èŠãŠãããã€ã€ãèªå㯠CLINICS åŽã® QA ãæåãèŠãããã«ããŸãããã©ã¡ãã®ãã¡ã€ã³ã«ãé¢ä¿ããå¥çŽãã©ã³çã®è€éãªä»æ§ã¯èªåãæ åœããŸããã QA 以å€ã®é¢ã ãšããªãªãŒã¹ããäžã§å¿ èŠãªæµ®ããããŒã«ãããã°ç©æ¥µçã«åãã«ããããã«ããŸããã äŸãã°ããããŸã§äžéšã®å»çæ©é¢æ§ã ãã«æ©èœãªãªãŒã¹ããå Žåããã®åŸã®ãã£ãŒãããã¯ååã¯ã¡ãŒã«ãé¢è«ã§åå¥ã«è¡ã£ãŠããŸããããæ¥ã ã®èšºçã®äžã§ãæéã確ä¿é ãã®ãé£ãããšããç¶æ³ããããŸããããã®çµæãæ¬ Pj ã«ãããŠãå šäœãªãªãŒã¹ããŠåé¡ãªããïŒã®å€æããã¥ããææããããŸããã ããã§ Google ãã©ãŒã ã§ã¢ã³ã±ãŒããäœæããŠçæéã§åçã§ãã圢ã«åãæ¿ããŸãããçµæçã« 100% åçãåŸãããšãã§ããŸããã ã¢ã³ã±ãŒãçµæãããåŸæ¥æ©èœãã䟡å€ããããé¢å ãªãã¬ãŒã·ã§ã³ã«çµã¿èŸŒãã§é ãã³ã¹ãããããŸã§é«ããªãããšããç¹ãè©äŸ¡ã§ããã®ã§ãèªä¿¡ãæã£ãŠå šäœå ¬éãªãªãŒã¹ã«åã㊠GO å€å®ã§ããŸããã** ã¡ãã¬ãŒã¯åœ¹å²ã«çžãããããŒã«ãä»»ããŠé ããç°å¢ãããã®ã§ãèªåã®å°éé å以å€ã®ããšãåŠã¹ãŠãã**ãšæãããšãå€ãã§ãã 幞ããªãªãŒã¹åŸã倧ããªäžå ·åã¯ãªãã®ã§ããã¯ããçããã®ãããã§ããã åæäºçŽ Pj ãçµã㊠ââ ã§ã¯æåŸã«ãã®ãããžã§ã¯ãã®ç·æ¬ãããŠãã ããã°ã æ±è€ : 暪æã§ã¯ãããã©åãã¡ã€ã³ã§ããããã®ãããã§ãã·ã§ãã«ãã¡ãããšåãçºæ®ããŠãããžã§ã¯ããããåãããšããã®ã¯ããã倧ããè³ç£ã§ããã å»ç PF ã¯ã¢ã»ãããããããæã£ãŠããã®ã§ãè²ã çµã¿åããããšãä»ã®äŒç€Ÿã ãšã§ããªããã©ããã¡ãªãã§ãããã ããã¿ãããªããšãè²ã ãã ãã§ãã ãªã®ã§ããã®åŸã暪æãããžã§ã¯ãã¯äºå®ãããŠããŸãããããã«å é§ããŠã²ãšã€ãããã£ãŠããã€åããæ¬²ããã£ãæåŸ ææãçŸç¶åºããŠãããšãããå«ãããšãããè¯ãäžæ©ã ã£ãã®ããªããšæã£ãŠãŸãã æ¬¡ã¯åè³ªãæ ä¿ãã€ã€ããã£ãšã¹ããŒããäžããŠãããããšããã®ã芳ç¹ãšããŠå€§ããã§ããã ââ ãªãã»ã©ãããããæšªæãããžã§ã¯ãããã£ãŠããå»ç PF ã§ã¯ã©ããªãšã³ãžãã¢ãããããããã€ã³ãã§ããã? æéЬ : æè¡ãšäœµããŠãŠãŒã¶ãŒãžã®äŸ¡å€æäŸãèããªãããšã³ãžãã¢ãªã³ã°ããã人ããããããã®ã§ã¯ãªãããšæããŸãã ââ åãããã¯ãã®æã£ãŠãã圹å²ãèžãŸããŠã俯ç°ã®èŠç¹ã§éçºãããããšããæ¹ã«ã¯ãããé åçã§ãããæ¬æ¥ã¯ããããšãããããŸããã ãããã« åæäºçŽ Pj ã«ã€ããŠããããžã§ã¯ããæšé²ããã¡ã³ããŒã«è©±ãèããŸããããè€éãªèŠä»¶ãå®çŸå¯èœãªåœ¢ã«ããŠåããŒã ã§å£æ ¹ãè¶ããŠéçºãããŠããæ§åããšãŠãå°è±¡çã§ãããç¹ã«å»ç PF ã§ã¯ãã¡ã€ã³åå£«ã§ææ©çã«çµåããŠãããã³ã©ãã¬ãŒã·ã§ã³ããããšã«ããã¹ããŒã¯ãã«ããŒãžã®äŸ¡å€ãé«ããŠãããšããã®ã¯ããããããããã®ã§ã¯ãªãããšæããŸãã ãã®ãããªãããžã§ã¯ãã§åãçºæ®ããããšæã£ãæ¹ã¯ãã²ããæ°è»œã«ã話ãããŸããã! åéã®äžèЧ | æ ªåŒäŒç€Ÿã¡ãã¬ãŒ ã¡ãã¬ãŒã®æ¡çšæ å ±ã¯ãã¡ãããã確èªãã ããã www.medley.jp
æ ªåŒäŒç€Ÿã¡ãã¬ãŒ
2024/02/29
<![CDATA[ è€æ°ãããã¯ã暪æãããããžã§ã¯ããã©ããã£ãŠæåãããã®ãã¡ã³ããŒã«èããŠã¿ãŸãã ]]>
ã¯ããã« ã¿ãªãããããã«ã¡ã¯ããšã³ãžãã¢ã®å€å·ã§ãã ä»å㯠CLINICS / Pharms åæäºçŽãããžã§ã¯ã(以äžãåæäºçŽ Pj)ãšãããããã¯ã暪æã§æ§ã ãªéšçœ²ãé¢ãã£ãéçºãããžã§ã¯ãã«ã€ããŠãå°œåãããçããã«åº§è«äŒåœ¢åŒã§ã話ã䌺ããŸããã ã¡ãã¬ãŒã®å»çãã©ãããã©ãŒã (以äžãå»ç PF)ã§ã©ã®ããã«ããããæšªæãããžã§ã¯ããå®éããã®ãã®æ§åãçããã«ç¥ã£ãŠããããã°ãšæããŸãã 察è«ã¡ã³ããŒçŽ¹ä» ââ ã¯ããã«ãçããã®èªå·±ç޹ä»ããé¡ãããŸãã æ±è€ : æå±ã¯å»ç PF ã®ãããã¯ãéçºå®€ã® Pharms éçºããŒã ã§ãã 圹å²ãšããŠã¯èª¿å€è¬å±åãã®ã·ã¹ãã ã® Pharms ã®ãããã¯ããªãŒããŒãæ ã£ãŠããŸãã çµæŽãšããŠã¯ã2021 幎㮠1 æãã Pharms ã®ã«ã¹ã¿ããŒãµã¯ã»ã¹ãšããŠã¡ãã¬ãŒã«ãžã§ã€ã³ããŸããŠã2023 幎 1 æããéçºããŒã ã«æ¥ãŸããã ãããŸã§ã¯äºæ¥åŽã®çµéšãé·ããå¶æ¥å šè¬ãäºæ¥éçºãã¡ã€ã³ã§ãã£ãŠãããã£ãªã¢ã§ãã ãã®ãããžã§ã¯ãã® PO ãšããŠãªãŒãããåããããŠãããPharms ãæ ã調å€åŽã®ãªãŒãã«å ããŠãå šäœã®ææ¯ãã調æŽçã䞻軞ã«ãã£ãŠããŸããã æ±è€ãã ââ æ±è€ããããããžã§ã¯ãã®äžå¿ãšãªã£ãŠæšé²ãããã§ããã æ±è€ : 調å€ãã¡ã€ã³ã® Pharms ã«ãšã£ãŠäºæ¥ã€ã³ãã¯ããããã倧ããéçºã ã£ãã®ã§ã調å€ãã¡ã€ã³ã責任æã£ãŠãããŸãããããšããæŽçã§ãã å°ç° : èªåã®æå±ãæ±è€ãããšåãã«ãªããŸãã çµæŽã¯ã2021 幎 7 æã«ãšã³ãžãã¢ãšããŠå ¥ç€ŸãããããŸã§ãã£ãš Pharms ã®éçºããã£ãŠãŸãã å ¥ç€ŸåŸã¯ã¯ã©ã€ã¢ã³ãèªèšŒæ©èœãæ³äººæ åœè åãã®æ¬éšæ©èœãªã©ã®æ©èœéçºãè¡ã£ãŠããŸããã æšå¹Žãã Pharms ã®ãªãŒããšã³ãžãã¢ãšããŠããŒã å šäœãèŠã€ã€ãPharms ã®æè¡è²¬ä»»è ãšããŠæ±è€ãããšäž¡èŒªã§åããããªåœ¢ã§ãããžã§ã¯ãã®æšé²ã«é¢ãã£ãŠããŸãã å°ç°ãã æéŠ¬ : å»ç PF ãããã¯ãéçºå®€ãæ£è çµ±ååºç€ããŒã ã«æå±ããŠããŸããæ£è çµ±ååºç€ãšã¯ãCLINICSïŒæ£è ã¢ããªïŒãšããã¢ããªã®ããã¯ãšã³ãã·ã¹ãã ã§ããã蚺çæãæ¯ç§å»é¢ãè¬å±åãã®ã·ã¹ãã ãšã®é£æºåºç€ãšããŠãæ©èœããŠãããããã¯ãã«ãªããŸãã çµæŽã¯ããã®ã¡ã³ããŒã®äžã§ã¯äžçªå€ã 2018 幎 3 æã«å ¥ç€ŸããŠãåœå㯠CLINICS ã«ã«ãã®æ©èœæ¡åŒµã®éçºã«åå ããPKI åºç€ã CLINICS ãšãŒãžã§ã³ããå§ããšããä»ç€Ÿã·ã¹ãã ãšã®é£æºåºç€ã®éçºãè¡ã£ãŠããŸããã2020 幎ãããããæ£è çµ±ååºç€ã®ç«ã¡äžãã«åå ããŠãçŸåšã«è³ããŸãã æéŠ¬ãã é äº : å ¥ç€Ÿã¯ 2019 幎 8 æãªã®ã§ã 5 幎ç®ãšãªããŸãã ãã¶ã€ããŒãšããŠå ¥ç€ŸåŸ 1 幎éã¯ãžã§ãã¡ãã¬ãŒã«åšç±ããŠããŸããããã®åŸãªã³ã©ã€ã³èšºçã䌞ã³ãŠããææã«ãªããCLINICS åŽã®ãã¶ã€ããŒã®äººæ°ãè¶³ããªããªã£ãããšããããŸããŠãããããã¯é»åã«ã«ããå«ãã CLINICS ã®ãã¶ã€ã³å šè¬ãæ åœããŠããŸãããå»å¹Žããé»åã«ã«ã以å€ã®æ¥åé åã® PdM ãšããŠæŽ»åããŠããŸãã軞足ã¯ãã¶ã€ããŒãªã®ã§ãããããã¯ãã®ãããžã¡ã³ãã¿ãããªããšããå§ããŠãŸãã ãã®ãããžã§ã¯ãã«ãããŠã¯ããã£ãæ±è€ããããã£ããã£ãéããPharms ã®äŸ¡å€åäžãäžå¿ã®ãããžã§ã¯ããªã®ã§ãããžã§ã¯ãã®äžçªå€§ãããªãŒãã¯æ±è€ããã«ãªãããšæããã§ããã©ãCLINICS ãªã©ã®å»ç§åŽã®ãããžã§ã¯ããªãŒããšèšãç«ã¡äœçœ®ãåã«ãªãããªãšæããŸãã é äºãã å°å³¶ : å»ç PF ãããã¯ãéçºå®€ã® QA ã°ã«ãŒãã«æå±ããŠããŸããQA ã°ã«ãŒãã®ãããŒãžã£ã§ãã 米山 ããã®ã玹ä»ã§ 2022 幎 4 æã«ã¡ãã¬ãŒïŒäººç®ã® QA ãšã³ãžãã¢ãšããŠå ¥ç€ŸããŸãããäž»æ åœã¯ CLINICS ã®äºçŽæ©èœãäžå¿ãšããåšèŸºé åã§ãããããŸã§é äºãããšäžç·ã«åãããŠé ãæ©äŒãå€ããçŽè¿ã§ã¯äºçŽæ¹æ³ãæ¡åŒµããããªã¯ãšã¹ãäºçŽãæ©èœã® QA ãæ åœããŸããã åæäºçŽã«é¢ããŠã¯ãäž»ã«å»ç§åŽã®éšåã® QA ããå§ãŸãã調å€åŽã® QA ãå¿ èŠãšããããšã«ãªããæçµçã«ã¯å šäœã® QA ãæ åœããŸããã å°å³¶ãã åæäºçŽã®æ©èœã解決ããèª²é¡ ââ ããããšãããããŸããæ¬¡ã«ãä»åã®åæäºçŽã«ã€ããŠã©ããã£ãæ©èœã§ãã©ããã£ã課é¡ã解決ããã¹ãããã話ãããã ãããã§ãã æ±è€ : æ©èœãšããŠã¯ã CLINICSïŒæ£è ã¢ããªïŒãããªã³ã©ã€ã³èšºçãäºçŽããéã«ãè¬ã®åãåãå ãšããŠè¬å±ãäºåæå®ã§ããæ©èœ ã«ãªã£ãŠããŸãã ãã®æ©èœã«é¢ä¿ãããã¡ã€ã³ã¯æ£è ã»å»çæ©é¢ã»èª¿å€è¬å±ã®ïŒã€ã§ãã æ£è ãšå»çæ©é¢ã®ã¡ãªãããšããŠã¯ãè¬ã®åŠæ¹ãŸã§ã®æéãæžãããšã§ãã ãªã³ã©ã€ã³èšºçã§ã¯ãæ£è ãå»çæ©é¢ã«çŽæ¥èšªåããããã§ã¯ãªãã®ã§ãè¬ãçŽæ¥è¬å±ã«è¡ã£ãŠåãåãã®ããè¬å±ããé éãåžæããã®ããšãã£ãè¬ã®åãåãæ¹ããå»çæ©é¢ãšæ£è ããã§å£é ã§è©±ããŠæ±ºããŠããã£ãŠããã確èªã«æéãçºçããŠããŸãããæ£è ããã¯å£é ã§è©±ããå å®¹ã«æ²¿ã£ãŠããªã³ã©ã€ã³èšºççµäºåŸã«ãè¬å±ãžã®äºçŽãåã£ãŠããŸããã åæäºçŽæ©èœãå®è£ ãããããšã«ããã蚺å¯ã®äºçŽæã«ã©ã®è¬å±ã§ã©ãããåãåãæ¹ãããŸããšããéšåãæ£è ãããäºåæå®ã§ããããã«ãªã£ãã®ã§ã å»çæ©é¢ã¯äºåçãªè©±ã«æéããããã«èšºå¯ã«éäžã§ãããŸãæ£è ããããå»åž«ã«å£é ã§è¿œå 説æããªããŠãåžæéãã«è¬ãããããããšãããããŒã«å€æŽãããããšãå»çæ©é¢ãšæ£è ã®ã¡ãªãã ã ãšæã£ãŠãŸãã åæäºçŽæ©èœã®ãªãªãŒã¹ååŸã§ã®ãããŒã®éã ããäžã€ã®ãã¡ã€ã³ã§ãã調å€è¬å±ã«ã€ããŠã¯ãåè¿°ã®ããã«èšºå¯ã®äºçŽãããæã«æ£è ãããã¡ãã¬ãŒã®ãµãŒãã¹ã§ãã Pharms ã䜿ã£ãŠããè¬å±ããäºåæå®ãã§ããŸãã®ã§ã ãªã³ã©ã€ã³èšºçåŸã«çºè¡ãããåŠæ¹ç®ã®æµå ¥ãå¢å ããŸã ã 調å€è¬å±ã®å£²ãäžãã¯åŠæ¹ç®ã®ææ° à å䟡ã§å€§éšåãæ±ºãŸããŸãã®ã§ããã®ææ°ãå¢ããããšãã芳ç¹ã§ã¯è¬å±ã«ãšã£ãŠã€ã³ãã¯ãã®ããæ©èœã ãšæã£ãŠããŸãã ââ æ£è ã®äœéšãæ¬åœã«è¯ããªãããæ£è ãšå»çæ©é¢ã®ç¡é§ãªã³ãã¥ãã±ãŒã·ã§ã³ãæžãããã€è¬å±ã«å¯ŸããŠãåŠæ¹ç®ææ°ãå¢ããŠãå°ç·ã楜ã«äœ¿ããããã«ãªã£ãŠãããšããã®ããä»åã®ãããžã§ã¯ãã®èã«ãªã£ãŠããæãã§ãããããããèžãŸãããããã¯ãéãæšªæããŠéçºããªããšãããªããšããã®ã倧å€ããã§ãã éçºãããžã§ã¯ãã«ã€ã㊠ââ ã©ã®ãããªããŒã ããã®æšªæãããžã§ã¯ãã«é¢ãã£ãŠããããæããŠãã ããã æ±è€ : éçºåŽã§èšããšïŒã€ã®ãã¡ã€ã³ã«ãªã£ãŠãŸãã 調å€ãæ£è ãå»ç§ããã㊠æ£è çµ±ååºç€ ã§ããæ£è çµ±ååºç€ãšã¯å»ç PF ã®åãã¡ã€ã³ã«ååšããæ¥åã·ã¹ãã ãšæ£è ã¢ããªãç¹ãæ ¹å¹¹ãšãªããããã¯ãã§ãã ãã ä»åã®æ©èœã¯å»çæ©é¢ã®ãªãã¬ãŒã·ã§ã³ãå€ãããããéçºåŽã§ã®ã¿å®çµãããããžã§ã¯ãã§ã¯ãªããã§ããã ããã«çŸå Žã®éçšã«åããã€ã€ãäœéšãæ¹åã§ãããïŒãšããèŠç¹ã§èãããšãåäºæ¥åŽã®ã«ã¹ã¿ããŒãµã¯ã»ã¹ããŒã ãéèŠã«ãªããŸã ãç¹ã«å»ç§ãšèª¿å€ã®ã«ã¹ã¿ããŒãµã¯ã»ã¹ããŒã ãšã¯ãå¯ã«å£æã¡ãããªããéçºãé²ããŠããŸããã ââ ä»åã®ãããžã§ã¯ãã¯ç¹ã«äºæ¥éšãšã®é¢ä¿æ§ãéèŠãªéµã ã£ããã§ããã æ±è€ : ããã§ãããç¹ã«å»ççŸå Žã¯æ¥åãéŒè¿«ããŠããå Žé¢ãå€ãã§ãã®ã§ãäŸãã°ãã¯ã³ã¯ãªãã¯å¢ããŸãããããã§ããŒãžé·ç§»ãå¢ããŸãããšãã£ãããšã§ãæ¥åãžã®åœ±é¿ãéåžžã«å€§ãããªããŸãã ãŸããªãã¬ãŒã·ã§ãã«ã«çŸå ŽãåããŠããç®æãå€ãããããã¯ãéœåã§åæã«ãã®æ¹ãè¯ããããåççã ããããšæ±ºããŠãããã¯ããäœã£ãŠããŸããšä»ãŸã§ã®çŸå Žãªãã¬ãŒã·ã§ã³ã厩ããŠããŸãæ··ä¹±ãæãããšããããŸãã çŸå Žã®ç¿æ £ãçè§£ããæã ãç®æãå§¿ãšèª¿æŽããªããæé©è§£ãåºã ã®ããå¿ é ã«ãªã£ãŠããæ¥çã»æ¥æ ã ãšæãã®ã§ããã®èª¿æŽã¯äºæ¥éšãšãããªãæ°ãé£ã£ãŠãã£ãŠããŸããã ââ åæäºçŽ Pj ã¯ãéçºåŽãããããšããããšã§å§ãŸã£ããããžã§ã¯ããªãã§ãããã? æ±è€ : ã¯ããããã¯ã¡ãã¬ãŒã®ã©ã®ãããã¯ãããããªã®ã§ãããäºæ¥è²¬ä»»è ãšãããã¯ã責任è ããããããããäºæ¥ãšéçºã®äž¡èгç¹ããè°è«ããäºæ¥æ¹éãæ±ºããŠããããšããäœå¶ããšã£ãŠããŸãã Pharms ãæ£ããæé·ãããŠãããšãã芳ç¹ã§èŠããšãçŸãã§ãŒãºã§ã¯åŠæ¹ç®ããã£ãããšèª¿å€è¬å±ã«å±ããããšãè³äžåœé¡ã§ããããµãŒãã¹ã®ããã¹ãå§¿ãšã¯ïŒãšãã芳ç¹ã§äºæ¥ãšéçºäž¡èŒªã§ãããŸããããšããåœ¢ã§æ±ºãŸã£ããã®ã«ãªããŸãã æšªæãããžã§ã¯ãã§å·¥å€«ããããã€ã³ã ââ ä»åãæšªæã§è²ã ãªéçºãããã¯ããé¢ä¿ããŠããŸããã工倫ããç¹ãšãæ°ãã€ããç¹ãªã©ãã©ããªãã®ããããŸãããã æ±è€ : äžçªã¯åãã¡ã€ã³ã§è¿œã£ãŠããäºæ¥ææãããªãéã£ãŠããŸããã®ã§ããã®èª¿æŽãæéããããŠæŠãåããããç¹ã§ãã äŸãã°ã調å€ã®èгç¹ã§ã¯åŠæ¹ç®ãã¡ãããšè¬å±ã«å±ãããšããã®ãããããéèŠãªäºæ¥ã€ã³ãã¯ãã®å€§ããé ç®ã§ããäžæ¹ã§ãå»çã®èгç¹ã§èŠãæã«ããã¡ããæéãæžããã®ã¯ãããéèŠã§ã¯ãããã§ãããå»çãã¡ã€ã³ãšããŠãã®æ¹åã«èª¿å€ãšåèŠæš¡ã®ã¡ãªãããèŠåºããŠããããããšèšããšåœç¶ããã§ã¯ãªãã£ããããŸãã ããããéšåã§ããã¡ã€ã³éã§ãã®ãããžã§ã¯ããéæããåŸã«åŸãããã¡ãªããã«å·®åãåºãŠããŸããã¡ãªããã倧ããäºæ¥ãããããå·¥æ°ã倧ããå²ããã®ã§ãããã¡ãªããã匱ãäºæ¥ã§ã¯åãã ãå·¥æ°ãããŠãããŸãããããšããæææ±ºå®ã¯é£ãããšæããŸãã ããã§ æ¬ Pj ãéããŠåãã¡ã€ã³ã§ã¯ã©ãããäºæ¥ææãçãã®ãããã®ããã«äœã® KPI ã远ãã®ãããæç¢ºã«ããŸãã ãäºæ¥çãªã¡ãªãããå€ã調å€ã®ããã«æäŒã£ãŠãã ãããšãã圢ã§ã¯ãªããåãã¡ã€ã³ã§ã©ãããã¡ãªãããçãã§ãããŸããïŒãšãããšãããæãããã®ãããããéèŠã ã£ããšæã£ãŠããŸãã ãããæ ããšãã¡ãªããã®åŒ±ãäºæ¥ã«ãšã£ãŠã¯ãæäŒãã¿ãããªãããžã§ã¯ãã«ãªããŸããåçŽã«ãšã³ãžãã¢ãªã³ã°ãšããéšåã§ãé¢çœããã®ã«ãªããªãã§ããããã§ãã®ã§ãé¢ä¿ããå šå¡ã§ãããžã§ã¯ãã宿œããããšã§ã©ãããçµæãåŸãã®ã?ãã¡ãããšåãã¡ã€ã³éã§æããŸããã ââ ãªãã»ã©ããããããšããããæŠãåããã¯æ±è€ãããšé äºããããã£ãŠãããã§ããããã é äº : ã¯ããåã®ã»ãã§è¡ã£ãŠããŸãããåãåæã®ããåããæã«éèŠããŠããã®ã¯ãã¹ã³ãŒããé©åã«åºåããšããéšåã§ããã調å€åŽã®æäŸäŸ¡å€ã®æå€§åã ãã远ã£ãŠåæãã倧ããªæ©èœè¿œå ãè¡ãã®ã§ã¯ãªãã倿Žã«ããå»ç§ã»æ£è ã»èª¿å€ãžäžãããªã¹ã¯ãéçºã³ã¹ããæãã€ã€ã䟡å€ãæå€§åã§ããèœãšãæã¯ã©ããããšããéšåããå·ãåããããŠãããŸããã ã¡ãã¬ãŒãé¢çœããªã£ãŠæãã®ãããããã¯ãåç¬ã§åããŠããããã§ã¯ãªããŠã ãã€ã·ã§ã³ããžã£ãŒããŒ(æ£è äœéš)ãäžå¿ãšããŠããã¿ã¯ã矀ãååšããŠãããšãã ã§ãã æ£è äœéšãããè¯ãæ§ç¯ããããã«ããããã®ãããã¯ããåããŠãããã®ã§ããæäŒããšãããã¥ã¢ã³ã¹ãããªãããããã¯ããè¶ ããŠããã¯ããããŠãããŸããããšèšããæåããããšãããããéšåããªãšæããŸããããããããããéšåããªãšæããŸãã æ±è€ : ç¹ã«æšªæã®ãããžã§ã¯ãã ãšããããç®çæèã®çµ±äžã«äžçªæéã䜿ã£ãŠãè¯ãããããªãããšèããŠããŸãããããæ±ºãŸãããããã°ãåŸã è¿·ã£ãå Žåãç®çã«å³ããæææ±ºå®ãã§ããŸããããããåºããåŸã«åãã¡ã€ã³ã§ã®èª¿æŽãããšããé çªã倧äºã ãšæããŸãã ââ æè¡é¢ã§æ°ãã€ãããã€ã³ãã¯ã©ããªãã®ããã£ããã§ããããã æéŠ¬ : åæäºçŽæ©èœãšããŠããããããšã¯ããã€ã€ã蚺çæåŽã®æ¥åãããŒãæ£è ã®å°ç·ãä»ããã·ã¹ãã ã®å¶çŽãªã©ãèžãŸããã©ã®ãããªåœ¢ã«èœãšã蟌ã㰠蚺çæãè¬å±ãæ£è ã«ãšã£ãŠã䟡å€ã®ããæ©èœãšãªãã ããã€ã³ãã§ãã ã§ãã®ã§ãæè¡çãªé¢ãšäºæ¥çãªé¢ã䜵ããŠèããªãããã·ã¹ãã å šäœã®èŠä»¶ã決ããŠãããšããã®ãæåã«æãããéšåã§ããã ââ æ©èœãèããäžã§ãå šäœãèŠæ®ããèšèšãªã©ããã£ãŠãããšæããã§ãããä»åã¯ã©ãããçæããããã§ãããã?æ£è ã®å°ç·ã ã£ããå»çæ©é¢ã®æ¥åãããŒãªã©ææ¡ããåŸã«ãåãããã£ãéšåãèãããã®ã§ããã æéŠ¬ : åæäºçŽã«ãããã·ã¹ãã å šäœã®èŠä»¶ãåºããŠãããšåæã«ãå šäœã®ã·ãŒã±ã³ã¹ãšã¹ããŒããã·ã³ãäœã£ãŠãããŸãããåã·ã¹ãã éã®é£æºãããŒãšãããã«ããçã¿åºãããäºçŽãåŠæ¹ç®ãšãã£ããšã³ãã£ãã£ã®ç¶æ é·ç§»ã決ããŠããããã®ç¶æ ã®æã¯ãããã£ãããšã¯ã§ããªããšãããããã£ã蟻è€ãåããããšããããã£ãããã£ãŠãã£ããšããæãã§ãããã é äº : ä»åã¯ãç¹ã« ãããã¯ã暪æã®å ±éåºç€ãšããŠãåãããã¯ãã§ããããå šãå¥ç©ã®ä»çµã¿ãã¹ããŒã¿ã¹ãä¿æããŠããã®ããå ±éåã»æœè±¡åãããšããæ¥åãå¿ èŠã«ãªã ã®ã§ããããé£ããããé£æåºŠãé«ãéšåã ãªãšæã£ãŠãããã§ããã©ãããã綺éºã«ã·ãŒã±ã³ã¹å³ã«èœãšã蟌ãã æéŠ¬ãããåããªãšæããŸããã æ±è€ : åºç€åŽã§äœã£ãŠããã ããã·ãŒã±ã³ã¹å³ã¯ UX ã®éªšçµã¿ãªãã§ããããããããããã UX ãã¶ã€ããŒãå¥éãããšãã£ã现ååããããå®è£ ã®å¶éãå å³ãã€ã€ãæ£ããéçšãåãããã«ããã®äœéšãäœãããã«ãã®ã¹ããŒã¿ã¹é·ç§»ã§ããã¹ãã ããããšããéšåãæéЬããããšã³ãžãã¢èгç¹ã§æåã«äœã£ãŠãããŠããšããã®ãã ã¡ãã¬ãŒã®ãšã³ãžãã¢ã®ãšãŠãè¯ãéšå ã ãšæã£ãŠããŸããæè¡ã ãã§ãªã UX ãªã©ã«ãå¿ èŠã§ããã°è¶å¢ããŠãããæåã§ããã åæäºçŽ Pj éçºã®å®é ââ ããããåæãã§ãŒãºãçµãŠ Pharms ãš CLINICS ã©ã¡ãã®éçºã«ãé¢ãã£ãå°ç°ããã«èãããã®ããéçºã®æµãã®äžã§ãããããªãœãŒã¹çãªåé¡ã£ãŠå€§å€ã ã£ããšæãã®ã§ãããããã¯ã©ã解決ãããã§ããããã å°ç° : å ã« Pharms åŽã®æ©èœ ãäœã£ãŠãã®åŸã« CLINICS ã®ä»æ§ã決ããŠããã£ãŠãã CLINICS ã®éçºã«å ¥ãæµãã ã£ãã®ã§éçºã䞊è¡ããããšã¯ãªãã£ãã§ãããã Pharms ã§ã¯ãªãŒããšã³ãžãã¢ãšããç«å Žãªã®ã§ ãCLINICS ã®éçºã«å ¥ãããã®æºåãšãPharms åŽã®ã¬ãã¥ãŒããã©ããŒã®ãªãœãŒã¹é åã¯èªåã§èããŠãåã¿ã¹ã¯ã宿œããæéãšã¿ã€ãã³ã°ã調æŽããªãããã£ãŠããŸããã äžæ¹ã§ããã®äœå¶ã§ãé²ããããšãã§ããã®ã¯ Pharms ããŒã ã®åã¡ã³ããŒãæ¢ã«èªèµ°ã§ããç¶æ ã«ãã£ãã®ã§ãããã«æ¯ããããããããã§ãã ããªãšæã£ãŠãŸãã ââ ãããã¯ããè¶å¢ããªããéçºãããšããæåã¯ãããè¯ããšæã£ãã®ã§ãããããã¯ãããŒãªã©ãã£ãããããã§ãã? æ±è€ : å çšã話ããéã Pharms ãšããŠæ¬ãããžã§ã¯ãã®åªå 床ã¯é«ãã£ãã®ã§ãããCLINICS ã®äºæ¥èšç»ããªãœãŒã¹ãèžãŸãããšå»ç§åŽã®å®è£ çæã倧ããé ããããªèŠç«ãŠã§ãããããã§ãå°ç°ããã å»ç§åŽã®éçºã«ãã¢ãµã€ã³ã§ããããªãœãŒã¹åé¡ã解決ã§ããã®ã§ã¯ãšèª¿æŽããŸãããå»ç§åŽã®ãšã³ãžãã¢ããã®ãã©ããŒã¢ããã¯å¿ èŠãªã®ã§ããã®èª¿æŽããã€ã€ã§ãããéçºãæ©ãããããªãè¯ãããšéçºããŒã éã§æçµçã«å€æããŸããã é äº : ä»ãŸã§è§Šã£ãŠãªãã£ã CLINICS ã®ã·ã¹ãã ã«ãå°ç°ããã¯ã¬ã³ã¬ã³åã蟌ãã§ãã ãã£ãã®ã§ãå ã CLINICS ã®éçºããã£ãŠãã®ã§ã¯ãšæãããããã£ããã¢ãããæ©ãã£ãã§ãã ââ ãããã¯ãã®ã°ããŒã¹ã®ããã«ãªãœãŒã¹èª¿æŽãæåããããšãã圢ã ã£ããã§ããããããã¯ãéã®è¶å¢ããããããããªæåã ã£ããããããžã§ã¯ããæåãããããšããç®ç·åãããèªç¶ã«ã§ããã®ã¯è¯ãã§ããã ããŒã éãšãã話ã§ããã° QA ã¯åããŒã ã«è·šã£ãŠã®æŽ»åã ãšæããŸããããã®èгç¹ã§ã¯ãããã§ãã? å°å³¶ : èªåã¯éçºãçµç€ã«å ¥ã£ãã¿ã€ãã³ã°ã§ãããžã§ã¯ãã«åæµããŸããããããŸã§ã¯ç±³å±±ããã QA ãšããŠå ¥ã£ãŠããã®ã§ãããå»ç§åŽã§ãæ€èšŒãã¹ããã¹ã芳ç¹ã倿°ãã£ãèæ¯ããããå»ç§åŽã® QA ãã¡ã€ã³ã§èŠãæ åœãšããŠåç»ããŸããã åŸåã«åç»ããèæ¯ããããããããåŠæ¹ç®éä»ãšããæ¥åã Pharms ãããã¯ãã®ä»æ§çè§£ãæµ ãâŠãšããç¶æ ã§ãããã éçºç®çã»èŠä»¶å®çŸ©ã»èšèšã詳现ã«ããã¥ã¡ã³ãåãããŠããã®ã§ãã¹ã ãŒãºã«æ€èšŒã«å ¥ãããšãã§ããŸãã ãæ€èšŒã®äžã§ QA ãšã³ãžãã¢ãšããŠãããã®éšåã®ä»æ§ã¯èŠçŽããæ¹ãè¯ããªãããšãããã€ã³ããããã€ãåºãŠããã®ã§ã仿§ã®æ¹åææ¡ãè¡ããŸãããåŸçºåå ã§ããããå®éã«åãå ¥ããŠããã£ãæ¹åãå€ãã§ãã ã¡ãã¬ãŒã®ãããã¯ãéçºã®æåãšã㊠QA ãšã³ãžãã¢ã èŠä»¶å®çŸ©ããã¬ãã¥ãŒã«åå ããããæèŠãèšãã€ã€ãããã¯ããããè¯ãããããã®æ¹åãè¡ãã ã®ã§ããšãŠãåããããã§ããã ââ åŸããå ¥ã£ãŠãåãããããšããã®ã¯ãããã¥ã¡ã³ããªã©ãæŽåãããŠããããã§ããããšã ãšããã®ãåãããŸãããæšªæãããžã§ã¯ãã ããããæ°ãã€ããä»ã®ããŒã ã®è¯ãç¹ãªã©ãã£ããããŸãã? é äº : Pharms ã®ãããžã§ã¯ãã£ãŠããããããªããšæã£ãã®ã KPI èšèšããããæç¢ºãªãšããã ã£ããšããç¹ã§ããã è²ã çŽäœæ²æãã£ãçµæããã«èŸ¿ãçããŠããšããèŠåŽãç¥ã£ãŠã¯ãããã§ããã©ãä»ã® KPI èšèšã£ãŠãã£ã±ããããã·ã³ãã« ã§åŠæ¹ç®éä¿¡æ°ã§ããšãªããšãããããéç®ãã KPI ãå PF ã«æ¯ãã°ãããšèšãäœå¶ã ã£ãã®ã§ããããããã¯ãããããã£ããã€ã³ãã®äžã€ããªãšæããŸãã 話ãè«ç¹ãçµå±ããã£ãŠããéšåããããã³ãã¥ãã±ãŒã·ã§ã³ã³ã¹ããå®ãããã éšåã§ã¯ããããªãšæããŸããã æšªæãããžã§ã¯ããªãã§ã¯ã®ãšã³ãžãã¢ãªã³ã° ââ å šäœã®è©±ããåå¥ã®ãã¡ã€ã³ããšã®ãšã³ãžãã¢ãªã³ã°ãšããç¹ã§ã¯ã©ã®ãããªããšããããŠããŸããã? å°ç° : åºæ¬çã«ã¯æéЬããã®ã·ãŒã±ã³ã¹å³ãå ã«éçºãé²ããŠããŸãããCLINICS ã§ã¯ A ãšããç¶æ ã«ãªãããã®æã« B ãšããã¢ã¯ã·ã§ã³ããããš Pharms ã§ã¯ C ãšããç¶æ ã«ãªããšããããã«ç¶æ é·ç§»ãè€éã ã£ããããèšèšæã«ããã¹ãå§¿ã«è¿·ãããšãå€ãã£ãã®ã§ãããã·ãŒã±ã³ã¹ã«ç«ã¡è¿ããšããã«ãã®çåã解決ãããšãã£ãå ·åã§ãã æéŠ¬ : ã·ãŒã±ã³ã¹ã®æŽåæ§ãé£ãããªããããªãããã«èšèšãã ããšã«ã¯æ°ãã€ããŸããããåæäºçŽããšããèšèãå è¡ãããšã€ãã€ãè€éãªæ°æ©èœã®ãããªãã®ãäœããã¡ã§ããã蚺çæãè¬å±ã®äºçŽæ©èœãåŠæ¹ç®éä¿¡æ©èœãšãã£ãåã ã®ããŒãã¯ããšããšããããã§ããªãã¹ãã·ã³ãã«ã«ããããã€ãªãåãããããããã«å¿ãããŸããã æ±è€ : 现ãããããã¯ãéã®èª¿æŽãå¿ èŠã«ãªãã®ã§ ã¡ãããšèª¿å€ã®æ¬²ãã KPI ãæ±ãã€ã€ããã€çŸå Žã®ãªãã¬ãŒã·ã§ã³å質ãèœãšããªãã£ãŠãã芳ç¹ã§èª¿æŽãåãã¡ã€ã³ã§ãããŸããã 工倫ããããšã§ãããšãUX 調æ»ã培åºãããšããã§ããããã ä»åã®ãµãŒãã¹ã£ãŠæ¥ççã«ã¿ãæã«æ°ããããšãããšããã§ã¯ãªããã§ããããã§ãã®ã§ã忥çã®äŒæ¥ããã®åã¢ããªã®äœéšãšããèªåã§ãçµæ§è²ã 䜿ããªããäœéšããŠã¿ãŸããããããããããŒã¹ã«éã«çŸç¶ã®ãã¡ã®ä»æ§ãèžãŸãããšããããã颚ã«ãã¡ã§ã¯å®è£ ããŸãããã¿ãããªãšãããè²ã ãã£ãŠããŸããã å°ç° : ãšã³ãžãã¢ãªã³ã°ã®èгç¹ã§ãããšãç¹ã«æ£è ã¢ããªããŒã ãšã® API 飿ºã®ä»æ§èª¿æŽãšãéçºã®é²ãæ¹ã¯å¯ã«é£æºããªããé²ããŸãããå ã«ãã£ã¡ãã§ããŠãªããšåãããéçºã§ããªãç¶æ ã«ãªãã®ã§ãæ åœè å士ã§ã³ãã¥ãã±ãŒã·ã§ã³ãšãã€ã€ã工倫ããªããé²ããŠããŸããã é äº : CLINICS ã§æ°ã«ããŠãéšåã¯ã©ã¡ãããšãããš ãªã¹ã¯ãšã³ã¹ãã®éšåãããã«æå°åããŠäŸ¡å€ãæå€§åããããäžçªéèŠ ããªãšæã£ãŠããã®ã§ãäžçªå€§äºãªã®ã¯ãã£ã±ãå»ç§ã«ãšã£ãŠã©ããã䟡å€ãåºãŠãå»ç§ã«ãšã£ãŠã©ããããªã¹ã¯ãçºçããããèããŠãŸããã äŸãã°äžçªæåã®ããåããã§è¬å±äºçŽããæã«æ¥æãŸã§ç¢ºå®ãããŸããããšãã話ããã£ããã§ããã©ããããŸã§ã¹ã³ãŒããåºããªããŠãã¡ãªãããåºãã®ã§ããã°ãåºããããªãã§ããšãã話ãããŠããŸããã ããšã¯ãªãªãŒã¹ãã©ã³ã®çå®ãšãããªïŒå šå»çæ©é¢ã«äžæã«åºãã®ã§ã¯ãªãããŸãã¯äžéšå»çæ©é¢æ§ã ãã«å ¬éãããªãªãŒã¹æ¹åŒã«ããŸãããã¿ãããªãšãããå«ããŠã§ããããå»ç§åŽã§äžæŠãã¹ãããã£ãŠæ€èšŒããŠãã¹ã ãŒãºã«æ©èœã䜿ãããšããã確èªãããããã¹ããããèšããŸããããšå®å šçãåããªããé²ããŸããã ããã¯ãã®ãããžã§ã¯ãã«é¢ããããã©ããªãããžã§ã¯ãã§ãäžçªéèŠã§ãããåŸããã²ã£ããè¿ãã®ãäžçªææ»ãã«ãªã£ãŠããã®ã§ãããã¯éèŠããªãšæããªããé²ããŠãŸãããã å°å³¶ : QA èŠç¹ã ãšæšªæãããžã§ã¯ãããã«ã¹ããŒããæ¬åœã«è€éã§ãã¡ãã¬ãŒå ¥ç€ŸåŸã«çµéšãããããžã§ã¯ãã®äžã§æ€èšŒã®é£æåºŠãæãé«ãã£ãã§ããã ã§ãããçããä»°ãããŠããããã«åãŠãŒã¹ã±ãŒã¹ã«å¯Ÿããèšèšãå³ã§ããã¥ã¡ã³ãåãããŠããã®ã§ããã¹ãã±ãŒã¹ãšããŠè»¢çšã§ããéšåãå€ããããŸãããæéЬãããäœæããèšèšå³ããã£ãããããæŒããªããã¹ãã§ããéšåã¯å€§ããã§ãã倧å¢ãåå ãããããžã§ã¯ãã«ãããŠãå šå¡ãèªèåãããäžã§ãèšèšå³ã¯æ¬åœã«å€§äºã ãªãšçæããŸããã 工倫ããç¹ãšããŠã¯ãå°ç°ãã㯠Pharms éçºã®ãã¡ã€ã³ç¥èãè±å¯ã ã£ãã®ã§ãQA æã¯ Pharms åŽãã¡ã€ã³ã«èŠãŠãããã€ã€ãèªå㯠CLINICS åŽã® QA ãæåãèŠãããã«ããŸãããã©ã¡ãã®ãã¡ã€ã³ã«ãé¢ä¿ããå¥çŽãã©ã³çã®è€éãªä»æ§ã¯èªåãæ åœããŸããã QA 以å€ã®é¢ã ãšããªãªãŒã¹ããäžã§å¿ èŠãªæµ®ããããŒã«ãããã°ç©æ¥µçã«åãã«ããããã«ããŸããã äŸãã°ããããŸã§äžéšã®å»çæ©é¢æ§ã ãã«æ©èœãªãªãŒã¹ããå Žåããã®åŸã®ãã£ãŒãããã¯ååã¯ã¡ãŒã«ãé¢è«ã§åå¥ã«è¡ã£ãŠããŸããããæ¥ã ã®èšºçã®äžã§ãæéã確ä¿é ãã®ãé£ãããšããç¶æ³ããããŸããããã®çµæãæ¬ Pj ã«ãããŠãå šäœãªãªãŒã¹ããŠåé¡ãªããïŒã®å€æããã¥ããææããããŸããã ããã§ Google ãã©ãŒã ã§ã¢ã³ã±ãŒããäœæããŠçæéã§åçã§ãã圢ã«åãæ¿ããŸãããçµæçã« 100% åçãåŸãããšãã§ããŸããã ã¢ã³ã±ãŒãçµæãããåŸæ¥æ©èœãã䟡å€ããããé¢å ãªãã¬ãŒã·ã§ã³ã«çµã¿èŸŒãã§é ãã³ã¹ãããããŸã§é«ããªãããšããç¹ãè©äŸ¡ã§ããã®ã§ãèªä¿¡ãæã£ãŠå šäœå ¬éãªãªãŒã¹ã«åã㊠GO å€å®ã§ããŸããã** ã¡ãã¬ãŒã¯åœ¹å²ã«çžãããããŒã«ãä»»ããŠé ããç°å¢ãããã®ã§ãèªåã®å°éé å以å€ã®ããšãåŠã¹ãŠãã**ãšæãããšãå€ãã§ãã 幞ããªãªãŒã¹åŸã倧ããªäžå ·åã¯ãªãã®ã§ããã¯ããçããã®ãããã§ããã åæäºçŽ Pj ãçµã㊠ââ ã§ã¯æåŸã«ãã®ãããžã§ã¯ãã®ç·æ¬ãããŠãã ããã°ã æ±è€ : 暪æã§ã¯ãããã©åãã¡ã€ã³ã§ããããã®ãããã§ãã·ã§ãã«ãã¡ãããšåãçºæ®ããŠãããžã§ã¯ããããåãããšããã®ã¯ããã倧ããè³ç£ã§ããã å»ç PF ã¯ã¢ã»ãããããããæã£ãŠããã®ã§ãè²ã çµã¿åããããšãä»ã®äŒç€Ÿã ãšã§ããªããã©ããã¡ãªãã§ãããã ããã¿ãããªããšãè²ã ãã ãã§ãã ãªã®ã§ããã®åŸã暪æãããžã§ã¯ãã¯äºå®ãããŠããŸãããããã«å é§ããŠã²ãšã€ãããã£ãŠããã€åããæ¬²ããã£ãæåŸ ææãçŸç¶åºããŠãããšãããå«ãããšãããè¯ãäžæ©ã ã£ãã®ããªããšæã£ãŠãŸãã æ¬¡ã¯åè³ªãæ ä¿ãã€ã€ããã£ãšã¹ããŒããäžããŠãããããšããã®ã芳ç¹ãšããŠå€§ããã§ããã ââ ãªãã»ã©ãããããæšªæãããžã§ã¯ãããã£ãŠããå»ç PF ã§ã¯ã©ããªãšã³ãžãã¢ãããããããã€ã³ãã§ããã? æéЬ : æè¡ãšäœµããŠãŠãŒã¶ãŒãžã®äŸ¡å€æäŸãèããªãããšã³ãžãã¢ãªã³ã°ããã人ããããããã®ã§ã¯ãªãããšæããŸãã ââ åãããã¯ãã®æã£ãŠãã圹å²ãèžãŸããŠã俯ç°ã®èŠç¹ã§éçºãããããšããæ¹ã«ã¯ãããé åçã§ãããæ¬æ¥ã¯ããããšãããããŸããã ãããã« åæäºçŽ Pj ã«ã€ããŠããããžã§ã¯ããæšé²ããã¡ã³ããŒã«è©±ãèããŸããããè€éãªèŠä»¶ãå®çŸå¯èœãªåœ¢ã«ããŠåããŒã ã§å£æ ¹ãè¶ããŠéçºãããŠããæ§åããšãŠãå°è±¡çã§ãããç¹ã«å»ç PF ã§ã¯ãã¡ã€ã³åå£«ã§ææ©çã«çµåããŠãããã³ã©ãã¬ãŒã·ã§ã³ããããšã«ããã¹ããŒã¯ãã«ããŒãžã®äŸ¡å€ãé«ããŠãããšããã®ã¯ããããããããã®ã§ã¯ãªãããšæããŸãã ãã®ãããªãããžã§ã¯ãã§åãçºæ®ããããšæã£ãæ¹ã¯ãã²ããæ°è»œã«ã話ãããŸããã! åéã®äžèЧ | æ ªåŒäŒç€Ÿã¡ãã¬ãŒ ã¡ãã¬ãŒã®æ¡çšæ å ±ã¯ãã¡ãããã確èªãã ããã www.medley.jp
æ ªåŒäŒç€Ÿã¡ãã¬ãŒ
2024/02/29
<![CDATA[ è€æ°ãããã¯ã暪æãããããžã§ã¯ããã©ããã£ãŠæåãããã®ãã¡ã³ããŒã«èããŠã¿ãŸãã ]]>
ã¯ããã« ã¿ãªãããããã«ã¡ã¯ããšã³ãžãã¢ã®å€å·ã§ãã ä»å㯠CLINICS / Pharms åæäºçŽãããžã§ã¯ã(以äžãåæäºçŽ Pj)ãšãããããã¯ã暪æã§æ§ã ãªéšçœ²ãé¢ãã£ãéçºãããžã§ã¯ãã«ã€ããŠãå°œåãããçããã«åº§è«äŒåœ¢åŒã§ã話ã䌺ããŸããã ã¡ãã¬ãŒã®å»çãã©ãããã©ãŒã (以äžãå»ç PF)ã§ã©ã®ããã«ããããæšªæãããžã§ã¯ããå®éããã®ãã®æ§åãçããã«ç¥ã£ãŠããããã°ãšæããŸãã 察è«ã¡ã³ããŒçŽ¹ä» ââ ã¯ããã«ãçããã®èªå·±ç޹ä»ããé¡ãããŸãã æ±è€ : æå±ã¯å»ç PF ã®ãããã¯ãéçºå®€ã® Pharms éçºããŒã ã§ãã 圹å²ãšããŠã¯èª¿å€è¬å±åãã®ã·ã¹ãã ã® Pharms ã®ãããã¯ããªãŒããŒãæ ã£ãŠããŸãã çµæŽãšããŠã¯ã2021 幎㮠1 æãã Pharms ã®ã«ã¹ã¿ããŒãµã¯ã»ã¹ãšããŠã¡ãã¬ãŒã«ãžã§ã€ã³ããŸããŠã2023 幎 1 æããéçºããŒã ã«æ¥ãŸããã ãããŸã§ã¯äºæ¥åŽã®çµéšãé·ããå¶æ¥å šè¬ãäºæ¥éçºãã¡ã€ã³ã§ãã£ãŠãããã£ãªã¢ã§ãã ãã®ãããžã§ã¯ãã® PO ãšããŠãªãŒãããåããããŠãããPharms ãæ ã調å€åŽã®ãªãŒãã«å ããŠãå šäœã®ææ¯ãã調æŽçã䞻軞ã«ãã£ãŠããŸããã æ±è€ãã ââ æ±è€ããããããžã§ã¯ãã®äžå¿ãšãªã£ãŠæšé²ãããã§ããã æ±è€ : 調å€ãã¡ã€ã³ã® Pharms ã«ãšã£ãŠäºæ¥ã€ã³ãã¯ããããã倧ããéçºã ã£ãã®ã§ã調å€ãã¡ã€ã³ã責任æã£ãŠãããŸãããããšããæŽçã§ãã å°ç° : èªåã®æå±ãæ±è€ãããšåãã«ãªããŸãã çµæŽã¯ã2021 幎 7 æã«ãšã³ãžãã¢ãšããŠå ¥ç€ŸãããããŸã§ãã£ãš Pharms ã®éçºããã£ãŠãŸãã å ¥ç€ŸåŸã¯ã¯ã©ã€ã¢ã³ãèªèšŒæ©èœãæ³äººæ åœè åãã®æ¬éšæ©èœãªã©ã®æ©èœéçºãè¡ã£ãŠããŸããã æšå¹Žãã Pharms ã®ãªãŒããšã³ãžãã¢ãšããŠããŒã å šäœãèŠã€ã€ãPharms ã®æè¡è²¬ä»»è ãšããŠæ±è€ãããšäž¡èŒªã§åããããªåœ¢ã§ãããžã§ã¯ãã®æšé²ã«é¢ãã£ãŠããŸãã å°ç°ãã æéŠ¬ : å»ç PF ãããã¯ãéçºå®€ãæ£è çµ±ååºç€ããŒã ã«æå±ããŠããŸããæ£è çµ±ååºç€ãšã¯ãCLINICSïŒæ£è ã¢ããªïŒãšããã¢ããªã®ããã¯ãšã³ãã·ã¹ãã ã§ããã蚺çæãæ¯ç§å»é¢ãè¬å±åãã®ã·ã¹ãã ãšã®é£æºåºç€ãšããŠãæ©èœããŠãããããã¯ãã«ãªããŸãã çµæŽã¯ããã®ã¡ã³ããŒã®äžã§ã¯äžçªå€ã 2018 幎 3 æã«å ¥ç€ŸããŠãåœå㯠CLINICS ã«ã«ãã®æ©èœæ¡åŒµã®éçºã«åå ããPKI åºç€ã CLINICS ãšãŒãžã§ã³ããå§ããšããä»ç€Ÿã·ã¹ãã ãšã®é£æºåºç€ã®éçºãè¡ã£ãŠããŸããã2020 幎ãããããæ£è çµ±ååºç€ã®ç«ã¡äžãã«åå ããŠãçŸåšã«è³ããŸãã æéŠ¬ãã é äº : å ¥ç€Ÿã¯ 2019 幎 8 æãªã®ã§ã 5 幎ç®ãšãªããŸãã ãã¶ã€ããŒãšããŠå ¥ç€ŸåŸ 1 幎éã¯ãžã§ãã¡ãã¬ãŒã«åšç±ããŠããŸããããã®åŸãªã³ã©ã€ã³èšºçã䌞ã³ãŠããææã«ãªããCLINICS åŽã®ãã¶ã€ããŒã®äººæ°ãè¶³ããªããªã£ãããšããããŸããŠãããããã¯é»åã«ã«ããå«ãã CLINICS ã®ãã¶ã€ã³å šè¬ãæ åœããŠããŸãããå»å¹Žããé»åã«ã«ã以å€ã®æ¥åé åã® PdM ãšããŠæŽ»åããŠããŸãã軞足ã¯ãã¶ã€ããŒãªã®ã§ãããããã¯ãã®ãããžã¡ã³ãã¿ãããªããšããå§ããŠãŸãã ãã®ãããžã§ã¯ãã«ãããŠã¯ããã£ãæ±è€ããããã£ããã£ãéããPharms ã®äŸ¡å€åäžãäžå¿ã®ãããžã§ã¯ããªã®ã§ãããžã§ã¯ãã®äžçªå€§ãããªãŒãã¯æ±è€ããã«ãªãããšæããã§ããã©ãCLINICS ãªã©ã®å»ç§åŽã®ãããžã§ã¯ããªãŒããšèšãç«ã¡äœçœ®ãåã«ãªãããªãšæããŸãã é äºãã å°å³¶ : å»ç PF ãããã¯ãéçºå®€ã® QA ã°ã«ãŒãã«æå±ããŠããŸããQA ã°ã«ãŒãã®ãããŒãžã£ã§ãã 米山 ããã®ã玹ä»ã§ 2022 幎 4 æã«ã¡ãã¬ãŒïŒäººç®ã® QA ãšã³ãžãã¢ãšããŠå ¥ç€ŸããŸãããäž»æ åœã¯ CLINICS ã®äºçŽæ©èœãäžå¿ãšããåšèŸºé åã§ãããããŸã§é äºãããšäžç·ã«åãããŠé ãæ©äŒãå€ããçŽè¿ã§ã¯äºçŽæ¹æ³ãæ¡åŒµããããªã¯ãšã¹ãäºçŽãæ©èœã® QA ãæ åœããŸããã åæäºçŽã«é¢ããŠã¯ãäž»ã«å»ç§åŽã®éšåã® QA ããå§ãŸãã調å€åŽã® QA ãå¿ èŠãšããããšã«ãªããæçµçã«ã¯å šäœã® QA ãæ åœããŸããã å°å³¶ãã åæäºçŽã®æ©èœã解決ããèª²é¡ ââ ããããšãããããŸããæ¬¡ã«ãä»åã®åæäºçŽã«ã€ããŠã©ããã£ãæ©èœã§ãã©ããã£ã課é¡ã解決ããã¹ãããã話ãããã ãããã§ãã æ±è€ : æ©èœãšããŠã¯ã CLINICSïŒæ£è ã¢ããªïŒãããªã³ã©ã€ã³èšºçãäºçŽããéã«ãè¬ã®åãåãå ãšããŠè¬å±ãäºåæå®ã§ããæ©èœ ã«ãªã£ãŠããŸãã ãã®æ©èœã«é¢ä¿ãããã¡ã€ã³ã¯æ£è ã»å»çæ©é¢ã»èª¿å€è¬å±ã®ïŒã€ã§ãã æ£è ãšå»çæ©é¢ã®ã¡ãªãããšããŠã¯ãè¬ã®åŠæ¹ãŸã§ã®æéãæžãããšã§ãã ãªã³ã©ã€ã³èšºçã§ã¯ãæ£è ãå»çæ©é¢ã«çŽæ¥èšªåããããã§ã¯ãªãã®ã§ãè¬ãçŽæ¥è¬å±ã«è¡ã£ãŠåãåãã®ããè¬å±ããé éãåžæããã®ããšãã£ãè¬ã®åãåãæ¹ããå»çæ©é¢ãšæ£è ããã§å£é ã§è©±ããŠæ±ºããŠããã£ãŠããã確èªã«æéãçºçããŠããŸãããæ£è ããã¯å£é ã§è©±ããå å®¹ã«æ²¿ã£ãŠããªã³ã©ã€ã³èšºççµäºåŸã«ãè¬å±ãžã®äºçŽãåã£ãŠããŸããã åæäºçŽæ©èœãå®è£ ãããããšã«ããã蚺å¯ã®äºçŽæã«ã©ã®è¬å±ã§ã©ãããåãåãæ¹ãããŸããšããéšåãæ£è ãããäºåæå®ã§ããããã«ãªã£ãã®ã§ã å»çæ©é¢ã¯äºåçãªè©±ã«æéããããã«èšºå¯ã«éäžã§ãããŸãæ£è ããããå»åž«ã«å£é ã§è¿œå 説æããªããŠãåžæéãã«è¬ãããããããšãããããŒã«å€æŽãããããšãå»çæ©é¢ãšæ£è ã®ã¡ãªãã ã ãšæã£ãŠãŸãã åæäºçŽæ©èœã®ãªãªãŒã¹ååŸã§ã®ãããŒã®éã ããäžã€ã®ãã¡ã€ã³ã§ãã調å€è¬å±ã«ã€ããŠã¯ãåè¿°ã®ããã«èšºå¯ã®äºçŽãããæã«æ£è ãããã¡ãã¬ãŒã®ãµãŒãã¹ã§ãã Pharms ã䜿ã£ãŠããè¬å±ããäºåæå®ãã§ããŸãã®ã§ã ãªã³ã©ã€ã³èšºçåŸã«çºè¡ãããåŠæ¹ç®ã®æµå ¥ãå¢å ããŸã ã 調å€è¬å±ã®å£²ãäžãã¯åŠæ¹ç®ã®ææ° à å䟡ã§å€§éšåãæ±ºãŸããŸãã®ã§ããã®ææ°ãå¢ããããšãã芳ç¹ã§ã¯è¬å±ã«ãšã£ãŠã€ã³ãã¯ãã®ããæ©èœã ãšæã£ãŠããŸãã ââ æ£è ã®äœéšãæ¬åœã«è¯ããªãããæ£è ãšå»çæ©é¢ã®ç¡é§ãªã³ãã¥ãã±ãŒã·ã§ã³ãæžãããã€è¬å±ã«å¯ŸããŠãåŠæ¹ç®ææ°ãå¢ããŠãå°ç·ã楜ã«äœ¿ããããã«ãªã£ãŠãããšããã®ããä»åã®ãããžã§ã¯ãã®èã«ãªã£ãŠããæãã§ãããããããèžãŸãããããã¯ãéãæšªæããŠéçºããªããšãããªããšããã®ã倧å€ããã§ãã éçºãããžã§ã¯ãã«ã€ã㊠ââ ã©ã®ãããªããŒã ããã®æšªæãããžã§ã¯ãã«é¢ãã£ãŠããããæããŠãã ããã æ±è€ : éçºåŽã§èšããšïŒã€ã®ãã¡ã€ã³ã«ãªã£ãŠãŸãã 調å€ãæ£è ãå»ç§ããã㊠æ£è çµ±ååºç€ ã§ããæ£è çµ±ååºç€ãšã¯å»ç PF ã®åãã¡ã€ã³ã«ååšããæ¥åã·ã¹ãã ãšæ£è ã¢ããªãç¹ãæ ¹å¹¹ãšãªããããã¯ãã§ãã ãã ä»åã®æ©èœã¯å»çæ©é¢ã®ãªãã¬ãŒã·ã§ã³ãå€ãããããéçºåŽã§ã®ã¿å®çµãããããžã§ã¯ãã§ã¯ãªããã§ããã ããã«çŸå Žã®éçšã«åããã€ã€ãäœéšãæ¹åã§ãããïŒãšããèŠç¹ã§èãããšãåäºæ¥åŽã®ã«ã¹ã¿ããŒãµã¯ã»ã¹ããŒã ãéèŠã«ãªããŸã ãç¹ã«å»ç§ãšèª¿å€ã®ã«ã¹ã¿ããŒãµã¯ã»ã¹ããŒã ãšã¯ãå¯ã«å£æã¡ãããªããéçºãé²ããŠããŸããã ââ ä»åã®ãããžã§ã¯ãã¯ç¹ã«äºæ¥éšãšã®é¢ä¿æ§ãéèŠãªéµã ã£ããã§ããã æ±è€ : ããã§ãããç¹ã«å»ççŸå Žã¯æ¥åãéŒè¿«ããŠããå Žé¢ãå€ãã§ãã®ã§ãäŸãã°ãã¯ã³ã¯ãªãã¯å¢ããŸãããããã§ããŒãžé·ç§»ãå¢ããŸãããšãã£ãããšã§ãæ¥åãžã®åœ±é¿ãéåžžã«å€§ãããªããŸãã ãŸããªãã¬ãŒã·ã§ãã«ã«çŸå ŽãåããŠããç®æãå€ãããããã¯ãéœåã§åæã«ãã®æ¹ãè¯ããããåççã ããããšæ±ºããŠãããã¯ããäœã£ãŠããŸããšä»ãŸã§ã®çŸå Žãªãã¬ãŒã·ã§ã³ã厩ããŠããŸãæ··ä¹±ãæãããšããããŸãã çŸå Žã®ç¿æ £ãçè§£ããæã ãç®æãå§¿ãšèª¿æŽããªããæé©è§£ãåºã ã®ããå¿ é ã«ãªã£ãŠããæ¥çã»æ¥æ ã ãšæãã®ã§ããã®èª¿æŽã¯äºæ¥éšãšãããªãæ°ãé£ã£ãŠãã£ãŠããŸããã ââ åæäºçŽ Pj ã¯ãéçºåŽãããããšããããšã§å§ãŸã£ããããžã§ã¯ããªãã§ãããã? æ±è€ : ã¯ããããã¯ã¡ãã¬ãŒã®ã©ã®ãããã¯ãããããªã®ã§ãããäºæ¥è²¬ä»»è ãšãããã¯ã責任è ããããããããäºæ¥ãšéçºã®äž¡èгç¹ããè°è«ããäºæ¥æ¹éãæ±ºããŠããããšããäœå¶ããšã£ãŠããŸãã Pharms ãæ£ããæé·ãããŠãããšãã芳ç¹ã§èŠããšãçŸãã§ãŒãºã§ã¯åŠæ¹ç®ããã£ãããšèª¿å€è¬å±ã«å±ããããšãè³äžåœé¡ã§ããããµãŒãã¹ã®ããã¹ãå§¿ãšã¯ïŒãšãã芳ç¹ã§äºæ¥ãšéçºäž¡èŒªã§ãããŸããããšããåœ¢ã§æ±ºãŸã£ããã®ã«ãªããŸãã æšªæãããžã§ã¯ãã§å·¥å€«ããããã€ã³ã ââ ä»åãæšªæã§è²ã ãªéçºãããã¯ããé¢ä¿ããŠããŸããã工倫ããç¹ãšãæ°ãã€ããç¹ãªã©ãã©ããªãã®ããããŸãããã æ±è€ : äžçªã¯åãã¡ã€ã³ã§è¿œã£ãŠããäºæ¥ææãããªãéã£ãŠããŸããã®ã§ããã®èª¿æŽãæéããããŠæŠãåããããç¹ã§ãã äŸãã°ã調å€ã®èгç¹ã§ã¯åŠæ¹ç®ãã¡ãããšè¬å±ã«å±ãããšããã®ãããããéèŠãªäºæ¥ã€ã³ãã¯ãã®å€§ããé ç®ã§ããäžæ¹ã§ãå»çã®èгç¹ã§èŠãæã«ããã¡ããæéãæžããã®ã¯ãããéèŠã§ã¯ãããã§ãããå»çãã¡ã€ã³ãšããŠãã®æ¹åã«èª¿å€ãšåèŠæš¡ã®ã¡ãªãããèŠåºããŠããããããšèšããšåœç¶ããã§ã¯ãªãã£ããããŸãã ããããéšåã§ããã¡ã€ã³éã§ãã®ãããžã§ã¯ããéæããåŸã«åŸãããã¡ãªããã«å·®åãåºãŠããŸããã¡ãªããã倧ããäºæ¥ãããããå·¥æ°ã倧ããå²ããã®ã§ãããã¡ãªããã匱ãäºæ¥ã§ã¯åãã ãå·¥æ°ãããŠãããŸãããããšããæææ±ºå®ã¯é£ãããšæããŸãã ããã§ æ¬ Pj ãéããŠåãã¡ã€ã³ã§ã¯ã©ãããäºæ¥ææãçãã®ãããã®ããã«äœã® KPI ã远ãã®ãããæç¢ºã«ããŸãã ãäºæ¥çãªã¡ãªãããå€ã調å€ã®ããã«æäŒã£ãŠãã ãããšãã圢ã§ã¯ãªããåãã¡ã€ã³ã§ã©ãããã¡ãªãããçãã§ãããŸããïŒãšãããšãããæãããã®ãããããéèŠã ã£ããšæã£ãŠããŸãã ãããæ ããšãã¡ãªããã®åŒ±ãäºæ¥ã«ãšã£ãŠã¯ãæäŒãã¿ãããªãããžã§ã¯ãã«ãªããŸããåçŽã«ãšã³ãžãã¢ãªã³ã°ãšããéšåã§ãé¢çœããã®ã«ãªããªãã§ããããã§ãã®ã§ãé¢ä¿ããå šå¡ã§ãããžã§ã¯ãã宿œããããšã§ã©ãããçµæãåŸãã®ã?ãã¡ãããšåãã¡ã€ã³éã§æããŸããã ââ ãªãã»ã©ããããããšããããæŠãåããã¯æ±è€ãããšé äºããããã£ãŠãããã§ããããã é äº : ã¯ããåã®ã»ãã§è¡ã£ãŠããŸãããåãåæã®ããåããæã«éèŠããŠããã®ã¯ãã¹ã³ãŒããé©åã«åºåããšããéšåã§ããã調å€åŽã®æäŸäŸ¡å€ã®æå€§åã ãã远ã£ãŠåæãã倧ããªæ©èœè¿œå ãè¡ãã®ã§ã¯ãªãã倿Žã«ããå»ç§ã»æ£è ã»èª¿å€ãžäžãããªã¹ã¯ãéçºã³ã¹ããæãã€ã€ã䟡å€ãæå€§åã§ããèœãšãæã¯ã©ããããšããéšåããå·ãåããããŠãããŸããã ã¡ãã¬ãŒãé¢çœããªã£ãŠæãã®ãããããã¯ãåç¬ã§åããŠããããã§ã¯ãªããŠã ãã€ã·ã§ã³ããžã£ãŒããŒ(æ£è äœéš)ãäžå¿ãšããŠããã¿ã¯ã矀ãååšããŠãããšãã ã§ãã æ£è äœéšãããè¯ãæ§ç¯ããããã«ããããã®ãããã¯ããåããŠãããã®ã§ããæäŒããšãããã¥ã¢ã³ã¹ãããªãããããã¯ããè¶ ããŠããã¯ããããŠãããŸããããšèšããæåããããšãããããéšåããªãšæããŸããããããããããéšåããªãšæããŸãã æ±è€ : ç¹ã«æšªæã®ãããžã§ã¯ãã ãšããããç®çæèã®çµ±äžã«äžçªæéã䜿ã£ãŠãè¯ãããããªãããšèããŠããŸãããããæ±ºãŸãããããã°ãåŸã è¿·ã£ãå Žåãç®çã«å³ããæææ±ºå®ãã§ããŸããããããåºããåŸã«åãã¡ã€ã³ã§ã®èª¿æŽãããšããé çªã倧äºã ãšæããŸãã ââ æè¡é¢ã§æ°ãã€ãããã€ã³ãã¯ã©ããªãã®ããã£ããã§ããããã æéŠ¬ : åæäºçŽæ©èœãšããŠããããããšã¯ããã€ã€ã蚺çæåŽã®æ¥åãããŒãæ£è ã®å°ç·ãä»ããã·ã¹ãã ã®å¶çŽãªã©ãèžãŸããã©ã®ãããªåœ¢ã«èœãšã蟌ã㰠蚺çæãè¬å±ãæ£è ã«ãšã£ãŠã䟡å€ã®ããæ©èœãšãªãã ããã€ã³ãã§ãã ã§ãã®ã§ãæè¡çãªé¢ãšäºæ¥çãªé¢ã䜵ããŠèããªãããã·ã¹ãã å šäœã®èŠä»¶ã決ããŠãããšããã®ãæåã«æãããéšåã§ããã ââ æ©èœãèããäžã§ãå šäœãèŠæ®ããèšèšãªã©ããã£ãŠãããšæããã§ãããä»åã¯ã©ãããçæããããã§ãããã?æ£è ã®å°ç·ã ã£ããå»çæ©é¢ã®æ¥åãããŒãªã©ææ¡ããåŸã«ãåãããã£ãéšåãèãããã®ã§ããã æéŠ¬ : åæäºçŽã«ãããã·ã¹ãã å šäœã®èŠä»¶ãåºããŠãããšåæã«ãå šäœã®ã·ãŒã±ã³ã¹ãšã¹ããŒããã·ã³ãäœã£ãŠãããŸãããåã·ã¹ãã éã®é£æºãããŒãšãããã«ããçã¿åºãããäºçŽãåŠæ¹ç®ãšãã£ããšã³ãã£ãã£ã®ç¶æ é·ç§»ã決ããŠããããã®ç¶æ ã®æã¯ãããã£ãããšã¯ã§ããªããšãããããã£ã蟻è€ãåããããšããããã£ãããã£ãŠãã£ããšããæãã§ãããã é äº : ä»åã¯ãç¹ã« ãããã¯ã暪æã®å ±éåºç€ãšããŠãåãããã¯ãã§ããããå šãå¥ç©ã®ä»çµã¿ãã¹ããŒã¿ã¹ãä¿æããŠããã®ããå ±éåã»æœè±¡åãããšããæ¥åãå¿ èŠã«ãªã ã®ã§ããããé£ããããé£æåºŠãé«ãéšåã ãªãšæã£ãŠãããã§ããã©ãããã綺éºã«ã·ãŒã±ã³ã¹å³ã«èœãšã蟌ãã æéŠ¬ãããåããªãšæããŸããã æ±è€ : åºç€åŽã§äœã£ãŠããã ããã·ãŒã±ã³ã¹å³ã¯ UX ã®éªšçµã¿ãªãã§ããããããããããã UX ãã¶ã€ããŒãå¥éãããšãã£ã现ååããããå®è£ ã®å¶éãå å³ãã€ã€ãæ£ããéçšãåãããã«ããã®äœéšãäœãããã«ãã®ã¹ããŒã¿ã¹é·ç§»ã§ããã¹ãã ããããšããéšåãæéЬããããšã³ãžãã¢èгç¹ã§æåã«äœã£ãŠãããŠããšããã®ãã ã¡ãã¬ãŒã®ãšã³ãžãã¢ã®ãšãŠãè¯ãéšå ã ãšæã£ãŠããŸããæè¡ã ãã§ãªã UX ãªã©ã«ãå¿ èŠã§ããã°è¶å¢ããŠãããæåã§ããã åæäºçŽ Pj éçºã®å®é ââ ããããåæãã§ãŒãºãçµãŠ Pharms ãš CLINICS ã©ã¡ãã®éçºã«ãé¢ãã£ãå°ç°ããã«èãããã®ããéçºã®æµãã®äžã§ãããããªãœãŒã¹çãªåé¡ã£ãŠå€§å€ã ã£ããšæãã®ã§ãããããã¯ã©ã解決ãããã§ããããã å°ç° : å ã« Pharms åŽã®æ©èœ ãäœã£ãŠãã®åŸã« CLINICS ã®ä»æ§ã決ããŠããã£ãŠãã CLINICS ã®éçºã«å ¥ãæµãã ã£ãã®ã§éçºã䞊è¡ããããšã¯ãªãã£ãã§ãããã Pharms ã§ã¯ãªãŒããšã³ãžãã¢ãšããç«å Žãªã®ã§ ãCLINICS ã®éçºã«å ¥ãããã®æºåãšãPharms åŽã®ã¬ãã¥ãŒããã©ããŒã®ãªãœãŒã¹é åã¯èªåã§èããŠãåã¿ã¹ã¯ã宿œããæéãšã¿ã€ãã³ã°ã調æŽããªãããã£ãŠããŸããã äžæ¹ã§ããã®äœå¶ã§ãé²ããããšãã§ããã®ã¯ Pharms ããŒã ã®åã¡ã³ããŒãæ¢ã«èªèµ°ã§ããç¶æ ã«ãã£ãã®ã§ãããã«æ¯ããããããããã§ãã ããªãšæã£ãŠãŸãã ââ ãããã¯ããè¶å¢ããªããéçºãããšããæåã¯ãããè¯ããšæã£ãã®ã§ãããããã¯ãããŒãªã©ãã£ãããããã§ãã? æ±è€ : å çšã話ããéã Pharms ãšããŠæ¬ãããžã§ã¯ãã®åªå 床ã¯é«ãã£ãã®ã§ãããCLINICS ã®äºæ¥èšç»ããªãœãŒã¹ãèžãŸãããšå»ç§åŽã®å®è£ çæã倧ããé ããããªèŠç«ãŠã§ãããããã§ãå°ç°ããã å»ç§åŽã®éçºã«ãã¢ãµã€ã³ã§ããããªãœãŒã¹åé¡ã解決ã§ããã®ã§ã¯ãšèª¿æŽããŸãããå»ç§åŽã®ãšã³ãžãã¢ããã®ãã©ããŒã¢ããã¯å¿ èŠãªã®ã§ããã®èª¿æŽããã€ã€ã§ãããéçºãæ©ãããããªãè¯ãããšéçºããŒã éã§æçµçã«å€æããŸããã é äº : ä»ãŸã§è§Šã£ãŠãªãã£ã CLINICS ã®ã·ã¹ãã ã«ãå°ç°ããã¯ã¬ã³ã¬ã³åã蟌ãã§ãã ãã£ãã®ã§ãå ã CLINICS ã®éçºããã£ãŠãã®ã§ã¯ãšæãããããã£ããã¢ãããæ©ãã£ãã§ãã ââ ãããã¯ãã®ã°ããŒã¹ã®ããã«ãªãœãŒã¹èª¿æŽãæåããããšãã圢ã ã£ããã§ããããããã¯ãéã®è¶å¢ããããããããªæåã ã£ããããããžã§ã¯ããæåãããããšããç®ç·åãããèªç¶ã«ã§ããã®ã¯è¯ãã§ããã ããŒã éãšãã話ã§ããã° QA ã¯åããŒã ã«è·šã£ãŠã®æŽ»åã ãšæããŸããããã®èгç¹ã§ã¯ãããã§ãã? å°å³¶ : èªåã¯éçºãçµç€ã«å ¥ã£ãã¿ã€ãã³ã°ã§ãããžã§ã¯ãã«åæµããŸããããããŸã§ã¯ç±³å±±ããã QA ãšããŠå ¥ã£ãŠããã®ã§ãããå»ç§åŽã§ãæ€èšŒãã¹ããã¹ã芳ç¹ã倿°ãã£ãèæ¯ããããå»ç§åŽã® QA ãã¡ã€ã³ã§èŠãæ åœãšããŠåç»ããŸããã åŸåã«åç»ããèæ¯ããããããããåŠæ¹ç®éä»ãšããæ¥åã Pharms ãããã¯ãã®ä»æ§çè§£ãæµ ãâŠãšããç¶æ ã§ãããã éçºç®çã»èŠä»¶å®çŸ©ã»èšèšã詳现ã«ããã¥ã¡ã³ãåãããŠããã®ã§ãã¹ã ãŒãºã«æ€èšŒã«å ¥ãããšãã§ããŸãã ãæ€èšŒã®äžã§ QA ãšã³ãžãã¢ãšããŠãããã®éšåã®ä»æ§ã¯èŠçŽããæ¹ãè¯ããªãããšãããã€ã³ããããã€ãåºãŠããã®ã§ã仿§ã®æ¹åææ¡ãè¡ããŸãããåŸçºåå ã§ããããå®éã«åãå ¥ããŠããã£ãæ¹åãå€ãã§ãã ã¡ãã¬ãŒã®ãããã¯ãéçºã®æåãšã㊠QA ãšã³ãžãã¢ã èŠä»¶å®çŸ©ããã¬ãã¥ãŒã«åå ããããæèŠãèšãã€ã€ãããã¯ããããè¯ãããããã®æ¹åãè¡ãã ã®ã§ããšãŠãåããããã§ããã ââ åŸããå ¥ã£ãŠãåãããããšããã®ã¯ãããã¥ã¡ã³ããªã©ãæŽåãããŠããããã§ããããšã ãšããã®ãåãããŸãããæšªæãããžã§ã¯ãã ããããæ°ãã€ããä»ã®ããŒã ã®è¯ãç¹ãªã©ãã£ããããŸãã? é äº : Pharms ã®ãããžã§ã¯ãã£ãŠããããããªããšæã£ãã®ã KPI èšèšããããæç¢ºãªãšããã ã£ããšããç¹ã§ããã è²ã çŽäœæ²æãã£ãçµæããã«èŸ¿ãçããŠããšããèŠåŽãç¥ã£ãŠã¯ãããã§ããã©ãä»ã® KPI èšèšã£ãŠãã£ã±ããããã·ã³ãã« ã§åŠæ¹ç®éä¿¡æ°ã§ããšãªããšãããããéç®ãã KPI ãå PF ã«æ¯ãã°ãããšèšãäœå¶ã ã£ãã®ã§ããããããã¯ãããããã£ããã€ã³ãã®äžã€ããªãšæããŸãã 話ãè«ç¹ãçµå±ããã£ãŠããéšåããããã³ãã¥ãã±ãŒã·ã§ã³ã³ã¹ããå®ãããã éšåã§ã¯ããããªãšæããŸããã æšªæãããžã§ã¯ããªãã§ã¯ã®ãšã³ãžãã¢ãªã³ã° ââ å šäœã®è©±ããåå¥ã®ãã¡ã€ã³ããšã®ãšã³ãžãã¢ãªã³ã°ãšããç¹ã§ã¯ã©ã®ãããªããšããããŠããŸããã? å°ç° : åºæ¬çã«ã¯æéЬããã®ã·ãŒã±ã³ã¹å³ãå ã«éçºãé²ããŠããŸãããCLINICS ã§ã¯ A ãšããç¶æ ã«ãªãããã®æã« B ãšããã¢ã¯ã·ã§ã³ããããš Pharms ã§ã¯ C ãšããç¶æ ã«ãªããšããããã«ç¶æ é·ç§»ãè€éã ã£ããããèšèšæã«ããã¹ãå§¿ã«è¿·ãããšãå€ãã£ãã®ã§ãããã·ãŒã±ã³ã¹ã«ç«ã¡è¿ããšããã«ãã®çåã解決ãããšãã£ãå ·åã§ãã æéŠ¬ : ã·ãŒã±ã³ã¹ã®æŽåæ§ãé£ãããªããããªãããã«èšèšãã ããšã«ã¯æ°ãã€ããŸããããåæäºçŽããšããèšèãå è¡ãããšã€ãã€ãè€éãªæ°æ©èœã®ãããªãã®ãäœããã¡ã§ããã蚺çæãè¬å±ã®äºçŽæ©èœãåŠæ¹ç®éä¿¡æ©èœãšãã£ãåã ã®ããŒãã¯ããšããšããããã§ããªãã¹ãã·ã³ãã«ã«ããããã€ãªãåãããããããã«å¿ãããŸããã æ±è€ : 现ãããããã¯ãéã®èª¿æŽãå¿ èŠã«ãªãã®ã§ ã¡ãããšèª¿å€ã®æ¬²ãã KPI ãæ±ãã€ã€ããã€çŸå Žã®ãªãã¬ãŒã·ã§ã³å質ãèœãšããªãã£ãŠãã芳ç¹ã§èª¿æŽãåãã¡ã€ã³ã§ãããŸããã 工倫ããããšã§ãããšãUX 調æ»ã培åºãããšããã§ããããã ä»åã®ãµãŒãã¹ã£ãŠæ¥ççã«ã¿ãæã«æ°ããããšãããšããã§ã¯ãªããã§ããããã§ãã®ã§ã忥çã®äŒæ¥ããã®åã¢ããªã®äœéšãšããèªåã§ãçµæ§è²ã 䜿ããªããäœéšããŠã¿ãŸããããããããããŒã¹ã«éã«çŸç¶ã®ãã¡ã®ä»æ§ãèžãŸãããšããããã颚ã«ãã¡ã§ã¯å®è£ ããŸãããã¿ãããªãšãããè²ã ãã£ãŠããŸããã å°ç° : ãšã³ãžãã¢ãªã³ã°ã®èгç¹ã§ãããšãç¹ã«æ£è ã¢ããªããŒã ãšã® API 飿ºã®ä»æ§èª¿æŽãšãéçºã®é²ãæ¹ã¯å¯ã«é£æºããªããé²ããŸãããå ã«ãã£ã¡ãã§ããŠãªããšåãããéçºã§ããªãç¶æ ã«ãªãã®ã§ãæ åœè å士ã§ã³ãã¥ãã±ãŒã·ã§ã³ãšãã€ã€ã工倫ããªããé²ããŠããŸããã é äº : CLINICS ã§æ°ã«ããŠãéšåã¯ã©ã¡ãããšãããš ãªã¹ã¯ãšã³ã¹ãã®éšåãããã«æå°åããŠäŸ¡å€ãæå€§åããããäžçªéèŠ ããªãšæã£ãŠããã®ã§ãäžçªå€§äºãªã®ã¯ãã£ã±ãå»ç§ã«ãšã£ãŠã©ããã䟡å€ãåºãŠãå»ç§ã«ãšã£ãŠã©ããããªã¹ã¯ãçºçããããèããŠãŸããã äŸãã°äžçªæåã®ããåããã§è¬å±äºçŽããæã«æ¥æãŸã§ç¢ºå®ãããŸããããšãã話ããã£ããã§ããã©ããããŸã§ã¹ã³ãŒããåºããªããŠãã¡ãªãããåºãã®ã§ããã°ãåºããããªãã§ããšãã話ãããŠããŸããã ããšã¯ãªãªãŒã¹ãã©ã³ã®çå®ãšãããªïŒå šå»çæ©é¢ã«äžæã«åºãã®ã§ã¯ãªãããŸãã¯äžéšå»çæ©é¢æ§ã ãã«å ¬éãããªãªãŒã¹æ¹åŒã«ããŸãããã¿ãããªãšãããå«ããŠã§ããããå»ç§åŽã§äžæŠãã¹ãããã£ãŠæ€èšŒããŠãã¹ã ãŒãºã«æ©èœã䜿ãããšããã確èªãããããã¹ããããèšããŸããããšå®å šçãåããªããé²ããŸããã ããã¯ãã®ãããžã§ã¯ãã«é¢ããããã©ããªãããžã§ã¯ãã§ãäžçªéèŠã§ãããåŸããã²ã£ããè¿ãã®ãäžçªææ»ãã«ãªã£ãŠããã®ã§ãããã¯éèŠããªãšæããªããé²ããŠãŸãããã å°å³¶ : QA èŠç¹ã ãšæšªæãããžã§ã¯ãããã«ã¹ããŒããæ¬åœã«è€éã§ãã¡ãã¬ãŒå ¥ç€ŸåŸã«çµéšãããããžã§ã¯ãã®äžã§æ€èšŒã®é£æåºŠãæãé«ãã£ãã§ããã ã§ãããçããä»°ãããŠããããã«åãŠãŒã¹ã±ãŒã¹ã«å¯Ÿããèšèšãå³ã§ããã¥ã¡ã³ãåãããŠããã®ã§ããã¹ãã±ãŒã¹ãšããŠè»¢çšã§ããéšåãå€ããããŸãããæéЬãããäœæããèšèšå³ããã£ãããããæŒããªããã¹ãã§ããéšåã¯å€§ããã§ãã倧å¢ãåå ãããããžã§ã¯ãã«ãããŠãå šå¡ãèªèåãããäžã§ãèšèšå³ã¯æ¬åœã«å€§äºã ãªãšçæããŸããã 工倫ããç¹ãšããŠã¯ãå°ç°ãã㯠Pharms éçºã®ãã¡ã€ã³ç¥èãè±å¯ã ã£ãã®ã§ãQA æã¯ Pharms åŽãã¡ã€ã³ã«èŠãŠãããã€ã€ãèªå㯠CLINICS åŽã® QA ãæåãèŠãããã«ããŸãããã©ã¡ãã®ãã¡ã€ã³ã«ãé¢ä¿ããå¥çŽãã©ã³çã®è€éãªä»æ§ã¯èªåãæ åœããŸããã QA 以å€ã®é¢ã ãšããªãªãŒã¹ããäžã§å¿ èŠãªæµ®ããããŒã«ãããã°ç©æ¥µçã«åãã«ããããã«ããŸããã äŸãã°ããããŸã§äžéšã®å»çæ©é¢æ§ã ãã«æ©èœãªãªãŒã¹ããå Žåããã®åŸã®ãã£ãŒãããã¯ååã¯ã¡ãŒã«ãé¢è«ã§åå¥ã«è¡ã£ãŠããŸããããæ¥ã ã®èšºçã®äžã§ãæéã確ä¿é ãã®ãé£ãããšããç¶æ³ããããŸããããã®çµæãæ¬ Pj ã«ãããŠãå šäœãªãªãŒã¹ããŠåé¡ãªããïŒã®å€æããã¥ããææããããŸããã ããã§ Google ãã©ãŒã ã§ã¢ã³ã±ãŒããäœæããŠçæéã§åçã§ãã圢ã«åãæ¿ããŸãããçµæçã« 100% åçãåŸãããšãã§ããŸããã ã¢ã³ã±ãŒãçµæãããåŸæ¥æ©èœãã䟡å€ããããé¢å ãªãã¬ãŒã·ã§ã³ã«çµã¿èŸŒãã§é ãã³ã¹ãããããŸã§é«ããªãããšããç¹ãè©äŸ¡ã§ããã®ã§ãèªä¿¡ãæã£ãŠå šäœå ¬éãªãªãŒã¹ã«åã㊠GO å€å®ã§ããŸããã** ã¡ãã¬ãŒã¯åœ¹å²ã«çžãããããŒã«ãä»»ããŠé ããç°å¢ãããã®ã§ãèªåã®å°éé å以å€ã®ããšãåŠã¹ãŠãã**ãšæãããšãå€ãã§ãã 幞ããªãªãŒã¹åŸã倧ããªäžå ·åã¯ãªãã®ã§ããã¯ããçããã®ãããã§ããã åæäºçŽ Pj ãçµã㊠ââ ã§ã¯æåŸã«ãã®ãããžã§ã¯ãã®ç·æ¬ãããŠãã ããã°ã æ±è€ : 暪æã§ã¯ãããã©åãã¡ã€ã³ã§ããããã®ãããã§ãã·ã§ãã«ãã¡ãããšåãçºæ®ããŠãããžã§ã¯ããããåãããšããã®ã¯ããã倧ããè³ç£ã§ããã å»ç PF ã¯ã¢ã»ãããããããæã£ãŠããã®ã§ãè²ã çµã¿åããããšãä»ã®äŒç€Ÿã ãšã§ããªããã©ããã¡ãªãã§ãããã ããã¿ãããªããšãè²ã ãã ãã§ãã ãªã®ã§ããã®åŸã暪æãããžã§ã¯ãã¯äºå®ãããŠããŸãããããã«å é§ããŠã²ãšã€ãããã£ãŠããã€åããæ¬²ããã£ãæåŸ ææãçŸç¶åºããŠãããšãããå«ãããšãããè¯ãäžæ©ã ã£ãã®ããªããšæã£ãŠãŸãã æ¬¡ã¯åè³ªãæ ä¿ãã€ã€ããã£ãšã¹ããŒããäžããŠãããããšããã®ã芳ç¹ãšããŠå€§ããã§ããã ââ ãªãã»ã©ãããããæšªæãããžã§ã¯ãããã£ãŠããå»ç PF ã§ã¯ã©ããªãšã³ãžãã¢ãããããããã€ã³ãã§ããã? æéЬ : æè¡ãšäœµããŠãŠãŒã¶ãŒãžã®äŸ¡å€æäŸãèããªãããšã³ãžãã¢ãªã³ã°ããã人ããããããã®ã§ã¯ãªãããšæããŸãã ââ åãããã¯ãã®æã£ãŠãã圹å²ãèžãŸããŠã俯ç°ã®èŠç¹ã§éçºãããããšããæ¹ã«ã¯ãããé åçã§ãããæ¬æ¥ã¯ããããšãããããŸããã ãããã« åæäºçŽ Pj ã«ã€ããŠããããžã§ã¯ããæšé²ããã¡ã³ããŒã«è©±ãèããŸããããè€éãªèŠä»¶ãå®çŸå¯èœãªåœ¢ã«ããŠåããŒã ã§å£æ ¹ãè¶ããŠéçºãããŠããæ§åããšãŠãå°è±¡çã§ãããç¹ã«å»ç PF ã§ã¯ãã¡ã€ã³åå£«ã§ææ©çã«çµåããŠãããã³ã©ãã¬ãŒã·ã§ã³ããããšã«ããã¹ããŒã¯ãã«ããŒãžã®äŸ¡å€ãé«ããŠãããšããã®ã¯ããããããããã®ã§ã¯ãªãããšæããŸãã ãã®ãããªãããžã§ã¯ãã§åãçºæ®ããããšæã£ãæ¹ã¯ãã²ããæ°è»œã«ã話ãããŸããã! åéã®äžèЧ | æ ªåŒäŒç€Ÿã¡ãã¬ãŒ ã¡ãã¬ãŒã®æ¡çšæ å ±ã¯ãã¡ãããã確èªãã ããã www.medley.jp
æ ªåŒäŒç€Ÿã¡ãã¬ãŒ
2024/02/29
<![CDATA[ è€æ°ãããã¯ã暪æãããããžã§ã¯ããã©ããã£ãŠæåãããã®ãã¡ã³ããŒã«èããŠã¿ãŸãã ]]>
ã¯ããã« ã¿ãªãããããã«ã¡ã¯ããšã³ãžãã¢ã®å€å·ã§ãã ä»å㯠CLINICS / Pharms åæäºçŽãããžã§ã¯ã(以äžãåæäºçŽ Pj)ãšãããããã¯ã暪æã§æ§ã ãªéšçœ²ãé¢ãã£ãéçºãããžã§ã¯ãã«ã€ããŠãå°œåãããçããã«åº§è«äŒåœ¢åŒã§ã話ã䌺ããŸããã ã¡ãã¬ãŒã®å»çãã©ãããã©ãŒã (以äžãå»ç PF)ã§ã©ã®ããã«ããããæšªæãããžã§ã¯ããå®éããã®ãã®æ§åãçããã«ç¥ã£ãŠããããã°ãšæããŸãã 察è«ã¡ã³ããŒçŽ¹ä» ââ ã¯ããã«ãçããã®èªå·±ç޹ä»ããé¡ãããŸãã æ±è€ : æå±ã¯å»ç PF ã®ãããã¯ãéçºå®€ã® Pharms éçºããŒã ã§ãã 圹å²ãšããŠã¯èª¿å€è¬å±åãã®ã·ã¹ãã ã® Pharms ã®ãããã¯ããªãŒããŒãæ ã£ãŠããŸãã çµæŽãšããŠã¯ã2021 幎㮠1 æãã Pharms ã®ã«ã¹ã¿ããŒãµã¯ã»ã¹ãšããŠã¡ãã¬ãŒã«ãžã§ã€ã³ããŸããŠã2023 幎 1 æããéçºããŒã ã«æ¥ãŸããã ãããŸã§ã¯äºæ¥åŽã®çµéšãé·ããå¶æ¥å šè¬ãäºæ¥éçºãã¡ã€ã³ã§ãã£ãŠãããã£ãªã¢ã§ãã ãã®ãããžã§ã¯ãã® PO ãšããŠãªãŒãããåããããŠãããPharms ãæ ã調å€åŽã®ãªãŒãã«å ããŠãå šäœã®ææ¯ãã調æŽçã䞻軞ã«ãã£ãŠããŸããã æ±è€ãã ââ æ±è€ããããããžã§ã¯ãã®äžå¿ãšãªã£ãŠæšé²ãããã§ããã æ±è€ : 調å€ãã¡ã€ã³ã® Pharms ã«ãšã£ãŠäºæ¥ã€ã³ãã¯ããããã倧ããéçºã ã£ãã®ã§ã調å€ãã¡ã€ã³ã責任æã£ãŠãããŸãããããšããæŽçã§ãã å°ç° : èªåã®æå±ãæ±è€ãããšåãã«ãªããŸãã çµæŽã¯ã2021 幎 7 æã«ãšã³ãžãã¢ãšããŠå ¥ç€ŸãããããŸã§ãã£ãš Pharms ã®éçºããã£ãŠãŸãã å ¥ç€ŸåŸã¯ã¯ã©ã€ã¢ã³ãèªèšŒæ©èœãæ³äººæ åœè åãã®æ¬éšæ©èœãªã©ã®æ©èœéçºãè¡ã£ãŠããŸããã æšå¹Žãã Pharms ã®ãªãŒããšã³ãžãã¢ãšããŠããŒã å šäœãèŠã€ã€ãPharms ã®æè¡è²¬ä»»è ãšããŠæ±è€ãããšäž¡èŒªã§åããããªåœ¢ã§ãããžã§ã¯ãã®æšé²ã«é¢ãã£ãŠããŸãã å°ç°ãã æéŠ¬ : å»ç PF ãããã¯ãéçºå®€ãæ£è çµ±ååºç€ããŒã ã«æå±ããŠããŸããæ£è çµ±ååºç€ãšã¯ãCLINICSïŒæ£è ã¢ããªïŒãšããã¢ããªã®ããã¯ãšã³ãã·ã¹ãã ã§ããã蚺çæãæ¯ç§å»é¢ãè¬å±åãã®ã·ã¹ãã ãšã®é£æºåºç€ãšããŠãæ©èœããŠãããããã¯ãã«ãªããŸãã çµæŽã¯ããã®ã¡ã³ããŒã®äžã§ã¯äžçªå€ã 2018 幎 3 æã«å ¥ç€ŸããŠãåœå㯠CLINICS ã«ã«ãã®æ©èœæ¡åŒµã®éçºã«åå ããPKI åºç€ã CLINICS ãšãŒãžã§ã³ããå§ããšããä»ç€Ÿã·ã¹ãã ãšã®é£æºåºç€ã®éçºãè¡ã£ãŠããŸããã2020 幎ãããããæ£è çµ±ååºç€ã®ç«ã¡äžãã«åå ããŠãçŸåšã«è³ããŸãã æéŠ¬ãã é äº : å ¥ç€Ÿã¯ 2019 幎 8 æãªã®ã§ã 5 幎ç®ãšãªããŸãã ãã¶ã€ããŒãšããŠå ¥ç€ŸåŸ 1 幎éã¯ãžã§ãã¡ãã¬ãŒã«åšç±ããŠããŸããããã®åŸãªã³ã©ã€ã³èšºçã䌞ã³ãŠããææã«ãªããCLINICS åŽã®ãã¶ã€ããŒã®äººæ°ãè¶³ããªããªã£ãããšããããŸããŠãããããã¯é»åã«ã«ããå«ãã CLINICS ã®ãã¶ã€ã³å šè¬ãæ åœããŠããŸãããå»å¹Žããé»åã«ã«ã以å€ã®æ¥åé åã® PdM ãšããŠæŽ»åããŠããŸãã軞足ã¯ãã¶ã€ããŒãªã®ã§ãããããã¯ãã®ãããžã¡ã³ãã¿ãããªããšããå§ããŠãŸãã ãã®ãããžã§ã¯ãã«ãããŠã¯ããã£ãæ±è€ããããã£ããã£ãéããPharms ã®äŸ¡å€åäžãäžå¿ã®ãããžã§ã¯ããªã®ã§ãããžã§ã¯ãã®äžçªå€§ãããªãŒãã¯æ±è€ããã«ãªãããšæããã§ããã©ãCLINICS ãªã©ã®å»ç§åŽã®ãããžã§ã¯ããªãŒããšèšãç«ã¡äœçœ®ãåã«ãªãããªãšæããŸãã é äºãã å°å³¶ : å»ç PF ãããã¯ãéçºå®€ã® QA ã°ã«ãŒãã«æå±ããŠããŸããQA ã°ã«ãŒãã®ãããŒãžã£ã§ãã 米山 ããã®ã玹ä»ã§ 2022 幎 4 æã«ã¡ãã¬ãŒïŒäººç®ã® QA ãšã³ãžãã¢ãšããŠå ¥ç€ŸããŸãããäž»æ åœã¯ CLINICS ã®äºçŽæ©èœãäžå¿ãšããåšèŸºé åã§ãããããŸã§é äºãããšäžç·ã«åãããŠé ãæ©äŒãå€ããçŽè¿ã§ã¯äºçŽæ¹æ³ãæ¡åŒµããããªã¯ãšã¹ãäºçŽãæ©èœã® QA ãæ åœããŸããã åæäºçŽã«é¢ããŠã¯ãäž»ã«å»ç§åŽã®éšåã® QA ããå§ãŸãã調å€åŽã® QA ãå¿ èŠãšããããšã«ãªããæçµçã«ã¯å šäœã® QA ãæ åœããŸããã å°å³¶ãã åæäºçŽã®æ©èœã解決ããèª²é¡ ââ ããããšãããããŸããæ¬¡ã«ãä»åã®åæäºçŽã«ã€ããŠã©ããã£ãæ©èœã§ãã©ããã£ã課é¡ã解決ããã¹ãããã話ãããã ãããã§ãã æ±è€ : æ©èœãšããŠã¯ã CLINICSïŒæ£è ã¢ããªïŒãããªã³ã©ã€ã³èšºçãäºçŽããéã«ãè¬ã®åãåãå ãšããŠè¬å±ãäºåæå®ã§ããæ©èœ ã«ãªã£ãŠããŸãã ãã®æ©èœã«é¢ä¿ãããã¡ã€ã³ã¯æ£è ã»å»çæ©é¢ã»èª¿å€è¬å±ã®ïŒã€ã§ãã æ£è ãšå»çæ©é¢ã®ã¡ãªãããšããŠã¯ãè¬ã®åŠæ¹ãŸã§ã®æéãæžãããšã§ãã ãªã³ã©ã€ã³èšºçã§ã¯ãæ£è ãå»çæ©é¢ã«çŽæ¥èšªåããããã§ã¯ãªãã®ã§ãè¬ãçŽæ¥è¬å±ã«è¡ã£ãŠåãåãã®ããè¬å±ããé éãåžæããã®ããšãã£ãè¬ã®åãåãæ¹ããå»çæ©é¢ãšæ£è ããã§å£é ã§è©±ããŠæ±ºããŠããã£ãŠããã確èªã«æéãçºçããŠããŸãããæ£è ããã¯å£é ã§è©±ããå å®¹ã«æ²¿ã£ãŠããªã³ã©ã€ã³èšºççµäºåŸã«ãè¬å±ãžã®äºçŽãåã£ãŠããŸããã åæäºçŽæ©èœãå®è£ ãããããšã«ããã蚺å¯ã®äºçŽæã«ã©ã®è¬å±ã§ã©ãããåãåãæ¹ãããŸããšããéšåãæ£è ãããäºåæå®ã§ããããã«ãªã£ãã®ã§ã å»çæ©é¢ã¯äºåçãªè©±ã«æéããããã«èšºå¯ã«éäžã§ãããŸãæ£è ããããå»åž«ã«å£é ã§è¿œå 説æããªããŠãåžæéãã«è¬ãããããããšãããããŒã«å€æŽãããããšãå»çæ©é¢ãšæ£è ã®ã¡ãªãã ã ãšæã£ãŠãŸãã åæäºçŽæ©èœã®ãªãªãŒã¹ååŸã§ã®ãããŒã®éã ããäžã€ã®ãã¡ã€ã³ã§ãã調å€è¬å±ã«ã€ããŠã¯ãåè¿°ã®ããã«èšºå¯ã®äºçŽãããæã«æ£è ãããã¡ãã¬ãŒã®ãµãŒãã¹ã§ãã Pharms ã䜿ã£ãŠããè¬å±ããäºåæå®ãã§ããŸãã®ã§ã ãªã³ã©ã€ã³èšºçåŸã«çºè¡ãããåŠæ¹ç®ã®æµå ¥ãå¢å ããŸã ã 調å€è¬å±ã®å£²ãäžãã¯åŠæ¹ç®ã®ææ° à å䟡ã§å€§éšåãæ±ºãŸããŸãã®ã§ããã®ææ°ãå¢ããããšãã芳ç¹ã§ã¯è¬å±ã«ãšã£ãŠã€ã³ãã¯ãã®ããæ©èœã ãšæã£ãŠããŸãã ââ æ£è ã®äœéšãæ¬åœã«è¯ããªãããæ£è ãšå»çæ©é¢ã®ç¡é§ãªã³ãã¥ãã±ãŒã·ã§ã³ãæžãããã€è¬å±ã«å¯ŸããŠãåŠæ¹ç®ææ°ãå¢ããŠãå°ç·ã楜ã«äœ¿ããããã«ãªã£ãŠãããšããã®ããä»åã®ãããžã§ã¯ãã®èã«ãªã£ãŠããæãã§ãããããããèžãŸãããããã¯ãéãæšªæããŠéçºããªããšãããªããšããã®ã倧å€ããã§ãã éçºãããžã§ã¯ãã«ã€ã㊠ââ ã©ã®ãããªããŒã ããã®æšªæãããžã§ã¯ãã«é¢ãã£ãŠããããæããŠãã ããã æ±è€ : éçºåŽã§èšããšïŒã€ã®ãã¡ã€ã³ã«ãªã£ãŠãŸãã 調å€ãæ£è ãå»ç§ããã㊠æ£è çµ±ååºç€ ã§ããæ£è çµ±ååºç€ãšã¯å»ç PF ã®åãã¡ã€ã³ã«ååšããæ¥åã·ã¹ãã ãšæ£è ã¢ããªãç¹ãæ ¹å¹¹ãšãªããããã¯ãã§ãã ãã ä»åã®æ©èœã¯å»çæ©é¢ã®ãªãã¬ãŒã·ã§ã³ãå€ãããããéçºåŽã§ã®ã¿å®çµãããããžã§ã¯ãã§ã¯ãªããã§ããã ããã«çŸå Žã®éçšã«åããã€ã€ãäœéšãæ¹åã§ãããïŒãšããèŠç¹ã§èãããšãåäºæ¥åŽã®ã«ã¹ã¿ããŒãµã¯ã»ã¹ããŒã ãéèŠã«ãªããŸã ãç¹ã«å»ç§ãšèª¿å€ã®ã«ã¹ã¿ããŒãµã¯ã»ã¹ããŒã ãšã¯ãå¯ã«å£æã¡ãããªããéçºãé²ããŠããŸããã ââ ä»åã®ãããžã§ã¯ãã¯ç¹ã«äºæ¥éšãšã®é¢ä¿æ§ãéèŠãªéµã ã£ããã§ããã æ±è€ : ããã§ãããç¹ã«å»ççŸå Žã¯æ¥åãéŒè¿«ããŠããå Žé¢ãå€ãã§ãã®ã§ãäŸãã°ãã¯ã³ã¯ãªãã¯å¢ããŸãããããã§ããŒãžé·ç§»ãå¢ããŸãããšãã£ãããšã§ãæ¥åãžã®åœ±é¿ãéåžžã«å€§ãããªããŸãã ãŸããªãã¬ãŒã·ã§ãã«ã«çŸå ŽãåããŠããç®æãå€ãããããã¯ãéœåã§åæã«ãã®æ¹ãè¯ããããåççã ããããšæ±ºããŠãããã¯ããäœã£ãŠããŸããšä»ãŸã§ã®çŸå Žãªãã¬ãŒã·ã§ã³ã厩ããŠããŸãæ··ä¹±ãæãããšããããŸãã çŸå Žã®ç¿æ £ãçè§£ããæã ãç®æãå§¿ãšèª¿æŽããªããæé©è§£ãåºã ã®ããå¿ é ã«ãªã£ãŠããæ¥çã»æ¥æ ã ãšæãã®ã§ããã®èª¿æŽã¯äºæ¥éšãšãããªãæ°ãé£ã£ãŠãã£ãŠããŸããã ââ åæäºçŽ Pj ã¯ãéçºåŽãããããšããããšã§å§ãŸã£ããããžã§ã¯ããªãã§ãããã? æ±è€ : ã¯ããããã¯ã¡ãã¬ãŒã®ã©ã®ãããã¯ãããããªã®ã§ãããäºæ¥è²¬ä»»è ãšãããã¯ã責任è ããããããããäºæ¥ãšéçºã®äž¡èгç¹ããè°è«ããäºæ¥æ¹éãæ±ºããŠããããšããäœå¶ããšã£ãŠããŸãã Pharms ãæ£ããæé·ãããŠãããšãã芳ç¹ã§èŠããšãçŸãã§ãŒãºã§ã¯åŠæ¹ç®ããã£ãããšèª¿å€è¬å±ã«å±ããããšãè³äžåœé¡ã§ããããµãŒãã¹ã®ããã¹ãå§¿ãšã¯ïŒãšãã芳ç¹ã§äºæ¥ãšéçºäž¡èŒªã§ãããŸããããšããåœ¢ã§æ±ºãŸã£ããã®ã«ãªããŸãã æšªæãããžã§ã¯ãã§å·¥å€«ããããã€ã³ã ââ ä»åãæšªæã§è²ã ãªéçºãããã¯ããé¢ä¿ããŠããŸããã工倫ããç¹ãšãæ°ãã€ããç¹ãªã©ãã©ããªãã®ããããŸãããã æ±è€ : äžçªã¯åãã¡ã€ã³ã§è¿œã£ãŠããäºæ¥ææãããªãéã£ãŠããŸããã®ã§ããã®èª¿æŽãæéããããŠæŠãåããããç¹ã§ãã äŸãã°ã調å€ã®èгç¹ã§ã¯åŠæ¹ç®ãã¡ãããšè¬å±ã«å±ãããšããã®ãããããéèŠãªäºæ¥ã€ã³ãã¯ãã®å€§ããé ç®ã§ããäžæ¹ã§ãå»çã®èгç¹ã§èŠãæã«ããã¡ããæéãæžããã®ã¯ãããéèŠã§ã¯ãããã§ãããå»çãã¡ã€ã³ãšããŠãã®æ¹åã«èª¿å€ãšåèŠæš¡ã®ã¡ãªãããèŠåºããŠããããããšèšããšåœç¶ããã§ã¯ãªãã£ããããŸãã ããããéšåã§ããã¡ã€ã³éã§ãã®ãããžã§ã¯ããéæããåŸã«åŸãããã¡ãªããã«å·®åãåºãŠããŸããã¡ãªããã倧ããäºæ¥ãããããå·¥æ°ã倧ããå²ããã®ã§ãããã¡ãªããã匱ãäºæ¥ã§ã¯åãã ãå·¥æ°ãããŠãããŸãããããšããæææ±ºå®ã¯é£ãããšæããŸãã ããã§ æ¬ Pj ãéããŠåãã¡ã€ã³ã§ã¯ã©ãããäºæ¥ææãçãã®ãããã®ããã«äœã® KPI ã远ãã®ãããæç¢ºã«ããŸãã ãäºæ¥çãªã¡ãªãããå€ã調å€ã®ããã«æäŒã£ãŠãã ãããšãã圢ã§ã¯ãªããåãã¡ã€ã³ã§ã©ãããã¡ãªãããçãã§ãããŸããïŒãšãããšãããæãããã®ãããããéèŠã ã£ããšæã£ãŠããŸãã ãããæ ããšãã¡ãªããã®åŒ±ãäºæ¥ã«ãšã£ãŠã¯ãæäŒãã¿ãããªãããžã§ã¯ãã«ãªããŸããåçŽã«ãšã³ãžãã¢ãªã³ã°ãšããéšåã§ãé¢çœããã®ã«ãªããªãã§ããããã§ãã®ã§ãé¢ä¿ããå šå¡ã§ãããžã§ã¯ãã宿œããããšã§ã©ãããçµæãåŸãã®ã?ãã¡ãããšåãã¡ã€ã³éã§æããŸããã ââ ãªãã»ã©ããããããšããããæŠãåããã¯æ±è€ãããšé äºããããã£ãŠãããã§ããããã é äº : ã¯ããåã®ã»ãã§è¡ã£ãŠããŸãããåãåæã®ããåããæã«éèŠããŠããã®ã¯ãã¹ã³ãŒããé©åã«åºåããšããéšåã§ããã調å€åŽã®æäŸäŸ¡å€ã®æå€§åã ãã远ã£ãŠåæãã倧ããªæ©èœè¿œå ãè¡ãã®ã§ã¯ãªãã倿Žã«ããå»ç§ã»æ£è ã»èª¿å€ãžäžãããªã¹ã¯ãéçºã³ã¹ããæãã€ã€ã䟡å€ãæå€§åã§ããèœãšãæã¯ã©ããããšããéšåããå·ãåããããŠãããŸããã ã¡ãã¬ãŒãé¢çœããªã£ãŠæãã®ãããããã¯ãåç¬ã§åããŠããããã§ã¯ãªããŠã ãã€ã·ã§ã³ããžã£ãŒããŒ(æ£è äœéš)ãäžå¿ãšããŠããã¿ã¯ã矀ãååšããŠãããšãã ã§ãã æ£è äœéšãããè¯ãæ§ç¯ããããã«ããããã®ãããã¯ããåããŠãããã®ã§ããæäŒããšãããã¥ã¢ã³ã¹ãããªãããããã¯ããè¶ ããŠããã¯ããããŠãããŸããããšèšããæåããããšãããããéšåããªãšæããŸããããããããããéšåããªãšæããŸãã æ±è€ : ç¹ã«æšªæã®ãããžã§ã¯ãã ãšããããç®çæèã®çµ±äžã«äžçªæéã䜿ã£ãŠãè¯ãããããªãããšèããŠããŸãããããæ±ºãŸãããããã°ãåŸã è¿·ã£ãå Žåãç®çã«å³ããæææ±ºå®ãã§ããŸããããããåºããåŸã«åãã¡ã€ã³ã§ã®èª¿æŽãããšããé çªã倧äºã ãšæããŸãã ââ æè¡é¢ã§æ°ãã€ãããã€ã³ãã¯ã©ããªãã®ããã£ããã§ããããã æéŠ¬ : åæäºçŽæ©èœãšããŠããããããšã¯ããã€ã€ã蚺çæåŽã®æ¥åãããŒãæ£è ã®å°ç·ãä»ããã·ã¹ãã ã®å¶çŽãªã©ãèžãŸããã©ã®ãããªåœ¢ã«èœãšã蟌ã㰠蚺çæãè¬å±ãæ£è ã«ãšã£ãŠã䟡å€ã®ããæ©èœãšãªãã ããã€ã³ãã§ãã ã§ãã®ã§ãæè¡çãªé¢ãšäºæ¥çãªé¢ã䜵ããŠèããªãããã·ã¹ãã å šäœã®èŠä»¶ã決ããŠãããšããã®ãæåã«æãããéšåã§ããã ââ æ©èœãèããäžã§ãå šäœãèŠæ®ããèšèšãªã©ããã£ãŠãããšæããã§ãããä»åã¯ã©ãããçæããããã§ãããã?æ£è ã®å°ç·ã ã£ããå»çæ©é¢ã®æ¥åãããŒãªã©ææ¡ããåŸã«ãåãããã£ãéšåãèãããã®ã§ããã æéŠ¬ : åæäºçŽã«ãããã·ã¹ãã å šäœã®èŠä»¶ãåºããŠãããšåæã«ãå šäœã®ã·ãŒã±ã³ã¹ãšã¹ããŒããã·ã³ãäœã£ãŠãããŸãããåã·ã¹ãã éã®é£æºãããŒãšãããã«ããçã¿åºãããäºçŽãåŠæ¹ç®ãšãã£ããšã³ãã£ãã£ã®ç¶æ é·ç§»ã決ããŠããããã®ç¶æ ã®æã¯ãããã£ãããšã¯ã§ããªããšãããããã£ã蟻è€ãåããããšããããã£ãããã£ãŠãã£ããšããæãã§ãããã é äº : ä»åã¯ãç¹ã« ãããã¯ã暪æã®å ±éåºç€ãšããŠãåãããã¯ãã§ããããå šãå¥ç©ã®ä»çµã¿ãã¹ããŒã¿ã¹ãä¿æããŠããã®ããå ±éåã»æœè±¡åãããšããæ¥åãå¿ èŠã«ãªã ã®ã§ããããé£ããããé£æåºŠãé«ãéšåã ãªãšæã£ãŠãããã§ããã©ãããã綺éºã«ã·ãŒã±ã³ã¹å³ã«èœãšã蟌ãã æéŠ¬ãããåããªãšæããŸããã æ±è€ : åºç€åŽã§äœã£ãŠããã ããã·ãŒã±ã³ã¹å³ã¯ UX ã®éªšçµã¿ãªãã§ããããããããããã UX ãã¶ã€ããŒãå¥éãããšãã£ã现ååããããå®è£ ã®å¶éãå å³ãã€ã€ãæ£ããéçšãåãããã«ããã®äœéšãäœãããã«ãã®ã¹ããŒã¿ã¹é·ç§»ã§ããã¹ãã ããããšããéšåãæéЬããããšã³ãžãã¢èгç¹ã§æåã«äœã£ãŠãããŠããšããã®ãã ã¡ãã¬ãŒã®ãšã³ãžãã¢ã®ãšãŠãè¯ãéšå ã ãšæã£ãŠããŸããæè¡ã ãã§ãªã UX ãªã©ã«ãå¿ èŠã§ããã°è¶å¢ããŠãããæåã§ããã åæäºçŽ Pj éçºã®å®é ââ ããããåæãã§ãŒãºãçµãŠ Pharms ãš CLINICS ã©ã¡ãã®éçºã«ãé¢ãã£ãå°ç°ããã«èãããã®ããéçºã®æµãã®äžã§ãããããªãœãŒã¹çãªåé¡ã£ãŠå€§å€ã ã£ããšæãã®ã§ãããããã¯ã©ã解決ãããã§ããããã å°ç° : å ã« Pharms åŽã®æ©èœ ãäœã£ãŠãã®åŸã« CLINICS ã®ä»æ§ã決ããŠããã£ãŠãã CLINICS ã®éçºã«å ¥ãæµãã ã£ãã®ã§éçºã䞊è¡ããããšã¯ãªãã£ãã§ãããã Pharms ã§ã¯ãªãŒããšã³ãžãã¢ãšããç«å Žãªã®ã§ ãCLINICS ã®éçºã«å ¥ãããã®æºåãšãPharms åŽã®ã¬ãã¥ãŒããã©ããŒã®ãªãœãŒã¹é åã¯èªåã§èããŠãåã¿ã¹ã¯ã宿œããæéãšã¿ã€ãã³ã°ã調æŽããªãããã£ãŠããŸããã äžæ¹ã§ããã®äœå¶ã§ãé²ããããšãã§ããã®ã¯ Pharms ããŒã ã®åã¡ã³ããŒãæ¢ã«èªèµ°ã§ããç¶æ ã«ãã£ãã®ã§ãããã«æ¯ããããããããã§ãã ããªãšæã£ãŠãŸãã ââ ãããã¯ããè¶å¢ããªããéçºãããšããæåã¯ãããè¯ããšæã£ãã®ã§ãããããã¯ãããŒãªã©ãã£ãããããã§ãã? æ±è€ : å çšã話ããéã Pharms ãšããŠæ¬ãããžã§ã¯ãã®åªå 床ã¯é«ãã£ãã®ã§ãããCLINICS ã®äºæ¥èšç»ããªãœãŒã¹ãèžãŸãããšå»ç§åŽã®å®è£ çæã倧ããé ããããªèŠç«ãŠã§ãããããã§ãå°ç°ããã å»ç§åŽã®éçºã«ãã¢ãµã€ã³ã§ããããªãœãŒã¹åé¡ã解決ã§ããã®ã§ã¯ãšèª¿æŽããŸãããå»ç§åŽã®ãšã³ãžãã¢ããã®ãã©ããŒã¢ããã¯å¿ èŠãªã®ã§ããã®èª¿æŽããã€ã€ã§ãããéçºãæ©ãããããªãè¯ãããšéçºããŒã éã§æçµçã«å€æããŸããã é äº : ä»ãŸã§è§Šã£ãŠãªãã£ã CLINICS ã®ã·ã¹ãã ã«ãå°ç°ããã¯ã¬ã³ã¬ã³åã蟌ãã§ãã ãã£ãã®ã§ãå ã CLINICS ã®éçºããã£ãŠãã®ã§ã¯ãšæãããããã£ããã¢ãããæ©ãã£ãã§ãã ââ ãããã¯ãã®ã°ããŒã¹ã®ããã«ãªãœãŒã¹èª¿æŽãæåããããšãã圢ã ã£ããã§ããããããã¯ãéã®è¶å¢ããããããããªæåã ã£ããããããžã§ã¯ããæåãããããšããç®ç·åãããèªç¶ã«ã§ããã®ã¯è¯ãã§ããã ããŒã éãšãã話ã§ããã° QA ã¯åããŒã ã«è·šã£ãŠã®æŽ»åã ãšæããŸããããã®èгç¹ã§ã¯ãããã§ãã? å°å³¶ : èªåã¯éçºãçµç€ã«å ¥ã£ãã¿ã€ãã³ã°ã§ãããžã§ã¯ãã«åæµããŸããããããŸã§ã¯ç±³å±±ããã QA ãšããŠå ¥ã£ãŠããã®ã§ãããå»ç§åŽã§ãæ€èšŒãã¹ããã¹ã芳ç¹ã倿°ãã£ãèæ¯ããããå»ç§åŽã® QA ãã¡ã€ã³ã§èŠãæ åœãšããŠåç»ããŸããã åŸåã«åç»ããèæ¯ããããããããåŠæ¹ç®éä»ãšããæ¥åã Pharms ãããã¯ãã®ä»æ§çè§£ãæµ ãâŠãšããç¶æ ã§ãããã éçºç®çã»èŠä»¶å®çŸ©ã»èšèšã詳现ã«ããã¥ã¡ã³ãåãããŠããã®ã§ãã¹ã ãŒãºã«æ€èšŒã«å ¥ãããšãã§ããŸãã ãæ€èšŒã®äžã§ QA ãšã³ãžãã¢ãšããŠãããã®éšåã®ä»æ§ã¯èŠçŽããæ¹ãè¯ããªãããšãããã€ã³ããããã€ãåºãŠããã®ã§ã仿§ã®æ¹åææ¡ãè¡ããŸãããåŸçºåå ã§ããããå®éã«åãå ¥ããŠããã£ãæ¹åãå€ãã§ãã ã¡ãã¬ãŒã®ãããã¯ãéçºã®æåãšã㊠QA ãšã³ãžãã¢ã èŠä»¶å®çŸ©ããã¬ãã¥ãŒã«åå ããããæèŠãèšãã€ã€ãããã¯ããããè¯ãããããã®æ¹åãè¡ãã ã®ã§ããšãŠãåããããã§ããã ââ åŸããå ¥ã£ãŠãåãããããšããã®ã¯ãããã¥ã¡ã³ããªã©ãæŽåãããŠããããã§ããããšã ãšããã®ãåãããŸãããæšªæãããžã§ã¯ãã ããããæ°ãã€ããä»ã®ããŒã ã®è¯ãç¹ãªã©ãã£ããããŸãã? é äº : Pharms ã®ãããžã§ã¯ãã£ãŠããããããªããšæã£ãã®ã KPI èšèšããããæç¢ºãªãšããã ã£ããšããç¹ã§ããã è²ã çŽäœæ²æãã£ãçµæããã«èŸ¿ãçããŠããšããèŠåŽãç¥ã£ãŠã¯ãããã§ããã©ãä»ã® KPI èšèšã£ãŠãã£ã±ããããã·ã³ãã« ã§åŠæ¹ç®éä¿¡æ°ã§ããšãªããšãããããéç®ãã KPI ãå PF ã«æ¯ãã°ãããšèšãäœå¶ã ã£ãã®ã§ããããããã¯ãããããã£ããã€ã³ãã®äžã€ããªãšæããŸãã 話ãè«ç¹ãçµå±ããã£ãŠããéšåããããã³ãã¥ãã±ãŒã·ã§ã³ã³ã¹ããå®ãããã éšåã§ã¯ããããªãšæããŸããã æšªæãããžã§ã¯ããªãã§ã¯ã®ãšã³ãžãã¢ãªã³ã° ââ å šäœã®è©±ããåå¥ã®ãã¡ã€ã³ããšã®ãšã³ãžãã¢ãªã³ã°ãšããç¹ã§ã¯ã©ã®ãããªããšããããŠããŸããã? å°ç° : åºæ¬çã«ã¯æéЬããã®ã·ãŒã±ã³ã¹å³ãå ã«éçºãé²ããŠããŸãããCLINICS ã§ã¯ A ãšããç¶æ ã«ãªãããã®æã« B ãšããã¢ã¯ã·ã§ã³ããããš Pharms ã§ã¯ C ãšããç¶æ ã«ãªããšããããã«ç¶æ é·ç§»ãè€éã ã£ããããèšèšæã«ããã¹ãå§¿ã«è¿·ãããšãå€ãã£ãã®ã§ãããã·ãŒã±ã³ã¹ã«ç«ã¡è¿ããšããã«ãã®çåã解決ãããšãã£ãå ·åã§ãã æéŠ¬ : ã·ãŒã±ã³ã¹ã®æŽåæ§ãé£ãããªããããªãããã«èšèšãã ããšã«ã¯æ°ãã€ããŸããããåæäºçŽããšããèšèãå è¡ãããšã€ãã€ãè€éãªæ°æ©èœã®ãããªãã®ãäœããã¡ã§ããã蚺çæãè¬å±ã®äºçŽæ©èœãåŠæ¹ç®éä¿¡æ©èœãšãã£ãåã ã®ããŒãã¯ããšããšããããã§ããªãã¹ãã·ã³ãã«ã«ããããã€ãªãåãããããããã«å¿ãããŸããã æ±è€ : 现ãããããã¯ãéã®èª¿æŽãå¿ èŠã«ãªãã®ã§ ã¡ãããšèª¿å€ã®æ¬²ãã KPI ãæ±ãã€ã€ããã€çŸå Žã®ãªãã¬ãŒã·ã§ã³å質ãèœãšããªãã£ãŠãã芳ç¹ã§èª¿æŽãåãã¡ã€ã³ã§ãããŸããã 工倫ããããšã§ãããšãUX 調æ»ã培åºãããšããã§ããããã ä»åã®ãµãŒãã¹ã£ãŠæ¥ççã«ã¿ãæã«æ°ããããšãããšããã§ã¯ãªããã§ããããã§ãã®ã§ã忥çã®äŒæ¥ããã®åã¢ããªã®äœéšãšããèªåã§ãçµæ§è²ã 䜿ããªããäœéšããŠã¿ãŸããããããããããŒã¹ã«éã«çŸç¶ã®ãã¡ã®ä»æ§ãèžãŸãããšããããã颚ã«ãã¡ã§ã¯å®è£ ããŸãããã¿ãããªãšãããè²ã ãã£ãŠããŸããã å°ç° : ãšã³ãžãã¢ãªã³ã°ã®èгç¹ã§ãããšãç¹ã«æ£è ã¢ããªããŒã ãšã® API 飿ºã®ä»æ§èª¿æŽãšãéçºã®é²ãæ¹ã¯å¯ã«é£æºããªããé²ããŸãããå ã«ãã£ã¡ãã§ããŠãªããšåãããéçºã§ããªãç¶æ ã«ãªãã®ã§ãæ åœè å士ã§ã³ãã¥ãã±ãŒã·ã§ã³ãšãã€ã€ã工倫ããªããé²ããŠããŸããã é äº : CLINICS ã§æ°ã«ããŠãéšåã¯ã©ã¡ãããšãããš ãªã¹ã¯ãšã³ã¹ãã®éšåãããã«æå°åããŠäŸ¡å€ãæå€§åããããäžçªéèŠ ããªãšæã£ãŠããã®ã§ãäžçªå€§äºãªã®ã¯ãã£ã±ãå»ç§ã«ãšã£ãŠã©ããã䟡å€ãåºãŠãå»ç§ã«ãšã£ãŠã©ããããªã¹ã¯ãçºçããããèããŠãŸããã äŸãã°äžçªæåã®ããåããã§è¬å±äºçŽããæã«æ¥æãŸã§ç¢ºå®ãããŸããããšãã話ããã£ããã§ããã©ããããŸã§ã¹ã³ãŒããåºããªããŠãã¡ãªãããåºãã®ã§ããã°ãåºããããªãã§ããšãã話ãããŠããŸããã ããšã¯ãªãªãŒã¹ãã©ã³ã®çå®ãšãããªïŒå šå»çæ©é¢ã«äžæã«åºãã®ã§ã¯ãªãããŸãã¯äžéšå»çæ©é¢æ§ã ãã«å ¬éãããªãªãŒã¹æ¹åŒã«ããŸãããã¿ãããªãšãããå«ããŠã§ããããå»ç§åŽã§äžæŠãã¹ãããã£ãŠæ€èšŒããŠãã¹ã ãŒãºã«æ©èœã䜿ãããšããã確èªãããããã¹ããããèšããŸããããšå®å šçãåããªããé²ããŸããã ããã¯ãã®ãããžã§ã¯ãã«é¢ããããã©ããªãããžã§ã¯ãã§ãäžçªéèŠã§ãããåŸããã²ã£ããè¿ãã®ãäžçªææ»ãã«ãªã£ãŠããã®ã§ãããã¯éèŠããªãšæããªããé²ããŠãŸãããã å°å³¶ : QA èŠç¹ã ãšæšªæãããžã§ã¯ãããã«ã¹ããŒããæ¬åœã«è€éã§ãã¡ãã¬ãŒå ¥ç€ŸåŸã«çµéšãããããžã§ã¯ãã®äžã§æ€èšŒã®é£æåºŠãæãé«ãã£ãã§ããã ã§ãããçããä»°ãããŠããããã«åãŠãŒã¹ã±ãŒã¹ã«å¯Ÿããèšèšãå³ã§ããã¥ã¡ã³ãåãããŠããã®ã§ããã¹ãã±ãŒã¹ãšããŠè»¢çšã§ããéšåãå€ããããŸãããæéЬãããäœæããèšèšå³ããã£ãããããæŒããªããã¹ãã§ããéšåã¯å€§ããã§ãã倧å¢ãåå ãããããžã§ã¯ãã«ãããŠãå šå¡ãèªèåãããäžã§ãèšèšå³ã¯æ¬åœã«å€§äºã ãªãšçæããŸããã 工倫ããç¹ãšããŠã¯ãå°ç°ãã㯠Pharms éçºã®ãã¡ã€ã³ç¥èãè±å¯ã ã£ãã®ã§ãQA æã¯ Pharms åŽãã¡ã€ã³ã«èŠãŠãããã€ã€ãèªå㯠CLINICS åŽã® QA ãæåãèŠãããã«ããŸãããã©ã¡ãã®ãã¡ã€ã³ã«ãé¢ä¿ããå¥çŽãã©ã³çã®è€éãªä»æ§ã¯èªåãæ åœããŸããã QA 以å€ã®é¢ã ãšããªãªãŒã¹ããäžã§å¿ èŠãªæµ®ããããŒã«ãããã°ç©æ¥µçã«åãã«ããããã«ããŸããã äŸãã°ããããŸã§äžéšã®å»çæ©é¢æ§ã ãã«æ©èœãªãªãŒã¹ããå Žåããã®åŸã®ãã£ãŒãããã¯ååã¯ã¡ãŒã«ãé¢è«ã§åå¥ã«è¡ã£ãŠããŸããããæ¥ã ã®èšºçã®äžã§ãæéã確ä¿é ãã®ãé£ãããšããç¶æ³ããããŸããããã®çµæãæ¬ Pj ã«ãããŠãå šäœãªãªãŒã¹ããŠåé¡ãªããïŒã®å€æããã¥ããææããããŸããã ããã§ Google ãã©ãŒã ã§ã¢ã³ã±ãŒããäœæããŠçæéã§åçã§ãã圢ã«åãæ¿ããŸãããçµæçã« 100% åçãåŸãããšãã§ããŸããã ã¢ã³ã±ãŒãçµæãããåŸæ¥æ©èœãã䟡å€ããããé¢å ãªãã¬ãŒã·ã§ã³ã«çµã¿èŸŒãã§é ãã³ã¹ãããããŸã§é«ããªãããšããç¹ãè©äŸ¡ã§ããã®ã§ãèªä¿¡ãæã£ãŠå šäœå ¬éãªãªãŒã¹ã«åã㊠GO å€å®ã§ããŸããã** ã¡ãã¬ãŒã¯åœ¹å²ã«çžãããããŒã«ãä»»ããŠé ããç°å¢ãããã®ã§ãèªåã®å°éé å以å€ã®ããšãåŠã¹ãŠãã**ãšæãããšãå€ãã§ãã 幞ããªãªãŒã¹åŸã倧ããªäžå ·åã¯ãªãã®ã§ããã¯ããçããã®ãããã§ããã åæäºçŽ Pj ãçµã㊠ââ ã§ã¯æåŸã«ãã®ãããžã§ã¯ãã®ç·æ¬ãããŠãã ããã°ã æ±è€ : 暪æã§ã¯ãããã©åãã¡ã€ã³ã§ããããã®ãããã§ãã·ã§ãã«ãã¡ãããšåãçºæ®ããŠãããžã§ã¯ããããåãããšããã®ã¯ããã倧ããè³ç£ã§ããã å»ç PF ã¯ã¢ã»ãããããããæã£ãŠããã®ã§ãè²ã çµã¿åããããšãä»ã®äŒç€Ÿã ãšã§ããªããã©ããã¡ãªãã§ãããã ããã¿ãããªããšãè²ã ãã ãã§ãã ãªã®ã§ããã®åŸã暪æãããžã§ã¯ãã¯äºå®ãããŠããŸãããããã«å é§ããŠã²ãšã€ãããã£ãŠããã€åããæ¬²ããã£ãæåŸ ææãçŸç¶åºããŠãããšãããå«ãããšãããè¯ãäžæ©ã ã£ãã®ããªããšæã£ãŠãŸãã æ¬¡ã¯åè³ªãæ ä¿ãã€ã€ããã£ãšã¹ããŒããäžããŠãããããšããã®ã芳ç¹ãšããŠå€§ããã§ããã ââ ãªãã»ã©ãããããæšªæãããžã§ã¯ãããã£ãŠããå»ç PF ã§ã¯ã©ããªãšã³ãžãã¢ãããããããã€ã³ãã§ããã? æéЬ : æè¡ãšäœµããŠãŠãŒã¶ãŒãžã®äŸ¡å€æäŸãèããªãããšã³ãžãã¢ãªã³ã°ããã人ããããããã®ã§ã¯ãªãããšæããŸãã ââ åãããã¯ãã®æã£ãŠãã圹å²ãèžãŸããŠã俯ç°ã®èŠç¹ã§éçºãããããšããæ¹ã«ã¯ãããé åçã§ãããæ¬æ¥ã¯ããããšãããããŸããã ãããã« åæäºçŽ Pj ã«ã€ããŠããããžã§ã¯ããæšé²ããã¡ã³ããŒã«è©±ãèããŸããããè€éãªèŠä»¶ãå®çŸå¯èœãªåœ¢ã«ããŠåããŒã ã§å£æ ¹ãè¶ããŠéçºãããŠããæ§åããšãŠãå°è±¡çã§ãããç¹ã«å»ç PF ã§ã¯ãã¡ã€ã³åå£«ã§ææ©çã«çµåããŠãããã³ã©ãã¬ãŒã·ã§ã³ããããšã«ããã¹ããŒã¯ãã«ããŒãžã®äŸ¡å€ãé«ããŠãããšããã®ã¯ããããããããã®ã§ã¯ãªãããšæããŸãã ãã®ãããªãããžã§ã¯ãã§åãçºæ®ããããšæã£ãæ¹ã¯ãã²ããæ°è»œã«ã話ãããŸããã! https://www.medley.jp/jobs/
æ ªåŒäŒç€Ÿã¡ãã¬ãŒ
2024/02/29
<![CDATA[ è€æ°ãããã¯ã暪æãããããžã§ã¯ããã©ããã£ãŠæåãããã®ãã¡ã³ããŒã«èããŠã¿ãŸãã ]]>
ã¯ããã« ã¿ãªãããããã«ã¡ã¯ããšã³ãžãã¢ã®å€å·ã§ãã ä»å㯠CLINICS / Pharms åæäºçŽãããžã§ã¯ã(以äžãåæäºçŽ Pj)ãšãããããã¯ã暪æã§æ§ã ãªéšçœ²ãé¢ãã£ãéçºãããžã§ã¯ãã«ã€ããŠãå°œåãããçããã«åº§è«äŒåœ¢åŒã§ã話ã䌺ããŸããã ã¡ãã¬ãŒã®å»çãã©ãããã©ãŒã (以äžãå»ç PF)ã§ã©ã®ããã«ããããæšªæãããžã§ã¯ããå®éããã®ãã®æ§åãçããã«ç¥ã£ãŠããããã°ãšæããŸãã 察è«ã¡ã³ããŒçŽ¹ä» ââ ã¯ããã«ãçããã®èªå·±ç޹ä»ããé¡ãããŸãã æ±è€ : æå±ã¯å»ç PF ã®ãããã¯ãéçºå®€ã® Pharms éçºããŒã ã§ãã 圹å²ãšããŠã¯èª¿å€è¬å±åãã®ã·ã¹ãã ã® Pharms ã®ãããã¯ããªãŒããŒãæ ã£ãŠããŸãã çµæŽãšããŠã¯ã2021 幎㮠1 æãã Pharms ã®ã«ã¹ã¿ããŒãµã¯ã»ã¹ãšããŠã¡ãã¬ãŒã«ãžã§ã€ã³ããŸããŠã2023 幎 1 æããéçºããŒã ã«æ¥ãŸããã ãããŸã§ã¯äºæ¥åŽã®çµéšãé·ããå¶æ¥å šè¬ãäºæ¥éçºãã¡ã€ã³ã§ãã£ãŠãããã£ãªã¢ã§ãã ãã®ãããžã§ã¯ãã® PO ãšããŠãªãŒãããåããããŠãããPharms ãæ ã調å€åŽã®ãªãŒãã«å ããŠãå šäœã®ææ¯ãã調æŽçã䞻軞ã«ãã£ãŠããŸããã æ±è€ãã ââ æ±è€ããããããžã§ã¯ãã®äžå¿ãšãªã£ãŠæšé²ãããã§ããã æ±è€ : 調å€ãã¡ã€ã³ã® Pharms ã«ãšã£ãŠäºæ¥ã€ã³ãã¯ããããã倧ããéçºã ã£ãã®ã§ã調å€ãã¡ã€ã³ã責任æã£ãŠãããŸãããããšããæŽçã§ãã å°ç° : èªåã®æå±ãæ±è€ãããšåãã«ãªããŸãã çµæŽã¯ã2021 幎 7 æã«ãšã³ãžãã¢ãšããŠå ¥ç€ŸãããããŸã§ãã£ãš Pharms ã®éçºããã£ãŠãŸãã å ¥ç€ŸåŸã¯ã¯ã©ã€ã¢ã³ãèªèšŒæ©èœãæ³äººæ åœè åãã®æ¬éšæ©èœãªã©ã®æ©èœéçºãè¡ã£ãŠããŸããã æšå¹Žãã Pharms ã®ãªãŒããšã³ãžãã¢ãšããŠããŒã å šäœãèŠã€ã€ãPharms ã®æè¡è²¬ä»»è ãšããŠæ±è€ãããšäž¡èŒªã§åããããªåœ¢ã§ãããžã§ã¯ãã®æšé²ã«é¢ãã£ãŠããŸãã å°ç°ãã æéŠ¬ : å»ç PF ãããã¯ãéçºå®€ãæ£è çµ±ååºç€ããŒã ã«æå±ããŠããŸããæ£è çµ±ååºç€ãšã¯ãCLINICSïŒæ£è ã¢ããªïŒãšããã¢ããªã®ããã¯ãšã³ãã·ã¹ãã ã§ããã蚺çæãæ¯ç§å»é¢ãè¬å±åãã®ã·ã¹ãã ãšã®é£æºåºç€ãšããŠãæ©èœããŠãããããã¯ãã«ãªããŸãã çµæŽã¯ããã®ã¡ã³ããŒã®äžã§ã¯äžçªå€ã 2018 幎 3 æã«å ¥ç€ŸããŠãåœå㯠CLINICS ã«ã«ãã®æ©èœæ¡åŒµã®éçºã«åå ããPKI åºç€ã CLINICS ãšãŒãžã§ã³ããå§ããšããä»ç€Ÿã·ã¹ãã ãšã®é£æºåºç€ã®éçºãè¡ã£ãŠããŸããã2020 幎ãããããæ£è çµ±ååºç€ã®ç«ã¡äžãã«åå ããŠãçŸåšã«è³ããŸãã æéŠ¬ãã é äº : å ¥ç€Ÿã¯ 2019 幎 8 æãªã®ã§ã 5 幎ç®ãšãªããŸãã ãã¶ã€ããŒãšããŠå ¥ç€ŸåŸ 1 幎éã¯ãžã§ãã¡ãã¬ãŒã«åšç±ããŠããŸããããã®åŸãªã³ã©ã€ã³èšºçã䌞ã³ãŠããææã«ãªããCLINICS åŽã®ãã¶ã€ããŒã®äººæ°ãè¶³ããªããªã£ãããšããããŸããŠãããããã¯é»åã«ã«ããå«ãã CLINICS ã®ãã¶ã€ã³å šè¬ãæ åœããŠããŸãããå»å¹Žããé»åã«ã«ã以å€ã®æ¥åé åã® PdM ãšããŠæŽ»åããŠããŸãã軞足ã¯ãã¶ã€ããŒãªã®ã§ãããããã¯ãã®ãããžã¡ã³ãã¿ãããªããšããå§ããŠãŸãã ãã®ãããžã§ã¯ãã«ãããŠã¯ããã£ãæ±è€ããããã£ããã£ãéããPharms ã®äŸ¡å€åäžãäžå¿ã®ãããžã§ã¯ããªã®ã§ãããžã§ã¯ãã®äžçªå€§ãããªãŒãã¯æ±è€ããã«ãªãããšæããã§ããã©ãCLINICS ãªã©ã®å»ç§åŽã®ãããžã§ã¯ããªãŒããšèšãç«ã¡äœçœ®ãåã«ãªãããªãšæããŸãã é äºãã å°å³¶ : å»ç PF ãããã¯ãéçºå®€ã® QA ã°ã«ãŒãã«æå±ããŠããŸããQA ã°ã«ãŒãã®ãããŒãžã£ã§ãã 米山 ããã®ã玹ä»ã§ 2022 幎 4 æã«ã¡ãã¬ãŒïŒäººç®ã® QA ãšã³ãžãã¢ãšããŠå ¥ç€ŸããŸãããäž»æ åœã¯ CLINICS ã®äºçŽæ©èœãäžå¿ãšããåšèŸºé åã§ãããããŸã§é äºãããšäžç·ã«åãããŠé ãæ©äŒãå€ããçŽè¿ã§ã¯äºçŽæ¹æ³ãæ¡åŒµããããªã¯ãšã¹ãäºçŽãæ©èœã® QA ãæ åœããŸããã åæäºçŽã«é¢ããŠã¯ãäž»ã«å»ç§åŽã®éšåã® QA ããå§ãŸãã調å€åŽã® QA ãå¿ èŠãšããããšã«ãªããæçµçã«ã¯å šäœã® QA ãæ åœããŸããã å°å³¶ãã åæäºçŽã®æ©èœã解決ããèª²é¡ ââ ããããšãããããŸããæ¬¡ã«ãä»åã®åæäºçŽã«ã€ããŠã©ããã£ãæ©èœã§ãã©ããã£ã課é¡ã解決ããã¹ãããã話ãããã ãããã§ãã æ±è€ : æ©èœãšããŠã¯ã CLINICSïŒæ£è ã¢ããªïŒãããªã³ã©ã€ã³èšºçãäºçŽããéã«ãè¬ã®åãåãå ãšããŠè¬å±ãäºåæå®ã§ããæ©èœ ã«ãªã£ãŠããŸãã ãã®æ©èœã«é¢ä¿ãããã¡ã€ã³ã¯æ£è ã»å»çæ©é¢ã»èª¿å€è¬å±ã®ïŒã€ã§ãã æ£è ãšå»çæ©é¢ã®ã¡ãªãããšããŠã¯ãè¬ã®åŠæ¹ãŸã§ã®æéãæžãããšã§ãã ãªã³ã©ã€ã³èšºçã§ã¯ãæ£è ãå»çæ©é¢ã«çŽæ¥èšªåããããã§ã¯ãªãã®ã§ãè¬ãçŽæ¥è¬å±ã«è¡ã£ãŠåãåãã®ããè¬å±ããé éãåžæããã®ããšãã£ãè¬ã®åãåãæ¹ããå»çæ©é¢ãšæ£è ããã§å£é ã§è©±ããŠæ±ºããŠããã£ãŠããã確èªã«æéãçºçããŠããŸãããæ£è ããã¯å£é ã§è©±ããå å®¹ã«æ²¿ã£ãŠããªã³ã©ã€ã³èšºççµäºåŸã«ãè¬å±ãžã®äºçŽãåã£ãŠããŸããã åæäºçŽæ©èœãå®è£ ãããããšã«ããã蚺å¯ã®äºçŽæã«ã©ã®è¬å±ã§ã©ãããåãåãæ¹ãããŸããšããéšåãæ£è ãããäºåæå®ã§ããããã«ãªã£ãã®ã§ã å»çæ©é¢ã¯äºåçãªè©±ã«æéããããã«èšºå¯ã«éäžã§ãããŸãæ£è ããããå»åž«ã«å£é ã§è¿œå 説æããªããŠãåžæéãã«è¬ãããããããšãããããŒã«å€æŽãããããšãå»çæ©é¢ãšæ£è ã®ã¡ãªãã ã ãšæã£ãŠãŸãã åæäºçŽæ©èœã®ãªãªãŒã¹ååŸã§ã®ãããŒã®éã ããäžã€ã®ãã¡ã€ã³ã§ãã調å€è¬å±ã«ã€ããŠã¯ãåè¿°ã®ããã«èšºå¯ã®äºçŽãããæã«æ£è ãããã¡ãã¬ãŒã®ãµãŒãã¹ã§ãã Pharms ã䜿ã£ãŠããè¬å±ããäºåæå®ãã§ããŸãã®ã§ã ãªã³ã©ã€ã³èšºçåŸã«çºè¡ãããåŠæ¹ç®ã®æµå ¥ãå¢å ããŸã ã 調å€è¬å±ã®å£²ãäžãã¯åŠæ¹ç®ã®ææ° à å䟡ã§å€§éšåãæ±ºãŸããŸãã®ã§ããã®ææ°ãå¢ããããšãã芳ç¹ã§ã¯è¬å±ã«ãšã£ãŠã€ã³ãã¯ãã®ããæ©èœã ãšæã£ãŠããŸãã ââ æ£è ã®äœéšãæ¬åœã«è¯ããªãããæ£è ãšå»çæ©é¢ã®ç¡é§ãªã³ãã¥ãã±ãŒã·ã§ã³ãæžãããã€è¬å±ã«å¯ŸããŠãåŠæ¹ç®ææ°ãå¢ããŠãå°ç·ã楜ã«äœ¿ããããã«ãªã£ãŠãããšããã®ããä»åã®ãããžã§ã¯ãã®èã«ãªã£ãŠããæãã§ãããããããèžãŸãããããã¯ãéãæšªæããŠéçºããªããšãããªããšããã®ã倧å€ããã§ãã éçºãããžã§ã¯ãã«ã€ã㊠ââ ã©ã®ãããªããŒã ããã®æšªæãããžã§ã¯ãã«é¢ãã£ãŠããããæããŠãã ããã æ±è€ : éçºåŽã§èšããšïŒã€ã®ãã¡ã€ã³ã«ãªã£ãŠãŸãã 調å€ãæ£è ãå»ç§ããã㊠æ£è çµ±ååºç€ ã§ããæ£è çµ±ååºç€ãšã¯å»ç PF ã®åãã¡ã€ã³ã«ååšããæ¥åã·ã¹ãã ãšæ£è ã¢ããªãç¹ãæ ¹å¹¹ãšãªããããã¯ãã§ãã ãã ä»åã®æ©èœã¯å»çæ©é¢ã®ãªãã¬ãŒã·ã§ã³ãå€ãããããéçºåŽã§ã®ã¿å®çµãããããžã§ã¯ãã§ã¯ãªããã§ããã ããã«çŸå Žã®éçšã«åããã€ã€ãäœéšãæ¹åã§ãããïŒãšããèŠç¹ã§èãããšãåäºæ¥åŽã®ã«ã¹ã¿ããŒãµã¯ã»ã¹ããŒã ãéèŠã«ãªããŸã ãç¹ã«å»ç§ãšèª¿å€ã®ã«ã¹ã¿ããŒãµã¯ã»ã¹ããŒã ãšã¯ãå¯ã«å£æã¡ãããªããéçºãé²ããŠããŸããã ââ ä»åã®ãããžã§ã¯ãã¯ç¹ã«äºæ¥éšãšã®é¢ä¿æ§ãéèŠãªéµã ã£ããã§ããã æ±è€ : ããã§ãããç¹ã«å»ççŸå Žã¯æ¥åãéŒè¿«ããŠããå Žé¢ãå€ãã§ãã®ã§ãäŸãã°ãã¯ã³ã¯ãªãã¯å¢ããŸãããããã§ããŒãžé·ç§»ãå¢ããŸãããšãã£ãããšã§ãæ¥åãžã®åœ±é¿ãéåžžã«å€§ãããªããŸãã ãŸããªãã¬ãŒã·ã§ãã«ã«çŸå ŽãåããŠããç®æãå€ãããããã¯ãéœåã§åæã«ãã®æ¹ãè¯ããããåççã ããããšæ±ºããŠãããã¯ããäœã£ãŠããŸããšä»ãŸã§ã®çŸå Žãªãã¬ãŒã·ã§ã³ã厩ããŠããŸãæ··ä¹±ãæãããšããããŸãã çŸå Žã®ç¿æ £ãçè§£ããæã ãç®æãå§¿ãšèª¿æŽããªããæé©è§£ãåºã ã®ããå¿ é ã«ãªã£ãŠããæ¥çã»æ¥æ ã ãšæãã®ã§ããã®èª¿æŽã¯äºæ¥éšãšãããªãæ°ãé£ã£ãŠãã£ãŠããŸããã ââ åæäºçŽ Pj ã¯ãéçºåŽãããããšããããšã§å§ãŸã£ããããžã§ã¯ããªãã§ãããã? æ±è€ : ã¯ããããã¯ã¡ãã¬ãŒã®ã©ã®ãããã¯ãããããªã®ã§ãããäºæ¥è²¬ä»»è ãšãããã¯ã責任è ããããããããäºæ¥ãšéçºã®äž¡èгç¹ããè°è«ããäºæ¥æ¹éãæ±ºããŠããããšããäœå¶ããšã£ãŠããŸãã Pharms ãæ£ããæé·ãããŠãããšãã芳ç¹ã§èŠããšãçŸãã§ãŒãºã§ã¯åŠæ¹ç®ããã£ãããšèª¿å€è¬å±ã«å±ããããšãè³äžåœé¡ã§ããããµãŒãã¹ã®ããã¹ãå§¿ãšã¯ïŒãšãã芳ç¹ã§äºæ¥ãšéçºäž¡èŒªã§ãããŸããããšããåœ¢ã§æ±ºãŸã£ããã®ã«ãªããŸãã æšªæãããžã§ã¯ãã§å·¥å€«ããããã€ã³ã ââ ä»åãæšªæã§è²ã ãªéçºãããã¯ããé¢ä¿ããŠããŸããã工倫ããç¹ãšãæ°ãã€ããç¹ãªã©ãã©ããªãã®ããããŸãããã æ±è€ : äžçªã¯åãã¡ã€ã³ã§è¿œã£ãŠããäºæ¥ææãããªãéã£ãŠããŸããã®ã§ããã®èª¿æŽãæéããããŠæŠãåããããç¹ã§ãã äŸãã°ã調å€ã®èгç¹ã§ã¯åŠæ¹ç®ãã¡ãããšè¬å±ã«å±ãããšããã®ãããããéèŠãªäºæ¥ã€ã³ãã¯ãã®å€§ããé ç®ã§ããäžæ¹ã§ãå»çã®èгç¹ã§èŠãæã«ããã¡ããæéãæžããã®ã¯ãããéèŠã§ã¯ãããã§ãããå»çãã¡ã€ã³ãšããŠãã®æ¹åã«èª¿å€ãšåèŠæš¡ã®ã¡ãªãããèŠåºããŠããããããšèšããšåœç¶ããã§ã¯ãªãã£ããããŸãã ããããéšåã§ããã¡ã€ã³éã§ãã®ãããžã§ã¯ããéæããåŸã«åŸãããã¡ãªããã«å·®åãåºãŠããŸããã¡ãªããã倧ããäºæ¥ãããããå·¥æ°ã倧ããå²ããã®ã§ãããã¡ãªããã匱ãäºæ¥ã§ã¯åãã ãå·¥æ°ãããŠãããŸãããããšããæææ±ºå®ã¯é£ãããšæããŸãã ããã§ æ¬ Pj ãéããŠåãã¡ã€ã³ã§ã¯ã©ãããäºæ¥ææãçãã®ãããã®ããã«äœã® KPI ã远ãã®ãããæç¢ºã«ããŸãã ãäºæ¥çãªã¡ãªãããå€ã調å€ã®ããã«æäŒã£ãŠãã ãããšãã圢ã§ã¯ãªããåãã¡ã€ã³ã§ã©ãããã¡ãªãããçãã§ãããŸããïŒãšãããšãããæãããã®ãããããéèŠã ã£ããšæã£ãŠããŸãã ãããæ ããšãã¡ãªããã®åŒ±ãäºæ¥ã«ãšã£ãŠã¯ãæäŒãã¿ãããªãããžã§ã¯ãã«ãªããŸããåçŽã«ãšã³ãžãã¢ãªã³ã°ãšããéšåã§ãé¢çœããã®ã«ãªããªãã§ããããã§ãã®ã§ãé¢ä¿ããå šå¡ã§ãããžã§ã¯ãã宿œããããšã§ã©ãããçµæãåŸãã®ã?ãã¡ãããšåãã¡ã€ã³éã§æããŸããã ââ ãªãã»ã©ããããããšããããæŠãåããã¯æ±è€ãããšé äºããããã£ãŠãããã§ããããã é äº : ã¯ããåã®ã»ãã§è¡ã£ãŠããŸãããåãåæã®ããåããæã«éèŠããŠããã®ã¯ãã¹ã³ãŒããé©åã«åºåããšããéšåã§ããã調å€åŽã®æäŸäŸ¡å€ã®æå€§åã ãã远ã£ãŠåæãã倧ããªæ©èœè¿œå ãè¡ãã®ã§ã¯ãªãã倿Žã«ããå»ç§ã»æ£è ã»èª¿å€ãžäžãããªã¹ã¯ãéçºã³ã¹ããæãã€ã€ã䟡å€ãæå€§åã§ããèœãšãæã¯ã©ããããšããéšåããå·ãåããããŠãããŸããã ã¡ãã¬ãŒãé¢çœããªã£ãŠæãã®ãããããã¯ãåç¬ã§åããŠããããã§ã¯ãªããŠã ãã€ã·ã§ã³ããžã£ãŒããŒ(æ£è äœéš)ãäžå¿ãšããŠããã¿ã¯ã矀ãååšããŠãããšãã ã§ãã æ£è äœéšãããè¯ãæ§ç¯ããããã«ããããã®ãããã¯ããåããŠãããã®ã§ããæäŒããšãããã¥ã¢ã³ã¹ãããªãããããã¯ããè¶ ããŠããã¯ããããŠãããŸããããšèšããæåããããšãããããéšåããªãšæããŸããããããããããéšåããªãšæããŸãã æ±è€ : ç¹ã«æšªæã®ãããžã§ã¯ãã ãšããããç®çæèã®çµ±äžã«äžçªæéã䜿ã£ãŠãè¯ãããããªãããšèããŠããŸãããããæ±ºãŸãããããã°ãåŸã è¿·ã£ãå Žåãç®çã«å³ããæææ±ºå®ãã§ããŸããããããåºããåŸã«åãã¡ã€ã³ã§ã®èª¿æŽãããšããé çªã倧äºã ãšæããŸãã ââ æè¡é¢ã§æ°ãã€ãããã€ã³ãã¯ã©ããªãã®ããã£ããã§ããããã æéŠ¬ : åæäºçŽæ©èœãšããŠããããããšã¯ããã€ã€ã蚺çæåŽã®æ¥åãããŒãæ£è ã®å°ç·ãä»ããã·ã¹ãã ã®å¶çŽãªã©ãèžãŸããã©ã®ãããªåœ¢ã«èœãšã蟌ã㰠蚺çæãè¬å±ãæ£è ã«ãšã£ãŠã䟡å€ã®ããæ©èœãšãªãã ããã€ã³ãã§ãã ã§ãã®ã§ãæè¡çãªé¢ãšäºæ¥çãªé¢ã䜵ããŠèããªãããã·ã¹ãã å šäœã®èŠä»¶ã決ããŠãããšããã®ãæåã«æãããéšåã§ããã ââ æ©èœãèããäžã§ãå šäœãèŠæ®ããèšèšãªã©ããã£ãŠãããšæããã§ãããä»åã¯ã©ãããçæããããã§ãããã?æ£è ã®å°ç·ã ã£ããå»çæ©é¢ã®æ¥åãããŒãªã©ææ¡ããåŸã«ãåãããã£ãéšåãèãããã®ã§ããã æéŠ¬ : åæäºçŽã«ãããã·ã¹ãã å šäœã®èŠä»¶ãåºããŠãããšåæã«ãå šäœã®ã·ãŒã±ã³ã¹ãšã¹ããŒããã·ã³ãäœã£ãŠãããŸãããåã·ã¹ãã éã®é£æºãããŒãšãããã«ããçã¿åºãããäºçŽãåŠæ¹ç®ãšãã£ããšã³ãã£ãã£ã®ç¶æ é·ç§»ã決ããŠããããã®ç¶æ ã®æã¯ãããã£ãããšã¯ã§ããªããšãããããã£ã蟻è€ãåããããšããããã£ãããã£ãŠãã£ããšããæãã§ãããã é äº : ä»åã¯ãç¹ã« ãããã¯ã暪æã®å ±éåºç€ãšããŠãåãããã¯ãã§ããããå šãå¥ç©ã®ä»çµã¿ãã¹ããŒã¿ã¹ãä¿æããŠããã®ããå ±éåã»æœè±¡åãããšããæ¥åãå¿ èŠã«ãªã ã®ã§ããããé£ããããé£æåºŠãé«ãéšåã ãªãšæã£ãŠãããã§ããã©ãããã綺éºã«ã·ãŒã±ã³ã¹å³ã«èœãšã蟌ãã æéŠ¬ãããåããªãšæããŸããã æ±è€ : åºç€åŽã§äœã£ãŠããã ããã·ãŒã±ã³ã¹å³ã¯ UX ã®éªšçµã¿ãªãã§ããããããããããã UX ãã¶ã€ããŒãå¥éãããšãã£ã现ååããããå®è£ ã®å¶éãå å³ãã€ã€ãæ£ããéçšãåãããã«ããã®äœéšãäœãããã«ãã®ã¹ããŒã¿ã¹é·ç§»ã§ããã¹ãã ããããšããéšåãæéЬããããšã³ãžãã¢èгç¹ã§æåã«äœã£ãŠãããŠããšããã®ãã ã¡ãã¬ãŒã®ãšã³ãžãã¢ã®ãšãŠãè¯ãéšå ã ãšæã£ãŠããŸããæè¡ã ãã§ãªã UX ãªã©ã«ãå¿ èŠã§ããã°è¶å¢ããŠãããæåã§ããã åæäºçŽ Pj éçºã®å®é ââ ããããåæãã§ãŒãºãçµãŠ Pharms ãš CLINICS ã©ã¡ãã®éçºã«ãé¢ãã£ãå°ç°ããã«èãããã®ããéçºã®æµãã®äžã§ãããããªãœãŒã¹çãªåé¡ã£ãŠå€§å€ã ã£ããšæãã®ã§ãããããã¯ã©ã解決ãããã§ããããã å°ç° : å ã« Pharms åŽã®æ©èœ ãäœã£ãŠãã®åŸã« CLINICS ã®ä»æ§ã決ããŠããã£ãŠãã CLINICS ã®éçºã«å ¥ãæµãã ã£ãã®ã§éçºã䞊è¡ããããšã¯ãªãã£ãã§ãããã Pharms ã§ã¯ãªãŒããšã³ãžãã¢ãšããç«å Žãªã®ã§ ãCLINICS ã®éçºã«å ¥ãããã®æºåãšãPharms åŽã®ã¬ãã¥ãŒããã©ããŒã®ãªãœãŒã¹é åã¯èªåã§èããŠãåã¿ã¹ã¯ã宿œããæéãšã¿ã€ãã³ã°ã調æŽããªãããã£ãŠããŸããã äžæ¹ã§ããã®äœå¶ã§ãé²ããããšãã§ããã®ã¯ Pharms ããŒã ã®åã¡ã³ããŒãæ¢ã«èªèµ°ã§ããç¶æ ã«ãã£ãã®ã§ãããã«æ¯ããããããããã§ãã ããªãšæã£ãŠãŸãã ââ ãããã¯ããè¶å¢ããªããéçºãããšããæåã¯ãããè¯ããšæã£ãã®ã§ãããããã¯ãããŒãªã©ãã£ãããããã§ãã? æ±è€ : å çšã話ããéã Pharms ãšããŠæ¬ãããžã§ã¯ãã®åªå 床ã¯é«ãã£ãã®ã§ãããCLINICS ã®äºæ¥èšç»ããªãœãŒã¹ãèžãŸãããšå»ç§åŽã®å®è£ çæã倧ããé ããããªèŠç«ãŠã§ãããããã§ãå°ç°ããã å»ç§åŽã®éçºã«ãã¢ãµã€ã³ã§ããããªãœãŒã¹åé¡ã解決ã§ããã®ã§ã¯ãšèª¿æŽããŸãããå»ç§åŽã®ãšã³ãžãã¢ããã®ãã©ããŒã¢ããã¯å¿ èŠãªã®ã§ããã®èª¿æŽããã€ã€ã§ãããéçºãæ©ãããããªãè¯ãããšéçºããŒã éã§æçµçã«å€æããŸããã é äº : ä»ãŸã§è§Šã£ãŠãªãã£ã CLINICS ã®ã·ã¹ãã ã«ãå°ç°ããã¯ã¬ã³ã¬ã³åã蟌ãã§ãã ãã£ãã®ã§ãå ã CLINICS ã®éçºããã£ãŠãã®ã§ã¯ãšæãããããã£ããã¢ãããæ©ãã£ãã§ãã ââ ãããã¯ãã®ã°ããŒã¹ã®ããã«ãªãœãŒã¹èª¿æŽãæåããããšãã圢ã ã£ããã§ããããããã¯ãéã®è¶å¢ããããããããªæåã ã£ããããããžã§ã¯ããæåãããããšããç®ç·åãããèªç¶ã«ã§ããã®ã¯è¯ãã§ããã ããŒã éãšãã話ã§ããã° QA ã¯åããŒã ã«è·šã£ãŠã®æŽ»åã ãšæããŸããããã®èгç¹ã§ã¯ãããã§ãã? å°å³¶ : èªåã¯éçºãçµç€ã«å ¥ã£ãã¿ã€ãã³ã°ã§ãããžã§ã¯ãã«åæµããŸããããããŸã§ã¯ç±³å±±ããã QA ãšããŠå ¥ã£ãŠããã®ã§ãããå»ç§åŽã§ãæ€èšŒãã¹ããã¹ã芳ç¹ã倿°ãã£ãèæ¯ããããå»ç§åŽã® QA ãã¡ã€ã³ã§èŠãæ åœãšããŠåç»ããŸããã åŸåã«åç»ããèæ¯ããããããããåŠæ¹ç®éä»ãšããæ¥åã Pharms ãããã¯ãã®ä»æ§çè§£ãæµ ãâŠãšããç¶æ ã§ãããã éçºç®çã»èŠä»¶å®çŸ©ã»èšèšã詳现ã«ããã¥ã¡ã³ãåãããŠããã®ã§ãã¹ã ãŒãºã«æ€èšŒã«å ¥ãããšãã§ããŸãã ãæ€èšŒã®äžã§ QA ãšã³ãžãã¢ãšããŠãããã®éšåã®ä»æ§ã¯èŠçŽããæ¹ãè¯ããªãããšãããã€ã³ããããã€ãåºãŠããã®ã§ã仿§ã®æ¹åææ¡ãè¡ããŸãããåŸçºåå ã§ããããå®éã«åãå ¥ããŠããã£ãæ¹åãå€ãã§ãã ã¡ãã¬ãŒã®ãããã¯ãéçºã®æåãšã㊠QA ãšã³ãžãã¢ã èŠä»¶å®çŸ©ããã¬ãã¥ãŒã«åå ããããæèŠãèšãã€ã€ãããã¯ããããè¯ãããããã®æ¹åãè¡ãã ã®ã§ããšãŠãåããããã§ããã ââ åŸããå ¥ã£ãŠãåãããããšããã®ã¯ãããã¥ã¡ã³ããªã©ãæŽåãããŠããããã§ããããšã ãšããã®ãåãããŸãããæšªæãããžã§ã¯ãã ããããæ°ãã€ããä»ã®ããŒã ã®è¯ãç¹ãªã©ãã£ããããŸãã? é äº : Pharms ã®ãããžã§ã¯ãã£ãŠããããããªããšæã£ãã®ã KPI èšèšããããæç¢ºãªãšããã ã£ããšããç¹ã§ããã è²ã çŽäœæ²æãã£ãçµæããã«èŸ¿ãçããŠããšããèŠåŽãç¥ã£ãŠã¯ãããã§ããã©ãä»ã® KPI èšèšã£ãŠãã£ã±ããããã·ã³ãã« ã§åŠæ¹ç®éä¿¡æ°ã§ããšãªããšãããããéç®ãã KPI ãå PF ã«æ¯ãã°ãããšèšãäœå¶ã ã£ãã®ã§ããããããã¯ãããããã£ããã€ã³ãã®äžã€ããªãšæããŸãã 話ãè«ç¹ãçµå±ããã£ãŠããéšåããããã³ãã¥ãã±ãŒã·ã§ã³ã³ã¹ããå®ãããã éšåã§ã¯ããããªãšæããŸããã æšªæãããžã§ã¯ããªãã§ã¯ã®ãšã³ãžãã¢ãªã³ã° ââ å šäœã®è©±ããåå¥ã®ãã¡ã€ã³ããšã®ãšã³ãžãã¢ãªã³ã°ãšããç¹ã§ã¯ã©ã®ãããªããšããããŠããŸããã? å°ç° : åºæ¬çã«ã¯æéЬããã®ã·ãŒã±ã³ã¹å³ãå ã«éçºãé²ããŠããŸãããCLINICS ã§ã¯ A ãšããç¶æ ã«ãªãããã®æã« B ãšããã¢ã¯ã·ã§ã³ããããš Pharms ã§ã¯ C ãšããç¶æ ã«ãªããšããããã«ç¶æ é·ç§»ãè€éã ã£ããããèšèšæã«ããã¹ãå§¿ã«è¿·ãããšãå€ãã£ãã®ã§ãããã·ãŒã±ã³ã¹ã«ç«ã¡è¿ããšããã«ãã®çåã解決ãããšãã£ãå ·åã§ãã æéŠ¬ : ã·ãŒã±ã³ã¹ã®æŽåæ§ãé£ãããªããããªãããã«èšèšãã ããšã«ã¯æ°ãã€ããŸããããåæäºçŽããšããèšèãå è¡ãããšã€ãã€ãè€éãªæ°æ©èœã®ãããªãã®ãäœããã¡ã§ããã蚺çæãè¬å±ã®äºçŽæ©èœãåŠæ¹ç®éä¿¡æ©èœãšãã£ãåã ã®ããŒãã¯ããšããšããããã§ããªãã¹ãã·ã³ãã«ã«ããããã€ãªãåãããããããã«å¿ãããŸããã æ±è€ : 现ãããããã¯ãéã®èª¿æŽãå¿ èŠã«ãªãã®ã§ ã¡ãããšèª¿å€ã®æ¬²ãã KPI ãæ±ãã€ã€ããã€çŸå Žã®ãªãã¬ãŒã·ã§ã³å質ãèœãšããªãã£ãŠãã芳ç¹ã§èª¿æŽãåãã¡ã€ã³ã§ãããŸããã 工倫ããããšã§ãããšãUX 調æ»ã培åºãããšããã§ããããã ä»åã®ãµãŒãã¹ã£ãŠæ¥ççã«ã¿ãæã«æ°ããããšãããšããã§ã¯ãªããã§ããããã§ãã®ã§ã忥çã®äŒæ¥ããã®åã¢ããªã®äœéšãšããèªåã§ãçµæ§è²ã 䜿ããªããäœéšããŠã¿ãŸããããããããããŒã¹ã«éã«çŸç¶ã®ãã¡ã®ä»æ§ãèžãŸãããšããããã颚ã«ãã¡ã§ã¯å®è£ ããŸãããã¿ãããªãšãããè²ã ãã£ãŠããŸããã å°ç° : ãšã³ãžãã¢ãªã³ã°ã®èгç¹ã§ãããšãç¹ã«æ£è ã¢ããªããŒã ãšã® API 飿ºã®ä»æ§èª¿æŽãšãéçºã®é²ãæ¹ã¯å¯ã«é£æºããªããé²ããŸãããå ã«ãã£ã¡ãã§ããŠãªããšåãããéçºã§ããªãç¶æ ã«ãªãã®ã§ãæ åœè å士ã§ã³ãã¥ãã±ãŒã·ã§ã³ãšãã€ã€ã工倫ããªããé²ããŠããŸããã é äº : CLINICS ã§æ°ã«ããŠãéšåã¯ã©ã¡ãããšãããš ãªã¹ã¯ãšã³ã¹ãã®éšåãããã«æå°åããŠäŸ¡å€ãæå€§åããããäžçªéèŠ ããªãšæã£ãŠããã®ã§ãäžçªå€§äºãªã®ã¯ãã£ã±ãå»ç§ã«ãšã£ãŠã©ããã䟡å€ãåºãŠãå»ç§ã«ãšã£ãŠã©ããããªã¹ã¯ãçºçããããèããŠãŸããã äŸãã°äžçªæåã®ããåããã§è¬å±äºçŽããæã«æ¥æãŸã§ç¢ºå®ãããŸããããšãã話ããã£ããã§ããã©ããããŸã§ã¹ã³ãŒããåºããªããŠãã¡ãªãããåºãã®ã§ããã°ãåºããããªãã§ããšãã話ãããŠããŸããã ããšã¯ãªãªãŒã¹ãã©ã³ã®çå®ãšãããªïŒå šå»çæ©é¢ã«äžæã«åºãã®ã§ã¯ãªãããŸãã¯äžéšå»çæ©é¢æ§ã ãã«å ¬éãããªãªãŒã¹æ¹åŒã«ããŸãããã¿ãããªãšãããå«ããŠã§ããããå»ç§åŽã§äžæŠãã¹ãããã£ãŠæ€èšŒããŠãã¹ã ãŒãºã«æ©èœã䜿ãããšããã確èªãããããã¹ããããèšããŸããããšå®å šçãåããªããé²ããŸããã ããã¯ãã®ãããžã§ã¯ãã«é¢ããããã©ããªãããžã§ã¯ãã§ãäžçªéèŠã§ãããåŸããã²ã£ããè¿ãã®ãäžçªææ»ãã«ãªã£ãŠããã®ã§ãããã¯éèŠããªãšæããªããé²ããŠãŸãããã å°å³¶ : QA èŠç¹ã ãšæšªæãããžã§ã¯ãããã«ã¹ããŒããæ¬åœã«è€éã§ãã¡ãã¬ãŒå ¥ç€ŸåŸã«çµéšãããããžã§ã¯ãã®äžã§æ€èšŒã®é£æåºŠãæãé«ãã£ãã§ããã ã§ãããçããä»°ãããŠããããã«åãŠãŒã¹ã±ãŒã¹ã«å¯Ÿããèšèšãå³ã§ããã¥ã¡ã³ãåãããŠããã®ã§ããã¹ãã±ãŒã¹ãšããŠè»¢çšã§ããéšåãå€ããããŸãããæéЬãããäœæããèšèšå³ããã£ãããããæŒããªããã¹ãã§ããéšåã¯å€§ããã§ãã倧å¢ãåå ãããããžã§ã¯ãã«ãããŠãå šå¡ãèªèåãããäžã§ãèšèšå³ã¯æ¬åœã«å€§äºã ãªãšçæããŸããã 工倫ããç¹ãšããŠã¯ãå°ç°ãã㯠Pharms éçºã®ãã¡ã€ã³ç¥èãè±å¯ã ã£ãã®ã§ãQA æã¯ Pharms åŽãã¡ã€ã³ã«èŠãŠãããã€ã€ãèªå㯠CLINICS åŽã® QA ãæåãèŠãããã«ããŸãããã©ã¡ãã®ãã¡ã€ã³ã«ãé¢ä¿ããå¥çŽãã©ã³çã®è€éãªä»æ§ã¯èªåãæ åœããŸããã QA 以å€ã®é¢ã ãšããªãªãŒã¹ããäžã§å¿ èŠãªæµ®ããããŒã«ãããã°ç©æ¥µçã«åãã«ããããã«ããŸããã äŸãã°ããããŸã§äžéšã®å»çæ©é¢æ§ã ãã«æ©èœãªãªãŒã¹ããå Žåããã®åŸã®ãã£ãŒãããã¯ååã¯ã¡ãŒã«ãé¢è«ã§åå¥ã«è¡ã£ãŠããŸããããæ¥ã ã®èšºçã®äžã§ãæéã確ä¿é ãã®ãé£ãããšããç¶æ³ããããŸããããã®çµæãæ¬ Pj ã«ãããŠãå šäœãªãªãŒã¹ããŠåé¡ãªããïŒã®å€æããã¥ããææããããŸããã ããã§ Google ãã©ãŒã ã§ã¢ã³ã±ãŒããäœæããŠçæéã§åçã§ãã圢ã«åãæ¿ããŸãããçµæçã« 100% åçãåŸãããšãã§ããŸããã ã¢ã³ã±ãŒãçµæãããåŸæ¥æ©èœãã䟡å€ããããé¢å ãªãã¬ãŒã·ã§ã³ã«çµã¿èŸŒãã§é ãã³ã¹ãããããŸã§é«ããªãããšããç¹ãè©äŸ¡ã§ããã®ã§ãèªä¿¡ãæã£ãŠå šäœå ¬éãªãªãŒã¹ã«åã㊠GO å€å®ã§ããŸããã** ã¡ãã¬ãŒã¯åœ¹å²ã«çžãããããŒã«ãä»»ããŠé ããç°å¢ãããã®ã§ãèªåã®å°éé å以å€ã®ããšãåŠã¹ãŠãã**ãšæãããšãå€ãã§ãã 幞ããªãªãŒã¹åŸã倧ããªäžå ·åã¯ãªãã®ã§ããã¯ããçããã®ãããã§ããã åæäºçŽ Pj ãçµã㊠ââ ã§ã¯æåŸã«ãã®ãããžã§ã¯ãã®ç·æ¬ãããŠãã ããã°ã æ±è€ : 暪æã§ã¯ãããã©åãã¡ã€ã³ã§ããããã®ãããã§ãã·ã§ãã«ãã¡ãããšåãçºæ®ããŠãããžã§ã¯ããããåãããšããã®ã¯ããã倧ããè³ç£ã§ããã å»ç PF ã¯ã¢ã»ãããããããæã£ãŠããã®ã§ãè²ã çµã¿åããããšãä»ã®äŒç€Ÿã ãšã§ããªããã©ããã¡ãªãã§ãããã ããã¿ãããªããšãè²ã ãã ãã§ãã ãªã®ã§ããã®åŸã暪æãããžã§ã¯ãã¯äºå®ãããŠããŸãããããã«å é§ããŠã²ãšã€ãããã£ãŠããã€åããæ¬²ããã£ãæåŸ ææãçŸç¶åºããŠãããšãããå«ãããšãããè¯ãäžæ©ã ã£ãã®ããªããšæã£ãŠãŸãã æ¬¡ã¯åè³ªãæ ä¿ãã€ã€ããã£ãšã¹ããŒããäžããŠãããããšããã®ã芳ç¹ãšããŠå€§ããã§ããã ââ ãªãã»ã©ãããããæšªæãããžã§ã¯ãããã£ãŠããå»ç PF ã§ã¯ã©ããªãšã³ãžãã¢ãããããããã€ã³ãã§ããã? æéЬ : æè¡ãšäœµããŠãŠãŒã¶ãŒãžã®äŸ¡å€æäŸãèããªãããšã³ãžãã¢ãªã³ã°ããã人ããããããã®ã§ã¯ãªãããšæããŸãã ââ åãããã¯ãã®æã£ãŠãã圹å²ãèžãŸããŠã俯ç°ã®èŠç¹ã§éçºãããããšããæ¹ã«ã¯ãããé åçã§ãããæ¬æ¥ã¯ããããšãããããŸããã ãããã« åæäºçŽ Pj ã«ã€ããŠããããžã§ã¯ããæšé²ããã¡ã³ããŒã«è©±ãèããŸããããè€éãªèŠä»¶ãå®çŸå¯èœãªåœ¢ã«ããŠåããŒã ã§å£æ ¹ãè¶ããŠéçºãããŠããæ§åããšãŠãå°è±¡çã§ãããç¹ã«å»ç PF ã§ã¯ãã¡ã€ã³åå£«ã§ææ©çã«çµåããŠãããã³ã©ãã¬ãŒã·ã§ã³ããããšã«ããã¹ããŒã¯ãã«ããŒãžã®äŸ¡å€ãé«ããŠãããšããã®ã¯ããããããããã®ã§ã¯ãªãããšæããŸãã ãã®ãããªãããžã§ã¯ãã§åãçºæ®ããããšæã£ãæ¹ã¯ãã²ããæ°è»œã«ã話ãããŸããã! åéã®äžèЧ | æ ªåŒäŒç€Ÿã¡ãã¬ãŒ ã¡ãã¬ãŒã®æ¡çšæ å ±ã¯ãã¡ãããã確èªãã ããã www.medley.jp
æ ªåŒäŒç€Ÿã¡ãã¬ãŒ
2024/02/29
<![CDATA[ è€æ°ãããã¯ã暪æãããããžã§ã¯ããã©ããã£ãŠæåãããã®ãã¡ã³ããŒã«èããŠã¿ãŸãã ]]>
ã¯ããã« ã¿ãªãããããã«ã¡ã¯ããšã³ãžãã¢ã®å€å·ã§ãã ä»å㯠CLINICS / Pharms åæäºçŽãããžã§ã¯ã(以äžãåæäºçŽ Pj)ãšãããããã¯ã暪æã§æ§ã ãªéšçœ²ãé¢ãã£ãéçºãããžã§ã¯ãã«ã€ããŠãå°œåãããçããã«åº§è«äŒåœ¢åŒã§ã話ã䌺ããŸããã ã¡ãã¬ãŒã®å»çãã©ãããã©ãŒã (以äžãå»ç PF)ã§ã©ã®ããã«ããããæšªæãããžã§ã¯ããå®éããã®ãã®æ§åãçããã«ç¥ã£ãŠããããã°ãšæããŸãã 察è«ã¡ã³ããŒçŽ¹ä» ââ ã¯ããã«ãçããã®èªå·±ç޹ä»ããé¡ãããŸãã æ±è€ : æå±ã¯å»ç PF ã®ãããã¯ãéçºå®€ã® Pharms éçºããŒã ã§ãã 圹å²ãšããŠã¯èª¿å€è¬å±åãã®ã·ã¹ãã ã® Pharms ã®ãããã¯ããªãŒããŒãæ ã£ãŠããŸãã çµæŽãšããŠã¯ã2021 幎㮠1 æãã Pharms ã®ã«ã¹ã¿ããŒãµã¯ã»ã¹ãšããŠã¡ãã¬ãŒã«ãžã§ã€ã³ããŸããŠã2023 幎 1 æããéçºããŒã ã«æ¥ãŸããã ãããŸã§ã¯äºæ¥åŽã®çµéšãé·ããå¶æ¥å šè¬ãäºæ¥éçºãã¡ã€ã³ã§ãã£ãŠãããã£ãªã¢ã§ãã ãã®ãããžã§ã¯ãã® PO ãšããŠãªãŒãããåããããŠãããPharms ãæ ã調å€åŽã®ãªãŒãã«å ããŠãå šäœã®ææ¯ãã調æŽçã䞻軞ã«ãã£ãŠããŸããã æ±è€ãã ââ æ±è€ããããããžã§ã¯ãã®äžå¿ãšãªã£ãŠæšé²ãããã§ããã æ±è€ : 調å€ãã¡ã€ã³ã® Pharms ã«ãšã£ãŠäºæ¥ã€ã³ãã¯ããããã倧ããéçºã ã£ãã®ã§ã調å€ãã¡ã€ã³ã責任æã£ãŠãããŸãããããšããæŽçã§ãã å°ç° : èªåã®æå±ãæ±è€ãããšåãã«ãªããŸãã çµæŽã¯ã2021 幎 7 æã«ãšã³ãžãã¢ãšããŠå ¥ç€ŸãããããŸã§ãã£ãš Pharms ã®éçºããã£ãŠãŸãã å ¥ç€ŸåŸã¯ã¯ã©ã€ã¢ã³ãèªèšŒæ©èœãæ³äººæ åœè åãã®æ¬éšæ©èœãªã©ã®æ©èœéçºãè¡ã£ãŠããŸããã æšå¹Žãã Pharms ã®ãªãŒããšã³ãžãã¢ãšããŠããŒã å šäœãèŠã€ã€ãPharms ã®æè¡è²¬ä»»è ãšããŠæ±è€ãããšäž¡èŒªã§åããããªåœ¢ã§ãããžã§ã¯ãã®æšé²ã«é¢ãã£ãŠããŸãã å°ç°ãã æéŠ¬ : å»ç PF ãããã¯ãéçºå®€ãæ£è çµ±ååºç€ããŒã ã«æå±ããŠããŸããæ£è çµ±ååºç€ãšã¯ãCLINICSïŒæ£è ã¢ããªïŒãšããã¢ããªã®ããã¯ãšã³ãã·ã¹ãã ã§ããã蚺çæãæ¯ç§å»é¢ãè¬å±åãã®ã·ã¹ãã ãšã®é£æºåºç€ãšããŠãæ©èœããŠãããããã¯ãã«ãªããŸãã çµæŽã¯ããã®ã¡ã³ããŒã®äžã§ã¯äžçªå€ã 2018 幎 3 æã«å ¥ç€ŸããŠãåœå㯠CLINICS ã«ã«ãã®æ©èœæ¡åŒµã®éçºã«åå ããPKI åºç€ã CLINICS ãšãŒãžã§ã³ããå§ããšããä»ç€Ÿã·ã¹ãã ãšã®é£æºåºç€ã®éçºãè¡ã£ãŠããŸããã2020 幎ãããããæ£è çµ±ååºç€ã®ç«ã¡äžãã«åå ããŠãçŸåšã«è³ããŸãã æéŠ¬ãã é äº : å ¥ç€Ÿã¯ 2019 幎 8 æãªã®ã§ã 5 幎ç®ãšãªããŸãã ãã¶ã€ããŒãšããŠå ¥ç€ŸåŸ 1 幎éã¯ãžã§ãã¡ãã¬ãŒã«åšç±ããŠããŸããããã®åŸãªã³ã©ã€ã³èšºçã䌞ã³ãŠããææã«ãªããCLINICS åŽã®ãã¶ã€ããŒã®äººæ°ãè¶³ããªããªã£ãããšããããŸããŠãããããã¯é»åã«ã«ããå«ãã CLINICS ã®ãã¶ã€ã³å šè¬ãæ åœããŠããŸãããå»å¹Žããé»åã«ã«ã以å€ã®æ¥åé åã® PdM ãšããŠæŽ»åããŠããŸãã軞足ã¯ãã¶ã€ããŒãªã®ã§ãããããã¯ãã®ãããžã¡ã³ãã¿ãããªããšããå§ããŠãŸãã ãã®ãããžã§ã¯ãã«ãããŠã¯ããã£ãæ±è€ããããã£ããã£ãéããPharms ã®äŸ¡å€åäžãäžå¿ã®ãããžã§ã¯ããªã®ã§ãããžã§ã¯ãã®äžçªå€§ãããªãŒãã¯æ±è€ããã«ãªãããšæããã§ããã©ãCLINICS ãªã©ã®å»ç§åŽã®ãããžã§ã¯ããªãŒããšèšãç«ã¡äœçœ®ãåã«ãªãããªãšæããŸãã é äºãã å°å³¶ : å»ç PF ãããã¯ãéçºå®€ã® QA ã°ã«ãŒãã«æå±ããŠããŸããQA ã°ã«ãŒãã®ãããŒãžã£ã§ãã 米山 ããã®ã玹ä»ã§ 2022 幎 4 æã«ã¡ãã¬ãŒïŒäººç®ã® QA ãšã³ãžãã¢ãšããŠå ¥ç€ŸããŸãããäž»æ åœã¯ CLINICS ã®äºçŽæ©èœãäžå¿ãšããåšèŸºé åã§ãããããŸã§é äºãããšäžç·ã«åãããŠé ãæ©äŒãå€ããçŽè¿ã§ã¯äºçŽæ¹æ³ãæ¡åŒµããããªã¯ãšã¹ãäºçŽãæ©èœã® QA ãæ åœããŸããã åæäºçŽã«é¢ããŠã¯ãäž»ã«å»ç§åŽã®éšåã® QA ããå§ãŸãã調å€åŽã® QA ãå¿ èŠãšããããšã«ãªããæçµçã«ã¯å šäœã® QA ãæ åœããŸããã å°å³¶ãã åæäºçŽã®æ©èœã解決ããèª²é¡ ââ ããããšãããããŸããæ¬¡ã«ãä»åã®åæäºçŽã«ã€ããŠã©ããã£ãæ©èœã§ãã©ããã£ã課é¡ã解決ããã¹ãããã話ãããã ãããã§ãã æ±è€ : æ©èœãšããŠã¯ã CLINICSïŒæ£è ã¢ããªïŒãããªã³ã©ã€ã³èšºçãäºçŽããéã«ãè¬ã®åãåãå ãšããŠè¬å±ãäºåæå®ã§ããæ©èœ ã«ãªã£ãŠããŸãã ãã®æ©èœã«é¢ä¿ãããã¡ã€ã³ã¯æ£è ã»å»çæ©é¢ã»èª¿å€è¬å±ã®ïŒã€ã§ãã æ£è ãšå»çæ©é¢ã®ã¡ãªãããšããŠã¯ãè¬ã®åŠæ¹ãŸã§ã®æéãæžãããšã§ãã ãªã³ã©ã€ã³èšºçã§ã¯ãæ£è ãå»çæ©é¢ã«çŽæ¥èšªåããããã§ã¯ãªãã®ã§ãè¬ãçŽæ¥è¬å±ã«è¡ã£ãŠåãåãã®ããè¬å±ããé éãåžæããã®ããšãã£ãè¬ã®åãåãæ¹ããå»çæ©é¢ãšæ£è ããã§å£é ã§è©±ããŠæ±ºããŠããã£ãŠããã確èªã«æéãçºçããŠããŸãããæ£è ããã¯å£é ã§è©±ããå å®¹ã«æ²¿ã£ãŠããªã³ã©ã€ã³èšºççµäºåŸã«ãè¬å±ãžã®äºçŽãåã£ãŠããŸããã åæäºçŽæ©èœãå®è£ ãããããšã«ããã蚺å¯ã®äºçŽæã«ã©ã®è¬å±ã§ã©ãããåãåãæ¹ãããŸããšããéšåãæ£è ãããäºåæå®ã§ããããã«ãªã£ãã®ã§ã å»çæ©é¢ã¯äºåçãªè©±ã«æéããããã«èšºå¯ã«éäžã§ãããŸãæ£è ããããå»åž«ã«å£é ã§è¿œå 説æããªããŠãåžæéãã«è¬ãããããããšãããããŒã«å€æŽãããããšãå»çæ©é¢ãšæ£è ã®ã¡ãªãã ã ãšæã£ãŠãŸãã åæäºçŽæ©èœã®ãªãªãŒã¹ååŸã§ã®ãããŒã®éã ããäžã€ã®ãã¡ã€ã³ã§ãã調å€è¬å±ã«ã€ããŠã¯ãåè¿°ã®ããã«èšºå¯ã®äºçŽãããæã«æ£è ãããã¡ãã¬ãŒã®ãµãŒãã¹ã§ãã Pharms ã䜿ã£ãŠããè¬å±ããäºåæå®ãã§ããŸãã®ã§ã ãªã³ã©ã€ã³èšºçåŸã«çºè¡ãããåŠæ¹ç®ã®æµå ¥ãå¢å ããŸã ã 調å€è¬å±ã®å£²ãäžãã¯åŠæ¹ç®ã®ææ° à å䟡ã§å€§éšåãæ±ºãŸããŸãã®ã§ããã®ææ°ãå¢ããããšãã芳ç¹ã§ã¯è¬å±ã«ãšã£ãŠã€ã³ãã¯ãã®ããæ©èœã ãšæã£ãŠããŸãã ââ æ£è ã®äœéšãæ¬åœã«è¯ããªãããæ£è ãšå»çæ©é¢ã®ç¡é§ãªã³ãã¥ãã±ãŒã·ã§ã³ãæžãããã€è¬å±ã«å¯ŸããŠãåŠæ¹ç®ææ°ãå¢ããŠãå°ç·ã楜ã«äœ¿ããããã«ãªã£ãŠãããšããã®ããä»åã®ãããžã§ã¯ãã®èã«ãªã£ãŠããæãã§ãããããããèžãŸãããããã¯ãéãæšªæããŠéçºããªããšãããªããšããã®ã倧å€ããã§ãã éçºãããžã§ã¯ãã«ã€ã㊠ââ ã©ã®ãããªããŒã ããã®æšªæãããžã§ã¯ãã«é¢ãã£ãŠããããæããŠãã ããã æ±è€ : éçºåŽã§èšããšïŒã€ã®ãã¡ã€ã³ã«ãªã£ãŠãŸãã 調å€ãæ£è ãå»ç§ããã㊠æ£è çµ±ååºç€ ã§ããæ£è çµ±ååºç€ãšã¯å»ç PF ã®åãã¡ã€ã³ã«ååšããæ¥åã·ã¹ãã ãšæ£è ã¢ããªãç¹ãæ ¹å¹¹ãšãªããããã¯ãã§ãã ãã ä»åã®æ©èœã¯å»çæ©é¢ã®ãªãã¬ãŒã·ã§ã³ãå€ãããããéçºåŽã§ã®ã¿å®çµãããããžã§ã¯ãã§ã¯ãªããã§ããã ããã«çŸå Žã®éçšã«åããã€ã€ãäœéšãæ¹åã§ãããïŒãšããèŠç¹ã§èãããšãåäºæ¥åŽã®ã«ã¹ã¿ããŒãµã¯ã»ã¹ããŒã ãéèŠã«ãªããŸã ãç¹ã«å»ç§ãšèª¿å€ã®ã«ã¹ã¿ããŒãµã¯ã»ã¹ããŒã ãšã¯ãå¯ã«å£æã¡ãããªããéçºãé²ããŠããŸããã ââ ä»åã®ãããžã§ã¯ãã¯ç¹ã«äºæ¥éšãšã®é¢ä¿æ§ãéèŠãªéµã ã£ããã§ããã æ±è€ : ããã§ãããç¹ã«å»ççŸå Žã¯æ¥åãéŒè¿«ããŠããå Žé¢ãå€ãã§ãã®ã§ãäŸãã°ãã¯ã³ã¯ãªãã¯å¢ããŸãããããã§ããŒãžé·ç§»ãå¢ããŸãããšãã£ãããšã§ãæ¥åãžã®åœ±é¿ãéåžžã«å€§ãããªããŸãã ãŸããªãã¬ãŒã·ã§ãã«ã«çŸå ŽãåããŠããç®æãå€ãããããã¯ãéœåã§åæã«ãã®æ¹ãè¯ããããåççã ããããšæ±ºããŠãããã¯ããäœã£ãŠããŸããšä»ãŸã§ã®çŸå Žãªãã¬ãŒã·ã§ã³ã厩ããŠããŸãæ··ä¹±ãæãããšããããŸãã çŸå Žã®ç¿æ £ãçè§£ããæã ãç®æãå§¿ãšèª¿æŽããªããæé©è§£ãåºã ã®ããå¿ é ã«ãªã£ãŠããæ¥çã»æ¥æ ã ãšæãã®ã§ããã®èª¿æŽã¯äºæ¥éšãšãããªãæ°ãé£ã£ãŠãã£ãŠããŸããã ââ åæäºçŽ Pj ã¯ãéçºåŽãããããšããããšã§å§ãŸã£ããããžã§ã¯ããªãã§ãããã? æ±è€ : ã¯ããããã¯ã¡ãã¬ãŒã®ã©ã®ãããã¯ãããããªã®ã§ãããäºæ¥è²¬ä»»è ãšãããã¯ã責任è ããããããããäºæ¥ãšéçºã®äž¡èгç¹ããè°è«ããäºæ¥æ¹éãæ±ºããŠããããšããäœå¶ããšã£ãŠããŸãã Pharms ãæ£ããæé·ãããŠãããšãã芳ç¹ã§èŠããšãçŸãã§ãŒãºã§ã¯åŠæ¹ç®ããã£ãããšèª¿å€è¬å±ã«å±ããããšãè³äžåœé¡ã§ããããµãŒãã¹ã®ããã¹ãå§¿ãšã¯ïŒãšãã芳ç¹ã§äºæ¥ãšéçºäž¡èŒªã§ãããŸããããšããåœ¢ã§æ±ºãŸã£ããã®ã«ãªããŸãã æšªæãããžã§ã¯ãã§å·¥å€«ããããã€ã³ã ââ ä»åãæšªæã§è²ã ãªéçºãããã¯ããé¢ä¿ããŠããŸããã工倫ããç¹ãšãæ°ãã€ããç¹ãªã©ãã©ããªãã®ããããŸãããã æ±è€ : äžçªã¯åãã¡ã€ã³ã§è¿œã£ãŠããäºæ¥ææãããªãéã£ãŠããŸããã®ã§ããã®èª¿æŽãæéããããŠæŠãåããããç¹ã§ãã äŸãã°ã調å€ã®èгç¹ã§ã¯åŠæ¹ç®ãã¡ãããšè¬å±ã«å±ãããšããã®ãããããéèŠãªäºæ¥ã€ã³ãã¯ãã®å€§ããé ç®ã§ããäžæ¹ã§ãå»çã®èгç¹ã§èŠãæã«ããã¡ããæéãæžããã®ã¯ãããéèŠã§ã¯ãããã§ãããå»çãã¡ã€ã³ãšããŠãã®æ¹åã«èª¿å€ãšåèŠæš¡ã®ã¡ãªãããèŠåºããŠããããããšèšããšåœç¶ããã§ã¯ãªãã£ããããŸãã ããããéšåã§ããã¡ã€ã³éã§ãã®ãããžã§ã¯ããéæããåŸã«åŸãããã¡ãªããã«å·®åãåºãŠããŸããã¡ãªããã倧ããäºæ¥ãããããå·¥æ°ã倧ããå²ããã®ã§ãããã¡ãªããã匱ãäºæ¥ã§ã¯åãã ãå·¥æ°ãããŠãããŸãããããšããæææ±ºå®ã¯é£ãããšæããŸãã ããã§ æ¬ Pj ãéããŠåãã¡ã€ã³ã§ã¯ã©ãããäºæ¥ææãçãã®ãããã®ããã«äœã® KPI ã远ãã®ãããæç¢ºã«ããŸãã ãäºæ¥çãªã¡ãªãããå€ã調å€ã®ããã«æäŒã£ãŠãã ãããšãã圢ã§ã¯ãªããåãã¡ã€ã³ã§ã©ãããã¡ãªãããçãã§ãããŸããïŒãšãããšãããæãããã®ãããããéèŠã ã£ããšæã£ãŠããŸãã ãããæ ããšãã¡ãªããã®åŒ±ãäºæ¥ã«ãšã£ãŠã¯ãæäŒãã¿ãããªãããžã§ã¯ãã«ãªããŸããåçŽã«ãšã³ãžãã¢ãªã³ã°ãšããéšåã§ãé¢çœããã®ã«ãªããªãã§ããããã§ãã®ã§ãé¢ä¿ããå šå¡ã§ãããžã§ã¯ãã宿œããããšã§ã©ãããçµæãåŸãã®ã?ãã¡ãããšåãã¡ã€ã³éã§æããŸããã ââ ãªãã»ã©ããããããšããããæŠãåããã¯æ±è€ãããšé äºããããã£ãŠãããã§ããããã é äº : ã¯ããåã®ã»ãã§è¡ã£ãŠããŸãããåãåæã®ããåããæã«éèŠããŠããã®ã¯ãã¹ã³ãŒããé©åã«åºåããšããéšåã§ããã調å€åŽã®æäŸäŸ¡å€ã®æå€§åã ãã远ã£ãŠåæãã倧ããªæ©èœè¿œå ãè¡ãã®ã§ã¯ãªãã倿Žã«ããå»ç§ã»æ£è ã»èª¿å€ãžäžãããªã¹ã¯ãéçºã³ã¹ããæãã€ã€ã䟡å€ãæå€§åã§ããèœãšãæã¯ã©ããããšããéšåããå·ãåããããŠãããŸããã ã¡ãã¬ãŒãé¢çœããªã£ãŠæãã®ãããããã¯ãåç¬ã§åããŠããããã§ã¯ãªããŠã ãã€ã·ã§ã³ããžã£ãŒããŒ(æ£è äœéš)ãäžå¿ãšããŠããã¿ã¯ã矀ãååšããŠãããšãã ã§ãã æ£è äœéšãããè¯ãæ§ç¯ããããã«ããããã®ãããã¯ããåããŠãããã®ã§ããæäŒããšãããã¥ã¢ã³ã¹ãããªãããããã¯ããè¶ ããŠããã¯ããããŠãããŸããããšèšããæåããããšãããããéšåããªãšæããŸããããããããããéšåããªãšæããŸãã æ±è€ : ç¹ã«æšªæã®ãããžã§ã¯ãã ãšããããç®çæèã®çµ±äžã«äžçªæéã䜿ã£ãŠãè¯ãããããªãããšèããŠããŸãããããæ±ºãŸãããããã°ãåŸã è¿·ã£ãå Žåãç®çã«å³ããæææ±ºå®ãã§ããŸããããããåºããåŸã«åãã¡ã€ã³ã§ã®èª¿æŽãããšããé çªã倧äºã ãšæããŸãã ââ æè¡é¢ã§æ°ãã€ãããã€ã³ãã¯ã©ããªãã®ããã£ããã§ããããã æéŠ¬ : åæäºçŽæ©èœãšããŠããããããšã¯ããã€ã€ã蚺çæåŽã®æ¥åãããŒãæ£è ã®å°ç·ãä»ããã·ã¹ãã ã®å¶çŽãªã©ãèžãŸããã©ã®ãããªåœ¢ã«èœãšã蟌ã㰠蚺çæãè¬å±ãæ£è ã«ãšã£ãŠã䟡å€ã®ããæ©èœãšãªãã ããã€ã³ãã§ãã ã§ãã®ã§ãæè¡çãªé¢ãšäºæ¥çãªé¢ã䜵ããŠèããªãããã·ã¹ãã å šäœã®èŠä»¶ã決ããŠãããšããã®ãæåã«æãããéšåã§ããã ââ æ©èœãèããäžã§ãå šäœãèŠæ®ããèšèšãªã©ããã£ãŠãããšæããã§ãããä»åã¯ã©ãããçæããããã§ãããã?æ£è ã®å°ç·ã ã£ããå»çæ©é¢ã®æ¥åãããŒãªã©ææ¡ããåŸã«ãåãããã£ãéšåãèãããã®ã§ããã æéŠ¬ : åæäºçŽã«ãããã·ã¹ãã å šäœã®èŠä»¶ãåºããŠãããšåæã«ãå šäœã®ã·ãŒã±ã³ã¹ãšã¹ããŒããã·ã³ãäœã£ãŠãããŸãããåã·ã¹ãã éã®é£æºãããŒãšãããã«ããçã¿åºãããäºçŽãåŠæ¹ç®ãšãã£ããšã³ãã£ãã£ã®ç¶æ é·ç§»ã決ããŠããããã®ç¶æ ã®æã¯ãããã£ãããšã¯ã§ããªããšãããããã£ã蟻è€ãåããããšããããã£ãããã£ãŠãã£ããšããæãã§ãããã é äº : ä»åã¯ãç¹ã« ãããã¯ã暪æã®å ±éåºç€ãšããŠãåãããã¯ãã§ããããå šãå¥ç©ã®ä»çµã¿ãã¹ããŒã¿ã¹ãä¿æããŠããã®ããå ±éåã»æœè±¡åãããšããæ¥åãå¿ èŠã«ãªã ã®ã§ããããé£ããããé£æåºŠãé«ãéšåã ãªãšæã£ãŠãããã§ããã©ãããã綺éºã«ã·ãŒã±ã³ã¹å³ã«èœãšã蟌ãã æéŠ¬ãããåããªãšæããŸããã æ±è€ : åºç€åŽã§äœã£ãŠããã ããã·ãŒã±ã³ã¹å³ã¯ UX ã®éªšçµã¿ãªãã§ããããããããããã UX ãã¶ã€ããŒãå¥éãããšãã£ã现ååããããå®è£ ã®å¶éãå å³ãã€ã€ãæ£ããéçšãåãããã«ããã®äœéšãäœãããã«ãã®ã¹ããŒã¿ã¹é·ç§»ã§ããã¹ãã ããããšããéšåãæéЬããããšã³ãžãã¢èгç¹ã§æåã«äœã£ãŠãããŠããšããã®ãã ã¡ãã¬ãŒã®ãšã³ãžãã¢ã®ãšãŠãè¯ãéšå ã ãšæã£ãŠããŸããæè¡ã ãã§ãªã UX ãªã©ã«ãå¿ èŠã§ããã°è¶å¢ããŠãããæåã§ããã åæäºçŽ Pj éçºã®å®é ââ ããããåæãã§ãŒãºãçµãŠ Pharms ãš CLINICS ã©ã¡ãã®éçºã«ãé¢ãã£ãå°ç°ããã«èãããã®ããéçºã®æµãã®äžã§ãããããªãœãŒã¹çãªåé¡ã£ãŠå€§å€ã ã£ããšæãã®ã§ãããããã¯ã©ã解決ãããã§ããããã å°ç° : å ã« Pharms åŽã®æ©èœ ãäœã£ãŠãã®åŸã« CLINICS ã®ä»æ§ã決ããŠããã£ãŠãã CLINICS ã®éçºã«å ¥ãæµãã ã£ãã®ã§éçºã䞊è¡ããããšã¯ãªãã£ãã§ãããã Pharms ã§ã¯ãªãŒããšã³ãžãã¢ãšããç«å Žãªã®ã§ ãCLINICS ã®éçºã«å ¥ãããã®æºåãšãPharms åŽã®ã¬ãã¥ãŒããã©ããŒã®ãªãœãŒã¹é åã¯èªåã§èããŠãåã¿ã¹ã¯ã宿œããæéãšã¿ã€ãã³ã°ã調æŽããªãããã£ãŠããŸããã äžæ¹ã§ããã®äœå¶ã§ãé²ããããšãã§ããã®ã¯ Pharms ããŒã ã®åã¡ã³ããŒãæ¢ã«èªèµ°ã§ããç¶æ ã«ãã£ãã®ã§ãããã«æ¯ããããããããã§ãã ããªãšæã£ãŠãŸãã ââ ãããã¯ããè¶å¢ããªããéçºãããšããæåã¯ãããè¯ããšæã£ãã®ã§ãããããã¯ãããŒãªã©ãã£ãããããã§ãã? æ±è€ : å çšã話ããéã Pharms ãšããŠæ¬ãããžã§ã¯ãã®åªå 床ã¯é«ãã£ãã®ã§ãããCLINICS ã®äºæ¥èšç»ããªãœãŒã¹ãèžãŸãããšå»ç§åŽã®å®è£ çæã倧ããé ããããªèŠç«ãŠã§ãããããã§ãå°ç°ããã å»ç§åŽã®éçºã«ãã¢ãµã€ã³ã§ããããªãœãŒã¹åé¡ã解決ã§ããã®ã§ã¯ãšèª¿æŽããŸãããå»ç§åŽã®ãšã³ãžãã¢ããã®ãã©ããŒã¢ããã¯å¿ èŠãªã®ã§ããã®èª¿æŽããã€ã€ã§ãããéçºãæ©ãããããªãè¯ãããšéçºããŒã éã§æçµçã«å€æããŸããã é äº : ä»ãŸã§è§Šã£ãŠãªãã£ã CLINICS ã®ã·ã¹ãã ã«ãå°ç°ããã¯ã¬ã³ã¬ã³åã蟌ãã§ãã ãã£ãã®ã§ãå ã CLINICS ã®éçºããã£ãŠãã®ã§ã¯ãšæãããããã£ããã¢ãããæ©ãã£ãã§ãã ââ ãããã¯ãã®ã°ããŒã¹ã®ããã«ãªãœãŒã¹èª¿æŽãæåããããšãã圢ã ã£ããã§ããããããã¯ãéã®è¶å¢ããããããããªæåã ã£ããããããžã§ã¯ããæåãããããšããç®ç·åãããèªç¶ã«ã§ããã®ã¯è¯ãã§ããã ããŒã éãšãã話ã§ããã° QA ã¯åããŒã ã«è·šã£ãŠã®æŽ»åã ãšæããŸããããã®èгç¹ã§ã¯ãããã§ãã? å°å³¶ : èªåã¯éçºãçµç€ã«å ¥ã£ãã¿ã€ãã³ã°ã§ãããžã§ã¯ãã«åæµããŸããããããŸã§ã¯ç±³å±±ããã QA ãšããŠå ¥ã£ãŠããã®ã§ãããå»ç§åŽã§ãæ€èšŒãã¹ããã¹ã芳ç¹ã倿°ãã£ãèæ¯ããããå»ç§åŽã® QA ãã¡ã€ã³ã§èŠãæ åœãšããŠåç»ããŸããã åŸåã«åç»ããèæ¯ããããããããåŠæ¹ç®éä»ãšããæ¥åã Pharms ãããã¯ãã®ä»æ§çè§£ãæµ ãâŠãšããç¶æ ã§ãããã éçºç®çã»èŠä»¶å®çŸ©ã»èšèšã詳现ã«ããã¥ã¡ã³ãåãããŠããã®ã§ãã¹ã ãŒãºã«æ€èšŒã«å ¥ãããšãã§ããŸãã ãæ€èšŒã®äžã§ QA ãšã³ãžãã¢ãšããŠãããã®éšåã®ä»æ§ã¯èŠçŽããæ¹ãè¯ããªãããšãããã€ã³ããããã€ãåºãŠããã®ã§ã仿§ã®æ¹åææ¡ãè¡ããŸãããåŸçºåå ã§ããããå®éã«åãå ¥ããŠããã£ãæ¹åãå€ãã§ãã ã¡ãã¬ãŒã®ãããã¯ãéçºã®æåãšã㊠QA ãšã³ãžãã¢ã èŠä»¶å®çŸ©ããã¬ãã¥ãŒã«åå ããããæèŠãèšãã€ã€ãããã¯ããããè¯ãããããã®æ¹åãè¡ãã ã®ã§ããšãŠãåããããã§ããã ââ åŸããå ¥ã£ãŠãåãããããšããã®ã¯ãããã¥ã¡ã³ããªã©ãæŽåãããŠããããã§ããããšã ãšããã®ãåãããŸãããæšªæãããžã§ã¯ãã ããããæ°ãã€ããä»ã®ããŒã ã®è¯ãç¹ãªã©ãã£ããããŸãã? é äº : Pharms ã®ãããžã§ã¯ãã£ãŠããããããªããšæã£ãã®ã KPI èšèšããããæç¢ºãªãšããã ã£ããšããç¹ã§ããã è²ã çŽäœæ²æãã£ãçµæããã«èŸ¿ãçããŠããšããèŠåŽãç¥ã£ãŠã¯ãããã§ããã©ãä»ã® KPI èšèšã£ãŠãã£ã±ããããã·ã³ãã« ã§åŠæ¹ç®éä¿¡æ°ã§ããšãªããšãããããéç®ãã KPI ãå PF ã«æ¯ãã°ãããšèšãäœå¶ã ã£ãã®ã§ããããããã¯ãããããã£ããã€ã³ãã®äžã€ããªãšæããŸãã 話ãè«ç¹ãçµå±ããã£ãŠããéšåããããã³ãã¥ãã±ãŒã·ã§ã³ã³ã¹ããå®ãããã éšåã§ã¯ããããªãšæããŸããã æšªæãããžã§ã¯ããªãã§ã¯ã®ãšã³ãžãã¢ãªã³ã° ââ å šäœã®è©±ããåå¥ã®ãã¡ã€ã³ããšã®ãšã³ãžãã¢ãªã³ã°ãšããç¹ã§ã¯ã©ã®ãããªããšããããŠããŸããã? å°ç° : åºæ¬çã«ã¯æéЬããã®ã·ãŒã±ã³ã¹å³ãå ã«éçºãé²ããŠããŸãããCLINICS ã§ã¯ A ãšããç¶æ ã«ãªãããã®æã« B ãšããã¢ã¯ã·ã§ã³ããããš Pharms ã§ã¯ C ãšããç¶æ ã«ãªããšããããã«ç¶æ é·ç§»ãè€éã ã£ããããèšèšæã«ããã¹ãå§¿ã«è¿·ãããšãå€ãã£ãã®ã§ãããã·ãŒã±ã³ã¹ã«ç«ã¡è¿ããšããã«ãã®çåã解決ãããšãã£ãå ·åã§ãã æéŠ¬ : ã·ãŒã±ã³ã¹ã®æŽåæ§ãé£ãããªããããªãããã«èšèšãã ããšã«ã¯æ°ãã€ããŸããããåæäºçŽããšããèšèãå è¡ãããšã€ãã€ãè€éãªæ°æ©èœã®ãããªãã®ãäœããã¡ã§ããã蚺çæãè¬å±ã®äºçŽæ©èœãåŠæ¹ç®éä¿¡æ©èœãšãã£ãåã ã®ããŒãã¯ããšããšããããã§ããªãã¹ãã·ã³ãã«ã«ããããã€ãªãåãããããããã«å¿ãããŸããã æ±è€ : 现ãããããã¯ãéã®èª¿æŽãå¿ èŠã«ãªãã®ã§ ã¡ãããšèª¿å€ã®æ¬²ãã KPI ãæ±ãã€ã€ããã€çŸå Žã®ãªãã¬ãŒã·ã§ã³å質ãèœãšããªãã£ãŠãã芳ç¹ã§èª¿æŽãåãã¡ã€ã³ã§ãããŸããã 工倫ããããšã§ãããšãUX 調æ»ã培åºãããšããã§ããããã ä»åã®ãµãŒãã¹ã£ãŠæ¥ççã«ã¿ãæã«æ°ããããšãããšããã§ã¯ãªããã§ããããã§ãã®ã§ã忥çã®äŒæ¥ããã®åã¢ããªã®äœéšãšããèªåã§ãçµæ§è²ã 䜿ããªããäœéšããŠã¿ãŸããããããããããŒã¹ã«éã«çŸç¶ã®ãã¡ã®ä»æ§ãèžãŸãããšããããã颚ã«ãã¡ã§ã¯å®è£ ããŸãããã¿ãããªãšãããè²ã ãã£ãŠããŸããã å°ç° : ãšã³ãžãã¢ãªã³ã°ã®èгç¹ã§ãããšãç¹ã«æ£è ã¢ããªããŒã ãšã® API 飿ºã®ä»æ§èª¿æŽãšãéçºã®é²ãæ¹ã¯å¯ã«é£æºããªããé²ããŸãããå ã«ãã£ã¡ãã§ããŠãªããšåãããéçºã§ããªãç¶æ ã«ãªãã®ã§ãæ åœè å士ã§ã³ãã¥ãã±ãŒã·ã§ã³ãšãã€ã€ã工倫ããªããé²ããŠããŸããã é äº : CLINICS ã§æ°ã«ããŠãéšåã¯ã©ã¡ãããšãããš ãªã¹ã¯ãšã³ã¹ãã®éšåãããã«æå°åããŠäŸ¡å€ãæå€§åããããäžçªéèŠ ããªãšæã£ãŠããã®ã§ãäžçªå€§äºãªã®ã¯ãã£ã±ãå»ç§ã«ãšã£ãŠã©ããã䟡å€ãåºãŠãå»ç§ã«ãšã£ãŠã©ããããªã¹ã¯ãçºçããããèããŠãŸããã äŸãã°äžçªæåã®ããåããã§è¬å±äºçŽããæã«æ¥æãŸã§ç¢ºå®ãããŸããããšãã話ããã£ããã§ããã©ããããŸã§ã¹ã³ãŒããåºããªããŠãã¡ãªãããåºãã®ã§ããã°ãåºããããªãã§ããšãã話ãããŠããŸããã ããšã¯ãªãªãŒã¹ãã©ã³ã®çå®ãšãããªïŒå šå»çæ©é¢ã«äžæã«åºãã®ã§ã¯ãªãããŸãã¯äžéšå»çæ©é¢æ§ã ãã«å ¬éãããªãªãŒã¹æ¹åŒã«ããŸãããã¿ãããªãšãããå«ããŠã§ããããå»ç§åŽã§äžæŠãã¹ãããã£ãŠæ€èšŒããŠãã¹ã ãŒãºã«æ©èœã䜿ãããšããã確èªãããããã¹ããããèšããŸããããšå®å šçãåããªããé²ããŸããã ããã¯ãã®ãããžã§ã¯ãã«é¢ããããã©ããªãããžã§ã¯ãã§ãäžçªéèŠã§ãããåŸããã²ã£ããè¿ãã®ãäžçªææ»ãã«ãªã£ãŠããã®ã§ãããã¯éèŠããªãšæããªããé²ããŠãŸãããã å°å³¶ : QA èŠç¹ã ãšæšªæãããžã§ã¯ãããã«ã¹ããŒããæ¬åœã«è€éã§ãã¡ãã¬ãŒå ¥ç€ŸåŸã«çµéšãããããžã§ã¯ãã®äžã§æ€èšŒã®é£æåºŠãæãé«ãã£ãã§ããã ã§ãããçããä»°ãããŠããããã«åãŠãŒã¹ã±ãŒã¹ã«å¯Ÿããèšèšãå³ã§ããã¥ã¡ã³ãåãããŠããã®ã§ããã¹ãã±ãŒã¹ãšããŠè»¢çšã§ããéšåãå€ããããŸãããæéЬãããäœæããèšèšå³ããã£ãããããæŒããªããã¹ãã§ããéšåã¯å€§ããã§ãã倧å¢ãåå ãããããžã§ã¯ãã«ãããŠãå šå¡ãèªèåãããäžã§ãèšèšå³ã¯æ¬åœã«å€§äºã ãªãšçæããŸããã 工倫ããç¹ãšããŠã¯ãå°ç°ãã㯠Pharms éçºã®ãã¡ã€ã³ç¥èãè±å¯ã ã£ãã®ã§ãQA æã¯ Pharms åŽãã¡ã€ã³ã«èŠãŠãããã€ã€ãèªå㯠CLINICS åŽã® QA ãæåãèŠãããã«ããŸãããã©ã¡ãã®ãã¡ã€ã³ã«ãé¢ä¿ããå¥çŽãã©ã³çã®è€éãªä»æ§ã¯èªåãæ åœããŸããã QA 以å€ã®é¢ã ãšããªãªãŒã¹ããäžã§å¿ èŠãªæµ®ããããŒã«ãããã°ç©æ¥µçã«åãã«ããããã«ããŸããã äŸãã°ããããŸã§äžéšã®å»çæ©é¢æ§ã ãã«æ©èœãªãªãŒã¹ããå Žåããã®åŸã®ãã£ãŒãããã¯ååã¯ã¡ãŒã«ãé¢è«ã§åå¥ã«è¡ã£ãŠããŸããããæ¥ã ã®èšºçã®äžã§ãæéã確ä¿é ãã®ãé£ãããšããç¶æ³ããããŸããããã®çµæãæ¬ Pj ã«ãããŠãå šäœãªãªãŒã¹ããŠåé¡ãªããïŒã®å€æããã¥ããææããããŸããã ããã§ Google ãã©ãŒã ã§ã¢ã³ã±ãŒããäœæããŠçæéã§åçã§ãã圢ã«åãæ¿ããŸãããçµæçã« 100% åçãåŸãããšãã§ããŸããã ã¢ã³ã±ãŒãçµæãããåŸæ¥æ©èœãã䟡å€ããããé¢å ãªãã¬ãŒã·ã§ã³ã«çµã¿èŸŒãã§é ãã³ã¹ãããããŸã§é«ããªãããšããç¹ãè©äŸ¡ã§ããã®ã§ãèªä¿¡ãæã£ãŠå šäœå ¬éãªãªãŒã¹ã«åã㊠GO å€å®ã§ããŸããã** ã¡ãã¬ãŒã¯åœ¹å²ã«çžãããããŒã«ãä»»ããŠé ããç°å¢ãããã®ã§ãèªåã®å°éé å以å€ã®ããšãåŠã¹ãŠãã**ãšæãããšãå€ãã§ãã 幞ããªãªãŒã¹åŸã倧ããªäžå ·åã¯ãªãã®ã§ããã¯ããçããã®ãããã§ããã åæäºçŽ Pj ãçµã㊠ââ ã§ã¯æåŸã«ãã®ãããžã§ã¯ãã®ç·æ¬ãããŠãã ããã°ã æ±è€ : 暪æã§ã¯ãããã©åãã¡ã€ã³ã§ããããã®ãããã§ãã·ã§ãã«ãã¡ãããšåãçºæ®ããŠãããžã§ã¯ããããåãããšããã®ã¯ããã倧ããè³ç£ã§ããã å»ç PF ã¯ã¢ã»ãããããããæã£ãŠããã®ã§ãè²ã çµã¿åããããšãä»ã®äŒç€Ÿã ãšã§ããªããã©ããã¡ãªãã§ãããã ããã¿ãããªããšãè²ã ãã ãã§ãã ãªã®ã§ããã®åŸã暪æãããžã§ã¯ãã¯äºå®ãããŠããŸãããããã«å é§ããŠã²ãšã€ãããã£ãŠããã€åããæ¬²ããã£ãæåŸ ææãçŸç¶åºããŠãããšãããå«ãããšãããè¯ãäžæ©ã ã£ãã®ããªããšæã£ãŠãŸãã æ¬¡ã¯åè³ªãæ ä¿ãã€ã€ããã£ãšã¹ããŒããäžããŠãããããšããã®ã芳ç¹ãšããŠå€§ããã§ããã ââ ãªãã»ã©ãããããæšªæãããžã§ã¯ãããã£ãŠããå»ç PF ã§ã¯ã©ããªãšã³ãžãã¢ãããããããã€ã³ãã§ããã? æéЬ : æè¡ãšäœµããŠãŠãŒã¶ãŒãžã®äŸ¡å€æäŸãèããªãããšã³ãžãã¢ãªã³ã°ããã人ããããããã®ã§ã¯ãªãããšæããŸãã ââ åãããã¯ãã®æã£ãŠãã圹å²ãèžãŸããŠã俯ç°ã®èŠç¹ã§éçºãããããšããæ¹ã«ã¯ãããé åçã§ãããæ¬æ¥ã¯ããããšãããããŸããã ãããã« åæäºçŽ Pj ã«ã€ããŠããããžã§ã¯ããæšé²ããã¡ã³ããŒã«è©±ãèããŸããããè€éãªèŠä»¶ãå®çŸå¯èœãªåœ¢ã«ããŠåããŒã ã§å£æ ¹ãè¶ããŠéçºãããŠããæ§åããšãŠãå°è±¡çã§ãããç¹ã«å»ç PF ã§ã¯ãã¡ã€ã³åå£«ã§ææ©çã«çµåããŠãããã³ã©ãã¬ãŒã·ã§ã³ããããšã«ããã¹ããŒã¯ãã«ããŒãžã®äŸ¡å€ãé«ããŠãããšããã®ã¯ããããããããã®ã§ã¯ãªãããšæããŸãã ãã®ãããªãããžã§ã¯ãã§åãçºæ®ããããšæã£ãæ¹ã¯ãã²ããæ°è»œã«ã話ãããŸããã! åéã®äžèЧ | æ ªåŒäŒç€Ÿã¡ãã¬ãŒ ã¡ãã¬ãŒã®æ¡çšæ å ±ã¯ãã¡ãããã確èªãã ããã www.medley.jp
æ ªåŒäŒç€Ÿã¡ãã¬ãŒ
2024/02/29
<![CDATA[ è€æ°ãããã¯ã暪æãããããžã§ã¯ããã©ããã£ãŠæåãããã®ãã¡ã³ããŒã«èããŠã¿ãŸãã ]]>
ã¯ããã« ã¿ãªãããããã«ã¡ã¯ããšã³ãžãã¢ã®å€å·ã§ãã ä»å㯠CLINICS / Pharms åæäºçŽãããžã§ã¯ã(以äžãåæäºçŽ Pj)ãšãããããã¯ã暪æã§æ§ã ãªéšçœ²ãé¢ãã£ãéçºãããžã§ã¯ãã«ã€ããŠãå°œåãããçããã«åº§è«äŒåœ¢åŒã§ã話ã䌺ããŸããã ã¡ãã¬ãŒã®å»çãã©ãããã©ãŒã (以äžãå»ç PF)ã§ã©ã®ããã«ããããæšªæãããžã§ã¯ããå®éããã®ãã®æ§åãçããã«ç¥ã£ãŠããããã°ãšæããŸãã 察è«ã¡ã³ããŒçŽ¹ä» ââ ã¯ããã«ãçããã®èªå·±ç޹ä»ããé¡ãããŸãã æ±è€ : æå±ã¯å»ç PF ã®ãããã¯ãéçºå®€ã® Pharms éçºããŒã ã§ãã 圹å²ãšããŠã¯èª¿å€è¬å±åãã®ã·ã¹ãã ã® Pharms ã®ãããã¯ããªãŒããŒãæ ã£ãŠããŸãã çµæŽãšããŠã¯ã2021 幎㮠1 æãã Pharms ã®ã«ã¹ã¿ããŒãµã¯ã»ã¹ãšããŠã¡ãã¬ãŒã«ãžã§ã€ã³ããŸããŠã2023 幎 1 æããéçºããŒã ã«æ¥ãŸããã ãããŸã§ã¯äºæ¥åŽã®çµéšãé·ããå¶æ¥å šè¬ãäºæ¥éçºãã¡ã€ã³ã§ãã£ãŠãããã£ãªã¢ã§ãã ãã®ãããžã§ã¯ãã® PO ãšããŠãªãŒãããåããããŠãããPharms ãæ ã調å€åŽã®ãªãŒãã«å ããŠãå šäœã®ææ¯ãã調æŽçã䞻軞ã«ãã£ãŠããŸããã æ±è€ãã ââ æ±è€ããããããžã§ã¯ãã®äžå¿ãšãªã£ãŠæšé²ãããã§ããã æ±è€ : 調å€ãã¡ã€ã³ã® Pharms ã«ãšã£ãŠäºæ¥ã€ã³ãã¯ããããã倧ããéçºã ã£ãã®ã§ã調å€ãã¡ã€ã³ã責任æã£ãŠãããŸãããããšããæŽçã§ãã å°ç° : èªåã®æå±ãæ±è€ãããšåãã«ãªããŸãã çµæŽã¯ã2021 幎 7 æã«ãšã³ãžãã¢ãšããŠå ¥ç€ŸãããããŸã§ãã£ãš Pharms ã®éçºããã£ãŠãŸãã å ¥ç€ŸåŸã¯ã¯ã©ã€ã¢ã³ãèªèšŒæ©èœãæ³äººæ åœè åãã®æ¬éšæ©èœãªã©ã®æ©èœéçºãè¡ã£ãŠããŸããã æšå¹Žãã Pharms ã®ãªãŒããšã³ãžãã¢ãšããŠããŒã å šäœãèŠã€ã€ãPharms ã®æè¡è²¬ä»»è ãšããŠæ±è€ãããšäž¡èŒªã§åããããªåœ¢ã§ãããžã§ã¯ãã®æšé²ã«é¢ãã£ãŠããŸãã å°ç°ãã æéŠ¬ : å»ç PF ãããã¯ãéçºå®€ãæ£è çµ±ååºç€ããŒã ã«æå±ããŠããŸããæ£è çµ±ååºç€ãšã¯ãCLINICSïŒæ£è ã¢ããªïŒãšããã¢ããªã®ããã¯ãšã³ãã·ã¹ãã ã§ããã蚺çæãæ¯ç§å»é¢ãè¬å±åãã®ã·ã¹ãã ãšã®é£æºåºç€ãšããŠãæ©èœããŠãããããã¯ãã«ãªããŸãã çµæŽã¯ããã®ã¡ã³ããŒã®äžã§ã¯äžçªå€ã 2018 幎 3 æã«å ¥ç€ŸããŠãåœå㯠CLINICS ã«ã«ãã®æ©èœæ¡åŒµã®éçºã«åå ããPKI åºç€ã CLINICS ãšãŒãžã§ã³ããå§ããšããä»ç€Ÿã·ã¹ãã ãšã®é£æºåºç€ã®éçºãè¡ã£ãŠããŸããã2020 幎ãããããæ£è çµ±ååºç€ã®ç«ã¡äžãã«åå ããŠãçŸåšã«è³ããŸãã æéŠ¬ãã é äº : å ¥ç€Ÿã¯ 2019 幎 8 æãªã®ã§ã 5 幎ç®ãšãªããŸãã ãã¶ã€ããŒãšããŠå ¥ç€ŸåŸ 1 幎éã¯ãžã§ãã¡ãã¬ãŒã«åšç±ããŠããŸããããã®åŸãªã³ã©ã€ã³èšºçã䌞ã³ãŠããææã«ãªããCLINICS åŽã®ãã¶ã€ããŒã®äººæ°ãè¶³ããªããªã£ãããšããããŸããŠãããããã¯é»åã«ã«ããå«ãã CLINICS ã®ãã¶ã€ã³å šè¬ãæ åœããŠããŸãããå»å¹Žããé»åã«ã«ã以å€ã®æ¥åé åã® PdM ãšããŠæŽ»åããŠããŸãã軞足ã¯ãã¶ã€ããŒãªã®ã§ãããããã¯ãã®ãããžã¡ã³ãã¿ãããªããšããå§ããŠãŸãã ãã®ãããžã§ã¯ãã«ãããŠã¯ããã£ãæ±è€ããããã£ããã£ãéããPharms ã®äŸ¡å€åäžãäžå¿ã®ãããžã§ã¯ããªã®ã§ãããžã§ã¯ãã®äžçªå€§ãããªãŒãã¯æ±è€ããã«ãªãããšæããã§ããã©ãCLINICS ãªã©ã®å»ç§åŽã®ãããžã§ã¯ããªãŒããšèšãç«ã¡äœçœ®ãåã«ãªãããªãšæããŸãã é äºãã å°å³¶ : å»ç PF ãããã¯ãéçºå®€ã® QA ã°ã«ãŒãã«æå±ããŠããŸããQA ã°ã«ãŒãã®ãããŒãžã£ã§ãã 米山 ããã®ã玹ä»ã§ 2022 幎 4 æã«ã¡ãã¬ãŒïŒäººç®ã® QA ãšã³ãžãã¢ãšããŠå ¥ç€ŸããŸãããäž»æ åœã¯ CLINICS ã®äºçŽæ©èœãäžå¿ãšããåšèŸºé åã§ãããããŸã§é äºãããšäžç·ã«åãããŠé ãæ©äŒãå€ããçŽè¿ã§ã¯äºçŽæ¹æ³ãæ¡åŒµããããªã¯ãšã¹ãäºçŽãæ©èœã® QA ãæ åœããŸããã åæäºçŽã«é¢ããŠã¯ãäž»ã«å»ç§åŽã®éšåã® QA ããå§ãŸãã調å€åŽã® QA ãå¿ èŠãšããããšã«ãªããæçµçã«ã¯å šäœã® QA ãæ åœããŸããã å°å³¶ãã åæäºçŽã®æ©èœã解決ããèª²é¡ ââ ããããšãããããŸããæ¬¡ã«ãä»åã®åæäºçŽã«ã€ããŠã©ããã£ãæ©èœã§ãã©ããã£ã課é¡ã解決ããã¹ãããã話ãããã ãããã§ãã æ±è€ : æ©èœãšããŠã¯ã CLINICSïŒæ£è ã¢ããªïŒãããªã³ã©ã€ã³èšºçãäºçŽããéã«ãè¬ã®åãåãå ãšããŠè¬å±ãäºåæå®ã§ããæ©èœ ã«ãªã£ãŠããŸãã ãã®æ©èœã«é¢ä¿ãããã¡ã€ã³ã¯æ£è ã»å»çæ©é¢ã»èª¿å€è¬å±ã®ïŒã€ã§ãã æ£è ãšå»çæ©é¢ã®ã¡ãªãããšããŠã¯ãè¬ã®åŠæ¹ãŸã§ã®æéãæžãããšã§ãã ãªã³ã©ã€ã³èšºçã§ã¯ãæ£è ãå»çæ©é¢ã«çŽæ¥èšªåããããã§ã¯ãªãã®ã§ãè¬ãçŽæ¥è¬å±ã«è¡ã£ãŠåãåãã®ããè¬å±ããé éãåžæããã®ããšãã£ãè¬ã®åãåãæ¹ããå»çæ©é¢ãšæ£è ããã§å£é ã§è©±ããŠæ±ºããŠããã£ãŠããã確èªã«æéãçºçããŠããŸãããæ£è ããã¯å£é ã§è©±ããå å®¹ã«æ²¿ã£ãŠããªã³ã©ã€ã³èšºççµäºåŸã«ãè¬å±ãžã®äºçŽãåã£ãŠããŸããã åæäºçŽæ©èœãå®è£ ãããããšã«ããã蚺å¯ã®äºçŽæã«ã©ã®è¬å±ã§ã©ãããåãåãæ¹ãããŸããšããéšåãæ£è ãããäºåæå®ã§ããããã«ãªã£ãã®ã§ã å»çæ©é¢ã¯äºåçãªè©±ã«æéããããã«èšºå¯ã«éäžã§ãããŸãæ£è ããããå»åž«ã«å£é ã§è¿œå 説æããªããŠãåžæéãã«è¬ãããããããšãããããŒã«å€æŽãããããšãå»çæ©é¢ãšæ£è ã®ã¡ãªãã ã ãšæã£ãŠãŸãã åæäºçŽæ©èœã®ãªãªãŒã¹ååŸã§ã®ãããŒã®éã ããäžã€ã®ãã¡ã€ã³ã§ãã調å€è¬å±ã«ã€ããŠã¯ãåè¿°ã®ããã«èšºå¯ã®äºçŽãããæã«æ£è ãããã¡ãã¬ãŒã®ãµãŒãã¹ã§ãã Pharms ã䜿ã£ãŠããè¬å±ããäºåæå®ãã§ããŸãã®ã§ã ãªã³ã©ã€ã³èšºçåŸã«çºè¡ãããåŠæ¹ç®ã®æµå ¥ãå¢å ããŸã ã 調å€è¬å±ã®å£²ãäžãã¯åŠæ¹ç®ã®ææ° à å䟡ã§å€§éšåãæ±ºãŸããŸãã®ã§ããã®ææ°ãå¢ããããšãã芳ç¹ã§ã¯è¬å±ã«ãšã£ãŠã€ã³ãã¯ãã®ããæ©èœã ãšæã£ãŠããŸãã ââ æ£è ã®äœéšãæ¬åœã«è¯ããªãããæ£è ãšå»çæ©é¢ã®ç¡é§ãªã³ãã¥ãã±ãŒã·ã§ã³ãæžãããã€è¬å±ã«å¯ŸããŠãåŠæ¹ç®ææ°ãå¢ããŠãå°ç·ã楜ã«äœ¿ããããã«ãªã£ãŠãããšããã®ããä»åã®ãããžã§ã¯ãã®èã«ãªã£ãŠããæãã§ãããããããèžãŸãããããã¯ãéãæšªæããŠéçºããªããšãããªããšããã®ã倧å€ããã§ãã éçºãããžã§ã¯ãã«ã€ã㊠ââ ã©ã®ãããªããŒã ããã®æšªæãããžã§ã¯ãã«é¢ãã£ãŠããããæããŠãã ããã æ±è€ : éçºåŽã§èšããšïŒã€ã®ãã¡ã€ã³ã«ãªã£ãŠãŸãã 調å€ãæ£è ãå»ç§ããã㊠æ£è çµ±ååºç€ ã§ããæ£è çµ±ååºç€ãšã¯å»ç PF ã®åãã¡ã€ã³ã«ååšããæ¥åã·ã¹ãã ãšæ£è ã¢ããªãç¹ãæ ¹å¹¹ãšãªããããã¯ãã§ãã ãã ä»åã®æ©èœã¯å»çæ©é¢ã®ãªãã¬ãŒã·ã§ã³ãå€ãããããéçºåŽã§ã®ã¿å®çµãããããžã§ã¯ãã§ã¯ãªããã§ããã ããã«çŸå Žã®éçšã«åããã€ã€ãäœéšãæ¹åã§ãããïŒãšããèŠç¹ã§èãããšãåäºæ¥åŽã®ã«ã¹ã¿ããŒãµã¯ã»ã¹ããŒã ãéèŠã«ãªããŸã ãç¹ã«å»ç§ãšèª¿å€ã®ã«ã¹ã¿ããŒãµã¯ã»ã¹ããŒã ãšã¯ãå¯ã«å£æã¡ãããªããéçºãé²ããŠããŸããã ââ ä»åã®ãããžã§ã¯ãã¯ç¹ã«äºæ¥éšãšã®é¢ä¿æ§ãéèŠãªéµã ã£ããã§ããã æ±è€ : ããã§ãããç¹ã«å»ççŸå Žã¯æ¥åãéŒè¿«ããŠããå Žé¢ãå€ãã§ãã®ã§ãäŸãã°ãã¯ã³ã¯ãªãã¯å¢ããŸãããããã§ããŒãžé·ç§»ãå¢ããŸãããšãã£ãããšã§ãæ¥åãžã®åœ±é¿ãéåžžã«å€§ãããªããŸãã ãŸããªãã¬ãŒã·ã§ãã«ã«çŸå ŽãåããŠããç®æãå€ãããããã¯ãéœåã§åæã«ãã®æ¹ãè¯ããããåççã ããããšæ±ºããŠãããã¯ããäœã£ãŠããŸããšä»ãŸã§ã®çŸå Žãªãã¬ãŒã·ã§ã³ã厩ããŠããŸãæ··ä¹±ãæãããšããããŸãã çŸå Žã®ç¿æ £ãçè§£ããæã ãç®æãå§¿ãšèª¿æŽããªããæé©è§£ãåºã ã®ããå¿ é ã«ãªã£ãŠããæ¥çã»æ¥æ ã ãšæãã®ã§ããã®èª¿æŽã¯äºæ¥éšãšãããªãæ°ãé£ã£ãŠãã£ãŠããŸããã ââ åæäºçŽ Pj ã¯ãéçºåŽãããããšããããšã§å§ãŸã£ããããžã§ã¯ããªãã§ãããã? æ±è€ : ã¯ããããã¯ã¡ãã¬ãŒã®ã©ã®ãããã¯ãããããªã®ã§ãããäºæ¥è²¬ä»»è ãšãããã¯ã責任è ããããããããäºæ¥ãšéçºã®äž¡èгç¹ããè°è«ããäºæ¥æ¹éãæ±ºããŠããããšããäœå¶ããšã£ãŠããŸãã Pharms ãæ£ããæé·ãããŠãããšãã芳ç¹ã§èŠããšãçŸãã§ãŒãºã§ã¯åŠæ¹ç®ããã£ãããšèª¿å€è¬å±ã«å±ããããšãè³äžåœé¡ã§ããããµãŒãã¹ã®ããã¹ãå§¿ãšã¯ïŒãšãã芳ç¹ã§äºæ¥ãšéçºäž¡èŒªã§ãããŸããããšããåœ¢ã§æ±ºãŸã£ããã®ã«ãªããŸãã æšªæãããžã§ã¯ãã§å·¥å€«ããããã€ã³ã ââ ä»åãæšªæã§è²ã ãªéçºãããã¯ããé¢ä¿ããŠããŸããã工倫ããç¹ãšãæ°ãã€ããç¹ãªã©ãã©ããªãã®ããããŸãããã æ±è€ : äžçªã¯åãã¡ã€ã³ã§è¿œã£ãŠããäºæ¥ææãããªãéã£ãŠããŸããã®ã§ããã®èª¿æŽãæéããããŠæŠãåããããç¹ã§ãã äŸãã°ã調å€ã®èгç¹ã§ã¯åŠæ¹ç®ãã¡ãããšè¬å±ã«å±ãããšããã®ãããããéèŠãªäºæ¥ã€ã³ãã¯ãã®å€§ããé ç®ã§ããäžæ¹ã§ãå»çã®èгç¹ã§èŠãæã«ããã¡ããæéãæžããã®ã¯ãããéèŠã§ã¯ãããã§ãããå»çãã¡ã€ã³ãšããŠãã®æ¹åã«èª¿å€ãšåèŠæš¡ã®ã¡ãªãããèŠåºããŠããããããšèšããšåœç¶ããã§ã¯ãªãã£ããããŸãã ããããéšåã§ããã¡ã€ã³éã§ãã®ãããžã§ã¯ããéæããåŸã«åŸãããã¡ãªããã«å·®åãåºãŠããŸããã¡ãªããã倧ããäºæ¥ãããããå·¥æ°ã倧ããå²ããã®ã§ãããã¡ãªããã匱ãäºæ¥ã§ã¯åãã ãå·¥æ°ãããŠãããŸãããããšããæææ±ºå®ã¯é£ãããšæããŸãã ããã§ æ¬ Pj ãéããŠåãã¡ã€ã³ã§ã¯ã©ãããäºæ¥ææãçãã®ãããã®ããã«äœã® KPI ã远ãã®ãããæç¢ºã«ããŸãã ãäºæ¥çãªã¡ãªãããå€ã調å€ã®ããã«æäŒã£ãŠãã ãããšãã圢ã§ã¯ãªããåãã¡ã€ã³ã§ã©ãããã¡ãªãããçãã§ãããŸããïŒãšãããšãããæãããã®ãããããéèŠã ã£ããšæã£ãŠããŸãã ãããæ ããšãã¡ãªããã®åŒ±ãäºæ¥ã«ãšã£ãŠã¯ãæäŒãã¿ãããªãããžã§ã¯ãã«ãªããŸããåçŽã«ãšã³ãžãã¢ãªã³ã°ãšããéšåã§ãé¢çœããã®ã«ãªããªãã§ããããã§ãã®ã§ãé¢ä¿ããå šå¡ã§ãããžã§ã¯ãã宿œããããšã§ã©ãããçµæãåŸãã®ã?ãã¡ãããšåãã¡ã€ã³éã§æããŸããã ââ ãªãã»ã©ããããããšããããæŠãåããã¯æ±è€ãããšé äºããããã£ãŠãããã§ããããã é äº : ã¯ããåã®ã»ãã§è¡ã£ãŠããŸãããåãåæã®ããåããæã«éèŠããŠããã®ã¯ãã¹ã³ãŒããé©åã«åºåããšããéšåã§ããã調å€åŽã®æäŸäŸ¡å€ã®æå€§åã ãã远ã£ãŠåæãã倧ããªæ©èœè¿œå ãè¡ãã®ã§ã¯ãªãã倿Žã«ããå»ç§ã»æ£è ã»èª¿å€ãžäžãããªã¹ã¯ãéçºã³ã¹ããæãã€ã€ã䟡å€ãæå€§åã§ããèœãšãæã¯ã©ããããšããéšåããå·ãåããããŠãããŸããã ã¡ãã¬ãŒãé¢çœããªã£ãŠæãã®ãããããã¯ãåç¬ã§åããŠããããã§ã¯ãªããŠã ãã€ã·ã§ã³ããžã£ãŒããŒ(æ£è äœéš)ãäžå¿ãšããŠããã¿ã¯ã矀ãååšããŠãããšãã ã§ãã æ£è äœéšãããè¯ãæ§ç¯ããããã«ããããã®ãããã¯ããåããŠãããã®ã§ããæäŒããšãããã¥ã¢ã³ã¹ãããªãããããã¯ããè¶ ããŠããã¯ããããŠãããŸããããšèšããæåããããšãããããéšåããªãšæããŸããããããããããéšåããªãšæããŸãã æ±è€ : ç¹ã«æšªæã®ãããžã§ã¯ãã ãšããããç®çæèã®çµ±äžã«äžçªæéã䜿ã£ãŠãè¯ãããããªãããšèããŠããŸãããããæ±ºãŸãããããã°ãåŸã è¿·ã£ãå Žåãç®çã«å³ããæææ±ºå®ãã§ããŸããããããåºããåŸã«åãã¡ã€ã³ã§ã®èª¿æŽãããšããé çªã倧äºã ãšæããŸãã ââ æè¡é¢ã§æ°ãã€ãããã€ã³ãã¯ã©ããªãã®ããã£ããã§ããããã æéŠ¬ : åæäºçŽæ©èœãšããŠããããããšã¯ããã€ã€ã蚺çæåŽã®æ¥åãããŒãæ£è ã®å°ç·ãä»ããã·ã¹ãã ã®å¶çŽãªã©ãèžãŸããã©ã®ãããªåœ¢ã«èœãšã蟌ã㰠蚺çæãè¬å±ãæ£è ã«ãšã£ãŠã䟡å€ã®ããæ©èœãšãªãã ããã€ã³ãã§ãã ã§ãã®ã§ãæè¡çãªé¢ãšäºæ¥çãªé¢ã䜵ããŠèããªãããã·ã¹ãã å šäœã®èŠä»¶ã決ããŠãããšããã®ãæåã«æãããéšåã§ããã ââ æ©èœãèããäžã§ãå šäœãèŠæ®ããèšèšãªã©ããã£ãŠãããšæããã§ãããä»åã¯ã©ãããçæããããã§ãããã?æ£è ã®å°ç·ã ã£ããå»çæ©é¢ã®æ¥åãããŒãªã©ææ¡ããåŸã«ãåãããã£ãéšåãèãããã®ã§ããã æéŠ¬ : åæäºçŽã«ãããã·ã¹ãã å šäœã®èŠä»¶ãåºããŠãããšåæã«ãå šäœã®ã·ãŒã±ã³ã¹ãšã¹ããŒããã·ã³ãäœã£ãŠãããŸãããåã·ã¹ãã éã®é£æºãããŒãšãããã«ããçã¿åºãããäºçŽãåŠæ¹ç®ãšãã£ããšã³ãã£ãã£ã®ç¶æ é·ç§»ã決ããŠããããã®ç¶æ ã®æã¯ãããã£ãããšã¯ã§ããªããšãããããã£ã蟻è€ãåããããšããããã£ãããã£ãŠãã£ããšããæãã§ãããã é äº : ä»åã¯ãç¹ã« ãããã¯ã暪æã®å ±éåºç€ãšããŠãåãããã¯ãã§ããããå šãå¥ç©ã®ä»çµã¿ãã¹ããŒã¿ã¹ãä¿æããŠããã®ããå ±éåã»æœè±¡åãããšããæ¥åãå¿ èŠã«ãªã ã®ã§ããããé£ããããé£æåºŠãé«ãéšåã ãªãšæã£ãŠãããã§ããã©ãããã綺éºã«ã·ãŒã±ã³ã¹å³ã«èœãšã蟌ãã æéŠ¬ãããåããªãšæããŸããã æ±è€ : åºç€åŽã§äœã£ãŠããã ããã·ãŒã±ã³ã¹å³ã¯ UX ã®éªšçµã¿ãªãã§ããããããããããã UX ãã¶ã€ããŒãå¥éãããšãã£ã现ååããããå®è£ ã®å¶éãå å³ãã€ã€ãæ£ããéçšãåãããã«ããã®äœéšãäœãããã«ãã®ã¹ããŒã¿ã¹é·ç§»ã§ããã¹ãã ããããšããéšåãæéЬããããšã³ãžãã¢èгç¹ã§æåã«äœã£ãŠãããŠããšããã®ãã ã¡ãã¬ãŒã®ãšã³ãžãã¢ã®ãšãŠãè¯ãéšå ã ãšæã£ãŠããŸããæè¡ã ãã§ãªã UX ãªã©ã«ãå¿ èŠã§ããã°è¶å¢ããŠãããæåã§ããã åæäºçŽ Pj éçºã®å®é ââ ããããåæãã§ãŒãºãçµãŠ Pharms ãš CLINICS ã©ã¡ãã®éçºã«ãé¢ãã£ãå°ç°ããã«èãããã®ããéçºã®æµãã®äžã§ãããããªãœãŒã¹çãªåé¡ã£ãŠå€§å€ã ã£ããšæãã®ã§ãããããã¯ã©ã解決ãããã§ããããã å°ç° : å ã« Pharms åŽã®æ©èœ ãäœã£ãŠãã®åŸã« CLINICS ã®ä»æ§ã決ããŠããã£ãŠãã CLINICS ã®éçºã«å ¥ãæµãã ã£ãã®ã§éçºã䞊è¡ããããšã¯ãªãã£ãã§ãããã Pharms ã§ã¯ãªãŒããšã³ãžãã¢ãšããç«å Žãªã®ã§ ãCLINICS ã®éçºã«å ¥ãããã®æºåãšãPharms åŽã®ã¬ãã¥ãŒããã©ããŒã®ãªãœãŒã¹é åã¯èªåã§èããŠãåã¿ã¹ã¯ã宿œããæéãšã¿ã€ãã³ã°ã調æŽããªãããã£ãŠããŸããã äžæ¹ã§ããã®äœå¶ã§ãé²ããããšãã§ããã®ã¯ Pharms ããŒã ã®åã¡ã³ããŒãæ¢ã«èªèµ°ã§ããç¶æ ã«ãã£ãã®ã§ãããã«æ¯ããããããããã§ãã ããªãšæã£ãŠãŸãã ââ ãããã¯ããè¶å¢ããªããéçºãããšããæåã¯ãããè¯ããšæã£ãã®ã§ãããããã¯ãããŒãªã©ãã£ãããããã§ãã? æ±è€ : å çšã話ããéã Pharms ãšããŠæ¬ãããžã§ã¯ãã®åªå 床ã¯é«ãã£ãã®ã§ãããCLINICS ã®äºæ¥èšç»ããªãœãŒã¹ãèžãŸãããšå»ç§åŽã®å®è£ çæã倧ããé ããããªèŠç«ãŠã§ãããããã§ãå°ç°ããã å»ç§åŽã®éçºã«ãã¢ãµã€ã³ã§ããããªãœãŒã¹åé¡ã解決ã§ããã®ã§ã¯ãšèª¿æŽããŸãããå»ç§åŽã®ãšã³ãžãã¢ããã®ãã©ããŒã¢ããã¯å¿ èŠãªã®ã§ããã®èª¿æŽããã€ã€ã§ãããéçºãæ©ãããããªãè¯ãããšéçºããŒã éã§æçµçã«å€æããŸããã é äº : ä»ãŸã§è§Šã£ãŠãªãã£ã CLINICS ã®ã·ã¹ãã ã«ãå°ç°ããã¯ã¬ã³ã¬ã³åã蟌ãã§ãã ãã£ãã®ã§ãå ã CLINICS ã®éçºããã£ãŠãã®ã§ã¯ãšæãããããã£ããã¢ãããæ©ãã£ãã§ãã ââ ãããã¯ãã®ã°ããŒã¹ã®ããã«ãªãœãŒã¹èª¿æŽãæåããããšãã圢ã ã£ããã§ããããããã¯ãéã®è¶å¢ããããããããªæåã ã£ããããããžã§ã¯ããæåãããããšããç®ç·åãããèªç¶ã«ã§ããã®ã¯è¯ãã§ããã ããŒã éãšãã話ã§ããã° QA ã¯åããŒã ã«è·šã£ãŠã®æŽ»åã ãšæããŸããããã®èгç¹ã§ã¯ãããã§ãã? å°å³¶ : èªåã¯éçºãçµç€ã«å ¥ã£ãã¿ã€ãã³ã°ã§ãããžã§ã¯ãã«åæµããŸããããããŸã§ã¯ç±³å±±ããã QA ãšããŠå ¥ã£ãŠããã®ã§ãããå»ç§åŽã§ãæ€èšŒãã¹ããã¹ã芳ç¹ã倿°ãã£ãèæ¯ããããå»ç§åŽã® QA ãã¡ã€ã³ã§èŠãæ åœãšããŠåç»ããŸããã åŸåã«åç»ããèæ¯ããããããããåŠæ¹ç®éä»ãšããæ¥åã Pharms ãããã¯ãã®ä»æ§çè§£ãæµ ãâŠãšããç¶æ ã§ãããã éçºç®çã»èŠä»¶å®çŸ©ã»èšèšã詳现ã«ããã¥ã¡ã³ãåãããŠããã®ã§ãã¹ã ãŒãºã«æ€èšŒã«å ¥ãããšãã§ããŸãã ãæ€èšŒã®äžã§ QA ãšã³ãžãã¢ãšããŠãããã®éšåã®ä»æ§ã¯èŠçŽããæ¹ãè¯ããªãããšãããã€ã³ããããã€ãåºãŠããã®ã§ã仿§ã®æ¹åææ¡ãè¡ããŸãããåŸçºåå ã§ããããå®éã«åãå ¥ããŠããã£ãæ¹åãå€ãã§ãã ã¡ãã¬ãŒã®ãããã¯ãéçºã®æåãšã㊠QA ãšã³ãžãã¢ã èŠä»¶å®çŸ©ããã¬ãã¥ãŒã«åå ããããæèŠãèšãã€ã€ãããã¯ããããè¯ãããããã®æ¹åãè¡ãã ã®ã§ããšãŠãåããããã§ããã ââ åŸããå ¥ã£ãŠãåãããããšããã®ã¯ãããã¥ã¡ã³ããªã©ãæŽåãããŠããããã§ããããšã ãšããã®ãåãããŸãããæšªæãããžã§ã¯ãã ããããæ°ãã€ããä»ã®ããŒã ã®è¯ãç¹ãªã©ãã£ããããŸãã? é äº : Pharms ã®ãããžã§ã¯ãã£ãŠããããããªããšæã£ãã®ã KPI èšèšããããæç¢ºãªãšããã ã£ããšããç¹ã§ããã è²ã çŽäœæ²æãã£ãçµæããã«èŸ¿ãçããŠããšããèŠåŽãç¥ã£ãŠã¯ãããã§ããã©ãä»ã® KPI èšèšã£ãŠãã£ã±ããããã·ã³ãã« ã§åŠæ¹ç®éä¿¡æ°ã§ããšãªããšãããããéç®ãã KPI ãå PF ã«æ¯ãã°ãããšèšãäœå¶ã ã£ãã®ã§ããããããã¯ãããããã£ããã€ã³ãã®äžã€ããªãšæããŸãã 話ãè«ç¹ãçµå±ããã£ãŠããéšåããããã³ãã¥ãã±ãŒã·ã§ã³ã³ã¹ããå®ãããã éšåã§ã¯ããããªãšæããŸããã æšªæãããžã§ã¯ããªãã§ã¯ã®ãšã³ãžãã¢ãªã³ã° ââ å šäœã®è©±ããåå¥ã®ãã¡ã€ã³ããšã®ãšã³ãžãã¢ãªã³ã°ãšããç¹ã§ã¯ã©ã®ãããªããšããããŠããŸããã? å°ç° : åºæ¬çã«ã¯æéЬããã®ã·ãŒã±ã³ã¹å³ãå ã«éçºãé²ããŠããŸãããCLINICS ã§ã¯ A ãšããç¶æ ã«ãªãããã®æã« B ãšããã¢ã¯ã·ã§ã³ããããš Pharms ã§ã¯ C ãšããç¶æ ã«ãªããšããããã«ç¶æ é·ç§»ãè€éã ã£ããããèšèšæã«ããã¹ãå§¿ã«è¿·ãããšãå€ãã£ãã®ã§ãããã·ãŒã±ã³ã¹ã«ç«ã¡è¿ããšããã«ãã®çåã解決ãããšãã£ãå ·åã§ãã æéŠ¬ : ã·ãŒã±ã³ã¹ã®æŽåæ§ãé£ãããªããããªãããã«èšèšãã ããšã«ã¯æ°ãã€ããŸããããåæäºçŽããšããèšèãå è¡ãããšã€ãã€ãè€éãªæ°æ©èœã®ãããªãã®ãäœããã¡ã§ããã蚺çæãè¬å±ã®äºçŽæ©èœãåŠæ¹ç®éä¿¡æ©èœãšãã£ãåã ã®ããŒãã¯ããšããšããããã§ããªãã¹ãã·ã³ãã«ã«ããããã€ãªãåãããããããã«å¿ãããŸããã æ±è€ : 现ãããããã¯ãéã®èª¿æŽãå¿ èŠã«ãªãã®ã§ ã¡ãããšèª¿å€ã®æ¬²ãã KPI ãæ±ãã€ã€ããã€çŸå Žã®ãªãã¬ãŒã·ã§ã³å質ãèœãšããªãã£ãŠãã芳ç¹ã§èª¿æŽãåãã¡ã€ã³ã§ãããŸããã 工倫ããããšã§ãããšãUX 調æ»ã培åºãããšããã§ããããã ä»åã®ãµãŒãã¹ã£ãŠæ¥ççã«ã¿ãæã«æ°ããããšãããšããã§ã¯ãªããã§ããããã§ãã®ã§ã忥çã®äŒæ¥ããã®åã¢ããªã®äœéšãšããèªåã§ãçµæ§è²ã 䜿ããªããäœéšããŠã¿ãŸããããããããããŒã¹ã«éã«çŸç¶ã®ãã¡ã®ä»æ§ãèžãŸãããšããããã颚ã«ãã¡ã§ã¯å®è£ ããŸãããã¿ãããªãšãããè²ã ãã£ãŠããŸããã å°ç° : ãšã³ãžãã¢ãªã³ã°ã®èгç¹ã§ãããšãç¹ã«æ£è ã¢ããªããŒã ãšã® API 飿ºã®ä»æ§èª¿æŽãšãéçºã®é²ãæ¹ã¯å¯ã«é£æºããªããé²ããŸãããå ã«ãã£ã¡ãã§ããŠãªããšåãããéçºã§ããªãç¶æ ã«ãªãã®ã§ãæ åœè å士ã§ã³ãã¥ãã±ãŒã·ã§ã³ãšãã€ã€ã工倫ããªããé²ããŠããŸããã é äº : CLINICS ã§æ°ã«ããŠãéšåã¯ã©ã¡ãããšãããš ãªã¹ã¯ãšã³ã¹ãã®éšåãããã«æå°åããŠäŸ¡å€ãæå€§åããããäžçªéèŠ ããªãšæã£ãŠããã®ã§ãäžçªå€§äºãªã®ã¯ãã£ã±ãå»ç§ã«ãšã£ãŠã©ããã䟡å€ãåºãŠãå»ç§ã«ãšã£ãŠã©ããããªã¹ã¯ãçºçããããèããŠãŸããã äŸãã°äžçªæåã®ããåããã§è¬å±äºçŽããæã«æ¥æãŸã§ç¢ºå®ãããŸããããšãã話ããã£ããã§ããã©ããããŸã§ã¹ã³ãŒããåºããªããŠãã¡ãªãããåºãã®ã§ããã°ãåºããããªãã§ããšãã話ãããŠããŸããã ããšã¯ãªãªãŒã¹ãã©ã³ã®çå®ãšãããªïŒå šå»çæ©é¢ã«äžæã«åºãã®ã§ã¯ãªãããŸãã¯äžéšå»çæ©é¢æ§ã ãã«å ¬éãããªãªãŒã¹æ¹åŒã«ããŸãããã¿ãããªãšãããå«ããŠã§ããããå»ç§åŽã§äžæŠãã¹ãããã£ãŠæ€èšŒããŠãã¹ã ãŒãºã«æ©èœã䜿ãããšããã確èªãããããã¹ããããèšããŸããããšå®å šçãåããªããé²ããŸããã ããã¯ãã®ãããžã§ã¯ãã«é¢ããããã©ããªãããžã§ã¯ãã§ãäžçªéèŠã§ãããåŸããã²ã£ããè¿ãã®ãäžçªææ»ãã«ãªã£ãŠããã®ã§ãããã¯éèŠããªãšæããªããé²ããŠãŸãããã å°å³¶ : QA èŠç¹ã ãšæšªæãããžã§ã¯ãããã«ã¹ããŒããæ¬åœã«è€éã§ãã¡ãã¬ãŒå ¥ç€ŸåŸã«çµéšãããããžã§ã¯ãã®äžã§æ€èšŒã®é£æåºŠãæãé«ãã£ãã§ããã ã§ãããçããä»°ãããŠããããã«åãŠãŒã¹ã±ãŒã¹ã«å¯Ÿããèšèšãå³ã§ããã¥ã¡ã³ãåãããŠããã®ã§ããã¹ãã±ãŒã¹ãšããŠè»¢çšã§ããéšåãå€ããããŸãããæéЬãããäœæããèšèšå³ããã£ãããããæŒããªããã¹ãã§ããéšåã¯å€§ããã§ãã倧å¢ãåå ãããããžã§ã¯ãã«ãããŠãå šå¡ãèªèåãããäžã§ãèšèšå³ã¯æ¬åœã«å€§äºã ãªãšçæããŸããã 工倫ããç¹ãšããŠã¯ãå°ç°ãã㯠Pharms éçºã®ãã¡ã€ã³ç¥èãè±å¯ã ã£ãã®ã§ãQA æã¯ Pharms åŽãã¡ã€ã³ã«èŠãŠãããã€ã€ãèªå㯠CLINICS åŽã® QA ãæåãèŠãããã«ããŸãããã©ã¡ãã®ãã¡ã€ã³ã«ãé¢ä¿ããå¥çŽãã©ã³çã®è€éãªä»æ§ã¯èªåãæ åœããŸããã QA 以å€ã®é¢ã ãšããªãªãŒã¹ããäžã§å¿ èŠãªæµ®ããããŒã«ãããã°ç©æ¥µçã«åãã«ããããã«ããŸããã äŸãã°ããããŸã§äžéšã®å»çæ©é¢æ§ã ãã«æ©èœãªãªãŒã¹ããå Žåããã®åŸã®ãã£ãŒãããã¯ååã¯ã¡ãŒã«ãé¢è«ã§åå¥ã«è¡ã£ãŠããŸããããæ¥ã ã®èšºçã®äžã§ãæéã確ä¿é ãã®ãé£ãããšããç¶æ³ããããŸããããã®çµæãæ¬ Pj ã«ãããŠãå šäœãªãªãŒã¹ããŠåé¡ãªããïŒã®å€æããã¥ããææããããŸããã ããã§ Google ãã©ãŒã ã§ã¢ã³ã±ãŒããäœæããŠçæéã§åçã§ãã圢ã«åãæ¿ããŸãããçµæçã« 100% åçãåŸãããšãã§ããŸããã ã¢ã³ã±ãŒãçµæãããåŸæ¥æ©èœãã䟡å€ããããé¢å ãªãã¬ãŒã·ã§ã³ã«çµã¿èŸŒãã§é ãã³ã¹ãããããŸã§é«ããªãããšããç¹ãè©äŸ¡ã§ããã®ã§ãèªä¿¡ãæã£ãŠå šäœå ¬éãªãªãŒã¹ã«åã㊠GO å€å®ã§ããŸããã** ã¡ãã¬ãŒã¯åœ¹å²ã«çžãããããŒã«ãä»»ããŠé ããç°å¢ãããã®ã§ãèªåã®å°éé å以å€ã®ããšãåŠã¹ãŠãã**ãšæãããšãå€ãã§ãã 幞ããªãªãŒã¹åŸã倧ããªäžå ·åã¯ãªãã®ã§ããã¯ããçããã®ãããã§ããã åæäºçŽ Pj ãçµã㊠ââ ã§ã¯æåŸã«ãã®ãããžã§ã¯ãã®ç·æ¬ãããŠãã ããã°ã æ±è€ : 暪æã§ã¯ãããã©åãã¡ã€ã³ã§ããããã®ãããã§ãã·ã§ãã«ãã¡ãããšåãçºæ®ããŠãããžã§ã¯ããããåãããšããã®ã¯ããã倧ããè³ç£ã§ããã å»ç PF ã¯ã¢ã»ãããããããæã£ãŠããã®ã§ãè²ã çµã¿åããããšãä»ã®äŒç€Ÿã ãšã§ããªããã©ããã¡ãªãã§ãããã ããã¿ãããªããšãè²ã ãã ãã§ãã ãªã®ã§ããã®åŸã暪æãããžã§ã¯ãã¯äºå®ãããŠããŸãããããã«å é§ããŠã²ãšã€ãããã£ãŠããã€åããæ¬²ããã£ãæåŸ ææãçŸç¶åºããŠãããšãããå«ãããšãããè¯ãäžæ©ã ã£ãã®ããªããšæã£ãŠãŸãã æ¬¡ã¯åè³ªãæ ä¿ãã€ã€ããã£ãšã¹ããŒããäžããŠãããããšããã®ã芳ç¹ãšããŠå€§ããã§ããã ââ ãªãã»ã©ãããããæšªæãããžã§ã¯ãããã£ãŠããå»ç PF ã§ã¯ã©ããªãšã³ãžãã¢ãããããããã€ã³ãã§ããã? æéЬ : æè¡ãšäœµããŠãŠãŒã¶ãŒãžã®äŸ¡å€æäŸãèããªãããšã³ãžãã¢ãªã³ã°ããã人ããããããã®ã§ã¯ãªãããšæããŸãã ââ åãããã¯ãã®æã£ãŠãã圹å²ãèžãŸããŠã俯ç°ã®èŠç¹ã§éçºãããããšããæ¹ã«ã¯ãããé åçã§ãããæ¬æ¥ã¯ããããšãããããŸããã ãããã« åæäºçŽ Pj ã«ã€ããŠããããžã§ã¯ããæšé²ããã¡ã³ããŒã«è©±ãèããŸããããè€éãªèŠä»¶ãå®çŸå¯èœãªåœ¢ã«ããŠåããŒã ã§å£æ ¹ãè¶ããŠéçºãããŠããæ§åããšãŠãå°è±¡çã§ãããç¹ã«å»ç PF ã§ã¯ãã¡ã€ã³åå£«ã§ææ©çã«çµåããŠãããã³ã©ãã¬ãŒã·ã§ã³ããããšã«ããã¹ããŒã¯ãã«ããŒãžã®äŸ¡å€ãé«ããŠãããšããã®ã¯ããããããããã®ã§ã¯ãªãããšæããŸãã ãã®ãããªãããžã§ã¯ãã§åãçºæ®ããããšæã£ãæ¹ã¯ãã²ããæ°è»œã«ã話ãããŸããã! åéã®äžèЧ | æ ªåŒäŒç€Ÿã¡ãã¬ãŒ ã¡ãã¬ãŒã®æ¡çšæ å ±ã¯ãã¡ãããã確èªãã ããã www.medley.jp
æ ªåŒäŒç€Ÿã¡ãã¬ãŒ
2024/02/29
<![CDATA[ è€æ°ãããã¯ã暪æãããããžã§ã¯ããã©ããã£ãŠæåãããã®ãã¡ã³ããŒã«èããŠã¿ãŸãã ]]>
ã¯ããã« ã¿ãªãããããã«ã¡ã¯ããšã³ãžãã¢ã®å€å·ã§ãã ä»å㯠CLINICS / Pharms åæäºçŽãããžã§ã¯ã(以äžãåæäºçŽ Pj)ãšãããããã¯ã暪æã§æ§ã ãªéšçœ²ãé¢ãã£ãéçºãããžã§ã¯ãã«ã€ããŠãå°œåãããçããã«åº§è«äŒåœ¢åŒã§ã話ã䌺ããŸããã ã¡ãã¬ãŒã®å»çãã©ãããã©ãŒã (以äžãå»ç PF)ã§ã©ã®ããã«ããããæšªæãããžã§ã¯ããå®éããã®ãã®æ§åãçããã«ç¥ã£ãŠããããã°ãšæããŸãã 察è«ã¡ã³ããŒçŽ¹ä» ââ ã¯ããã«ãçããã®èªå·±ç޹ä»ããé¡ãããŸãã æ±è€ : æå±ã¯å»ç PF ã®ãããã¯ãéçºå®€ã® Pharms éçºããŒã ã§ãã 圹å²ãšããŠã¯èª¿å€è¬å±åãã®ã·ã¹ãã ã® Pharms ã®ãããã¯ããªãŒããŒãæ ã£ãŠããŸãã çµæŽãšããŠã¯ã2021 幎㮠1 æãã Pharms ã®ã«ã¹ã¿ããŒãµã¯ã»ã¹ãšããŠã¡ãã¬ãŒã«ãžã§ã€ã³ããŸããŠã2023 幎 1 æããéçºããŒã ã«æ¥ãŸããã ãããŸã§ã¯äºæ¥åŽã®çµéšãé·ããå¶æ¥å šè¬ãäºæ¥éçºãã¡ã€ã³ã§ãã£ãŠãããã£ãªã¢ã§ãã ãã®ãããžã§ã¯ãã® PO ãšããŠãªãŒãããåããããŠãããPharms ãæ ã調å€åŽã®ãªãŒãã«å ããŠãå šäœã®ææ¯ãã調æŽçã䞻軞ã«ãã£ãŠããŸããã æ±è€ãã ââ æ±è€ããããããžã§ã¯ãã®äžå¿ãšãªã£ãŠæšé²ãããã§ããã æ±è€ : 調å€ãã¡ã€ã³ã® Pharms ã«ãšã£ãŠäºæ¥ã€ã³ãã¯ããããã倧ããéçºã ã£ãã®ã§ã調å€ãã¡ã€ã³ã責任æã£ãŠãããŸãããããšããæŽçã§ãã å°ç° : èªåã®æå±ãæ±è€ãããšåãã«ãªããŸãã çµæŽã¯ã2021 幎 7 æã«ãšã³ãžãã¢ãšããŠå ¥ç€ŸãããããŸã§ãã£ãš Pharms ã®éçºããã£ãŠãŸãã å ¥ç€ŸåŸã¯ã¯ã©ã€ã¢ã³ãèªèšŒæ©èœãæ³äººæ åœè åãã®æ¬éšæ©èœãªã©ã®æ©èœéçºãè¡ã£ãŠããŸããã æšå¹Žãã Pharms ã®ãªãŒããšã³ãžãã¢ãšããŠããŒã å šäœãèŠã€ã€ãPharms ã®æè¡è²¬ä»»è ãšããŠæ±è€ãããšäž¡èŒªã§åããããªåœ¢ã§ãããžã§ã¯ãã®æšé²ã«é¢ãã£ãŠããŸãã å°ç°ãã æéŠ¬ : å»ç PF ãããã¯ãéçºå®€ãæ£è çµ±ååºç€ããŒã ã«æå±ããŠããŸããæ£è çµ±ååºç€ãšã¯ãCLINICSïŒæ£è ã¢ããªïŒãšããã¢ããªã®ããã¯ãšã³ãã·ã¹ãã ã§ããã蚺çæãæ¯ç§å»é¢ãè¬å±åãã®ã·ã¹ãã ãšã®é£æºåºç€ãšããŠãæ©èœããŠãããããã¯ãã«ãªããŸãã çµæŽã¯ããã®ã¡ã³ããŒã®äžã§ã¯äžçªå€ã 2018 幎 3 æã«å ¥ç€ŸããŠãåœå㯠CLINICS ã«ã«ãã®æ©èœæ¡åŒµã®éçºã«åå ããPKI åºç€ã CLINICS ãšãŒãžã§ã³ããå§ããšããä»ç€Ÿã·ã¹ãã ãšã®é£æºåºç€ã®éçºãè¡ã£ãŠããŸããã2020 幎ãããããæ£è çµ±ååºç€ã®ç«ã¡äžãã«åå ããŠãçŸåšã«è³ããŸãã æéŠ¬ãã é äº : å ¥ç€Ÿã¯ 2019 幎 8 æãªã®ã§ã 5 幎ç®ãšãªããŸãã ãã¶ã€ããŒãšããŠå ¥ç€ŸåŸ 1 幎éã¯ãžã§ãã¡ãã¬ãŒã«åšç±ããŠããŸããããã®åŸãªã³ã©ã€ã³èšºçã䌞ã³ãŠããææã«ãªããCLINICS åŽã®ãã¶ã€ããŒã®äººæ°ãè¶³ããªããªã£ãããšããããŸããŠãããããã¯é»åã«ã«ããå«ãã CLINICS ã®ãã¶ã€ã³å šè¬ãæ åœããŠããŸãããå»å¹Žããé»åã«ã«ã以å€ã®æ¥åé åã® PdM ãšããŠæŽ»åããŠããŸãã軞足ã¯ãã¶ã€ããŒãªã®ã§ãããããã¯ãã®ãããžã¡ã³ãã¿ãããªããšããå§ããŠãŸãã ãã®ãããžã§ã¯ãã«ãããŠã¯ããã£ãæ±è€ããããã£ããã£ãéããPharms ã®äŸ¡å€åäžãäžå¿ã®ãããžã§ã¯ããªã®ã§ãããžã§ã¯ãã®äžçªå€§ãããªãŒãã¯æ±è€ããã«ãªãããšæããã§ããã©ãCLINICS ãªã©ã®å»ç§åŽã®ãããžã§ã¯ããªãŒããšèšãç«ã¡äœçœ®ãåã«ãªãããªãšæããŸãã é äºãã å°å³¶ : å»ç PF ãããã¯ãéçºå®€ã® QA ã°ã«ãŒãã«æå±ããŠããŸããQA ã°ã«ãŒãã®ãããŒãžã£ã§ãã 米山 ããã®ã玹ä»ã§ 2022 幎 4 æã«ã¡ãã¬ãŒïŒäººç®ã® QA ãšã³ãžãã¢ãšããŠå ¥ç€ŸããŸãããäž»æ åœã¯ CLINICS ã®äºçŽæ©èœãäžå¿ãšããåšèŸºé åã§ãããããŸã§é äºãããšäžç·ã«åãããŠé ãæ©äŒãå€ããçŽè¿ã§ã¯äºçŽæ¹æ³ãæ¡åŒµããããªã¯ãšã¹ãäºçŽãæ©èœã® QA ãæ åœããŸããã åæäºçŽã«é¢ããŠã¯ãäž»ã«å»ç§åŽã®éšåã® QA ããå§ãŸãã調å€åŽã® QA ãå¿ èŠãšããããšã«ãªããæçµçã«ã¯å šäœã® QA ãæ åœããŸããã å°å³¶ãã åæäºçŽã®æ©èœã解決ããèª²é¡ ââ ããããšãããããŸããæ¬¡ã«ãä»åã®åæäºçŽã«ã€ããŠã©ããã£ãæ©èœã§ãã©ããã£ã課é¡ã解決ããã¹ãããã話ãããã ãããã§ãã æ±è€ : æ©èœãšããŠã¯ã CLINICSïŒæ£è ã¢ããªïŒãããªã³ã©ã€ã³èšºçãäºçŽããéã«ãè¬ã®åãåãå ãšããŠè¬å±ãäºåæå®ã§ããæ©èœ ã«ãªã£ãŠããŸãã ãã®æ©èœã«é¢ä¿ãããã¡ã€ã³ã¯æ£è ã»å»çæ©é¢ã»èª¿å€è¬å±ã®ïŒã€ã§ãã æ£è ãšå»çæ©é¢ã®ã¡ãªãããšããŠã¯ãè¬ã®åŠæ¹ãŸã§ã®æéãæžãããšã§ãã ãªã³ã©ã€ã³èšºçã§ã¯ãæ£è ãå»çæ©é¢ã«çŽæ¥èšªåããããã§ã¯ãªãã®ã§ãè¬ãçŽæ¥è¬å±ã«è¡ã£ãŠåãåãã®ããè¬å±ããé éãåžæããã®ããšãã£ãè¬ã®åãåãæ¹ããå»çæ©é¢ãšæ£è ããã§å£é ã§è©±ããŠæ±ºããŠããã£ãŠããã確èªã«æéãçºçããŠããŸãããæ£è ããã¯å£é ã§è©±ããå å®¹ã«æ²¿ã£ãŠããªã³ã©ã€ã³èšºççµäºåŸã«ãè¬å±ãžã®äºçŽãåã£ãŠããŸããã åæäºçŽæ©èœãå®è£ ãããããšã«ããã蚺å¯ã®äºçŽæã«ã©ã®è¬å±ã§ã©ãããåãåãæ¹ãããŸããšããéšåãæ£è ãããäºåæå®ã§ããããã«ãªã£ãã®ã§ã å»çæ©é¢ã¯äºåçãªè©±ã«æéããããã«èšºå¯ã«éäžã§ãããŸãæ£è ããããå»åž«ã«å£é ã§è¿œå 説æããªããŠãåžæéãã«è¬ãããããããšãããããŒã«å€æŽãããããšãå»çæ©é¢ãšæ£è ã®ã¡ãªãã ã ãšæã£ãŠãŸãã åæäºçŽæ©èœã®ãªãªãŒã¹ååŸã§ã®ãããŒã®éã ããäžã€ã®ãã¡ã€ã³ã§ãã調å€è¬å±ã«ã€ããŠã¯ãåè¿°ã®ããã«èšºå¯ã®äºçŽãããæã«æ£è ãããã¡ãã¬ãŒã®ãµãŒãã¹ã§ãã Pharms ã䜿ã£ãŠããè¬å±ããäºåæå®ãã§ããŸãã®ã§ã ãªã³ã©ã€ã³èšºçåŸã«çºè¡ãããåŠæ¹ç®ã®æµå ¥ãå¢å ããŸã ã 調å€è¬å±ã®å£²ãäžãã¯åŠæ¹ç®ã®ææ° à å䟡ã§å€§éšåãæ±ºãŸããŸãã®ã§ããã®ææ°ãå¢ããããšãã芳ç¹ã§ã¯è¬å±ã«ãšã£ãŠã€ã³ãã¯ãã®ããæ©èœã ãšæã£ãŠããŸãã ââ æ£è ã®äœéšãæ¬åœã«è¯ããªãããæ£è ãšå»çæ©é¢ã®ç¡é§ãªã³ãã¥ãã±ãŒã·ã§ã³ãæžãããã€è¬å±ã«å¯ŸããŠãåŠæ¹ç®ææ°ãå¢ããŠãå°ç·ã楜ã«äœ¿ããããã«ãªã£ãŠãããšããã®ããä»åã®ãããžã§ã¯ãã®èã«ãªã£ãŠããæãã§ãããããããèžãŸãããããã¯ãéãæšªæããŠéçºããªããšãããªããšããã®ã倧å€ããã§ãã éçºãããžã§ã¯ãã«ã€ã㊠ââ ã©ã®ãããªããŒã ããã®æšªæãããžã§ã¯ãã«é¢ãã£ãŠããããæããŠãã ããã æ±è€ : éçºåŽã§èšããšïŒã€ã®ãã¡ã€ã³ã«ãªã£ãŠãŸãã 調å€ãæ£è ãå»ç§ããã㊠æ£è çµ±ååºç€ ã§ããæ£è çµ±ååºç€ãšã¯å»ç PF ã®åãã¡ã€ã³ã«ååšããæ¥åã·ã¹ãã ãšæ£è ã¢ããªãç¹ãæ ¹å¹¹ãšãªããããã¯ãã§ãã ãã ä»åã®æ©èœã¯å»çæ©é¢ã®ãªãã¬ãŒã·ã§ã³ãå€ãããããéçºåŽã§ã®ã¿å®çµãããããžã§ã¯ãã§ã¯ãªããã§ããã ããã«çŸå Žã®éçšã«åããã€ã€ãäœéšãæ¹åã§ãããïŒãšããèŠç¹ã§èãããšãåäºæ¥åŽã®ã«ã¹ã¿ããŒãµã¯ã»ã¹ããŒã ãéèŠã«ãªããŸã ãç¹ã«å»ç§ãšèª¿å€ã®ã«ã¹ã¿ããŒãµã¯ã»ã¹ããŒã ãšã¯ãå¯ã«å£æã¡ãããªããéçºãé²ããŠããŸããã ââ ä»åã®ãããžã§ã¯ãã¯ç¹ã«äºæ¥éšãšã®é¢ä¿æ§ãéèŠãªéµã ã£ããã§ããã æ±è€ : ããã§ãããç¹ã«å»ççŸå Žã¯æ¥åãéŒè¿«ããŠããå Žé¢ãå€ãã§ãã®ã§ãäŸãã°ãã¯ã³ã¯ãªãã¯å¢ããŸãããããã§ããŒãžé·ç§»ãå¢ããŸãããšãã£ãããšã§ãæ¥åãžã®åœ±é¿ãéåžžã«å€§ãããªããŸãã ãŸããªãã¬ãŒã·ã§ãã«ã«çŸå ŽãåããŠããç®æãå€ãããããã¯ãéœåã§åæã«ãã®æ¹ãè¯ããããåççã ããããšæ±ºããŠãããã¯ããäœã£ãŠããŸããšä»ãŸã§ã®çŸå Žãªãã¬ãŒã·ã§ã³ã厩ããŠããŸãæ··ä¹±ãæãããšããããŸãã çŸå Žã®ç¿æ £ãçè§£ããæã ãç®æãå§¿ãšèª¿æŽããªããæé©è§£ãåºã ã®ããå¿ é ã«ãªã£ãŠããæ¥çã»æ¥æ ã ãšæãã®ã§ããã®èª¿æŽã¯äºæ¥éšãšãããªãæ°ãé£ã£ãŠãã£ãŠããŸããã ââ åæäºçŽ Pj ã¯ãéçºåŽãããããšããããšã§å§ãŸã£ããããžã§ã¯ããªãã§ãããã? æ±è€ : ã¯ããããã¯ã¡ãã¬ãŒã®ã©ã®ãããã¯ãããããªã®ã§ãããäºæ¥è²¬ä»»è ãšãããã¯ã責任è ããããããããäºæ¥ãšéçºã®äž¡èгç¹ããè°è«ããäºæ¥æ¹éãæ±ºããŠããããšããäœå¶ããšã£ãŠããŸãã Pharms ãæ£ããæé·ãããŠãããšãã芳ç¹ã§èŠããšãçŸãã§ãŒãºã§ã¯åŠæ¹ç®ããã£ãããšèª¿å€è¬å±ã«å±ããããšãè³äžåœé¡ã§ããããµãŒãã¹ã®ããã¹ãå§¿ãšã¯ïŒãšãã芳ç¹ã§äºæ¥ãšéçºäž¡èŒªã§ãããŸããããšããåœ¢ã§æ±ºãŸã£ããã®ã«ãªããŸãã æšªæãããžã§ã¯ãã§å·¥å€«ããããã€ã³ã ââ ä»åãæšªæã§è²ã ãªéçºãããã¯ããé¢ä¿ããŠããŸããã工倫ããç¹ãšãæ°ãã€ããç¹ãªã©ãã©ããªãã®ããããŸãããã æ±è€ : äžçªã¯åãã¡ã€ã³ã§è¿œã£ãŠããäºæ¥ææãããªãéã£ãŠããŸããã®ã§ããã®èª¿æŽãæéããããŠæŠãåããããç¹ã§ãã äŸãã°ã調å€ã®èгç¹ã§ã¯åŠæ¹ç®ãã¡ãããšè¬å±ã«å±ãããšããã®ãããããéèŠãªäºæ¥ã€ã³ãã¯ãã®å€§ããé ç®ã§ããäžæ¹ã§ãå»çã®èгç¹ã§èŠãæã«ããã¡ããæéãæžããã®ã¯ãããéèŠã§ã¯ãããã§ãããå»çãã¡ã€ã³ãšããŠãã®æ¹åã«èª¿å€ãšåèŠæš¡ã®ã¡ãªãããèŠåºããŠããããããšèšããšåœç¶ããã§ã¯ãªãã£ããããŸãã ããããéšåã§ããã¡ã€ã³éã§ãã®ãããžã§ã¯ããéæããåŸã«åŸãããã¡ãªããã«å·®åãåºãŠããŸããã¡ãªããã倧ããäºæ¥ãããããå·¥æ°ã倧ããå²ããã®ã§ãããã¡ãªããã匱ãäºæ¥ã§ã¯åãã ãå·¥æ°ãããŠãããŸãããããšããæææ±ºå®ã¯é£ãããšæããŸãã ããã§ æ¬ Pj ãéããŠåãã¡ã€ã³ã§ã¯ã©ãããäºæ¥ææãçãã®ãããã®ããã«äœã® KPI ã远ãã®ãããæç¢ºã«ããŸãã ãäºæ¥çãªã¡ãªãããå€ã調å€ã®ããã«æäŒã£ãŠãã ãããšãã圢ã§ã¯ãªããåãã¡ã€ã³ã§ã©ãããã¡ãªãããçãã§ãããŸããïŒãšãããšãããæãããã®ãããããéèŠã ã£ããšæã£ãŠããŸãã ãããæ ããšãã¡ãªããã®åŒ±ãäºæ¥ã«ãšã£ãŠã¯ãæäŒãã¿ãããªãããžã§ã¯ãã«ãªããŸããåçŽã«ãšã³ãžãã¢ãªã³ã°ãšããéšåã§ãé¢çœããã®ã«ãªããªãã§ããããã§ãã®ã§ãé¢ä¿ããå šå¡ã§ãããžã§ã¯ãã宿œããããšã§ã©ãããçµæãåŸãã®ã?ãã¡ãããšåãã¡ã€ã³éã§æããŸããã ââ ãªãã»ã©ããããããšããããæŠãåããã¯æ±è€ãããšé äºããããã£ãŠãããã§ããããã é äº : ã¯ããåã®ã»ãã§è¡ã£ãŠããŸãããåãåæã®ããåããæã«éèŠããŠããã®ã¯ãã¹ã³ãŒããé©åã«åºåããšããéšåã§ããã調å€åŽã®æäŸäŸ¡å€ã®æå€§åã ãã远ã£ãŠåæãã倧ããªæ©èœè¿œå ãè¡ãã®ã§ã¯ãªãã倿Žã«ããå»ç§ã»æ£è ã»èª¿å€ãžäžãããªã¹ã¯ãéçºã³ã¹ããæãã€ã€ã䟡å€ãæå€§åã§ããèœãšãæã¯ã©ããããšããéšåããå·ãåããããŠãããŸããã ã¡ãã¬ãŒãé¢çœããªã£ãŠæãã®ãããããã¯ãåç¬ã§åããŠããããã§ã¯ãªããŠã ãã€ã·ã§ã³ããžã£ãŒããŒ(æ£è äœéš)ãäžå¿ãšããŠããã¿ã¯ã矀ãååšããŠãããšãã ã§ãã æ£è äœéšãããè¯ãæ§ç¯ããããã«ããããã®ãããã¯ããåããŠãããã®ã§ããæäŒããšãããã¥ã¢ã³ã¹ãããªãããããã¯ããè¶ ããŠããã¯ããããŠãããŸããããšèšããæåããããšãããããéšåããªãšæããŸããããããããããéšåããªãšæããŸãã æ±è€ : ç¹ã«æšªæã®ãããžã§ã¯ãã ãšããããç®çæèã®çµ±äžã«äžçªæéã䜿ã£ãŠãè¯ãããããªãããšèããŠããŸãããããæ±ºãŸãããããã°ãåŸã è¿·ã£ãå Žåãç®çã«å³ããæææ±ºå®ãã§ããŸããããããåºããåŸã«åãã¡ã€ã³ã§ã®èª¿æŽãããšããé çªã倧äºã ãšæããŸãã ââ æè¡é¢ã§æ°ãã€ãããã€ã³ãã¯ã©ããªãã®ããã£ããã§ããããã æéŠ¬ : åæäºçŽæ©èœãšããŠããããããšã¯ããã€ã€ã蚺çæåŽã®æ¥åãããŒãæ£è ã®å°ç·ãä»ããã·ã¹ãã ã®å¶çŽãªã©ãèžãŸããã©ã®ãããªåœ¢ã«èœãšã蟌ã㰠蚺çæãè¬å±ãæ£è ã«ãšã£ãŠã䟡å€ã®ããæ©èœãšãªãã ããã€ã³ãã§ãã ã§ãã®ã§ãæè¡çãªé¢ãšäºæ¥çãªé¢ã䜵ããŠèããªãããã·ã¹ãã å šäœã®èŠä»¶ã決ããŠãããšããã®ãæåã«æãããéšåã§ããã ââ æ©èœãèããäžã§ãå šäœãèŠæ®ããèšèšãªã©ããã£ãŠãããšæããã§ãããä»åã¯ã©ãããçæããããã§ãããã?æ£è ã®å°ç·ã ã£ããå»çæ©é¢ã®æ¥åãããŒãªã©ææ¡ããåŸã«ãåãããã£ãéšåãèãããã®ã§ããã æéŠ¬ : åæäºçŽã«ãããã·ã¹ãã å šäœã®èŠä»¶ãåºããŠãããšåæã«ãå šäœã®ã·ãŒã±ã³ã¹ãšã¹ããŒããã·ã³ãäœã£ãŠãããŸãããåã·ã¹ãã éã®é£æºãããŒãšãããã«ããçã¿åºãããäºçŽãåŠæ¹ç®ãšãã£ããšã³ãã£ãã£ã®ç¶æ é·ç§»ã決ããŠããããã®ç¶æ ã®æã¯ãããã£ãããšã¯ã§ããªããšãããããã£ã蟻è€ãåããããšããããã£ãããã£ãŠãã£ããšããæãã§ãããã é äº : ä»åã¯ãç¹ã« ãããã¯ã暪æã®å ±éåºç€ãšããŠãåãããã¯ãã§ããããå šãå¥ç©ã®ä»çµã¿ãã¹ããŒã¿ã¹ãä¿æããŠããã®ããå ±éåã»æœè±¡åãããšããæ¥åãå¿ èŠã«ãªã ã®ã§ããããé£ããããé£æåºŠãé«ãéšåã ãªãšæã£ãŠãããã§ããã©ãããã綺éºã«ã·ãŒã±ã³ã¹å³ã«èœãšã蟌ãã æéŠ¬ãããåããªãšæããŸããã æ±è€ : åºç€åŽã§äœã£ãŠããã ããã·ãŒã±ã³ã¹å³ã¯ UX ã®éªšçµã¿ãªãã§ããããããããããã UX ãã¶ã€ããŒãå¥éãããšãã£ã现ååããããå®è£ ã®å¶éãå å³ãã€ã€ãæ£ããéçšãåãããã«ããã®äœéšãäœãããã«ãã®ã¹ããŒã¿ã¹é·ç§»ã§ããã¹ãã ããããšããéšåãæéЬããããšã³ãžãã¢èгç¹ã§æåã«äœã£ãŠãããŠããšããã®ãã ã¡ãã¬ãŒã®ãšã³ãžãã¢ã®ãšãŠãè¯ãéšå ã ãšæã£ãŠããŸããæè¡ã ãã§ãªã UX ãªã©ã«ãå¿ èŠã§ããã°è¶å¢ããŠãããæåã§ããã åæäºçŽ Pj éçºã®å®é ââ ããããåæãã§ãŒãºãçµãŠ Pharms ãš CLINICS ã©ã¡ãã®éçºã«ãé¢ãã£ãå°ç°ããã«èãããã®ããéçºã®æµãã®äžã§ãããããªãœãŒã¹çãªåé¡ã£ãŠå€§å€ã ã£ããšæãã®ã§ãããããã¯ã©ã解決ãããã§ããããã å°ç° : å ã« Pharms åŽã®æ©èœ ãäœã£ãŠãã®åŸã« CLINICS ã®ä»æ§ã決ããŠããã£ãŠãã CLINICS ã®éçºã«å ¥ãæµãã ã£ãã®ã§éçºã䞊è¡ããããšã¯ãªãã£ãã§ãããã Pharms ã§ã¯ãªãŒããšã³ãžãã¢ãšããç«å Žãªã®ã§ ãCLINICS ã®éçºã«å ¥ãããã®æºåãšãPharms åŽã®ã¬ãã¥ãŒããã©ããŒã®ãªãœãŒã¹é åã¯èªåã§èããŠãåã¿ã¹ã¯ã宿œããæéãšã¿ã€ãã³ã°ã調æŽããªãããã£ãŠããŸããã äžæ¹ã§ããã®äœå¶ã§ãé²ããããšãã§ããã®ã¯ Pharms ããŒã ã®åã¡ã³ããŒãæ¢ã«èªèµ°ã§ããç¶æ ã«ãã£ãã®ã§ãããã«æ¯ããããããããã§ãã ããªãšæã£ãŠãŸãã ââ ãããã¯ããè¶å¢ããªããéçºãããšããæåã¯ãããè¯ããšæã£ãã®ã§ãããããã¯ãããŒãªã©ãã£ãããããã§ãã? æ±è€ : å çšã話ããéã Pharms ãšããŠæ¬ãããžã§ã¯ãã®åªå 床ã¯é«ãã£ãã®ã§ãããCLINICS ã®äºæ¥èšç»ããªãœãŒã¹ãèžãŸãããšå»ç§åŽã®å®è£ çæã倧ããé ããããªèŠç«ãŠã§ãããããã§ãå°ç°ããã å»ç§åŽã®éçºã«ãã¢ãµã€ã³ã§ããããªãœãŒã¹åé¡ã解決ã§ããã®ã§ã¯ãšèª¿æŽããŸãããå»ç§åŽã®ãšã³ãžãã¢ããã®ãã©ããŒã¢ããã¯å¿ èŠãªã®ã§ããã®èª¿æŽããã€ã€ã§ãããéçºãæ©ãããããªãè¯ãããšéçºããŒã éã§æçµçã«å€æããŸããã é äº : ä»ãŸã§è§Šã£ãŠãªãã£ã CLINICS ã®ã·ã¹ãã ã«ãå°ç°ããã¯ã¬ã³ã¬ã³åã蟌ãã§ãã ãã£ãã®ã§ãå ã CLINICS ã®éçºããã£ãŠãã®ã§ã¯ãšæãããããã£ããã¢ãããæ©ãã£ãã§ãã ââ ãããã¯ãã®ã°ããŒã¹ã®ããã«ãªãœãŒã¹èª¿æŽãæåããããšãã圢ã ã£ããã§ããããããã¯ãéã®è¶å¢ããããããããªæåã ã£ããããããžã§ã¯ããæåãããããšããç®ç·åãããèªç¶ã«ã§ããã®ã¯è¯ãã§ããã ããŒã éãšãã話ã§ããã° QA ã¯åããŒã ã«è·šã£ãŠã®æŽ»åã ãšæããŸããããã®èгç¹ã§ã¯ãããã§ãã? å°å³¶ : èªåã¯éçºãçµç€ã«å ¥ã£ãã¿ã€ãã³ã°ã§ãããžã§ã¯ãã«åæµããŸããããããŸã§ã¯ç±³å±±ããã QA ãšããŠå ¥ã£ãŠããã®ã§ãããå»ç§åŽã§ãæ€èšŒãã¹ããã¹ã芳ç¹ã倿°ãã£ãèæ¯ããããå»ç§åŽã® QA ãã¡ã€ã³ã§èŠãæ åœãšããŠåç»ããŸããã åŸåã«åç»ããèæ¯ããããããããåŠæ¹ç®éä»ãšããæ¥åã Pharms ãããã¯ãã®ä»æ§çè§£ãæµ ãâŠãšããç¶æ ã§ãããã éçºç®çã»èŠä»¶å®çŸ©ã»èšèšã詳现ã«ããã¥ã¡ã³ãåãããŠããã®ã§ãã¹ã ãŒãºã«æ€èšŒã«å ¥ãããšãã§ããŸãã ãæ€èšŒã®äžã§ QA ãšã³ãžãã¢ãšããŠãããã®éšåã®ä»æ§ã¯èŠçŽããæ¹ãè¯ããªãããšãããã€ã³ããããã€ãåºãŠããã®ã§ã仿§ã®æ¹åææ¡ãè¡ããŸãããåŸçºåå ã§ããããå®éã«åãå ¥ããŠããã£ãæ¹åãå€ãã§ãã ã¡ãã¬ãŒã®ãããã¯ãéçºã®æåãšã㊠QA ãšã³ãžãã¢ã èŠä»¶å®çŸ©ããã¬ãã¥ãŒã«åå ããããæèŠãèšãã€ã€ãããã¯ããããè¯ãããããã®æ¹åãè¡ãã ã®ã§ããšãŠãåããããã§ããã ââ åŸããå ¥ã£ãŠãåãããããšããã®ã¯ãããã¥ã¡ã³ããªã©ãæŽåãããŠããããã§ããããšã ãšããã®ãåãããŸãããæšªæãããžã§ã¯ãã ããããæ°ãã€ããä»ã®ããŒã ã®è¯ãç¹ãªã©ãã£ããããŸãã? é äº : Pharms ã®ãããžã§ã¯ãã£ãŠããããããªããšæã£ãã®ã KPI èšèšããããæç¢ºãªãšããã ã£ããšããç¹ã§ããã è²ã çŽäœæ²æãã£ãçµæããã«èŸ¿ãçããŠããšããèŠåŽãç¥ã£ãŠã¯ãããã§ããã©ãä»ã® KPI èšèšã£ãŠãã£ã±ããããã·ã³ãã« ã§åŠæ¹ç®éä¿¡æ°ã§ããšãªããšãããããéç®ãã KPI ãå PF ã«æ¯ãã°ãããšèšãäœå¶ã ã£ãã®ã§ããããããã¯ãããããã£ããã€ã³ãã®äžã€ããªãšæããŸãã 話ãè«ç¹ãçµå±ããã£ãŠããéšåããããã³ãã¥ãã±ãŒã·ã§ã³ã³ã¹ããå®ãããã éšåã§ã¯ããããªãšæããŸããã æšªæãããžã§ã¯ããªãã§ã¯ã®ãšã³ãžãã¢ãªã³ã° ââ å šäœã®è©±ããåå¥ã®ãã¡ã€ã³ããšã®ãšã³ãžãã¢ãªã³ã°ãšããç¹ã§ã¯ã©ã®ãããªããšããããŠããŸããã? å°ç° : åºæ¬çã«ã¯æéЬããã®ã·ãŒã±ã³ã¹å³ãå ã«éçºãé²ããŠããŸãããCLINICS ã§ã¯ A ãšããç¶æ ã«ãªãããã®æã« B ãšããã¢ã¯ã·ã§ã³ããããš Pharms ã§ã¯ C ãšããç¶æ ã«ãªããšããããã«ç¶æ é·ç§»ãè€éã ã£ããããèšèšæã«ããã¹ãå§¿ã«è¿·ãããšãå€ãã£ãã®ã§ãããã·ãŒã±ã³ã¹ã«ç«ã¡è¿ããšããã«ãã®çåã解決ãããšãã£ãå ·åã§ãã æéŠ¬ : ã·ãŒã±ã³ã¹ã®æŽåæ§ãé£ãããªããããªãããã«èšèšãã ããšã«ã¯æ°ãã€ããŸããããåæäºçŽããšããèšèãå è¡ãããšã€ãã€ãè€éãªæ°æ©èœã®ãããªãã®ãäœããã¡ã§ããã蚺çæãè¬å±ã®äºçŽæ©èœãåŠæ¹ç®éä¿¡æ©èœãšãã£ãåã ã®ããŒãã¯ããšããšããããã§ããªãã¹ãã·ã³ãã«ã«ããããã€ãªãåãããããããã«å¿ãããŸããã æ±è€ : 现ãããããã¯ãéã®èª¿æŽãå¿ èŠã«ãªãã®ã§ ã¡ãããšèª¿å€ã®æ¬²ãã KPI ãæ±ãã€ã€ããã€çŸå Žã®ãªãã¬ãŒã·ã§ã³å質ãèœãšããªãã£ãŠãã芳ç¹ã§èª¿æŽãåãã¡ã€ã³ã§ãããŸããã 工倫ããããšã§ãããšãUX 調æ»ã培åºãããšããã§ããããã ä»åã®ãµãŒãã¹ã£ãŠæ¥ççã«ã¿ãæã«æ°ããããšãããšããã§ã¯ãªããã§ããããã§ãã®ã§ã忥çã®äŒæ¥ããã®åã¢ããªã®äœéšãšããèªåã§ãçµæ§è²ã 䜿ããªããäœéšããŠã¿ãŸããããããããããŒã¹ã«éã«çŸç¶ã®ãã¡ã®ä»æ§ãèžãŸãããšããããã颚ã«ãã¡ã§ã¯å®è£ ããŸãããã¿ãããªãšãããè²ã ãã£ãŠããŸããã å°ç° : ãšã³ãžãã¢ãªã³ã°ã®èгç¹ã§ãããšãç¹ã«æ£è ã¢ããªããŒã ãšã® API 飿ºã®ä»æ§èª¿æŽãšãéçºã®é²ãæ¹ã¯å¯ã«é£æºããªããé²ããŸãããå ã«ãã£ã¡ãã§ããŠãªããšåãããéçºã§ããªãç¶æ ã«ãªãã®ã§ãæ åœè å士ã§ã³ãã¥ãã±ãŒã·ã§ã³ãšãã€ã€ã工倫ããªããé²ããŠããŸããã é äº : CLINICS ã§æ°ã«ããŠãéšåã¯ã©ã¡ãããšãããš ãªã¹ã¯ãšã³ã¹ãã®éšåãããã«æå°åããŠäŸ¡å€ãæå€§åããããäžçªéèŠ ããªãšæã£ãŠããã®ã§ãäžçªå€§äºãªã®ã¯ãã£ã±ãå»ç§ã«ãšã£ãŠã©ããã䟡å€ãåºãŠãå»ç§ã«ãšã£ãŠã©ããããªã¹ã¯ãçºçããããèããŠãŸããã äŸãã°äžçªæåã®ããåããã§è¬å±äºçŽããæã«æ¥æãŸã§ç¢ºå®ãããŸããããšãã話ããã£ããã§ããã©ããããŸã§ã¹ã³ãŒããåºããªããŠãã¡ãªãããåºãã®ã§ããã°ãåºããããªãã§ããšãã話ãããŠããŸããã ããšã¯ãªãªãŒã¹ãã©ã³ã®çå®ãšãããªïŒå šå»çæ©é¢ã«äžæã«åºãã®ã§ã¯ãªãããŸãã¯äžéšå»çæ©é¢æ§ã ãã«å ¬éãããªãªãŒã¹æ¹åŒã«ããŸãããã¿ãããªãšãããå«ããŠã§ããããå»ç§åŽã§äžæŠãã¹ãããã£ãŠæ€èšŒããŠãã¹ã ãŒãºã«æ©èœã䜿ãããšããã確èªãããããã¹ããããèšããŸããããšå®å šçãåããªããé²ããŸããã ããã¯ãã®ãããžã§ã¯ãã«é¢ããããã©ããªãããžã§ã¯ãã§ãäžçªéèŠã§ãããåŸããã²ã£ããè¿ãã®ãäžçªææ»ãã«ãªã£ãŠããã®ã§ãããã¯éèŠããªãšæããªããé²ããŠãŸãããã å°å³¶ : QA èŠç¹ã ãšæšªæãããžã§ã¯ãããã«ã¹ããŒããæ¬åœã«è€éã§ãã¡ãã¬ãŒå ¥ç€ŸåŸã«çµéšãããããžã§ã¯ãã®äžã§æ€èšŒã®é£æåºŠãæãé«ãã£ãã§ããã ã§ãããçããä»°ãããŠããããã«åãŠãŒã¹ã±ãŒã¹ã«å¯Ÿããèšèšãå³ã§ããã¥ã¡ã³ãåãããŠããã®ã§ããã¹ãã±ãŒã¹ãšããŠè»¢çšã§ããéšåãå€ããããŸãããæéЬãããäœæããèšèšå³ããã£ãããããæŒããªããã¹ãã§ããéšåã¯å€§ããã§ãã倧å¢ãåå ãããããžã§ã¯ãã«ãããŠãå šå¡ãèªèåãããäžã§ãèšèšå³ã¯æ¬åœã«å€§äºã ãªãšçæããŸããã 工倫ããç¹ãšããŠã¯ãå°ç°ãã㯠Pharms éçºã®ãã¡ã€ã³ç¥èãè±å¯ã ã£ãã®ã§ãQA æã¯ Pharms åŽãã¡ã€ã³ã«èŠãŠãããã€ã€ãèªå㯠CLINICS åŽã® QA ãæåãèŠãããã«ããŸãããã©ã¡ãã®ãã¡ã€ã³ã«ãé¢ä¿ããå¥çŽãã©ã³çã®è€éãªä»æ§ã¯èªåãæ åœããŸããã QA 以å€ã®é¢ã ãšããªãªãŒã¹ããäžã§å¿ èŠãªæµ®ããããŒã«ãããã°ç©æ¥µçã«åãã«ããããã«ããŸããã äŸãã°ããããŸã§äžéšã®å»çæ©é¢æ§ã ãã«æ©èœãªãªãŒã¹ããå Žåããã®åŸã®ãã£ãŒãããã¯ååã¯ã¡ãŒã«ãé¢è«ã§åå¥ã«è¡ã£ãŠããŸããããæ¥ã ã®èšºçã®äžã§ãæéã確ä¿é ãã®ãé£ãããšããç¶æ³ããããŸããããã®çµæãæ¬ Pj ã«ãããŠãå šäœãªãªãŒã¹ããŠåé¡ãªããïŒã®å€æããã¥ããææããããŸããã ããã§ Google ãã©ãŒã ã§ã¢ã³ã±ãŒããäœæããŠçæéã§åçã§ãã圢ã«åãæ¿ããŸãããçµæçã« 100% åçãåŸãããšãã§ããŸããã ã¢ã³ã±ãŒãçµæãããåŸæ¥æ©èœãã䟡å€ããããé¢å ãªãã¬ãŒã·ã§ã³ã«çµã¿èŸŒãã§é ãã³ã¹ãããããŸã§é«ããªãããšããç¹ãè©äŸ¡ã§ããã®ã§ãèªä¿¡ãæã£ãŠå šäœå ¬éãªãªãŒã¹ã«åã㊠GO å€å®ã§ããŸããã** ã¡ãã¬ãŒã¯åœ¹å²ã«çžãããããŒã«ãä»»ããŠé ããç°å¢ãããã®ã§ãèªåã®å°éé å以å€ã®ããšãåŠã¹ãŠãã**ãšæãããšãå€ãã§ãã 幞ããªãªãŒã¹åŸã倧ããªäžå ·åã¯ãªãã®ã§ããã¯ããçããã®ãããã§ããã åæäºçŽ Pj ãçµã㊠ââ ã§ã¯æåŸã«ãã®ãããžã§ã¯ãã®ç·æ¬ãããŠãã ããã°ã æ±è€ : 暪æã§ã¯ãããã©åãã¡ã€ã³ã§ããããã®ãããã§ãã·ã§ãã«ãã¡ãããšåãçºæ®ããŠãããžã§ã¯ããããåãããšããã®ã¯ããã倧ããè³ç£ã§ããã å»ç PF ã¯ã¢ã»ãããããããæã£ãŠããã®ã§ãè²ã çµã¿åããããšãä»ã®äŒç€Ÿã ãšã§ããªããã©ããã¡ãªãã§ãããã ããã¿ãããªããšãè²ã ãã ãã§ãã ãªã®ã§ããã®åŸã暪æãããžã§ã¯ãã¯äºå®ãããŠããŸãããããã«å é§ããŠã²ãšã€ãããã£ãŠããã€åããæ¬²ããã£ãæåŸ ææãçŸç¶åºããŠãããšãããå«ãããšãããè¯ãäžæ©ã ã£ãã®ããªããšæã£ãŠãŸãã æ¬¡ã¯åè³ªãæ ä¿ãã€ã€ããã£ãšã¹ããŒããäžããŠãããããšããã®ã芳ç¹ãšããŠå€§ããã§ããã ââ ãªãã»ã©ãããããæšªæãããžã§ã¯ãããã£ãŠããå»ç PF ã§ã¯ã©ããªãšã³ãžãã¢ãããããããã€ã³ãã§ããã? æéЬ : æè¡ãšäœµããŠãŠãŒã¶ãŒãžã®äŸ¡å€æäŸãèããªãããšã³ãžãã¢ãªã³ã°ããã人ããããããã®ã§ã¯ãªãããšæããŸãã ââ åãããã¯ãã®æã£ãŠãã圹å²ãèžãŸããŠã俯ç°ã®èŠç¹ã§éçºãããããšããæ¹ã«ã¯ãããé åçã§ãããæ¬æ¥ã¯ããããšãããããŸããã ãããã« åæäºçŽ Pj ã«ã€ããŠããããžã§ã¯ããæšé²ããã¡ã³ããŒã«è©±ãèããŸããããè€éãªèŠä»¶ãå®çŸå¯èœãªåœ¢ã«ããŠåããŒã ã§å£æ ¹ãè¶ããŠéçºãããŠããæ§åããšãŠãå°è±¡çã§ãããç¹ã«å»ç PF ã§ã¯ãã¡ã€ã³åå£«ã§ææ©çã«çµåããŠãããã³ã©ãã¬ãŒã·ã§ã³ããããšã«ããã¹ããŒã¯ãã«ããŒãžã®äŸ¡å€ãé«ããŠãããšããã®ã¯ããããããããã®ã§ã¯ãªãããšæããŸãã ãã®ãããªãããžã§ã¯ãã§åãçºæ®ããããšæã£ãæ¹ã¯ãã²ããæ°è»œã«ã話ãããŸããã! åéã®äžèЧ | æ ªåŒäŒç€Ÿã¡ãã¬ãŒ ã¡ãã¬ãŒã®æ¡çšæ å ±ã¯ãã¡ãããã確èªãã ããã www.medley.jp
æ ªåŒäŒç€Ÿã¡ãã¬ãŒ
1
More pages
11
12
13
14
15
More pages
71
ã³ã³ãã³ã
ããã
ã€ãã³ã
ããã°
ã°ã«ãŒãã«é¢ãããåãåãã